<SEC-DOCUMENT>0001193125-25-116509.txt : 20250509
<SEC-HEADER>0001193125-25-116509.hdr.sgml : 20250509
<ACCEPTANCE-DATETIME>20250509090941
ACCESSION NUMBER:		0001193125-25-116509
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20250703
FILED AS OF DATE:		20250509
DATE AS OF CHANGE:		20250509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Alaunos Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001107421
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				841475642
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33038
		FILM NUMBER:		25928598

	BUSINESS ADDRESS:	
		STREET 1:		2617 BISSONNET ST
		STREET 2:		SUITE 233
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77005
		BUSINESS PHONE:		(346) 355-4099

	MAIL ADDRESS:	
		STREET 1:		2617 BISSONNET ST
		STREET 2:		SUITE 233
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZIOPHARM ONCOLOGY INC
		DATE OF NAME CHANGE:	20050919

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EASYWEB INC
		DATE OF NAME CHANGE:	20010213
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>d921291dpre14a.htm
<DESCRIPTION>PRE 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:tcrt="http://www.alaunos.com/20241231" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>PRE 14A</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="line-height:normal;background-color:white;"><div style="display: none"><ix:header><ix:hidden><ix:nonNumeric name="dei:DocumentType" id="hidden140659358" contextRef="P01_01_2024To12_31_2024">PRE 14A</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="P01_01_2024To12_31_2024" id="ixv-5709">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P01_01_2024To12_31_2024" id="ixv-5710">0001107421</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="tcrt-20241231.xsd"/></ix:references><ix:resources><xbrli:context id="P01_01_2024To12_31_2024"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_MrhogueMemberecdIndividualAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrhogueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_MrhogueMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrhogueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_MrhogueMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrhogueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_NonPeoNeoMemberecdExecutiveCategoryAxis_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_MrboyleMemberecdIndividualAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To12_31_2023_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecdAdjToCompAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:unit id="Unit_USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit></ix:resources></ix:header></div><div><div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 18pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">UNITED STATES </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 18pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">SECURITIES AND EXCHANGE COMMISSION </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Washington, DC 20549 </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 18pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="-sec-ix-hidden:hidden140659358;display:inline;">SCHEDULE 14A</div> </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">(Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">14a-101)</div> </div></div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 12pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">INFORMATION REQUIRED IN PROXY STATEMENT </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">SCHEDULE 14A INFORMATION </div></div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 12pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Proxy Statement Pursuant to Section&#160;14(a) of the </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Securities Exchange Act of 1934 </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the Registrant&#8194;&#9746; </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a Party other than the Registrant&#8194;&#9744; </div><div style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9746;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Preliminary Proxy Statement </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9744;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Confidential, for Use of the Commission Only (as permitted by Rule <div style="white-space:nowrap;display:inline;">14a-6(e)(2))</div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div> </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9744;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Definitive Proxy Statement </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9744;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Definitive Additional Materials </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9744;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Soliciting Material Pursuant to &#167; <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">240.14a-12</div> </div></td></tr></table><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 18pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P01_01_2024To12_31_2024" id="ixv-5957">Alaunos Therapeutics, Inc.</ix:nonNumeric> </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">(Name of Registrant as Specified in Its Charter) </div></div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) </div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9746;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">No fee required. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9744;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Fee paid previously with preliminary materials. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9744;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">14a-6(i)(1)</div> and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">0-11.</div> </div></td></tr></table></div></div></div></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">2617 Bissonnet, Suite 233 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Houston, TX 77005 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">To be Held on July 3, 2025 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[&#9679;], 2025 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the stockholders of Alaunos Therapeutics, Inc.: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We cordially invite you to the 2025 annual meeting of stockholders (the &#8220;Annual Meeting&#8221;) of Alaunos Therapeutics, Inc. (&#8220;we,&#8221; &#8220;Alaunos&#8221; or the &#8220;Company&#8221;), which will be held virtually and exclusively online via live audio-only webcast, on July&#160;3, 2025, at 9:00 a.m. Eastern Time, for the following purposes: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">1.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To elect each of the four nominees for director named in the accompanying proxy statement (the &#8220;proxy statement&#8221;) to hold office until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified or, if sooner, until his or her earlier death, resignation or removal (&#8220;Proposal 1&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">2.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To ratify the selection of Cherry Bekaert LLP as the independent registered public accounting firm of the Company for its fiscal year ending December&#160;31, 2025 by the audit committee (the &#8220;audit committee&#8221;) of the board of directors of the Company (the &#8220;Board&#8221;) (&#8220;Proposal 2&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">3.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers as disclosed in the proxy statement (&#8220;Proposal 3&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">4.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve the Second amendment and restatement of the Company&#8217;s amended and restated certificate of incorporation, as amended (our &#8220;Charter&#8221;), in substantially the form attached to the proxy statement as Annex A, to, at the discretion of the Board, effect a reverse stock split with respect to the Company&#8217;s issued and outstanding common stock, par value $0.001 per share, including stock held by the Company as treasury shares, at a reverse stock split ratio of <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-5</span></span> to <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-20,</span></span> inclusive (&#8220;Proposal 4&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">5.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve the Certificate of Amendment to the Company&#8217;s Charter, in substantially the form attached to the proxy statement as Annex B, to, at the discretion of the Board, increase the number of shares of common stock authorized for issuance thereunder from 5,000,000 shares to 50,000,000 shares (&#8220;Proposal 5&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">6.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve an amendment to the Company&#8217;s 2020 Equity Incentive Plan to increase the number of shares that the Company may issue under the Plan from 130,745 shares to 1,130,745 shares (&#8220;Proposal 6&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">7.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve a proposal to adjourn the Annual Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Proposals in the proxy statement (&#8220;Proposal 7&#8221;); and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">8.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To transact any other business as may properly come before the Annual Meeting or any adjournments thereof. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These items of business are more fully described in the proxy statement accompanying this notice. The proxy statement accompanying this notice is being issued in connection with the solicitation by the Board of a proxy on the enclosed form of proxy card for use at the Annual Meeting. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be able to attend and participate in the Annual Meeting online, submit your questions during the Annual Meeting and vote your shares electronically during the meeting by visiting www.virtualshareholdermeeting.com/TCRT2025. <span style="font-weight:bold">Because the Annual Meeting is being held electronically, you will not be able to attend the Annual Meeting in person.</span></p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The record date for the Annual Meeting is May&#160;5, 2025. Only stockholders of record at the close of business on that date may vote at the Annual Meeting or any adjournment or postponement thereof. To participate in and vote at the Annual Meeting, stockholders will need the unique <span style="white-space:nowrap">16-digit</span> control number (printed in the box marked by the arrow) in their Notice of Internet Availability of Proxy Materials or proxy card (if you requested a printed copy of the proxy materials). </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border-spacing:0;margin-left:auto">


<tr>

<td style="width:100%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By Order of the Board of Directors,</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">/s/ Melinda Lackey</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Melinda Lackey</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Legal and Administration; Secretary</span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Houston, Texas</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[&#9679;], 2025</p></td></tr>
</table></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Your vote is very important. Whether or not you attend the Annual Meeting virtually, it is important that your shares be represented. You may vote your proxy through the Internet, by telephone or, if you receive a paper proxy card by mail, by completing and returning the proxy card mailed to you. Voting instructions are provided in the Notice of Internet Availability of Proxy Materials, or, if you receive a paper proxy card by mail, the instructions are printed on your proxy card and included in the proxy statement. If you participate virtually in the Annual Meeting, you may vote at that time, even if you previously submitted your vote. Even if you plan to participate in the Annual Meeting, we urge you to vote as soon as possible over the internet, by telephone or by mail as described in the proxy statement. </span></p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc">Table of Contents </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:97%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_1">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_2">PROPOSALS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">9</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_3">Proposal 1 Election of Directors</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">9</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_4">Proposal 2 Ratification of Selection of Independent Registered Public Accounting Firm</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_5">Proposal 3 Advisory Vote on Executive Compensation</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">13</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_6">Proposal 4 Approval of the Second Amended and Restated Certificate of Incorporation to Effect a Reverse Stock Split of Common Stock</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">14</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_7">Proposal 5 Approval of the Certificate of Amendment to our Charter to Increase our Authorized Stock</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">24</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_7a">Proposal 6 Amendment of Equity Incentive Plan</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">27</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_8">Proposal 7 Adjournment of Annual Meeting</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">40</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_9">STOCKHOLDER PROPOSALS FOR THE 2026 ANNUAL MEETING OF STOCKHOLDERS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">41</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_10">CURRENT DIRECTORS, DIRECTOR NOMINEES AND EXECUTIVE OFFICERS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">43</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_11">EXECUTIVE COMPENSATION</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">47</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_12">Summary Compensation Table</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">47</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_13">Narrative to the Summary Compensation Table</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">49</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_15">Role of our Compensation Committee, Management and Consultant</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_16">Outstanding Equity Awards at 2024 Fiscal <span style="white-space:nowrap">Year-End</span></a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">52</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_17">Stockholder Engagement</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">52</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_14">Pay Versus Performance</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">52</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_18">INFORMATION REGARDING THE BOARD AND CORPORATE GOVERNANCE</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">55</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_19">Independence of the Board</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">55</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_20">Board Leadership Structure</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">55</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_21">Director Attendance at Board and Stockholder Meetings</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">55</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_22">Board Committees</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">55</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_23">Director Nomination Process</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">57</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_24">Risk Management and Oversight</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">58</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_25">Stockholder Communications with Directors</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">58</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_26">Code of Ethics and Business Conduct</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">58</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_27">Corporate Governance Guidelines</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">58</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_28">Whistleblower Policy</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">59</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_29">Corporate Governance Documents</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">59</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_30">Report of the Audit Committee</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">59</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_31">DIRECTOR COMPENSATION</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">60</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_32"><span style="white-space:nowrap">Non-Employee</span> Director Compensation</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">60</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_33">Director Compensation Table</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">60</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_35">LIMITATION OF LIABILITY AND INDEMNIFICATION</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">61</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_36">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">62</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_37">Related-Party Transaction Policy</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">62</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_38">Certain Related-Party Transactions</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">62</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_39">DELINQUENT SECTION 16(A) REPORTS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">64</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_40">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">65</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_41">HOUSEHOLDING OF PROXY MATERIALS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">67</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc921291_42">OTHER MATTERS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">68</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">i </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Alaunos Therapeutics, Inc. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">2617 Bissonnet, Suite 233, </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Houston, TX 77005 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">PROXY STATEMENT </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">FOR THE ANNUAL MEETING OF STOCKHOLDERS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">To Be Held On July&#160;3, 2025 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_1">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Who is soliciting my vote? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are providing you with these proxy materials because the board of directors (the &#8220;Board&#8221;) of Alaunos Therapeutics, Inc. (&#8220;we,&#8221; &#8220;Alaunos&#8221; or the &#8220;Company&#8221;) is soliciting your proxy to vote at the 2025 annual meeting (the &#8220;Annual Meeting&#8221;), including at any adjournments or postponements thereof. The Annual Meeting will be held on July&#160;3, 2025 at 9:00 a.m., Eastern Time virtually and exclusively online via live audio-only webcast at www.virtualshareholdermeeting.com/TCRT2025. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Why did I receive a notice regarding the availability of proxy materials through the internet? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to rules adopted by the Securities and Exchange Commission (the &#8220;SEC&#8221;), we have elected to provide access to our proxy materials over the internet. Accordingly, we have sent you a Notice of Internet Availability of Proxy Materials (the &#8220;Notice&#8221;) because the Board is soliciting your proxy to vote at the Annual Meeting, including at any adjournments or postponements thereof. All stockholders will have the ability to access the proxy materials through the website referred to in the Notice or to request a printed set of the proxy materials. Instructions on how to access the proxy materials over the internet or to request a printed set of the proxy materials may be found in the Notice. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to mail the Notice on or about May&#160;23, 2025 to all stockholders of record entitled to vote at the Annual Meeting. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Will I receive any other proxy materials by mail? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may send you a proxy card, along with a second Notice, on or about May&#160;23, 2025. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How do I attend the Annual Meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You cannot attend the Annual Meeting physically. You can attend the Annual Meeting by visiting www.virtualshareholdermeeting.com/TCRT2025, where you will be able to listen to the Annual Meeting live, submit questions and vote online. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Annual Meeting will start at 9:00 a.m. Eastern Time on July&#160;3, 2025. We encourage you to access the Annual Meeting prior to the start time to allow time for online <span style="white-space:nowrap">check-in.</span> We have worked to offer the same participation opportunities as would be provided at an <span style="white-space:nowrap">in-person</span> meeting while further enhancing the online experience available to all stockholders regardless of their location. However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet access providers and telephone companies. If you experience technical difficulties during the Annual Meeting, you should call the technical support phone number provided when you log in to the Annual Meeting. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to enter the Annual Meeting virtually, you will need the unique <span style="white-space:nowrap">16-digit</span> control number, which is included in the Notice or on your proxy card if you are a stockholder of record of the shares, or included with your voting instruction card and voting instructions received from your broker, bank, trustee, or nominee if you are the beneficial owner of the shares held in &#8220;street name.&#8221; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What if I cannot virtually attend the Annual Meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may vote your shares electronically before the meeting by internet, by proxy or by telephone as described below. You do not need to access the Annual Meeting audio-only webcast to vote if you submitted your vote via proxy, by internet or by telephone in advance of the Annual Meeting. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Who can vote at the Annual Meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Only stockholders of record at the close of business on May&#160;5, 2025 (the &#8220;Record Date&#8221;) will be entitled to vote at the Annual Meeting. On the Record Date, there were 1,639,521 shares of common stock outstanding and entitled to vote. A list of such holders will be open to the examination of any stockholder for any purpose germane to the Annual Meeting at Alaunos Therapeutics, Inc., 2617 Bissonnet, Suite 233, Houston, TX 77005 for a period of 10 days prior to the Annual Meeting. Please contact the Secretary of the Company to make arrangements to inspect the list. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stockholder of Record&#8212;Shares Registered in Your Name:</span> If on May&#160;5, 2025, your shares were registered directly in your name with our transfer agent, Equiniti Trust Company (&#8220;EQ&#8221;), then you are a stockholder of record. As a stockholder of record, you may vote at the Annual Meeting virtually or vote by proxy prior to the Annual Meeting. Whether or not you plan to attend the Annual Meeting, we urge you to vote by proxy through the internet, by telephone or using a proxy card that you may request as instructed below, to ensure your vote is counted. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Beneficial Owner&#8212;Shares Registered in the Name of a Broker or Bank:</span> If on May&#160;5, 2025, your shares were not registered in your name, but instead are held in an account at a brokerage firm, bank, dealer or similar organization, then you are the beneficial owner of shares held in &#8220;street name&#8221; and the Notice is being forwarded to you by that organization. The organization holding your account is considered to be the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker, bank or other agent regarding how to vote the shares in your account. You are also invited to attend the Annual Meeting. Since you are not the stockholder of record, however, you may not vote your shares at the Annual Meeting even if you participate virtually unless you request and obtain a valid proxy from your broker, bank or other agent. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What am I voting on? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are six matters scheduled for a vote: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">1.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To elect each of the four nominees for director named in this proxy statement (the &#8220;proxy statement&#8221;) to hold office until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified or, if sooner, until his or her earlier death, resignation or removal (&#8220;Proposal 1&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">2.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To ratify the selection of Cherry Bekaert LLC as the independent registered public accounting firm of the Company for its fiscal year ending December&#160;31, 2025 by the audit committee (the &#8220;audit committee&#8221;) of the Board (&#8220;Proposal 2&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">3.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers as disclosed in the proxy statement (&#8220;Proposal 3&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">4.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve the amendment and restatement of the Company&#8217;s third amended and restated certificate of incorporation, as amended (our &#8220;Charter&#8221;), in substantially the form attached to the proxy statement as Annex A, to, at the discretion of the Board, effect a reverse stock split with respect to the Company&#8217;s issued and outstanding common stock, par value $0.001 per share, including stock held by the Company as treasury shares, at a reverse stock split ratio of <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-5</span></span> to <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-20,</span></span> inclusive (&#8220;Proposal 4&#8221; or the &#8220;Reverse Stock Split Proposal&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">5.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve an amendment to the Company&#8217;s Charter, in substantially the form attached to the proxy statement as Annex B, to, at the discretion of the Board, increase the number of shares of common stock authorized for issuance thereunder from 5,000,000 shares to 50,000,000 shares (&#8220;Proposal 5&#8221; or the &#8220;Authorized Stock Increase Proposal&#8221;); </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">6.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve an amendment to the Company&#8217;s 2020 Equity Incentive Plan to increase the number of shares that the Company may issue under the Plan from 130,745 shares to 1,130,745 shares (&#8220;Proposal 6&#8221; or the &#8220;EIP Amendment Proposal&#8221;); and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">7.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve a proposal to adjourn the Annual Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal 4 and Proposal 5 (&#8220;Proposal 7&#8221; or the &#8220;Adjournment Proposal&#8221;). </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How does the Board recommend that I vote? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board unanimously recommends that you: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Vote your shares &#8220;FOR&#8221; Proposal 1 </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Vote your shares &#8220;FOR&#8221; Proposal 2 </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Vote your shares &#8220;FOR&#8221; Proposal 3 </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Vote your shares &#8220;FOR&#8221; Proposal 4 </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Vote your shares &#8220;FOR&#8221; Proposal 5 </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Vote your shares &#8220;FOR&#8221; Proposal 6 </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Vote your shares &#8220;FOR&#8221; Proposal 7 </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What if another matter is properly brought before the Annual Meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the Annual Meeting, it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with their best judgment. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How do I vote? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With respect to Proposal 1, you may vote &#8220;For&#8221; all the nominees to the Board, or you may &#8220;Withhold&#8221; your vote for any of the nominees you specify. With respect to the other proposals, you may vote &#8220;For&#8221; or &#8220;Against,&#8221; or you may abstain from voting. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The procedures for voting are fairly simple: </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stockholder of Record&#8212;Shares Registered in Your Name:</span> If you are a stockholder of record, you may vote electronically over the internet before or during Annual Meeting, vote by proxy over the telephone, vote by proxy through the internet, or vote by proxy using a proxy card that you may request or that we may elect to deliver at a later time. Whether or not you plan to attend the virtual Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the Annual Meeting virtually and vote electronically at the Annual Meeting even if you have already voted by proxy. You may vote as follows: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">To vote through the internet before the Annual Meeting, go to www.proxyvote.com to complete an electronic proxy card. You will be asked to provide the <span style="white-space:nowrap">16-digit</span> control number from the Notice. Your vote must be received by 11:59 p.m. Eastern Time, on July&#160;2, 2025 to be counted. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">To vote your shares electronically at the Annual Meeting, you will need to visit www.virtualshareholdermeeting.com/TCRT2025 during the Annual Meeting while the polls are open and follow the instructions provided on the Notice or the proxy card. You will be asked to provide the control number from the notice and follow the instructions. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">To vote over the telephone from a location in the United States, dial toll-free <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">1-800-690-6903,</span></span></span> using a touch-tone phone and follow the recorded instructions. You will be asked to provide the <span style="white-space:nowrap">16-digit</span> control number from the Notice. Your vote must be received by 11:59 p.m. Eastern Time, on July&#160;2, 2025 to be counted. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">To vote using a proxy card, you may request a proxy card by following the instructions in the Notice. Once you receive the proxy card, simply mark, sign, and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Beneficial Owner&#8212;Shares Registered in the Name of a Broker or Bank:</span> If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received a Notice containing voting instructions from that organization rather than from us. Simply follow the voting instructions in the Notice to ensure that your vote is counted. To vote electronically at the Annual Meeting, you must obtain a valid proxy from your broker, bank or other agent. Follow the instructions from your broker, bank or other agent included with these proxy materials, or contact your broker, bank or other agent to request a proxy form. You can also visit www.proxyvote.com, call <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">1-800-454-8683,</span></span></span> or return the voting instruction form in the enclosed postage-paid envelope. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We provide Internet proxy voting to allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet access providers and telephone companies. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How many votes do I have? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On each matter to be voted upon, you have one vote for each share of our common stock you own as of the Record Date. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">If I am a stockholder of record and I do not vote, or if I return a proxy card or otherwise vote without giving specific voting instructions, what happens? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a stockholder of record and do not vote by completing your proxy card, by telephone, through the internet or by voting electronically at the Annual Meeting, your shares will not be voted. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted, as applicable, &#8220;For&#8221; the election of all four nominees for director, &#8220;For&#8221; the ratification of the selection by the audit committee of Cherry Bekaert LLC as our independent registered public accounting firm for our fiscal year ending December&#160;31, 2025, &#8220;For&#8221; the approval, on an advisory basis, of the compensation of our named executive officers as disclosed in this proxy statement, &#8220;For&#8221; the approval of the Reverse Stock Split Proposal, &#8220;For&#8221; the Authorized Stock Increase Proposal, &#8220;For&#8221; the amendment of our Equity Incentive Plan, and &#8220;For&#8221; the Adjournment Proposal. If any other matter is properly presented at the Annual Meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares using his or her best judgment. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">If I am a beneficial owner of shares held in street name and I do not provide my broker or bank with voting instructions, what happens? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a beneficial owner of shares held in street name and you do not instruct your broker, bank or other agent how to vote your shares, your broker, bank or other agent may still be able to vote your shares in its discretion on certain &#8220;routine&#8221; proposals. Under the rules of the New York Stock Exchange (&#8220;NYSE&#8221;), brokers, banks and other securities intermediaries that are subject to NYSE rules may use their discretion to vote your &#8220;uninstructed&#8221; shares with respect to matters considered to be &#8220;routine&#8221; under NYSE rules, but not with respect to <span style="white-space:nowrap">&#8220;non-routine&#8221;</span> matters. Proposals 1, 3 and the EIP Amendment Proposal are considered to be <span style="white-space:nowrap">&#8220;non-routine&#8221;</span> under NYSE rules, meaning that your broker, bank or other agent may not vote your shares on those proposals in the absence of your voting instructions. However, Proposal 2, the Reverse Stock Split Proposal, the Authorized </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Stock Increase Proposal and the Adjournment Proposal are considered to be &#8220;routine&#8221; matters under NYSE rules, meaning that if you do not return voting instructions to your broker, bank or other agent by its deadline, your shares may be voted by your broker, bank or other agent in its discretion on Proposal 2, the Reverse Stock Split Proposal, the Authorized Stock Increase Proposal and the Adjournment Proposal. Accordingly, if you own shares through a nominee, such as a broker, bank or other agent, please be sure to instruct your nominee how to vote to ensure that your vote is counted on all of the proposals. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If you are a beneficial owner of shares held in street name, in order to ensure your shares are voted in the way you would prefer, you must provide voting instructions to your broker, bank or other agent by the deadline provided in the materials you receive from your broker, bank or other agent. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What does it mean if I receive more than one Notice? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you receive more than one Notice, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on each Notice to ensure that all of your shares are voted. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Can I change my vote after submitting my proxy? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stockholder of Record: Shares Registered in Your Name </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Yes. You can revoke your proxy at any time before the final vote at the Annual Meeting. If you are the record holder of your shares, you may revoke your proxy in any one of the following ways: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">You may submit another properly completed proxy card with a later date (which automatically revokes the earlier proxy). </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">You may grant a subsequent proxy by telephone or through the internet. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">You may send a timely written notice that you are revoking your proxy to our Secretary at our principal executive offices at 2617 Bissonnet, Suite 233, Houston, TX 77005. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">You may attend the Annual Meeting virtually and vote electronically. Simply attending the Annual Meeting virtually will not, by itself, revoke your proxy. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Even if you plan to attend the Annual Meeting virtually, we recommend that you also submit your proxy or voting instructions or vote by telephone or through the Internet so that your vote will be counted if you later decide not to attend the Annual Meeting. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your most current proxy card, telephone proxy or internet proxy is the one that is counted. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Beneficial Owner: Shares Registered in the Name of Broker, Bank or Other Agent </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If your shares are held by your broker, bank or other agent as a nominee, you should follow the instructions provided by such broker, bank or other agent. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How are votes counted? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Votes will be counted by the inspector of election appointed for the Annual Meeting, who will separately count, for the proposal to elect directors (Proposal 1), votes &#8220;For,&#8221; &#8220;Withhold&#8221; and broker <span style="white-space:nowrap">non-votes;</span> and with respect to all other proposals, votes &#8220;For&#8221; and &#8220;Against,&#8221; abstentions and, if applicable, broker <span style="white-space:nowrap">non-votes.</span> Abstentions will have the same effect as &#8220;Against&#8221; votes on Proposal 2, Proposal 3 and the Adjournment Proposal, and will have no effect on Proposal 1, Proposal 4, Proposal 5 and proposal 6. Broker <span style="white-space:nowrap">non-votes</span> on Proposals 1, 3 and 6 will have no effect and will not be counted towards the vote total for those proposals. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What are &#8220;broker <span style="white-space:nowrap">non-votes&#8221;?</span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As discussed above, when a beneficial owner of shares held in street name does not give voting instructions to his or her broker, bank or other agent holding his or her shares as to how to vote on matters deemed to be <span style="white-space:nowrap">&#8220;non-routine,&#8221;</span> under the NYSE rules, the broker, bank or agent cannot vote the shares. These <span style="white-space:nowrap">un-voted</span> shares are counted as &#8220;broker <span style="white-space:nowrap">non-votes.&#8221;</span> Proposals 1, 3 and the EIP Amendment Proposal are considered to be <span style="white-space:nowrap">&#8220;non-routine&#8221;</span> under the NYSE rules and therefore we expect broker <span style="white-space:nowrap">non-votes</span> to exist in connection with those proposals. Broker <span style="white-space:nowrap">non-votes</span> will have no effect on those proposals. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">As a reminder, if you are a beneficial owner of shares held in street name, in order to ensure your shares are voted in the way you would prefer, you must provide voting instructions to your broker, bank or other agent by the deadline provided in the materials you receive from your broker, bank or other agent. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How many votes are needed to approve each proposal? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the minimum vote needed to approve each proposal and the effect of abstentions and broker <span style="white-space:nowrap">non-votes.</span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:7%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:34%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:33%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Proposal<br/>No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Proposal Description</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Vote Required for Approval</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Effect of <br/>Abstentions</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Effect of <br/>Broker <br/><span style="white-space:nowrap">Non-Votes</span></span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top">1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Election of directors</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Directors will be elected by a plurality of the votes cast by the holders of shares present or represented by proxy and entitled to vote on the election of directors. The four nominees receiving the most &#8220;For&#8221; votes will be elected as directors.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">No<br/>effect</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">No effect</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Ratification of the selection of Cherry Bekaert LLP as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2025</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The affirmative vote of a majority in voting power of shares of stock present in person or represented by proxy and entitled to vote thereon.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">Against</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">Not<br/>Applicable&#160;(1)</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top">3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Approval, on an advisory basis, of the compensation of our named executive officers</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The affirmative vote of a majority in voting power of shares of stock present in person or represented by proxy and entitled to vote thereon.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">Against</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">No effect</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Reverse Stock Split</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The votes cast &#8220;For&#8221; the amendment exceed the votes cast against the amendment.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">No<br/>effect</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">Not<br/>Applicable&#160;(1)</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top">5</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Authorized Stock Increase</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The votes cast &#8220;For&#8221; the amendment exceed the votes cast against the amendment.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">No<br/>effect</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">Not<br/>Applicable&#160;(1)</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">6</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">EIP Amendment</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The votes cast &#8220;For&#8221; the amendment exceed the votes cast against the amendment</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">No<br/>effect </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">No effect </td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top">7</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Adjournment</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The affirmative vote of a majority in voting power of shares of stock present in person or represented by proxy and entitled to vote thereon.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">Against</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">Not<br/>Applicable&#160;(1)</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Under NYSE rules, this proposal is considered to be a &#8220;routine&#8221; matter. Accordingly, if you hold your shares in street name and do not provide voting instructions to your broker, bank or agent that holds your </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="vertical-align:top;text-align:left">
shares, your broker, bank or other such agent has discretionary authority to vote your shares on this proposal. Any failure by a broker, bank or other agent to vote a share over which it exercises discretion will have the same effect as a vote against the proposal. </td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What is the quorum requirement? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if stockholders holding at least a majority in voting power of the outstanding shares entitled to vote are deemed present at the Annual Meeting in person or represented by proxy. On the Record Date, there were 1,639,521 shares outstanding and entitled to vote. Thus, the holders of 819,762 shares must be deemed present in person or represented by proxy at the Annual Meeting to have a quorum. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or agent) or if you vote electronically at the Annual Meeting. Abstentions and broker <span style="white-space:nowrap">non-votes</span> will be counted towards the quorum requirement. If there is no quorum, the holders of a majority of shares deemed present at the Annual Meeting in person or represented by proxy may adjourn the Annual Meeting to another date. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Who will serve as inspector of elections? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A representative of Broadridge Financial Solutions (&#8220;Broadridge&#8221;) will serve as inspector of elections and Broadridge will tabulate votes. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How can I find out the results of the voting at the Annual Meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Preliminary voting results will be announced at the Annual Meeting. In addition, final voting results will be published in a current report on Form <span style="white-space:nowrap">8-K</span> that we expect to file within four business days after the Annual Meeting. If final voting results are not available to us in time to file a Form <span style="white-space:nowrap">8-K</span> within four business days after the Annual Meeting, we intend to file a Form <span style="white-space:nowrap">8-K</span> to publish preliminary results and, within four business days after the final results are known to us, file an additional Form <span style="white-space:nowrap">8-K</span> to publish the final results. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What if I have questions for the Company&#8217;s transfer agent? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please contact EQ, at the phone number or address listed below, if you are a registered stockholder and have questions concerning stock certificates, transfers or ownership or other matters pertaining to your stock account. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap"><span style="white-space:nowrap">800-937-5449</span></span> </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">48 Wall Street, Floor 23 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">New York, NY 10005 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What if I want to request a paper or email copy of these documents? </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you want to receive a paper or <span style="white-space:nowrap">e-mail</span> copy of these documents, you must request one. There is no charge for requesting a copy. Please choose one of the following methods to make your request:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">BY INTERNET:&#160;www.proxyvote.com</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">BY TELEPHONE: <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">1-800-579-1639</span></span></span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">3)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">BY <span style="white-space:nowrap">E-MAIL*:&#160;sendmaterial@proxyvote.com</span> </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">* If requesting materials by <span style="white-space:nowrap">e-mail,</span> please send a blank <span style="white-space:nowrap">e-mail</span> with the information that is printed in the box marked by the arrow&#160;XXXX XXXX XXXX XXXX (located on the following page) in the subject line. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Proxy Statement contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are all statements contained in this Proxy Statement that are not historical fact, and in some cases can be identified by terms such as: &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;target,&#8221; &#8220;potential,&#8221; &#8220;will&#8221; and other words and terms of similar meaning.&#160;These statements are based on management&#8217;s current beliefs and assumptions and on information currently available to management. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. Any forward-looking statements in this Proxy Statement reflect our current views with respect to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, level of activity, performance or achievements to be materially different from any future results, level of activity, performance or achievements expressed or implied by these forward-looking statements. Factors that may cause actual results, levels of activity or performance of achievements to differ materially from current expectations include, among other things, those described under Part I, Item 1A, &#8220;Risk Factors&#8221; and elsewhere in the Annual Report on Form <span style="white-space:nowrap">10-K</span> for the fiscal year ended December&#160;31, 2024. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">8 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_2">PROPOSALS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_3">Proposal 1 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Election of Directors </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board presently has four directors: Dale Curtis Hogue, Jr.; Robert W. Postma; Jaime Vieser; and Holger Weis. Each were previously elected by the stockholders. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&#160;10, 2025, our Board nominated all of our existing directors for election at the Annual Meeting. If elected, each of our proposed nominees has consented to serve as one of our directors, to hold office until our next annual meeting of stockholders and until his successor has been duly elected and qualified, or, if sooner, until his earlier death, resignation or removal. Proxies cannot be voted for a greater number of persons than the number of nominees named in the proxy statement. If any director nominee should withdraw or otherwise become unavailable to serve, the proxies which would have otherwise been voted for that director nominee may be voted for a substitute director nominee selected by our Board. We are not aware of any reason that a nominee will be unable or unwilling to serve as a director. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth each nominee to be elected at the Annual Meeting, the year each nominee was first elected as a director, the position(s) currently held by each nominee with us and the year each nominee&#8217;s term will expire, if such nominee is elected at the Annual Meeting. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:26%"/>

<td style="vertical-align:bottom;width:9%"/>
<td style="width:39%"/>

<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">Name of Nominee</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Position(s) with<br/>the Company</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Year&#160;First&#160;Became&#160;a<br/>Director</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Year&#160;Proposed&#160;Term<br/>Will Expire</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dale Curtis Hogue, Jr.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Interim&#160;Chief&#160;Executive&#160;Officer&#160;and&#160;Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2026</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert W. Postma</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2021</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2026</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jaime Vieser</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2020</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2026</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holger Weis</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Director - Chair</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2020</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2026</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under our director resignation policy, any nominee in an uncontested election who does not receive a majority of the votes cast (i.e. receives a greater number of votes &#8220;withheld&#8221; from his or her election than votes &#8220;for&#8221; in such election) shall submit his or her offer of resignation for consideration by the corporate governance and nominating committee of the Board (the &#8220;corporate governance and nominating committee&#8221;). The corporate governance and nominating committee shall consider all of the relevant facts and circumstances and recommend to the Board the action to be taken with respect to such offer of resignation, and the Board will then act on such recommendation. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our corporate governance and nominating committee seeks to assemble a Board that, as a whole, possesses the appropriate balance of professional and industry knowledge, financial expertise and management experience necessary to oversee and direct our business. The corporate governance and nominating committee maintains a goal of recruiting members who complement and strengthen the skills of other members and who also exhibit integrity, collegiality, sound business judgment and other qualities that the corporate governance and nominating committee views as critical to effective functioning of the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None of the director nominees are related by blood, marriage or adoption to any of our other director nominees or executive officers. Certain of our directors were previously selected or nominated for election as a director, pursuant to a settlement agreement, dated February&#160;4, 2021 (the &#8220;WaterMill Settlement Agreement&#8221;), with WaterMill Asset Management Corp. and Robert W. Postma (collectively, the &#8220;WaterMill Parties&#8221;). The WaterMill Settlement Agreement is no longer in effect and none of the directors originally nominated pursuant to its terms were nominated pursuant to the agreement for this meeting. Pursuant to the WaterMill Settlement Agreement, we increased the size of our Board from eight to nine directors (and which has subsequently been reduced to seven as directors have left the Board) and appointed Mr.&#160;Postma to fill the newly created </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">9 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
directorship. Under the WaterMill Settlement Agreement, we agreed that until the earlier of (i)&#160;January&#160;1, 2023 and (ii)&#160;thirty (30) calendar days prior to the nomination deadline for our 2023 annual meeting of stockholders, we would nominate each of Messrs. Postma, Vieser and Weis for election at any stockholder meeting at which directors are to be elected and would recommend, support and solicit proxies for the election of each of Messrs. Postma, Vieser and Weis. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Hogue, our Interim Chief Executive Officer and a director, was appointed as a <span style="white-space:nowrap">non-employee</span> director in December 2023, prior to his appointment as interim Chief Executive Officer in January 2024. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Directors are elected by a plurality of the votes of the holders of shares deemed present in person or represented by proxy and entitled to vote on the election of directors. Accordingly, if a quorum is present, the four nominees receiving the highest number of &#8220;FOR&#8221; votes will be elected. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the four nominees named above. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="font-style:italic">The Board recommends that you vote &#8220;FOR&#8221; the election of each named nominee. </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">10 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_4">Proposal 2 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Ratification of Selection of Independent Registered Public Accounting Firm </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The audit committee of the Board has selected Cherry Bekaert LLC as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2025. Cherry Bekaert LLC has audited our financial statements since 2024. A representative of Cherry Bekaert LLC is expected to virtually attend the Annual Meeting. He or she will have an opportunity to make a statement if he or she so desires and will be available to respond to appropriate questions from stockholders. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are not required by statute or our bylaws or other governing documents to obtain stockholder ratification of the appointment of Cherry Bekaert LLC as our independent registered public accounting firm. The audit committee has submitted the selection of Cherry Bekaert LLC to the stockholders for ratification as a matter of good corporate practice. If the stockholders do not ratify the appointment, the audit committee may reconsider its selection. Notwithstanding the proposed ratification of the selection of Cherry Bekaert LLC by the stockholders, the audit committee, in its discretion, may direct the appointment of a new independent registered public accounting firm at any time during the year without notice to, or the consent of, the stockholders, if the audit committee determines that such a change would be in our best interest and the best interest of our stockholders. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Principal Accountant Fees and Services </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table presents the aggregate fees billed by RSM US LLP and Cherry Bekaert LLP for the years ended December&#160;31, 2024 and 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:72%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Fee Category</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">2024</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees (1)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">177,575</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">308,304</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-Related Fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:center">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:center">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:center">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:center">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:center">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:center">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">177,575</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">308,304</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Represents fees billed for professional services provided to us in connection with the annual audit of our financial statements and the review of our quarterly condensed financial statements, as well as audit services that are normally provided by an independent registered public accounting firm in connection with statutory and regulatory filings or engagements for those fiscal years, such as statutory audits, administrative fees and <span style="white-space:nowrap"><span style="white-space:nowrap">out-of-pocket</span></span> costs. For 2024, $99,750 of the fees were billed by Cherry Bekaert LLP and $77,825 of the fees were billed by RSM US LLP, of which $48,950 were associated with work paper transition and consents. For 2023, there were no fees associated with registration statements, comfort letters, work paper transition and consents. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than as discussed above, we did not incur any fees of RSM US LLP and Cherry Bekaert LLP for audit-related, tax or other services in 2024 or 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All fees described above were <span style="white-space:nowrap">pre-approved</span> by the audit committee. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="white-space:nowrap">Pre-Approval</span> Policy and Procedures </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The audit committee has adopted a policy and procedures for the <span style="white-space:nowrap">pre-approval</span> of audit and <span style="white-space:nowrap">non-audit</span> services rendered by our independent registered public accounting firm, Cherry Bekaert LLC. The policy generally authorizes <span style="white-space:nowrap">pre-approval</span> by the audit committee of specified services in the defined categories of audit services, audit-related services and tax services up to specified amounts. <span style="white-space:nowrap">Pre-approval</span> may also be given as part of the audit committee&#8217;s approval of the scope of the engagement of the independent registered public accounting firm or on an individual, explicit, <span style="white-space:nowrap"><span style="white-space:nowrap">case-by-case</span></span> basis before the independent registered public accounting firm is </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">11 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
engaged to provide each service. The pre-approval of services may be delegated to one or more of the audit committee&#8217;s members, but the decision must be reported to the full audit committee at its next scheduled meeting. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The affirmative vote of the holders of a majority in voting power of the shares of stock deemed present in person or represented by proxy and entitled to vote thereon at the annual meeting will be required to ratify the selection of Cherry Bekaert LLC. Abstentions will be counted toward the vote total for Proposal 2 and will have the same effect as &#8220;AGAINST&#8221; votes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="font-style:italic">The Board recommends that you vote &#8220;FOR&#8221; the ratification of the selection of Cherry Bekaert LLC as our independent registered public accounting firm for our fiscal year ending December&#160;31, 2025. </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">12 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_5">Proposal 3 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Advisory Vote on Executive Compensation </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Dodd-Frank Wall Street Reform and Consumer Protection Act and Section&#160;14A of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), our stockholders are entitled to vote to approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement in accordance with the SEC&#8217;s rules. At the 2024 annual meeting of stockholders, our stockholders indicated their preference that we solicit a <span style="white-space:nowrap">non-binding</span> advisory vote on the compensation of the named executive officers, commonly referred to as a <span style="white-space:nowrap"><span style="white-space:nowrap">&#8220;say-on-pay</span></span> vote,&#8221; every year. The Board has adopted a policy that is consistent with that preference indicated by our stockholders. Accordingly, this year we are again asking the stockholders to approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and the philosophy, policies and practices described in this proxy statement. The compensation of our named executive officers is disclosed in the section titled &#8220;<span style="font-style:italic">Executive Compensation</span>&#8221; below, including the tabular and narrative disclosures set forth in such section under the same heading. We believe that our compensation policies and decisions are focused on <span style="white-space:nowrap"><span style="white-space:nowrap">pay-for-performance</span></span> principles and strongly aligned with our stockholders&#8217; interests. Compensation of our named executive officers is designed to enable us to attract and retain talented and experienced executives, whose knowledge, skills and performance are critical to our success, and motivate these executive officers to achieve our business objectives and to lead us in a competitive environment. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are asking our stockholders to indicate their support for the compensation of our named executive officers as described in this proxy statement by casting a <span style="white-space:nowrap">non-binding</span> advisory vote &#8220;FOR&#8221; the following resolution: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">&#8220;RESOLVED, that the stockholders hereby approve the compensation of the &#8220;named executive officers&#8221; of Alaunos Therapeutics, Inc., as disclosed in the section titled &#8220;Executive Compensation&#8221; in the proxy statement for the Alaunos Therapeutics, Inc. 2025 Annual Meeting of stockholders pursuant to the compensation disclosure rules of the SEC, including the compensation tables and narrative discussion.&#8221; </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The affirmative vote of the holders of a majority in voting power of the shares of stock deemed present in person or represented by proxy and entitled to vote at the Annual Meeting will be required to approve, on an advisory basis, the compensation of our named executive officers as described herein. Because the vote is advisory, it will not be binding on us, the Board or the Board&#8217;s compensation committee (the &#8220;compensation committee&#8221;). Nevertheless, the views expressed by our stockholders, whether through this vote or otherwise, are important to us and, accordingly, the Board and our compensation committee intend to consider the results of this vote in making determinations in the future regarding executive compensation arrangements. Abstentions will be counted toward the vote total for Proposal 3 and will have the same effect as &#8220;AGAINST&#8221; votes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="font-style:italic">The Board recommends that you vote &#8220;FOR&#8221; the proposal to approve the compensation of our named executive officers, as described in this proxy statement. </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">13 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_6">Proposal 4 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Approval of the Fourth Amended and Restated Certificate of Incorporation to Effect a Reverse Stock Split of Common Stock </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Overview </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&#160;10, 2025, our Board unanimously approved and recommended that our stockholders approve the amendment and restatement of our Charter to, at the discretion of the Board, effect a reverse stock split with respect to the Company&#8217;s issued and outstanding common stock, par value $0.001 per share, including stock held by the Company as treasury shares, at any reverse stock split ratio within a range of <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-5</span></span> to <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-20,</span></span> inclusive, and a proportionate decrease in the number of our total authorized capital stock and common stock, as further described below. As further described below, we are seeking approval of this Reverse Stock Split Proposal primarily to provide our Board with the authority to effect a reverse stock split only if needed to maintain our listing on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;). Our Board has accordingly determined that it is advisable and in the best interest of the Company and its stockholders for this Reverse Stock Split Proposal to be approved so that the Board has the necessary flexibility if we fall below the Minimum Price Standard between the time of this meeting and the next stockholder meeting, and the Board makes the determination that a reverse stock split provides us the best chance to avoid delisting. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A reverse stock split, if implemented, would be at any ratio approved by our stockholders in this proposal within the range described above and would apply equally to all outstanding shares of our common stock. Accordingly, each stockholder would hold the same percentage of common stock outstanding immediately following a reverse stock split as that stockholder held immediately prior to a reverse stock split, except for adjustments that may result from the treatment of fractional shares as described below. In addition, the Board has unanimously approved and recommends that the Board would have the sole discretion whether or not to proportionately reduce the number of shares of common stock authorized under the Charter in the event the Board does effect a reverse stock split pursuant to this proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Approval of this proposal would permit, but not require, our Board to effect a reverse stock split by any ratio between <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-5</span></span> to <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-20,</span></span> inclusive, with the exact ratio to be selected at a whole number within this range as determined by our Board in its sole discretion, provided that any reverse stock split is implemented within one year after the conclusion of the Annual Meeting. As described in more detail below, we are currently in compliance with the Minimum Price Standard. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon receiving stockholder approval of a reverse stock split, the Board will have the authority, but not the obligation, to elect, in its sole discretion, without further action on the part of our stockholders and as it determines to be in our and our stockholders&#8217; best interests, to effect a reverse stock split and, if so, to select the reverse stock split ratio from within the approved range of ratios described above, each ratio within such range having been approved by our stockholders. We believe that enabling our Board to select the ratio from within the stated range will provide us with the flexibility to implement a reverse stock split in a manner designed to maximize the anticipated benefits for our stockholders. In determining the ratio following the receipt of stockholder approval, our Board may consider, among other factors, the following: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the historical trading price and trading volume of our common stock; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the number of outstanding shares of our common stock; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the then-prevailing trading price and trading volume of our common stock and the anticipated impact of a reverse stock split on the trading market for our common stock; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the continued listing requirements of Nasdaq, including the requirement that, subject to limited exceptions, listed companies maintain a minimum bid price of at least $1.00; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the number of authorized but unissued shares of our common stock that would result from a reverse stock split, and potential uses of those additional authorized but unissued shares; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">14 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the anticipated impact of a particular ratio on our ability to reduce administrative and transactional costs; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">prevailing general market and economic conditions. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this Reverse Stock Split Proposal is approved by the stockholders and the Board determines to implement a reverse stock split, we will file an amended and restated Charter (the &#8220;Fourth Amended and Restated Charter&#8221;), with the Delaware Secretary of State. The material changes in the proposed Fourth Amended and Restated Charter are described in this proposal. This description is qualified in its entirety by reference to the complete text of the Fourth Amended and Restated Charter, which is attached as Annex A to this proxy statement and incorporated into this proposal by reference. You are strongly encouraged to read the actual text of the Fourth Amended and Restated Charter. The proposed Fourth Amended and Restated Charter is subject to revision for such changes as may be required by the Delaware General Corporation Law and any other changes consistent with this proposal that we may deem necessary or appropriate. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this Reverse Stock Split Proposal is approved by the stockholders and a reverse stock split is implemented by our Board, no less than 5 and no more than 20 shares of existing common stock, as determined by our Board, will be combined into one share of common stock. Holders will receive, in lieu of any fractional share, an amount in cash (without interest) equal to such fraction multiplied by the closing sales price of our common stock as reported on Nasdaq on the trading day immediately preceding the effective date of the Fourth Amended and Restated Charter. The Fourth Amended and Restated Charter, if adopted, will include only the reverse stock split ratio determined by our Board to be in the best interest of the Company and its stockholders and all of the other ratios approved by our stockholders within the proposed range will be abandoned. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this Reverse Stock Split Proposal is approved and the Board elects to implement a reverse stock split, the number of outstanding shares of our common stock may, at the sole discretion of the Board, be reduced in proportion to the ratio of the reverse stock split chosen by our Board. If a reverse stock split is implemented, the number of authorized shares of our common stock may decrease by the same proportion as the number of shares of common stock that are outstanding at the time of the reverse stock split. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board reserves the right to elect not to effect a reverse stock split, including any or all reverse stock split ratios within the proposed range, if it determines, in its sole discretion, that implementing a reverse stock split is not in the best interest of the Company and its stockholders. If our Board does not implement a reverse stock split on or prior to the one year anniversary of the conclusion of the Annual Meeting, stockholder approval would again be required prior to implementing any future reverse stock split. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Background and Reasons for a Reverse Stock Split </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As further described below, we and our Board are seeking approval for the Reverse Stock Split Proposal primarily to provide our Board with authority to effect a reverse stock split if needed to maintain our listing on Nasdaq. However, we cannot provide assurance that a reverse stock split would achieve its intended or desired benefits, and we strongly encourage you to review the discussion below in the section titled &#8220;<span style="font-style:italic">Risks and Potential Disadvantages Associated with a Reverse Stock Split</span>.&#8221; </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Nasdaq Minimum Price Standard&#160;&amp; Low Priced Stocks Rule </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nasdaq Listing Rule 5450(a)(1) requires that companies listed on the Nasdaq maintain a minimum closing bid price of at least $1.00 per share (the &#8220;Minimum Price Standard&#8221;). Companies are considered out of compliance with the Minimum Price Standard if the Nasdaq closing bid price is below $1.00 per share for 30 consecutive business days. Under Nasdaq Listing Rule 5810(c)(3)(A), once out of compliance with the Minimum Price Standard, a company has 180 calendar days to regain compliance by meeting the Minimum Price Standard. On November&#160;8, 2023, we were notified that our shares had traded below $0.10 for ten consecutive days in violation </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">15 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of Nasdaq Listing Rule 5810(c)(3)(A)(iii) or the &#8220;Low Priced Stocks Rule.&#8221; We appealed this determination pursuant to the instructions provided by Nasdaq to the Hearings Panel or the &#8220;Panel.&#8221; On February&#160;16, 2024, we were notified by the Panel that, following a 15 to 1 reverse stock split, our shares had traded above $1.00 for 10 consecutive days and we were then in compliance. However, we were also advised that in application of Listing Rule 5815(d)(4)(B), we were subject to a Mandatory Panel Monitor for a period of one year from February&#160;16, 2024 or the Compliance Period. If, within that <span style="white-space:nowrap">one-year</span> monitoring period, we were determined to again be out of compliance with the Minimum Price Standard, we would not have been able to provide Nasdaq with a plan of compliance with respect to that deficiency nor would Nasdaq have been able to grant additional time for us to regain compliance with respect to that deficiency. We also would not have been afforded an applicable cure or compliance period pursuant to Rule 5810(c)(3). Instead, as with the Low Priced Stocks Rule, we would have been immediately be delisted but would again have had an opportunity to request a new hearing with the initial Panel or a newly convened Hearings Panel if the initial Panel is unavailable. We would have been able to respond/present to the Hearings Panel as provided by Listing Rule 5815(d)(4)(C). At this time, the Board would likely have had to undergo a reverse stock split in order to ensure that our shares trade at a compliant price to prevent delisting. The Minimum Price Standard will be met if our common stock has a minimum closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days within the time frame allowed by the Panel to gain compliance. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&#160;26, 2024, the Board unanimously approved a reverse stock split, at a ratio of 1 for 10 given the fact that our stock price had been trading for several days under the Nasdaq Minimum Price Standard in order to avoid a second delisting notice from Nasdaq. This reverse stock split and accompanying decrease in the number of shares of common stock authorized under the Charter was effective on July&#160;16, 2024. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the date of this proxy statement, we are in compliance with the Minimum Price Standard. The equity markets have experienced and continue to experience substantial volatility due to, among other factors, recent tariffs instituted by the Trump Administration, the wars in Ukraine and Israel, dramatic interest rate increases, and high levels of inflation. On May&#160;5, 2025, the reported closing price of our common stock was $2.90 per share. Accordingly, there is a significant risk that we may fall below the Minimum Price Standard before our next stockholders&#8217; meeting in 2026. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The primary purpose of a reverse stock split would be to achieve an increase in the per share market price of our common stock as necessary to meet the Minimum Price Standard. A delisting of our common stock would materially and adversely affect a stockholder&#8217;s ability to dispose of, or to obtain accurate quotations as to the market value of, our common stock. Furthermore, any delisting may cause our common stock to be subject to &#8220;penny stock&#8221; regulations promulgated by the SEC. Under such regulations, broker-dealers are required to, among other things, comply with disclosure and special suitability determinations prior to the sale of shares of common stock. If our common stock becomes subject to these regulations, the market price of our common stock and the liquidity thereof would be materially and adversely affected. Absent other factors, we believe that reducing the number of outstanding shares of our common stock is a potentially effective means to increase the per share market price of our common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If our shares of common stock are delisted from Nasdaq, we believe that our shares of common stock would likely be eligible to be quoted <span style="white-space:nowrap"><span style="white-space:nowrap">over-the-counter</span></span> on an inter-dealer electronic quotation and trading system operated by OTC Markets Group. These markets are generally considered not to be as efficient as, and not as broad as, Nasdaq. Selling our shares of common stock on these markets could be more difficult because smaller quantities of shares would likely be bought and sold, and transactions could be delayed. In addition, in the event our shares of common stock are delisted, broker-dealers would have certain regulatory burdens imposed upon them with respect to our common stock, which may discourage broker-dealers from effecting transactions in our common stock, further limiting the liquidity of our common stock. These factors could result in lower prices and larger spreads in the bid and ask prices for our common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A delisting from Nasdaq and continued or further declines in our share price could also greatly impair our ability to raise additional necessary capital through equity or debt financing, or to use our shares for business </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">16 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
development or other corporate initiatives, and could significantly increase the ownership dilution to stockholders caused by our issuing equity in financing or other transactions. Without the ability to raise additional capital, our ability to carry on our business and advance the development of our product candidates would be significantly impaired. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board believes that the proposed reverse stock split would be a potentially effective means for us to obtain and/or maintain compliance with the Minimum Price Standard and to avoid, or at least defer, the consequences of our common stock being delisted from Nasdaq by producing the immediate effect of increasing the bid price of our common stock. <span style="font-weight:bold">Our Board currently intends to effect a reverse stock split only if, in its sole discretion, it deems it to be a necessary step to gain compliance with the Minimum Price Standard, if needed during the Compliance Period.</span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">General Investment Considerations </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, we believe that a reverse stock split could make our common stock more attractive to a broader range of institutional and other investors, as we have been advised that the current market price of our common stock may affect its acceptability to certain institutional investors and other members of the investing public. In particular, many brokerage houses and institutional investors have internal policies and practices that may prohibit them from investing in <span style="white-space:nowrap">low-priced</span> stocks or discourage individual brokers from recommending <span style="white-space:nowrap">low-priced</span> stocks to their customers. Moreover, because brokers&#8217; commissions on <span style="white-space:nowrap">low-priced</span> stocks generally represent a relatively high percentage of the stock price, transaction costs would represent a higher percentage of total share value, which could result in decreased trading volume and increased volatility in the trading price of our common stock. We believe that a reverse stock split could make our common stock a more attractive and cost-effective investment for many investors, which could enhance the liquidity of our common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks and Potential Disadvantages Associated with a Reverse Stock Split </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board believes that a reverse stock split is a potentially effective means to increase the per share market price of our common stock and thus enable us to regain compliance with the Minimum Price Standard, if we fail below the Minimum Price Standard during the Compliance Period. However, there are a number of risks and potential disadvantages associated with a reverse stock split, including the following: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Board cannot predict the effect of a reverse stock split upon the market price for shares of our common stock, and the success of similar reverse stock splits for companies in like circumstances has varied. Some investors may have a negative view of a reverse stock split. Recently, the market price of our common stock has declined substantially, and the equity markets have experienced and continue to experience substantial volatility due to, among other factors, the wars in Ukraine and Israel, dramatic interest rate increases, and high levels of inflation. The principal purpose of a reverse stock split would be to increase the trading price of our common stock to meet the Minimum Price Standard. However, the effect of a reverse stock split on the market price of our common stock cannot be predicted with any certainty, and we cannot assure you that a reverse stock split will accomplish this objective for any meaningful period of time, or at all. Even if a reverse stock split has a positive effect on the market price for shares of our common stock, performance of our business and financial results, general economic conditions and the market perception of our business, and other adverse factors which may not be in our control could lead to a decrease in the price of our common stock following a reverse stock split. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Although the Board believes that a higher stock price may help generate the interest of new investors, the reverse stock split may not result in a <span style="white-space:nowrap">per-share</span> price that will successfully attract certain types of investors and such resulting share price may not satisfy the investing guidelines of institutional investors or investment funds. Further, other factors, such as our financial results, market conditions and the market perception of our business, may adversely affect the interest of new investors in the shares of our common stock. As a result, the trading liquidity of the shares of our common stock may not improve as a result of a reverse stock split and there can be no assurance that a reverse stock split, if completed, will result in the intended benefits described above. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">17 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Even if a reverse stock split does result in an increased market price per share of our common stock, the market price per share following a reverse stock split may not increase in proportion to the reduction of the number of shares of our common stock outstanding before the implementation of a reverse stock split. Accordingly, even with an increased market price per share, the total market capitalization of shares of our common stock after a reverse stock split could be lower than the total market capitalization before a reverse stock split. Also, even if there is an initial increase in the market price per share of our common stock after a reverse stock split, the market price many not remain at that level due to factors described in this proposal or other factors, including the risks described in our Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2024, as updated in reports we subsequently file with the SEC. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If a reverse stock split is implemented and the market price of shares of our common stock then declines, the percentage decline may be greater than would occur in the absence of a reverse stock split due to decreased liquidity in the market for our common stock. If the market price of shares of our common stock declines after a reverse stock split, the percentage decline as an absolute number and as a percentage of our overall market capitalization may be greater than would occur in the absence of a reverse stock split. Accordingly, the total market capitalization of our common stock following a reverse stock split could be lower than the total market capitalization before a reverse stock split. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Procedures for and Effects of Implementing a Reverse Stock Split </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Procedures </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A reverse stock split would become effective upon the filing of the Fourth Amended and Restated Charter with the Secretary of State of the State of Delaware. The exact timing of the filing of the Fourth Amended and Restated Charter, if it is filed, would be determined by our Board based on its evaluation as to when such action would be in the best interest of the Company and its stockholders. In addition, our Board reserves the right, notwithstanding stockholder approval and without further action by the stockholders, to elect not to proceed with a reverse stock split if, at any time prior to filing the Fourth Amended and Restated Charter, our Board determines in its sole discretion that it is not in our best interest and the best interest of our stockholders to proceed with a reverse stock split. If the Fourth Amended and Restated Charter has not been filed with the Secretary of State of the State of Delaware on or prior to the one year anniversary of the conclusion of the Annual Meeting, our Board will abandon the reverse stock split or seek stockholder reauthorization of a reverse stock split. Following are descriptions of how a reverse stock split would be implemented for beneficial holders, registered book entry holders, and certificated holders. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Beneficial Holders</span>. Upon the implementation of a reverse stock split, we intend to treat shares held by stockholders through a broker, bank or other agent in the same manner as registered stockholders whose shares are registered in their names. Brokers, banks and other agents would be instructed to effect a reverse stock split for their beneficial holders holding our common stock in street name. However, these brokers, banks and other agents may have different procedures than registered stockholders for processing a reverse stock split. Stockholders who hold shares of our common stock with a broker, bank or other agent and who have any questions in this regard are strongly encouraged to contact their brokers, banks or other agents for more information. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Registered &#8220;Book Entry&#8221; Holders</span>. Certain of our registered holders of common stock may hold some or all of their shares electronically in book-entry form with EQ. These stockholders do not have stock certificates evidencing their ownership of the common stock. They are, however, provided with a statement reflecting the number of shares registered in their accounts. If a reverse stock split is implemented, stockholders who hold shares electronically in book-entry form with EQ would not need to take action (the exchange will be automatic) to receive whole shares of post-reverse split common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Certificated Holders</span>. If a reverse stock split is implemented, stockholders holding shares of our common stock in certificated form would be sent a letter of transmittal by EQ following the reverse stock split. The letter of </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">18 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transmittal would contain instructions on how a stockholder should surrender their certificate(s) representing shares of our common stock (the &#8220;Old Certificates&#8221;) to EQ in exchange for information regarding their book entry shares. We no longer certificate the Company&#8217;s shares. A stockholder must deliver all Old Certificates, together with a properly completed and executed letter of transmittal, to EQ. No stockholder would be required to pay a transfer or other fee to receive their book entry information.. Until surrendered, we would deem outstanding Old Certificates held by stockholders to be cancelled and only to represent the number of whole shares of post-reverse split common stock to which these stockholders are entitled and the right to receive cash in lieu of any fractional shares as described below. If an Old Certificate has a restrictive legend on it, the book entry for those shares would be issued with the same restrictive legends that are on the Old Certificate. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a reverse stock split is implemented, we expect that EQ would act as the exchange agent for purposes of implementing the exchange of Old Certificates for book entry information. No service charges would be payable by holders of shares of common stock in connection with the exchange of information. We would bear all of such expenses. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">STOCKHOLDERS SHOULD <span style="text-decoration:underline">NOT</span> DESTROY ANY STOCK CERTIFICATES. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">STOCKHOLDERS SHOULD <span style="text-decoration:underline">NOT</span> SUBMIT STOCK CERTIFICATES UNLESS AND UNTIL REQUESTED TO DO SO, AND THEN STOCK CERTIFICATES SHOULD BE SUBMITTED ONLY IN THE MANNER INSTRUCTED. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">STOCK CERTIFICATES SHOULD <span style="text-decoration:underline">NOT</span> BE SUBMITTED DIRECTLY TO THE COMPANY. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Outstanding Shares of Common Stock </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depending on the ratio for a reverse stock split determined by our Board, a minimum of 5 and a maximum of 20 shares of existing common stock would be combined into one new share of common stock. Based on 1,639,521 shares of common stock issued and outstanding as of the Record Date, immediately following a reverse stock split we would have approximately 327,904 shares of common stock issued and outstanding (without giving effect to the treatment of fractional shares) if the ratio for a reverse stock split is <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-5,</span></span> and 81,976 shares of common stock issued and outstanding (without giving effect to the treatment of fractional shares) if the ratio for a reverse stock split is <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-20.</span></span> Any other ratio selected within such range would result in a number of shares of common stock issued and outstanding following the reverse stock split between approximately 273,253 and 86,290 shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The actual number of shares issued after giving effect to a reverse stock split, if implemented, would depend on the reverse stock split ratio that is ultimately selected by our Board. A reverse stock split would affect all holders of our common stock uniformly and would not affect any stockholder&#8217;s percentage ownership interest in the Company, except that, as described below in the section titled &#8220;<span style="font-style:italic">Fractional Shares</span>,&#8221; stockholders of record otherwise entitled to a fractional share, as a result of a reverse stock split, would instead receive an amount in cash. In addition, a reverse stock split would not affect any stockholder&#8217;s proportionate voting power, except for adjustments that may result from the treatment of fractional shares as described below. A reverse stock split may result in some stockholders owning &#8220;odd lots&#8221; of less than 100 shares of common stock. Odd lot shares may be more difficult to sell, and brokerage commissions and other costs of transactions in odd lots are generally somewhat higher than the costs of transactions in &#8220;round lots&#8221; of even multiples of 100 shares. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Authorized Shares of Common Stock </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A reverse stock split may, at the discretion of the Board, result in a proportionate reduction in the number of authorized shares of our common stock under the Charter at the time a reverse stock split is effected. A reverse stock split would not have any effect on the number of authorized shares of preferred stock, which would remain at 30,000,000 shares of preferred stock, par value $0.001. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">19 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For clarity, if the Authorized Stock Increase Proposal described below is approved by our stockholders and implemented by our Board, in its discretion, through the filing of a certificate of amendment to our Charter prior to the implementation of the reverse stock split, the reverse stock split may, at the discretion of the Board, have the effect of reducing the increased number of authorized shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following the effective time of a reverse stock split, any authorized shares of our common stock, if and when issued, would be part of our existing class of our common stock and would have the same rights and privileges as the shares of our common stock currently outstanding. Our stockholders do not, as such, have preemptive rights or preferential rights to purchase additional shares of our common stock that we may issue. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Fractional Shares </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We would not issue fractional shares in connection with a reverse stock split. Stockholders would receive, in lieu of any fractional share, an amount in cash (without interest) equal to such fraction multiplied by the closing sales price of our common stock as reported on Nasdaq on the trading day immediately preceding the effective date of the Fourth Amended and Restated Charter. The ownership of a fractional share interest following a reverse stock split would not give the holder any voting, dividend or other rights, except to receive payment as described above. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If our Board elects to implement the proposed reverse stock split, stockholders owning, prior to the reverse stock split, less than the number of whole shares of common stock that will be combined into one share of common stock in the reverse stock split would no longer be stockholders. The exact number by which the number of holders of our common stock would be reduced will depend on the specific reverse stock split ratio adopted by the Board and the number of stockholders that hold less than that ratio as of the effective date of the reverse stock split. As of the Record Date, there were approximately 129 holders of record of our common stock, of which 77 held fewer than 100 shares of common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Effects on Equity Compensation Plans and Awards, Convertible Securities and Warrants </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a reverse stock split is implemented, proportionate adjustments would generally be required to be made with regard to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the per share exercise price of, and the number of shares issuable upon exercise of, outstanding stock options issued under our equity compensation plans; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the number of shares deliverable upon vesting and settlement of outstanding restricted stock and restricted stock unit awards; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the number of shares reserved for issuance under our equity compensation plans; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the per share conversion price, and the number of shares issuable upon conversion of, outstanding convertible securities entitling the holders to purchase or convert into, or otherwise acquire shares of our common stock; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the strike price and the number of shares issuable upon exercise of warrants entitling the holders to receive shares of our common stock. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the case of options, convertible securities or other rights to acquire shares of our common stock, these adjustments would result in approximately the same aggregate price required under such options, convertible securities or other rights upon exercise, conversion, or settlement, and approximately the same value of shares of common stock being delivered upon such exercise, conversion, or settlement, immediately following a reverse stock split as was the case immediately preceding such reverse stock split. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the case of our outstanding warrants, the number of shares issuable under the warrants will be proportionately decreased and the exercise price of each warrant proportionately increased. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">20 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The number of shares of common stock issuable upon exercise or vesting of outstanding equity awards, options and warrants and the exercise or purchase price related thereto, if any, would be equitably adjusted in accordance with the terms of our 2012 Equity Incentive Plan and our 2020 Equity Incentive Plan, as applicable, or such stock option grants or warrants, as the case may be, which may include rounding the number of shares of common stock issuable down to the nearest whole share or the payment of cash for fractional shares. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Exchange Act Registration; Nasdaq Listing; CUSIP </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock is currently registered under Section&#160;12(b) of the Exchange Act, and we are subject to periodic reporting and other requirements of the Exchange Act. The implementation of a reverse stock split would not affect the registration of our common stock under the Exchange Act or our reporting or other requirements under the Exchange Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are currently listed on the Nasdaq Capital Market under the trading symbol &#8220;TCRT.&#8221; If our common stock remains listed on the Nasdaq Capital Market up to the time of a reverse stock split, then immediately following the reverse stock split our common stock would continue to be listed on the Nasdaq Capital Market under the &#8220;TCRT&#8221; symbol, although it is likely that Nasdaq would add the letter &#8220;D&#8221; to the end of the trading symbol for a period of 20 trading days after the effective date of the reverse stock split to indicate that the reverse stock split had occurred. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following a reverse stock split, our common stock would have a new Committee on Uniform Securities Identification Procedures (&#8220;CUSIP&#8221;) number, which is a number used to identify our equity securities, and stock certificates with the older CUSIP number will need to be exchanged for stock certificates with the new CUSIP number by following the procedures described above. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Accounting Matters </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The filing of the Fourth Amended and Restated Charter and implementation of a reverse stock split would not affect the par value of our common stock per share, which will remain $0.001. As a result, the stated capital attributable to common stock and the additional <span style="white-space:nowrap">paid-in</span> capital account on our balance sheet would not change due to a reverse stock split. However, the stated capital attributable specifically to our common stock would be reduced proportionally depending on the reverse stock split ratio, and the additional <span style="white-space:nowrap">paid-in</span> capital account would be credited with the amount by which the stated capital would be reduced. Also, if a reverse stock split is implemented, reported per share net income or loss would be higher because there will be fewer shares of our common stock outstanding. We do not anticipate that any other accounting consequences would arise as a result of a reverse stock split. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Appraisal Rights </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our stockholders are not entitled to dissenters&#8217; or appraisal rights under the Delaware General Corporation Law with respect to any of the proposals being voted on at the Annual Meeting and described in this proxy statement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Certain Material U.S. Federal Income Tax Consequences of the Reverse Stock Split </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following describes certain material U.S. federal income tax consequences of the reverse stock split expected to apply generally to U.S. Holders (as defined below) of our common stock. This description is based upon current provisions of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), existing Treasury Regulations promulgated under the Code and current published administrative rulings and court decisions, all of which are subject to change or different interpretation. Any change, which may or may not be retroactive, could alter the tax consequences described in this section. No ruling from the U.S. Internal Revenue Service has been or will be requested in connection with the reverse stock split. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No attempt has been made to comment on all U.S. federal income tax consequences of the reverse stock split that may be relevant to particular U.S. Holders, including holders: (i)&#160;that are subject to special tax rules such as </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">21 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
dealers, brokers and traders in securities, mutual funds, regulated investment companies, real estate investment trusts, insurance companies, banks or other financial institutions, <span style="white-space:nowrap">tax-exempt</span> entities, grantor trusts, tax-qualified retirement plans, individual retirement accounts, pension funds or other tax deferred accounts; (ii)&#160;that hold their shares as a hedge or as part of a hedging, straddle, &#8220;conversion transaction,&#8221; &#8220;synthetic security,&#8221; integrated investment or any risk reduction strategy; (iii)&#160;that are partnerships, S corporations, or other pass-through entities or investors in such pass-through entities; or (iv)&#160;that do not hold their shares as capital assets for U.S. federal income tax purposes (generally, property held for investment). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the following discussion does not address U.S. federal estate or gift, alternative minimum or Medicare contribution tax consequences, tax reporting requirements or the tax consequences of the reverse stock split under state, local or non-U.S. tax laws. The discussion assumes that for U.S. federal income tax purposes, the reverse stock split will not be integrated, or otherwise treated as part of a unified transaction, with any other transaction. Furthermore, the following discussion does not address the tax consequences of transactions effectuated before, after or at the same time as the reverse stock split, whether or not they are in connection with the reverse stock split. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a partnership (or other entity treated as a partnership for U.S. federal income tax purposes) is the beneficial owner of common stock, the U.S. federal income tax treatment of a partner in the partnership will generally depend on the status of the partner and the activities of the partnership. Accordingly, partnerships (and other entities treated as partnerships for U.S. federal income tax purposes) holding common stock and the partners in such entities should consult their own tax advisors regarding the U.S. federal income tax consequences of the proposed reverse stock split to them in light of their own circumstances. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, a &#8220;U.S. Holder&#8221; means a beneficial owner of our common stock that is, for U.S. income tax purposes: (i)&#160;an individual who is a citizen or resident of the U.S.; (ii) a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) created or organized in the U.S. any state thereof or the District of Columbia; (iii)&#160;an estate the income of which is includible in gross income for U.S. federal income tax purposes regardless of its source; or (iv)&#160;a trust (other than a grantor trust) if (A)&#160;a court within the U.S. is able to exercise primary supervision over the administration of the trust and one or more U.S. persons have the authority to control all substantial decisions of the trust or (B)&#160;it has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">HOLDERS OF OUR COMMON STOCK ARE ADVISED TO CONSULT THEIR OWN TAX ADVISORS REGARDING THE U.S. FEDERAL INCOME TAX CONSEQUENCES OF A REVERSE STOCK SPLIT TO THEM IN LIGHT OF THEIR PERSONAL CIRCUMSTANCES AND THE CONSEQUENCES OF A REVERSE STOCK SPLIT UNDER OTHER FEDERAL, STATE, LOCAL AND NON-U.S. TAX LAWS. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proposed reverse stock split is intended to be treated as a &#8220;recapitalization&#8221; pursuant to Section 368(a)(1)(E) of the Code. Assuming that the reverse stock split is treated as a <span style="white-space:nowrap">tax-free</span> &#8220;recapitalization&#8221; for U.S. federal income tax purposes, if the reverse stock split is adopted: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">A U.S. Holder that receives a reduced number of shares of our common stock pursuant to the reverse stock split will not recognize any gain or loss, except with respect to the amount of cash (if any) received in respect of a fractional share; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">A U.S. Holder&#8217;s aggregate tax basis in the shares of common stock received in the reverse stock split will equal the aggregate tax basis of U.S. Holder&#8217;s shares of common stock held immediately before the reverse stock split, but not including the aggregate tax basis of shares surrendered in exchange for cash received in respect of a fractional share (if any); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">A U.S. Holder&#8217;s holding period of shares of our common stock received in the reverse stock split will include the holding period of the <span style="white-space:nowrap">pre-reverse</span> stock split shares exchanged therefor; and </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">22 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">A U.S. Holder that receives cash in lieu of a fractional share of common stock generally will recognize gain or loss equal to the difference (if any) between the amount of cash received and the U.S. Holder&#8217;s tax basis in the shares of common stock surrendered therefor. Such capital gain or loss generally will be long-term capital gain or loss if the U.S. Holder&#8217;s holding period for the common stock surrendered in the reverse stock split exceeds one year at the effective time of the reverse stock split. Long-term capital gains of <span style="white-space:nowrap">non-corporate</span> U.S. Holders are generally subject to preferential tax rates. There are limitations on the deductibility of capital losses under the Code. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of determining the tax basis and holding period of shares of our common stock received in the reverse stock split, U.S. Holders that acquired different blocks of shares our common stock at different times for different prices must calculate their basis and holding periods separately for each identifiable block of such stock exchanged in the reverse stock split. U.S. Holders of shares of common stock acquired on different dates and at different prices should consult their own tax advisors regarding the allocation of the tax basis and holding period of their shares in light of their own circumstances. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The U.S. federal income tax discussion set forth above does not discuss all aspects of U.S. federal income taxation that may be relevant to a particular shareholder in light of such shareholder&#8217;s circumstances and income tax situation and our view regarding the U.S. federal income tax consequences of the reverse stock split is not binding on the Internal Revenue Service or the courts. <span style="font-weight:bold">Accordingly, we urge all of our stockholders to consult their own tax advisors with respect to all of the potential U.S. federal, state, local and non-U.S. tax consequences of the reverse stock split to them in light of their own circumstances</span>. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Affirmative votes &#8220;For&#8221; the amendment must exceed the votes cast against the amendment for approval of this proposal. Abstentions will have no effect on the vote required for approval. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The approval of this proposal is not conditioned on the approval or disapproval of Authorized Stock Increase Proposal. However, should both this proposal and the Authorized Stock Increase Proposal be approved by our stockholders, the Board would, in its discretion, choose which proposal(s) to implement, subject to its discretion to determine that neither proposal is in the best interest of the Company or its stockholders. In the event that this proposal is approved by the stockholders and the Authorized Stock Increase Proposal is not, the Board currently intends to nonetheless implement this proposal if, in its sole discretion, it deems it to be a necessary step to regain compliance with the Minimum Price Standard, should we fail to comply with the Standard during the Compliance Period. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="font-style:italic">The Board recommends that you vote &#8220;FOR&#8221; the proposal to approve the Fourth Amended and Restated Charter to effect a reverse stock split, at our Board&#8217;s discretion. </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">23 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_7">Proposal 5 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Approval of the Certificate of Amendment to our Charter to Increase our Authorized Stock </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Overview </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&#160;10, 2025, our Board unanimously approved and recommended that our stockholders approve an amendment to our Charter to, at the discretion of the Board, increase the authorized shares of our common stock from 5,000,000 shares of common stock to 50,000,000 shares of common stock within one year after the conclusion of the Annual Meeting, representing an increase of approximately 5-fold. The number of shares of preferred stock authorized for issuance will remain the same, at 30,000,000 shares of preferred stock, and will not be impacted by the increase in the authorized shares of capital stock or common stock, if approved by our stockholders. As of the Record Date, there were 1,639,521 shares of common stock issued and outstanding, 1,000 shares of common stock held as treasury stock, no shares of preferred stock issued or outstanding and 394,000 shares of our common stock reserved for issuance in connection with the following: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the conversion of preferred stock into 181,159 shares of common stock, subject to proportional adjustments in accordance with the certificate of designation </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the exercise of outstanding warrants to purchase 26,555 shares of common stock; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the exercise and/or vesting of outstanding awards in the aggregate amount of 56,141 shares of common stock under our 2012 Equity Incentive Plan and our 2020 Equity Incentive Plan; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the granting of future awards in the aggregate amount of 130,745 shares of common stock under our 2020 Equity Incentive Plan. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the Record Date, 3,360,479 authorized shares of common stock remained available for future issuance. Accordingly, our Board unanimously determined it was advisable and in the best interest of the stockholders and the Company to amend our Charter to increase the number of authorized shares of common stock (the &#8220;Share Increase&#8221;) and directed that it be submitted for approval by the stockholders at the Annual Meeting in light of the time and expense that would otherwise be required to convene a special meeting for consideration of the proposed amendment at a later time. The form of the proposed Share Increase amendment is attached to this Proxy Statement as Annex B. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The amendment would increase the number of shares of common stock the Company is authorized to issue by 45,000,000 shares of common stock, Thus, if this proposal is approved by our stockholders, our total authorized capital stock would increase from 5,000,000 to 50,000,000, with the number of authorized shares of our preferred stock remaining unchanged at 30,000,000. The additional shares of common stock proposed to be authorized under this proposal would have rights identical to our currently outstanding shares of common stock. This description is qualified in its entirety by reference to the complete text of the certificate of amendment to our Charter, which is attached as Annex B to this proxy statement and incorporated into this proposal by reference. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Reasons for Increasing the Number of Authorized Shares of Common Stock </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board believes that the increase in our authorized shares of common stock will provide us with the ability to support our future anticipated growth and would provide us with greater flexibility to consider and respond to future business opportunities and needs as they arise, including equity financings. The availability of additional shares of common stock would permit us to undertake certain of the foregoing actions without the delay and expense associate with holding a special meeting of our stockholders to obtain stockholder approval each time such an opportunity arises. Unless and until we can generate sufficient revenues, we expect to finance our cash needs in whole or in part through equity offerings. If the authorization of the Share Increase is postponed until the foregoing specific needs arise, the delay and expense incident to obtaining stockholder approval at that time could impair our ability to meet our objectives. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">24 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Possible Effects of Increasing the Number of Authorized Shares of Common Stock </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except for the conversion or exercise of outstanding convertible or exercisable securities (which conversion or exercise would be at the option of the respective holders), we currently have no plans, proposals, arrangements, or understandings to issue any authorized but unissued shares of our common stock. However, these additional authorized shares could be used in the future for various purposes without further stockholder approval, except as such approval may be required in particular cases by our organizational documents, applicable law or the rules of any stock exchange or other system on which our securities may then be listed. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, authorized but unissued shares of common stock may enable our Board to render more difficult or to discourage an attempt to obtain control of the Company. One of the consequences of such an action would be to protect the continuity of or entrench our management. This may adversely affect the market price of our common stock. If, in the due exercise of its fiduciary obligations, for example, our Board were to determine that a takeover proposal were not in the best interest of the Company, such shares could be issued by the Board without stockholder approval in one or more private placements or other transactions that might prevent or render more difficult or make more costly the completion of any attempted takeover transactions by diluting voting or other rights of the proposed acquirer or insurgent stockholder group, by creating a substantial voting block in institutional or other hands that might support the position of the incumbent Board, by effecting an acquisition that might complicate or preclude the takeover, or otherwise. We have no current intention to issue shares for anti-takeover purposes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Failure to approve this Authorized Stock Increase Proposal could have adverse results for, and effects on, the Company. Without a reasonable amount of authorized shares available to us for issuance, we may not have the ability to raise additional capital, establish strategic relationships with other companies or expand our business or product lines through acquisition. In addition, if we effect a reverse stock split as described in Proposal 4, we will have a more limited number of authorized shares available for issuance which could further exacerbate the problems described above. Furthermore, our future success depends upon our ability to attract, retain and motivate highly-skilled scientific, commercial and managerial employees, and if this proposal is not approved by our stockholders, the lack of sufficient unissued and unreserved authorized shares of common stock to provide future equity incentive opportunities could adversely impact our ability to achieve these goals. Furthermore, given the decline in the price of our common stock, we may need additional shares of authorized common stock to satisfy our capital needs. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Effectiveness of Amendment </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Share Increase, if approved by our stockholders, would become effective upon the filing and effectiveness of the certificate of amendment, the form of which is attached hereto as Annex B, with the Secretary of State of the State of Delaware. Such filing would take place only in the event the Board determines, following approval by our stockholders, that it remains in the best interest of the Company and its stockholders to effect the Share Increase. The exact timing of the filing of the amendment to effect the Share Increase, however, will be determined by our Board based on its evaluation as to when such action will be the most advantageous to the Company and our stockholders; provided, however, that the Share Increase amendment must be effective within one year after the conclusion of the Annual Meeting. In addition, our Board reserves the right, notwithstanding stockholder approval and without further action by the stockholders, to elect not to proceed with the Share Increase amendment if, at any time prior to the filing of the Share Increase amendment with the Secretary of State of the State of Delaware, our Board, in its sole discretion, determines that it is no longer in our Company&#8217;s best interest or the best interest of our stockholders to proceed with the Share Increase. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Bifurcation of Proposals 4 and 5 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The approval of this proposal is not conditioned on the approval of the Reverse Stock Split Proposal. To the extent that only one of either of these proposals is approved by our stockholders, only the amendment to our </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">25 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Charter to affect the proposal that was approved by our stockholders may be filed with the Secretary of State of the State of Delaware. To the extent that both the Authorized Stock Increase Proposal and Reverse Stock Split Proposal are approved by our stockholders, the amendment to our Charter to effect the Share Increase is expected, subject the Board&#8217;s discretion, to be filed in advance of the Fourth Amended and Restated Charter. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding approval of these proposals by our stockholders, our Board has reserved its right to abandon, at any time, either or both of the proposed amendments if, in its sole discretion, it determines doing so is in the best interest of the Company and our stockholders. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required for Approval </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Affirmative votes &#8220;For&#8221; the amendment must exceed the votes cast against the amendment for approval of this proposal. Abstentions will have no effect on the outcome of the vote. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The approval of this proposal is not conditioned on the approval or disapproval of Reverse Stock Split Proposal. However, should both this proposal and the Reverse Stock Split Proposal be approved by our stockholders, the Board would, in its discretion, choose which proposal(s) to implement, subject to its discretion to determine that neither proposal is in the best interest of the Company or its stockholders. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="font-style:italic">The Board recommends that you vote &#8220;FOR&#8221; the proposal to approve the amendment to implement the Share Increase, at our Board&#8217;s discretion. </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">26 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_7a">Proposal 6 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Amendment of Equity Incentive Plan </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Overview </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May 5, 2025, the board of directors (&#8220;Board&#8221;) adopted an amendment of our 2020 Equity Incentive Plan, as amended (the &#8220;2020 Plan&#8221;), subject to the approval of our stockholders at the 2025 Annual Meeting. The amendment adopted by the Board would increase the number of shares of our Common Stock (the &#8220;Shares&#8221;) reserved for issuance under the 2020 Plan by 1,000,000 million (to 1,130,745 million shares from 130,745 million shares) (the &#8220;Amendment&#8221;). We are not seeking stockholder approval of any other changes to the 2020 Plan. The full text of the proposed Amendment is attached hereto as <span style="font-style:italic">Annex C</span>. Our common stock is listed on Nasdaq and we are subject to Nasdaq rules and regulations. Nasdaq rules require stockholder approval for any material revision to an equity compensation plan. We are seeking stockholder approval of the Amendment because it is deemed a material revision to the 2020 Plan. The Board has approved the increase of the available Shares under the 2020 Plan, subject to stockholder approval. The Board has also determined that it is in the best interests of the Company and its stockholders to approve this proposal, and recommends that stockholders vote in favor of this proposal at the Annual Meeting. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If stockholders approve this proposal, the proposed Amendment will become effective as of the date of stockholder approval. If this proposal is approved by our stockholders, we intend to file with the SEC a registration statement on Form <span style="white-space:nowrap">S-8</span> covering the additional 1,000,000 shares of our Common Stock issuable under the 2020 Plan. If stockholders do not approve this proposal, the proposed Amendment to the 2020 Plan described in this proposal will not take effect and our current 2020 Plan will continue to be administered in its current form, subject to any amendment for which stockholder approval is not required to the extent permitted by the 2020 Plan. However, as a result of the limited number of Shares remaining available for issuance under the 2020 Plan, our projections show that the current share reserve will not likely be sufficient to cover anticipated new equity grants needed beyond the Company&#8217;s 2025 annual meeting of stockholders. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our executive officers and directors have an interest in this proposal by virtue of their being eligible to receive equity awards under the 2020 Plan. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Shares Available for Future Awards </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of March&#160;31, 2025, approximately 130,745 Shares remained available for grant under the 2020 Plan. The Board believes that the Shares reserved for issuance under it following stockholder approval of the proposed Amendment (along with Shares becoming available for future grant due to forfeitures and cancellations) would be sufficient to enable us to continue to grant equity awards under the 2020 Plan for approximately 3 years. This estimate is based on a forecast that takes into account our anticipated rate of growth in hiring, an estimated range of our stock price over time and our historical forfeiture rates, as well as the number of Shares we have available for grant under our plan. However, future circumstances may require a change to expected equity grant practices. Our share usage may vary from our historical practice depending on a number of factors, including the size of our workforce, which may continue to grow due to acquisitions and our drillings and development plan, our hiring needs, our incentive and retention objectives, award levels and amounts provided by the Company&#8217;s competitors and our stock price. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Reasons for Voting for the Proposal </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Equity Awards Are an Important Part of Our Compensation Philosophy </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our overall compensation objective is to compensate our personnel in a manner that attracts and retains the highly talented employees necessary to manage and staff a fast-paced and operationally complex business in an innovative and competitive industry. Our employees are our most valuable asset, and we strive to provide them with compensation packages that are competitive, that reward individual and Company performance and that </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">27 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
help meet our retention needs. Equity awards, whose value depends on our stock performance and which require continued service over time before any value can be realized, help achieve these objectives and are a key element of our compensation program. Equity awards also incentivize our employees to manage our business as owners, aligning their interests with those of our stockholders. Our Board believes that our broad-based equity compensation program is essential to attract, retain and motivate people with the necessary talent and experience and to provide additional incentive to achieve our short- and long-term business objectives, and ultimately increase stockholder value. As of March&#160;31, 2025, approximately 14 of our current and former employees held outstanding equity awards. Our board of directors believes we must continue to offer competitive equity compensation packages in order to attract and motivate the talent necessary for our continued growth and success. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The 2020 Plan Requires Additional Shares to Meet Our Forecasted Needs </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We currently forecast granting equity awards representing approximately 300,000 Shares (over a <span style="white-space:nowrap">two-year</span> period), or approximately 18.3% of our Shares outstanding as of March&#160;31, 2025. We also anticipate Share forfeitures and cancellations of approximately 5,500 Shares over this period, based on our historic rates. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If our expectation for grants and forfeitures is accurate, our net grants (grants less forfeitures and cancellations) over the next year would be approximately 147,000 Shares, or approximately 9.19% of our Shares outstanding as of March&#160;31, 2025. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As described above, the 2020 Plan had 130,745 Shares available for grant as of March&#160;31, 2025. We believe additional Shares should be reserved for issuance under our 2020 Plan to meet our estimated near-term equity compensation needs. The proposed Amendment will allow us to continue to utilize equity awards as long-term incentives to secure and retain the services of our employees and directors as well as certain consultants, consistent with our compensation philosophy and common compensation practices for our industry. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One alternative to using equity awards would be to significantly increase cash compensation. We do not believe this would be practical or advisable. We believe that a combination of equity and cash compensation is better for attracting, retaining, and motivating employees, consultants and directors, particularly in light of the highly innovative and competitive industry in which we operate. Any significant increase in cash compensation in lieu of equity awards would reduce the cash otherwise available for operations and investment in our business. Furthermore, we do not believe a more cash-oriented program would have the same long-term retention value or serve to align employees&#8217;, consultants&#8217; and directors&#8217; interests to those of our stockholders as effectively as a program that includes equity. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Size of Our Share Reserve Request is Reasonable and We Manage Our Equity Use Responsibly </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our compensation philosophy reflects broad-based eligibility for equity awards, and we grant awards to all of our employees. However, we recognize that equity awards dilute existing stockholders, and, therefore, we are mindful to responsibly manage the growth of our equity compensation program. We are committed to effectively monitoring our equity compensation share reserve, including our &#8220;burn rate,&#8221; to ensure that we maximize stockholders&#8217; value by granting the appropriate number of equity awards necessary to attract, reward, and retain employees,&#160;directors and consultants. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Therefore, our Board believes that the Amendment is in the best interests of our business and our stockholders and unanimously recommends a vote in favor of this Proposal&#160;6. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">28 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">2022 - 2025 Burn Rate and 2025 Outstanding Awards Overhang </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides certain additional information regarding our equity incentive program and our equity burn rate over the last three fiscal years and current overhang. Note that burn rate and overhang are calculated <span style="white-space:nowrap">on&#160;a&#160;non-diluted&#160;basis.</span> </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:72%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">Burn&#160;Rate</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">2024</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock Options Granted</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">31,316</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">25,912</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">13,289</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Full Value Shares Granted</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">163,391</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,442</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">-</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Equity Awards</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">69,390</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">46,589</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">33,237</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted Average Common Shares Outstanding</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,447,535</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,599,532</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,601,252</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Burn Rate<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2.16</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1.62</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">0.82</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Equity Awards Forfeited</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">35,784</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">51,641</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">-</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Net Burn Rate<sup style="font-size:75%; vertical-align:top">(2)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(0.31</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(1.61</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">0.82</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Burn Rate equals number of shares subject to equity awards granted during a fiscal year divided by weighted average common shares outstanding for that fiscal year. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Net Burn Rate equals (i)&#160;number of shares subject to equity awards granted during a fiscal year minus total equity awards forfeited during that fiscal year, divided by (ii)&#160;weighted average shares of common stock outstanding for that fiscal year. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:87%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Current Overhang (As of March&#160;31, 2025)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock Options Outstanding</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">45,237</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted Average Exercise Price of Outstanding Stock Options</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">153.79</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted Average Remaining Term of Outstanding Stock Options</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7.81 years</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Full Value Awards Outstanding</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">-</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Equity Awards Outstanding</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">18,160</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares Remaining Available for Future Grant<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">130,745</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock Outstanding as of March&#160;31, 2025</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,601,252</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">As of March&#160;31, 2025, there were no shares of common stock available for grant under any of our equity incentive plans, other than the 2020 Plan. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The closing price of our common stock as reported on Nasdaq Capital Market on May&#160;5, 2025, the record date for this annual meeting, was $2.85. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Amendment Does Not Affect the 2020 Plan&#8217;s Compensation and Governance Best Practices </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Amendment does not alter any provisions in the 2020 Plan that are designed to protect our stockholders&#8217; interests and to reflect corporate governance best practices, including: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">No stock option repricing/exchange.</span>&#160;Our Board does not have the authority to reprice any outstanding stock option or stock appreciation right by reducing the exercise price of the stock option or stock appreciation right or to cancel any outstanding stock option or stock appreciation right that has an exercise price or strike price in excess of the current fair market value in exchange for cash or other stock awards without obtaining the approval of our stockholders within 12 months prior to the repricing or cancellation <span style="white-space:nowrap">and&#160;re-grant&#160;event.</span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">No &#8220;evergreen&#8221; provision; stockholder approval is required for additional shares</span>. The 2020 Plan does not contain an annual &#8220;evergreen&#8221; provision. The 2020 Plan authorizes a fixed number of shares, so that stockholder approval is required to issue any additional shares. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Restrictions on dividends</span>. The 2020 Plan provides that (i)&#160;no dividends or dividend equivalents may be paid with respect to any Shares subject to an award before the date such shares have vested, (ii)&#160;any dividends or dividend equivalents that are credited with respect to any such shares </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">29 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
will be subject to all of the terms and conditions applicable to such shares under the terms of the applicable award agreement (including, but not limited to, any vesting conditions), and (iii)&#160;any dividends or dividend equivalents that are credited with respect to any such shares will be forfeited to us on the date, if any, such shares are forfeited to or repurchased by us due to a failure to vest. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Fungible share counting.</span> The 2020 Plan contains a &#8220;fungible share counting&#8221; structure, which increases the rate at which the share reserve is depleted for stock awards other than stock options and stock appreciation rights in order to minimize stockholder dilution. Specifically, the number of Shares available for issuance under the 2020 Plan will be reduced by (i)&#160;one share for each share issued pursuant to a stock option or stock appreciation right with an exercise price that is at least 100% of the fair market value of a share on the date of grant (an &#8220;Appreciation Award&#8221;), and (ii)&#160;1.5 Shares for each Share issued pursuant to a stock award that is not an Appreciation Award (a &#8220;Full Value Award&#8221;). Such Shares will return to the share reserve at the same rates. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">No liberal share counting provisions for Appreciation Awards</span>. The following shares will not become available again for issuance under the 2020 Plan: (i)&#160;any shares that are reacquired or withheld (or not issued) by us to satisfy the exercise or strike price of an Appreciation Award; (ii)&#160;any shares that are reacquired or withheld (or not issued) by us to satisfy a tax withholding obligation in connection with an Appreciation Award; (iii)&#160;any shares repurchased by us on the open market with the proceeds of the exercise or strike price of an Appreciation Award; and (iv)&#160;in the event that a stock appreciation right granted under the 2020 Plan is settled in Shares, the gross number of Shares subject to such stock appreciate right. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">No liberal change in control definition</span>. The change in control definition in the 2020 Plan is not a &#8220;liberal&#8221; definition. A change in control transaction must actually occur in order for the change in control provisions in the 2020 Plan to be triggered. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Awards subject to forfeiture/clawback</span>. Awards granted under the 2020 Plan will be subject to recoupment in accordance with any clawback policy that we are required to adopt pursuant to the listing standards of any national securities exchange or association on which our securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law, and any other clawback policy that the Company adopts. In addition, the board may impose other clawback, recovery or recoupment provisions in an award agreement, including a reacquisition right in respect of previously acquired shares or other cash or property upon the occurrence of cause. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Material amendments require stockholder approval</span>. Consistent with Nasdaq rules, the 2020 Plan requires stockholder approval of any material revisions to the 2020 Plan. In addition, certain other amendments to the 2020 Plan require stockholder approval. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Description of the 2020 Plan </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The material features of the 2020 Plan and the Amendment were described below. The following description of the 2020 Plan and the Amendment is a summary only and is qualified in its entirety by reference to the complete text of the 2020 Plan, which is included as Appendix A of the Company&#8217;s definitive Proxy Statement on Schedule 14A filed on May&#160;18, 2020, and the Amendment, which is attached to this proxy statement as<span style="font-style:italic">&#160;Annex C</span>. Stockholders are urged to read the actual text of the 2020 Plan and the Amendment in their entirety. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Purpose </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2020 Plan is designed to secure and retain the services of <span style="white-space:nowrap">our&#160;employees,&#160;non-employee&#160;directors&#160;and</span> consultants, to provide incentives for such persons to exert maximum efforts for the success of the Company and our affiliates, and to provide a means by which such persons may be given an opportunity to benefit from increases in the value of our Shares. The 2020 Plan is also designed to align employees&#8217; interests with stockholder interests. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">30 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Types of Awards </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The terms of the 2020 Plan provide for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, and performance awards. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Shares Available for Awards </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to adjustment for certain changes in our capitalization, if the Amendment is approved by our Stockholders, the aggregate number of Shares that may be issued under the 2020 Plan will not exceed 1,130,745 shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The number of Shares available for issuance under the 2020 Plan will be reduced or increased by (i)&#160;one Share for each Share issued pursuant to an Appreciation Award, and (ii)&#160;1.5 Shares for each Share issued pursuant to a Full Value Award. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following actions will not result in an issuance of Shares under the 2020 Plan and accordingly will not reduce the number of Shares available for issuance under the 2020 Plan: (i)&#160;the expiration or termination of any portion of an award granted under the 2020 Plan without the Shares covered by such portion of the award having been issued; (ii)&#160;the settlement of any portion of an award granted under the 2020 Plan in cash; (iii)&#160;the withholding of Shares that would otherwise be issued by the Company to satisfy the exercise, strike or purchase price of a Full Value Award; and (iv)&#160;the withholding of Shares that would otherwise be issued by the Company to satisfy a tax withholding obligation in connection with a Full Value Award. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Eligibility </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of our (including our affiliates&#8217;) <span style="white-space:nowrap">employees,&#160;non-employee&#160;directors&#160;and</span> consultants are eligible to participate in the 2020 Plan and may receive all types of awards other than incentive stock options. Incentive stock options may be granted under the 2020 Plan only to our (including our affiliates&#8217;) employees. As of May&#160;1, 2025, we (including our affiliates) had approximately one employee, <span style="white-space:nowrap">four&#160;non-employee&#160;directors</span> and approximately four consultants. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Administration </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2020 Plan will be administered by our Board, which may in turn delegate some or all of the administration of the 2020 Plan to a committee or committees composed of members of our Board. Our Board has delegated concurrent authority to administer the 2020 Plan to our Compensation Committee, but may, at any time, revest in itself some or all of the power delegated to our Compensation Committee. Our Board and or the Compensation Committee, as applicable, is herein referred to as the &#8220;Plan Administrator&#8221;. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the terms of the 2020 Plan, the Plan Administrator may determine the recipients, the types of awards to be granted, the number of Shares of our common stock subject to or the cash value of awards, and the terms and conditions of awards granted under the 2020 Plan, including the period of their exercisability and vesting. The Plan Administrator has the authority to provide for accelerated exercisability and vesting of awards. Subject to the limitations set forth below, the Plan Administrator also determines the fair market value applicable to an award and the exercise or strike price of stock options and stock appreciation rights granted under the 2020 Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the Plan Administrator may delegate to one or more executive officers the authority to designate employees who are not executive officers to be recipients of certain awards and the number of Shares subject to such awards. Under any such delegation, the Plan Administrator will specify the total number of Shares that may be subject to the awards granted by such executive officer. The executive officer may not grant an award to himself or herself. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">31 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Repricing; <span style="white-space:nowrap">Cancellation&#160;and&#160;Re-Grant&#160;of&#160;Stock</span> Options or Stock Appreciation Rights </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the 2020 Plan, unless our stockholders have approved such an action within 12 months prior to such an event, the Plan Administrator does not have the authority to reprice any outstanding stock option or stock appreciation right by (1)&#160;reducing the exercise or strike price of the stock option or stock appreciation right, (2)&#160;canceling any outstanding stock option or stock appreciation right that has an exercise or strike price greater than the then-current fair market value of a Share in exchange for cash or other awards (other than in connection with a Transaction, as defined in the 2020 Plan and described below), or (3)&#160;take any other action with respect to an outstanding stock option or stock appreciation right that would be treated as a repricing under the rules and regulations of the principal U.S. national securities exchange on which the Shares are listed. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Dividends and Dividend Equivalents </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2020 Plan provides that dividends or dividend equivalents may be paid or credited with respect to any Shares subject to an award other than an option or stock appreciation right, as determined by the Plan Administrator and contained in the applicable award agreement;<span style="font-style:italic"></span><span style="font-style:italic">&#160;provided, however</span>, that (i)&#160;no dividends or dividend equivalents may be paid with respect to any such Shares before the date such shares have vested, (ii)&#160;any dividends or dividend equivalents that are credited with respect to any such Shares will be subject to all of the terms and conditions applicable to such Shares under the terms of the applicable award agreement (including any vesting conditions), and (iii)&#160;any dividends or dividend equivalents that are credited with respect to any such Shares will be forfeited to us on the date such Shares are forfeited to or repurchased by us due to a failure to vest. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Stock Options </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock options may be granted under the 2020 Plan pursuant to stock option agreements. The 2020 Plan permits the grant of stock options that are intended to qualify as incentive stock options, or ISOs, and nonstatutory stock options, or NSOs. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The exercise price of a stock option granted under the 2020 Plan may not be less than 100% of the fair market value of a Shares on the date of grant and, in some cases (see &#8220;&#8212;Limitations on Incentive Stock Options&#8221; below), may not be less than 110% of such fair market value. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The term of stock options granted under the 2020 Plan may not exceed ten years from the date of grant and, in some cases (see &#8220;&#8212;Limitations on Incentive Stock Options&#8221; below), may not exceed five years from the date of grant. Except as otherwise provided in a participant&#8217;s stock option agreement or other written agreement with us or one of our affiliates, if a participant&#8217;s service relationship with us or any of our affiliates (referred to in this Proposal 4 as &#8220;continuous service&#8221;) terminates (other than for cause (as defined in the 2020 Plan) or the participant&#8217;s death or disability (as defined in the 2020 Plan)), the participant may exercise any vested stock options for up to three&#160;months following the participant&#8217;s termination of continuous service. Except as otherwise provided in a participant&#8217;s stock option agreement or other written agreement with us or one of our affiliates, if a participant&#8217;s continuous service terminates due to the participant&#8217;s disability, the participant may exercise any vested stock options for up to 12 months following the participant&#8217;s termination due to the participant&#8217;s disability. Except as otherwise provided in a participant&#8217;s stock option agreement or other written agreement with us or one of our affiliates, if a participant&#8217;s continuous service terminates due to the participant&#8217;s death (or the participant dies within a specified period following termination of continuous service), the participant&#8217;s beneficiary may exercise any vested stock options for up to 18 months following the participant&#8217;s death. Except as explicitly provided otherwise in a participant&#8217;s stock option agreement or other written agreement with us or one of our affiliates, if a participant&#8217;s continuous service is terminated for cause, all stock options held by the participant will terminate upon the participant&#8217;s termination of continuous service and the participant will be prohibited from exercising any stock option from and after such termination date. Except as otherwise provided in a participant&#8217;s stock option agreement or other written agreement with us or one of our affiliates, the term of a stock option may be extended if a participant&#8217;s continuous service terminates for any reason other than for cause </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">32 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and, at any time during the applicable post-termination exercise period, the exercise of the stock option would be prohibited by applicable laws or the sale of any Shares received upon such exercise would violate our insider trading policy. In no event, however, may a stock option be exercised after its original expiration date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Acceptable forms of consideration for the purchase of our Shares pursuant to the exercise of a stock option under the 2020 Plan will be determined by the Plan Administrator and may include payment: (i)&#160;by cash, check, bank draft or money order payable to us; (ii)&#160;pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board; (iii)&#160;by delivery to us of Shares (either by actual delivery or attestation); (iv) by a net exercise arrangement (for NSOs only); or (v)&#160;in other legal consideration approved by the Plan Administrator. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock options granted under the 2020 Plan may become exercisable in cumulative increments, or &#8220;vest,&#8221; as determined by the Plan Administrator at the rate specified in the stock option agreement. Shares covered by different stock options granted under the 2020 Plan may be subject to different vesting schedules as the Plan Administrator may determine. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Plan Administrator may impose limitations on the transferability of stock options granted under the 2020 Plan in its discretion. Generally, a participant may not transfer a stock option granted under the 2020 Plan other than by will or the laws of descent and distribution or, subject to approval by the Plan Administrator, pursuant to a domestic relations order. However, the Plan Administrator may permit transfer of a stock option in a manner that is not prohibited by applicable tax and securities laws. Options may not be transferred to a third party financial institution for value. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Limitations on Incentive Stock Options </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with current federal tax laws, the aggregate fair market value, determined at the time of grant, of Shares with respect to ISOs that are exercisable for the first time by a participant during any calendar year under all of our stock plans may not exceed $100,000. The stock options or portions of stock options that exceed this limit or otherwise fail to qualify as ISOs are treated as NSOs. No ISO may be granted to any person who, at the time of grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power unless the following conditions are satisfied: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the exercise price of the ISO must be at least 110% of the fair market value of a Share on the date of grant; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the term of the ISO must not exceed five years from the date of grant. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to adjustment for certain changes in our capitalization, the aggregate maximum number of Shares that may be issued pursuant to the exercise of ISOs under the 2020 Plan is 10,435 shares. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Stock Appreciation Rights </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock appreciation rights may be granted under the 2020 Plan pursuant to stock appreciation right agreements. Each stock appreciation right is denominated in Share equivalents. The strike price of each stock appreciation right will be determined by the Plan Administrator, but will in no event be less than 100% of the fair market value of a Share subject to the stock appreciation right on the date of grant. The term of stock appreciation rights granted under the 2020 Plan may not exceed ten years from the date of grant. The Plan Administrator may also impose restrictions or conditions upon the vesting of stock appreciation rights that it deems appropriate. The appreciation distribution payable upon exercise of a stock appreciation right may be paid in Shares, in cash, in a combination of cash and stock, or in any other form of consideration determined by the Plan Administrator and set forth in the stock appreciation right agreement. Stock appreciation rights will be subject to the same conditions upon termination of continuous service and restrictions on transfer as stock options under the 2020 Plan. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">33 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Restricted Stock Awards </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted stock awards may be granted under the 2020 Plan pursuant to restricted stock award agreements. A restricted stock award may be granted in consideration for cash, check, bank draft or money order payable to us, the participant&#8217;s services performed for us, or any other form of legal consideration acceptable to the Plan Administrator. Shares under a restricted stock award may be subject to forfeiture to or repurchase by us in accordance with a vesting schedule to be determined by the Plan Administrator. Rights to acquire Shares under a restricted stock award may be transferred only upon such terms and conditions as are set forth in the restricted stock award agreement. Upon a participant&#8217;s termination of continuous service for any reason, any shares subject to restricted stock awards held by the participant that have not vested as of such termination date may be forfeited to or repurchased by us. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Restricted Stock Unit Awards </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted stock unit awards may be granted under the 2020 Plan pursuant to restricted stock unit award agreements. Payment of any purchase price may be made in any form of legal consideration acceptable to the Plan Administrator. A restricted stock unit award may be settled by the delivery of Shares, in cash, in a combination of cash and stock, or in any other form of consideration determined by the Plan Administrator and set forth in the restricted stock unit award agreement. Restricted stock unit awards may be subject to vesting in accordance with a vesting schedule to be determined by the Plan Administrator. Except as otherwise provided in a participant&#8217;s restricted stock unit award agreement or other written agreement with us, restricted stock units that have not vested will be forfeited upon the participant&#8217;s termination of continuous service for any reason. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Performance Awards </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2020 Plan allows us to grant performance awards. A performance award is an award that may vest or may be exercised, or that may become earned and paid, contingent upon the attainment of&#160;certain performance goals during a performance period. A performance award may require the completion of a specified period of continuous service. The length of any performance period, the performance goals to be achieved during the performance period, and the measure of whether and to what degree such performance goals have been attained will be determined by the Plan Administrator in its discretion. In addition, to the extent permitted by applicable law and the applicable award agreement, the Plan Administrator may determine that cash may be used in payment of performance awards. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Performance goals under the 2020 Plan will be established by the board of directors for a performance period. The performance criteria used to establish such goals may be based on any measure of performance selected by the board of directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Performance goals may be based on a Company-wide basis, with respect to one or more business units, divisions, affiliates or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise by the Plan Administrator (i)&#160;in the award agreement at the time the award is granted or (ii)&#160;in such other document setting forth the performance goals at the time the performance goals are established, the Plan Administrator will appropriately make adjustments in the method of calculating the attainment of the performance goals for a performance period as follows: (1)&#160;to exclude restructuring and/or other nonrecurring charges; (2)&#160;to exclude exchange rate effects; (3)&#160;to exclude the effects of changes to generally accepted accounting principles; (4)&#160;to exclude the effects of any statutory adjustments to corporate tax rates; (5)&#160;to exclude the effects of items that are &#8220;unusual&#8221; in nature or occur &#8220;infrequently&#8221; as determined under generally accepted accounting principles; (6)&#160;to exclude the dilutive effects of acquisitions or joint ventures; (7)&#160;to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a performance period following such divestiture; (8)&#160;to exclude the effect of any change in the outstanding Shares of the Company by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, <span style="white-space:nowrap">consolidation,&#160;spin-off,&#160;combination</span> or exchange of shares or other similar corporate change, or any distributions </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">34 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to common stockholders other than regular cash dividends; (9)&#160;to exclude the effects of stock based compensation and the award of bonuses under the Company&#8217;s bonus plans; (10)&#160;to exclude costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles; (11)&#160;to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting principles; and (12)&#160;to exclude the effects of the timing of acceptance for review and/or approval of submissions to the U.S. Food and Drug Administration or any other regulatory body. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the Plan Administrator retains the discretion to define the manner of calculating the performance criteria it selects to use for a performance period and to reduce, increase or eliminate the compensation or economic benefit due upon the attainment of any performance goal. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Clawback Policy </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Awards granted under the 2020 Plan will be subject to recoupment in accordance with any clawback policy that we are required to adopt pursuant to the listing standards of any national securities exchange or association on which our securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law, and any other clawback policy that the Company adopts. In addition, the board of directors may impose such other clawback, recovery or recoupment provisions in an award agreement as the board of directors determines necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired Shares or other cash or property upon the occurrence of cause. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Changes to Capital Structure </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of certain capitalization adjustments, the Plan Administrator will appropriately and proportionately adjust: (i)&#160;the class(es) and maximum number of Shares issuable under the 2020 Plan; (ii)&#160;the class(es) and maximum number of Shares that may be issued pursuant to the exercise of ISOs; and (iii)&#160;the class(es) and number of Shares and the exercise, strike or purchase price per Share subject to outstanding awards. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Corporate Transaction and Change in Control </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following applies to each outstanding award under the 2020 Plan in the event of a corporate transaction (as defined in the 2020 Plan and described below) or a change in control (as defined in the 2020 Plan and described below), unless provided otherwise in the applicable award agreement or in any other written agreement between a participant and the Company or an affiliate. For purposes of this Proposal 4, the term &#8220;Transaction&#8221; will mean such corporate transaction or change in control. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of a Transaction, any awards outstanding under the 2020 Plan may be assumed, continued or substituted for by any surviving or acquiring corporation (or its parent company) (such entity, the &#8220;acquiring entity&#8221;), and any reacquisition or repurchase rights held by us with respect to the award may be assigned to the acquiring entity. If the acquiring entity does not assume, continue or substitute for such awards, then with respect to any such awards that are held by participants whose continuous service has not terminated prior to the effective time of the Transaction (such participants, the &#8220;current participants&#8221;), the vesting (and exercisability, if applicable) of such awards will be accelerated in full to a date prior to the effective time of the Transaction (contingent upon the effectiveness of the Transaction), and such awards will terminate if not exercised (if applicable) at or prior to the effective time of the Transaction, and any reacquisition or repurchase rights held by us with respect to such awards will lapse (contingent upon the effectiveness of the Transaction).&#160;With respect to the vesting of performance awards that will accelerate upon the occurrence of a Transaction and that have multiple vesting levels depending on the level of performance, unless otherwise provided in the relevant award agreement, the vesting of such performance awards will accelerate at 100% of the target level upon the occurrence of the Transaction. If the acquiring entity does not assume, continue or substitute for such awards, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">35 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
then any such awards that are held by persons other than current participants will terminate if not exercised (if applicable) at or prior to the effective time of the Transaction, except that any reacquisition or repurchase rights held by us with respect to such awards will not terminate and may continue to be exercised notwithstanding the Transaction. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event an award will terminate if not exercised at or prior to the effective time of a Transaction, the Plan Administrator may provide that the holder of such award may not exercise such award but instead will receive a payment equal in value to the excess, if any, of (i)&#160;the value of the property the participant would have received upon the exercise of the award, over (ii)&#160;any exercise price payable by such holder in connection with such exercise. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the 2020 Plan, a &#8220;corporate transaction&#8221; generally means the consummation of any one or more of the following events: (1)&#160;a sale or other disposition of all or substantially all of our assets; (2)&#160;a sale or other </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">disposition of at least 50% of our outstanding securities; (3)&#160;a merger, consolidation or similar transaction where we do not survive the transaction; or (4)&#160;a merger, consolidation or similar transaction where we do survive the transaction but the Shares outstanding immediately before such transaction are converted or exchanged into other property by virtue of the transaction. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the 2020 Plan, a &#8220;change in control&#8221; generally means the occurrence of any one or more of the following events: (1)&#160;the acquisition by any person, entity or group of our securities representing more than 50% of the combined voting power of our then outstanding securities, other than by virtue of a merger, consolidation, or similar transaction; (2)&#160;a consummated merger, consolidation or similar transaction in which our stockholders immediately before such transaction do not own, directly or indirectly, more than 50% of the combined voting power of the surviving entity (or the parent of the surviving entity) in substantially the same proportions as their ownership immediately prior to such transaction; (3)&#160;a consummated sale, lease, exclusive license or other disposition of all or substantially all of our assets, other than to an entity, more than 50% of the combined voting power of which is owned by our stockholders in substantially the same proportions as their ownership of our outstanding voting securities immediately prior to such transaction; or (4)&#160;when a majority of our board of directors becomes comprised of individuals who were not serving on our board of directors on the date the 2020 Plan was adopted by our board of directors (the &#8220;incumbent board of directors&#8221;), or whose nomination, appointment, or election was not approved by a majority of the incumbent board of directors still in office. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Plan Amendments and Termination </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Plan Administrator will have the authority to amend or terminate the 2020 Plan at any time. However, except as otherwise provided in the 2020 Plan, no amendment or termination of the 2020 Plan may materially impair a participant&#8217;s rights under his or her outstanding awards without the participant&#8217;s consent. We will obtain stockholder approval of any amendment to the 2020 Plan as required by applicable law and listing requirements. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">U.S. Federal Income Tax Consequences </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a summary of the principal United States federal income tax consequences to participants and us with respect to participation in the 2020 Plan. This summary is not intended to be exhaustive and does not discuss the income tax laws of any local, state or foreign jurisdiction in which a participant may reside. The information is based upon current federal income tax rules and therefore is subject to change when those rules change. Because the tax consequences to any participant may depend on his or her particular situation, each participant should consult the participant&#8217;s tax adviser regarding the federal, state, local and other tax consequences of the grant or exercise of an award or the disposition of stock acquired the 2020 Plan. The 2020 Plan is not qualified under the provisions of Section&#160;401(a) of the Internal Revenue Code of 1986, as amended, (the &#8220;Code&#8221;) and is not subject to any of the provisions of the Employee Retirement Income Security Act of 1974. Our ability to realize the benefit of any tax deductions described below depends on our generation of taxable income as well as the requirement of reasonableness and the satisfaction of our tax reporting obligations. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">36 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Nonstatutory Stock Options </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, there is no taxation upon the grant of an NSO if the stock option is granted with an exercise price equal to the fair market value of the underlying stock on the grant date. Upon exercise, a participant will recognize ordinary income equal to the excess, if any, of the fair market value of the underlying stock on the date of exercise of the stock option over the exercise price. If the participant is employed by us or one of our affiliates, that income will be subject to withholding taxes. The participant&#8217;s tax basis in those shares will be equal to his or her fair market value on the date of exercise of the stock option, and the participant&#8217;s capital gain holding period for those shares will begin on that date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the requirement of reasonableness, the provisions of Section&#160;162(m) of the Code, and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Incentive Stock Options </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2020 Plan provides for the grant of stock options that are intended to qualify as &#8220;incentive stock options,&#8221; as defined in Section&#160;422 of the Code. Under the Code, a participant generally is not subject to ordinary income tax upon the grant or exercise of an ISO. If the participant holds a share received upon exercise of an ISO for more than two years from the date the stock option was granted and more than one year from the date the stock option was exercised, which is referred to as the required holding period, the difference, if any, between the amount realized on a sale or other taxable disposition of that share and the participant&#8217;s tax basis in that share will be long-term capital gain or loss. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If, however, a participant disposes of a share acquired upon exercise of an ISO before the end of the required holding period, which is referred to as a disqualifying disposition, the participant generally will recognize ordinary income in the year of the disqualifying disposition equal to the excess, if any, of the fair market value of the share on the date of exercise of the stock option over the exercise price. However, if the sales proceeds are less than the fair market value of the share on the date of exercise of the stock option, the amount of ordinary income recognized by the participant will not exceed the gain, if any, realized on the sale. If the amount realized on a disqualifying disposition exceeds the fair market value of the share on the date of exercise of the stock option, that excess will be short-term or long-term capital gain, depending on whether the holding period for the share exceeds one year. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of the alternative minimum tax, the amount by which the fair market value of a share of stock acquired upon exercise of an ISO exceeds the exercise price of the stock option generally will be an adjustment included in the participant&#8217;s alternative minimum taxable income for the year in which the stock option is exercised. If, however, there is a disqualifying disposition of the share in the year in which the stock option is exercised, there will be no adjustment for alternative minimum tax purposes with respect to that share. In computing alternative minimum taxable income, the tax basis of a share acquired upon exercise of an ISO is increased by the amount of the adjustment taken into account with respect to that share for alternative minimum tax purposes in the year the stock option is exercised. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are not allowed a tax deduction with respect to the grant or exercise of an ISO or the disposition of a share acquired upon exercise of an ISO after the required holding period. If there is a disqualifying disposition of a share, however, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant, subject to the requirement of reasonableness, the provisions of Section&#160;162(m) of the Code, and provided that either the employee includes that amount in income or we timely satisfy our reporting requirements with respect to that amount. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">37 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Restricted Stock Awards </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, the recipient of a restricted stock award will recognize ordinary income at the time the stock is received equal to the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. If, however, the stock is not vested when it is received (for example, if the employee is required to work for a period of time in order to have the right to sell the stock), the recipient generally will not recognize income until the stock becomes vested, at which time the recipient will recognize ordinary income equal to the excess, if any, of the fair market value of the stock on the date it becomes vested over any amount paid by the recipient in exchange for the stock. A recipient may, however, file an election with the Internal Revenue Service, within 30&#160;days following his or her receipt of the restricted stock award, to recognize ordinary income, as of the date the recipient receives the restricted stock award, equal to the excess, if any, of the fair market value of the stock on the date the restricted stock award is granted over any amount paid by the recipient for the stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The recipient&#8217;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a restricted stock award will be the amount paid for such shares plus any ordinary income recognized either when the stock is received or when the stock becomes vested. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the requirement of reasonableness, the provisions of Section&#160;162(m) of the Code, and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock award. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Restricted Stock Unit Awards </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, the recipient of a restricted stock unit award structured to comply with the requirements of Section&#160;409A of the Code or an exception to Section&#160;409A of the Code will recognize ordinary income at the time the stock is delivered equal to the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. To comply with the requirements of Section&#160;409A of the Code, the stock subject to a restricted stock unit award may generally only be delivered upon one of the following events: a fixed calendar date (or dates), separation from service, death, disability or a change in control. If delivery occurs on another date, unless the restricted stock unit award otherwise complies with or qualifies for an exception to the requirements of Section&#160;409A of the Code (including delivery upon achievement of a performance goal), in addition to the tax treatment described above, the recipient will owe an additional 20% federal tax and interest on any taxes owed. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The recipient&#8217;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a restricted stock unit award will be the amount paid for such shares plus any ordinary income recognized when the stock is delivered. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the requirement of reasonableness, the provisions of Section&#160;162(m) of the Code, and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock unit award. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Stock Appreciation Rights </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, if a stock appreciation right is granted with an exercise price equal to the fair market value of the underlying stock on the grant date, the recipient will recognize ordinary income equal to the fair market value of the stock or cash received upon such exercise. Subject to the requirement of reasonableness, the provisions of Section&#160;162(m) of the Code, and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the stock appreciation right. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">38 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Section&#160;162(m) Limitations </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Section&#160;162(m) of the Code, compensation paid to any publicly held corporation&#8217;s &#8220;covered employees&#8221; that exceeds $1&#160;million per taxable year for any covered employee is <span style="white-space:nowrap">generally&#160;non-deductible.&#160;Awards</span> granted under the 2020 Plan will be subject to the deduction limit under Section&#160;162(m) of the Code and will not be eligible to qualify for the performance-based compensation exception under Section&#160;162(m) of the Code pursuant to the transition relief provided by the Tax Cuts and Jobs Act. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">New Plan Benefits under 2020 Plan </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Awards granted under the 2020 Plan to our executive officers and other employees are discretionary and are not subject to set benefits or amounts under the terms of the 2020 Plan. Accordingly, the benefits or amounts that will be received by or allocated to our executive officers and other employees under the 2020 Plan are not determinable, and the New Plan Benefits Table is not provided. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Awards granted under the 2020 Plan to <span style="white-space:nowrap">our&#160;non-employee&#160;directors</span> are discretionary and are not subject to set benefits or amounts under the terms of the 2020 Plan. However, pursuant to our current compensation program <span style="white-space:nowrap">for&#160;non-employee&#160;directors,</span> in connection with a director&#8217;s initial election of the Board, each director receives options to purchase 25,600 Shares on the date of each new <span style="white-space:nowrap">non-employee</span> director&#8217;s appointment to our Board. <span style="white-space:nowrap">One-thirty-sixth</span> of these options shall vest each month on the monthly anniversary of the grant date. <span style="white-space:nowrap">Non-employee</span> directors are also entitled to receive options to purchase 12,800 Shares on an annual basis upon their election at the annual meeting of our stockholders, with the chair of our Board receiving additional options to purchase 6,400 Shares. <span style="white-space:nowrap">One-twelfth</span> of the annual option grant will vest each month on the monthly anniversary of the grant. If a new director is appointed to the Board between annual meetings of our stockholders, they will be entitled to a prorated option grant. For additional information regarding our current compensation program <span style="white-space:nowrap">for&#160;non-employee&#160;directors,</span> please see &#8220;Director Compensation&#8221; below. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Registration with the SEC </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this Proposal is approved by our stockholders, we intend to file with the SEC a registration statement on Form <span style="white-space:nowrap">S-8</span> covering the additional 1,000,000 shares of our common stock issuable under the 2020 Plan. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The affirmative vote of the holders of a majority of the vote cast on the proposal will be required to approve this Proposal 6. Abstentions and <span style="white-space:nowrap">broker&#160;non-votes&#160;are</span> not considered to be &#8220;votes cast&#8221; on this Proposal, and as a result, abstentions and broker <span style="white-space:nowrap">non-votes</span> will have no impact on the outcome of the proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="font-style:italic">The Board recommends that you vote &#8220;FOR&#8221; the proposal to approve the amendment to the 2020 Equity Incentive Plan. </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">39 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_8">PROPOSAL 7 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Adjournment of Annual Meeting </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are asking you to vote to approve one or more adjournments of the Annual Meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to approve either the Reverse Stock Split Proposal or the Authorized Stock Increase Proposal at the time of the Annual Meeting or if we do not have a quorum. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If our stockholders approve this Adjournment Proposal, we could adjourn the Annual Meeting and any reconvened session of the Annual Meeting and use the additional time to solicit additional proxies, including proxies from stockholders that have previously returned properly executed proxies voting against the approval of the Reverse Stock Split Proposal or the Authorized Stock Increase Proposal. Among other things, approval of the Adjournment Proposal could mean that, even if we had received proxies representing a sufficient number of votes against the approval of the Reverse Stock Split Proposal or the Authorized Stock Increase Proposal such that the proposal to approve any such proposal would be defeated, we could adjourn the Annual Meeting without a vote on the approval of such proposal and seek to convince the holders of those shares to change their votes to votes in favor of approval of such proposal. Additionally, we may seek to adjourn the Annual Meeting if a quorum is not present. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board believes that it is in the best interest of the Company and our stockholders to be able to adjourn the Annual Meeting to a later date or dates if necessary or appropriate for the purpose of soliciting additional proxies in respect of the approval of the Reverse Stock Split Proposal or the Authorized Stock Increase Proposal if there are insufficient votes to approve either or both at the time of the Annual Meeting or in the absence of a quorum. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The affirmative vote of the holders of a majority in voting power of the shares of stock present in person or represented by proxy and entitled to vote at the Annual Meeting is required for approval of the Adjournment Proposal. Abstentions will be counted toward the vote total for Proposal 7 and will have the same effect as &#8220;AGAINST&#8221; votes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="font-style:italic">The Board recommends that you vote &#8220;FOR&#8221; approval of the adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting to approve the other Proposals. </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">40 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_9">STOCKHOLDER PROPOSALS FOR THE 2026 ANNUAL MEETING OF STOCKHOLDERS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For a proposal to be considered for inclusion in our proxy materials for presentation at the 2026 annual meeting of stockholders pursuant to Rule <span style="white-space:nowrap">14a-8</span> under the Exchange Act, the proposal must be received by our Secretary at our principal executive offices at 2617 Bissonnet, Suite 233, Houston, TX 77005, by no later than January&#160;19, 2026, unless the date of 2026 annual meeting of stockholders is changed by more than 30 days from the <span style="white-space:nowrap">one-year</span> anniversary of this year&#8217;s annual meeting, in which case the deadline will be a reasonable time before we begin to distribute the proxy materials for the 2026 annual meeting of stockholders. Due to the complexity of the respective rights of the stockholders and us in this area, any stockholder desiring to propose such an action is advised to consult with his or her legal counsel with respect to such rights. We suggest that any such proposal be submitted to us by certified mail, return receipt requested. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rule <span style="white-space:nowrap">14a-4</span> under the Exchange Act governs our use of our discretionary proxy voting authority with respect to a stockholder proposal that the stockholder has not sought to include in our proxy statement. Rule <span style="white-space:nowrap">14a-4</span> provides that if a proponent of a proposal fails to notify us at least 45 days prior to the <span style="white-space:nowrap">one-year</span> anniversary of the day of mailing of the prior year&#8217;s proxy statement, management proxyholders will be allowed to use their discretionary voting authority as to whether the proposal is raised at the annual meeting, without any discussion of the matter. If a stockholder wishes to bring a matter before the stockholders at the 2026 annual meeting of stockholders but does not notify us before April 4, 2026 (or a reasonable time before we begin to distribute the proxy materials for the 2026 annual meeting of stockholders if the date of the 2026 annual meeting of stockholders is changed by more than 30 days from the <span style="white-space:nowrap">one-year</span> anniversary of this year&#8217;s annual meeting), for all proxies we receive, the management proxyholders will have discretionary authority to vote on the matter, including discretionary authority to vote in opposition to the stockholder&#8217;s proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to comply with the new universal proxy rules, stockholders who intend to solicit proxies in support of director nominees, other than the Company&#8217;s nominees, must provide notice that sets forth the information required by Rule <span style="white-space:nowrap">14a-19</span> under the Exchange Act to our Secretary at our principal executive offices at 2617 Bissonnet, Suite 233, Houston, TX 77005 no later than 60 days prior to the anniversary of the prior year&#8217;s Annual Meeting (i.e., May&#160;4, 2026) to be properly nominated before the 2026 Annual Meeting, except that, if the date of the meeting has changed by more than 30 calendar days from the previous year, then notice must be provided by the later of 60 calendar days prior to the date of the annual meeting or the 10th calendar day following the day on which public announcement of the date of the annual meeting is first made by the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Recommendations for candidates to be considered for election to the Board at the 2026 annual meeting of stockholders may be submitted to the corporate governance and nominating committee by our stockholders. In order to make such a recommendation, a stockholder must submit the recommendation in writing to the Chairperson of the corporate governance and nominating committee, in care of our Secretary at our principal executive offices at 2617 Bissonnet, Suite 233, Houston, TX 77005, at least 120 days prior to the mailing date of the <span style="white-space:nowrap">one-year</span> anniversary of the previous year&#8217;s annual meeting proxy statement. To enable the corporate governance and nominating committee to evaluate the candidate&#8217;s qualifications, stockholder recommendations must include the following information: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The name and address of the nominating stockholder and of the director candidate; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">A representation that the nominating stockholder is a holder of record of ours entitled to vote at the current year&#8217;s annual meeting; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">A description of any arrangements or understandings between the nominating stockholder and the director candidate or candidates being recommended pursuant to which the nomination or nominations are to be made by the stockholder; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">A resume detailing the educational, professional and other information necessary to determine if the nominee is qualified to become a director of ours; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">41 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Such other information regarding each nominee proposed by such stockholder as would have been required to be included in a proxy statement filed pursuant to the proxy rules of the SEC had each nominee been nominated by the Board; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The consent of each nominee to serve as a director of ours if so elected. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">42 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_10">CURRENT DIRECTORS, DIRECTOR NOMINEES AND EXECUTIVE OFFICERS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Our Board </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board presently has four directors: Dale Curtis Hogue, Jr., Robert W. Postma, Jaime Vieser and Holger Weis. Each of Mr.&#160;Postma, Mr.&#160;Vieser and Mr.&#160;Weis was previously elected by the stockholders. Mr.&#160;Hogue was appointed as a member of our Board effective December&#160;29, 2023 in connection with the termination of Mr.&#160;Kevin Boyle, Sr. and resignation of Ms.&#160;Mary Thistle. Robert Hofmeister, Ph.D. resigned as a director on April&#160;15, 2025. There was no disagreement between Dr.&#160;Hofmeister and the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Set forth below are the names and certain information about each of our directors as of April&#160;30, 2025. The information presented includes each director&#8217;s age, principal occupation and business experience for the past five years and the names of other public companies of which he or she has served as a director during the past five years. In addition, the table contains information about the specific and particular experience, qualifications, attributes or skills of each current director and each nominee for director at the Annual Meeting that led the corporate governance and nominating committee to believe that such current director was appropriate for nomination at a previous annual meeting of stockholders or otherwise and, in the case of each nominee for director at the Annual Meeting, that such nominee should serve on the Board following election at the Annual Meeting. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:46%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:42%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">Name</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Positions and Offices Held</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Director<br/>Since</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Age</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dale Curtis Hogue, Jr.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Interim Chief Executive Officer and Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">2023</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">56</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert W. Postma</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">2021</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">71</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jaime Vieser</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">2020</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">55</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holger Weis</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">2020</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">62</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under our director resignation policy, any nominee in an uncontested election who does not receive a majority of the votes cast (i.e. receives a greater number of votes &#8220;withheld&#8221; from his or her election than votes &#8220;for&#8221; in such election) shall submit his or her offer of resignation for consideration by the corporate governance and nominating committee of the Board (the &#8220;corporate governance and nominating committee&#8221;). The corporate governance and nominating committee shall consider all of the relevant facts and circumstances and recommend to the Board the action to be taken with respect to such offer of resignation, and the Board will then act on such recommendation. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our corporate governance and nominating committee seeks to assemble a Board that, as a whole, possesses the appropriate balance of professional and industry knowledge, financial expertise and management experience necessary to oversee and direct our business. The corporate governance and nominating committee maintains a goal of recruiting members who complement and strengthen the skills of other members and who also exhibit integrity, collegiality, sound business judgment and other qualities that the corporate governance and nominating committee views as critical to effective functioning of the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None of the directors are related by blood, marriage or adoption to any of our other directors or executive officers. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Hogue, our Interim Chief Executive Officer and a director, was appointed as a <span style="white-space:nowrap">non-employee</span> director in December 2023, prior to his appointment as interim Chief Executive Officer in January 2024. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:20%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:79%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dale&#160;Curtis&#160;Hogue,&#160;Jr.</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Director</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Mr.&#160;Hogue was appointed our interim Chief Executive Officer in January 2024 and a member of our Board in December 2023. Mr.&#160;Hogue has worked for over 20 years in various roles on both <span style="white-space:nowrap">the&#160;buy-&#160;and</span> sell-side covering biotechnology and pharmaceutical equities. Most recently, he founded Dune Lake Capital, a family office focused on the healthcare industry. Mr.&#160;Hogue spent almost 8 years as a senior analyst at Discovery Capital Management where he covered global healthcare stocks including US</td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">43 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:20%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:79%"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">therapeutics, Japanese pharmaceuticals and European pharma&#160;&amp; biotech. Early in his career, he worked as a research scientist and as a patent examiner at the US Patent&#160;&amp; Trademark Office. Mr.&#160;Hogue holds an MBA from Duke University, an MS in Biotechnology from the Johns Hopkins University and a BS in Physics form James Madison University.</p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Our Board believes that Mr.&#160;Hogue&#8217;s management and industry experience, as well as his financial expertise, qualify him to serve on our Board.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Robert W. Postma</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Director</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Postma has served as a member of our Board since February 2021. Mr.&#160;Postma has also served as the president of WaterMill Asset Management Corp. (&#8220;WaterMill&#8221;), a company which he founded in July 1999. WaterMill actively trades in municipal bonds and equities, using the funds of Mr.&#160;Postma. Mr.&#160;Postma has over 44 years of trading experience and received a B.A. in Business and Economics from Lafayette College.</p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Our Board believes that Mr.&#160;Postma&#8217;s management and trading experience allows Mr.&#160;Postma to provide financial guidance to us and qualifies him to serve on our Board.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jaime Vieser</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Director</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Vieser has served as a member of our Board since December 2020. Mr.&#160;Vieser currently manages Brushwood LLC, a private investment firm. From 2010-2017, he was a Managing Partner <span style="white-space:nowrap">and&#160;co-principal&#160;of</span> Castle Hill Asset Management LLC, a $2.7&#160;billion asset manager and hedge fund focusing on high yield and distressed debt. Prior to founding Castle Hill, Mr.&#160;Vieser was responsible for Deutsche Bank&#8217;s High Yield Sales and Trading Group in London from 1998 to 2008. Mr.&#160;Vieser originally joined Bankers Trust in New York in 1994 and worked in the Investment Banking/Leveraged Finance division. Mr.&#160;Vieser graduated from the University of Michigan with a degree in Economics and from the Cox School of Business at Southern Methodist University with a Master&#8217;s in Business Administration.</p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Our Board believes that Mr.&#160;Vieser&#8217;s financial expertise and investment experience allows Mr.&#160;Vieser to provide business guidance to us and qualifies him to serve on the Board.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holger&#160;Weis</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Director</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Weis has served as a member of our Board since December 2020. Mr.&#160;Weis continues to serve as the principal of Weis Advisors, Inc., a company that provides consulting services to life science companies, since founding the company in April 2018. Prior to that, he served in a number of roles at DemeRx, Inc., a clinical stage pharmaceutical company <span style="white-space:nowrap">developing&#160;non-addictive&#160;treatments</span> for drug addiction, including serving as Chief Operating Officer and Chief Financial Officer from December 2011 to July 2017, and also as President from September 2014 to July 2017, and as a Consultant from July 2017 to April 2018. Earlier in his career, Mr.&#160;Weis served as the Chief Financial Officer of EnSA Holdings, LLC, a company that focuses on environmentally sustainable agriculture techniques and technologies for the production of rice, from August 2010 to November 2011. From 2006 to 2010, he served as the Vice President&#160;&amp; Chief Financial Officer, Secretary and Treasurer of NovaVision, Inc., a therapeutic and diagnostic vision restoration company. Prior to that, he served as the Chief Financial Officer&#160;&amp; Treasurer of GMP Companies, Inc., a company that develops and commercializes pharmaceutical, medical device and diagnostic technologies, from 2000 to 2005. Mr.&#160;Weis served as a Senior Manager at Ernst&#160;&amp; Young, a multinational professional services company, from 1986 to 2000. Mr.&#160;Weis <span style="white-space:nowrap">has&#160;co-authored&#160;a</span> number of scientific papers and presentations and is an inventor on a number of patents and patent applications. Mr.&#160;Weis also serves on the board of directors of Jupiter NeuroSciences, Inc. Mr.&#160;Weis received a Bachelor of Business Administration in Accounting from the University of Georgia and is a Certified Public Accountant.</p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Our Board believes that Mr.&#160;Weis&#8217; management and industry experience, as well as his financial expertise, qualifies him to serve on the Board.</p></td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">44 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Agreement to Appoint Directors </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Postma, Mr.&#160;Vieser and Mr.&#160;Weis were all originally nominated for election as directors at our 2022 annual meeting pursuant to a settlement agreement, dated February&#160;4, 2021 (the &#8220;WaterMill Settlement Agreement&#8221;), with WaterMill Asset Management Corp. and Robert W. Postma (collectively, the &#8220;WaterMill Parties&#8221;). The WaterMill Settlement Agreement is no longer in effect and none of the directors originally nominated pursuant to its terms were nominated pursuant to the agreement for our 2025 annual meeting. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Our Executive Officers </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors appoints our executive officers and updates the executive officer positions as needed throughout the fiscal year. Each executive officer serves at the behest of our board of directors and until their successors are appointed, or until the earlier of their death, resignation or removal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information concerning our executive officers as of April&#160;30, 2025. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:48%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:46%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">Name</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Position(s)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Age</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dale Curtis Hogue, Jr.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Interim Chief Executive Officer and Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">56</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ferdinand Groenewald</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Vice President, Finance</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">40</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Melinda Lackey</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Legal&#160;&amp; Administration, Corporate Secretary</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">48</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:20%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:79%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Dale Curtis Hogue, Jr. <span style="font-style:italic">Interim Chief Executive Officer and Director</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Mr.&#160;Hogue&#8217;s biography is included above under the section titled &#8220;Our Board.&#8221;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Ferdinand Groenewald<br/><span style="font-style:italic">Vice President, Finance</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Mr.&#160;Groenewald was appointed to be our Vice President, Finance in February 2025. Since July 2023, Mr.&#160;Groenewald, age 40, has served in several capacities at the CFO Squad, which provides outsourced accounting and consulting services. From January&#160;2, 2023 to July&#160;31, 2023, Mr.&#160;Groenewald had served as the Chief Accounting Officer of Muscle Maker, Inc., a Nasdaq-listed company. From September 2018 to January&#160;2, 2023, Mr.&#160;Groenewald served as the Chief Financial Officer of Muscle Maker, Inc. From January&#160;25, 2018 through July&#160;3, 2018, Mr.&#160;Groenewald served as the Vice President of Finance, Principal Financial Officer and Principal Accounting Officer of Muscle Maker, Inc., Muscle Maker Development, LLC and Muscle Maker Corp., LLC. In addition, from October 2017 through July&#160;3, 2018, he served as the controller of Muscle Maker, Inc. Mr.&#160;Groenewald is a certified public accountant with significant experience in finance and accounting. From July 2018 through August 2018, he served as senior financial reporting accountant of Wrinkle Gardner&#160;&amp; Company, a full-service tax, accounting and business consulting firm. From February 2017 to October 2017, Mr.&#160;Groenewald served as Senior Financial Accounting Consultant at Pharos Advisors, Inc. serving a broad range of industries. From November 2013 to February 2017, he served as a Senior Staff Accountant at Financial Consulting Strategies, LLC, where he provided a broad range of accounting, financial reporting, and <span style="white-space:nowrap">pre-auditing</span> services to various industries. From August 2015 to December 2015, Mr.&#160;Groenewald served as a Financial Reporting Analyst at Valley National Bank. Mr.&#160;Groenewald holds a Bachelor of Science in accounting from the University of South Africa. Mr.&#160;Groenewald has served as a member of the Board of Directors of (i)&#160;HeartCore Enterprises, Inc., a company listed on the Nasdaq Capital Market, since January&#160;24, 2023; (ii) SYLA Technologies Co., Ltd., a publicly reporting company that is listed on the Nasdaq Capital Market, since December&#160;1, 2023; and (iii)&#160;Sushi Ginza Onodera, Inc., a company that has publicly filed a registration statement on Form <span style="white-space:nowrap">S-1</span> in connection with its initial public offering, since July&#160;1, 2024.</td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">45 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:20%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:79%"/></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Melinda Lackey, <br/><span style="font-style:italic">Legal</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;&amp; Administration, Corporate Secretary</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Ms.&#160;Lackey joined as our Senior Vice President, Legal&#160;&amp; Administration in November 2021. She previously served as Counsel for Hogan Lovells from August 2021 until November 2021, where she supported life sciences companies at all stages with a focus on licensing and intellectual property. Ms.&#160;Lackey previously served as legal counsel Kuur Therapeutics, Inc. (and after its acquisition by Athenex, Inc., Athenex) from June 2018 until August 2021. Before industry, Ms.&#160;Lackey practiced law for 10 years focusing on intellectual property strategy and patent litigation from March 2008 until June 2018. Ms.&#160;Lackey has a J.D. from University of Houston Law Center (2007)&#160;and graduated from Texas Tech Health Sciences Center with an M.S. in medical microbiology and immunology (2003), focusing on molecular biology and immunology and a B.S. in Microbiology from Texas Tech University (1998).</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no family relationships among any of our directors, director nominees or executive officers. None of our executive officers is related by blood, marriage or adoption to any of our directors, director nominees or other executive officers. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">46 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_11">EXECUTIVE COMPENSATION </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_12">Summary Compensation Table </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Named Executive Officers </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our named executive officers for&#160;2024&#160;and the positions they held with the company as of&#160;April 30, 2025&#160;are: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Dale Curtis Hogue, Jr., our interim Chief Executive Officer; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Ferdinand Groenewald, our Vice President, Finance; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Melinda Lackey, who leads our Legal&#160;&amp; Administration and is corporate secretary of the Company; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Kevin S. Boyle, Sr., our former Chief Executive Officer until December 2023 and served as a consultant to the Company from January 2024 through June 2024; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Drew Deniger, our former VP, Research and Development until November 2023. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Throughout this section, the term &#8220;named executive officer&#8221; is intended to refer to the individuals identified above. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Summary Compensation Table </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding compensation awarded to or earned by our named executive officers. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:36%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">Name of Principal Position</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><span style="font-weight:bold">Year</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><span style="font-weight:bold">Salary<br/>($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><span style="font-weight:bold">Bonus<br/>($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><span style="font-weight:bold">Stock<br/>Awards<br/>($)<sup style="font-size:75%; vertical-align:top">(1)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><span style="font-weight:bold">Option<br/>Awards<br/>($)<sup style="font-size:75%; vertical-align:top">(1)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><span style="font-weight:bold">All Other<br/>Compensation<br/>($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><span style="font-weight:bold">Total ($)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dale Curtis Hogue, Jr. (2)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">233,974</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">59,880</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">14,490</td>
<td style="white-space:nowrap;vertical-align:bottom">(3)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">308,344</td>
<td style="white-space:nowrap;vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Interim Chief Executive Officer</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2023</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11,090</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">37,063</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">48,153</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ferdinand Groenewald (4)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,087</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">159,217</td>
<td style="white-space:nowrap;vertical-align:bottom">(5)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">162,304</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Vice President, Finance</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2023</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Melinda Lackey (6)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,087</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">427,283</td>
<td style="white-space:nowrap;vertical-align:bottom">(7)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">430,370</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Legal&#160;&amp; Administration, Corporate Secretary</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2023</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">312,084</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">130,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">76,620</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">313,033</td>
<td style="white-space:nowrap;vertical-align:bottom">(8)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">831,737</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin S. Boyle, Sr. (9)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">317,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">75,000</td>
<td style="white-space:nowrap;vertical-align:bottom">(10)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">392,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Former Chief Executive Officer</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2023</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">617,836</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">270,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">689,580</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">409,529</td>
<td style="white-space:nowrap;vertical-align:bottom">(11)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,986,946</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Drew Deniger (12)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2023</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">317,757</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">103,672</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">47,888</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">264,035</td>
<td style="white-space:nowrap;vertical-align:bottom">(13)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">733,352</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Former VP, Research and Development</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
</table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">These amounts have been calculated in accordance with ASC Topic 718. Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions. For a discussion of the assumptions relating to our valuations of these restricted stock awards and stock options, please see Note 3 to the financial statements included in our Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2024. These amounts reflect our accounting expense for these restricted stock awards and stock options and do not correspond to the actual value that may be recognized by our named executive officer. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Mr.&#160;Hogue was appointed as interim Chief Executive Officer on January&#160;20, 2024. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Of such amount, $825 represents the dollar value of the reimbursement of cell phone charges by Mr.&#160;Hogue during 2024 and the remaining amount represents the amount we reimbursed for Mr.&#160;Hogue&#8217;s health insurance premiums. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">47 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Mr.&#160;Groenewald was contracted to act as the VP, Finance on a consulting basis for the Company on February&#160;22, 2024. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(5)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This amount reflects the total compensation payments made to Mr.&#160;Groenewald in 2024. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(6)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Ms.&#160;Lackey employment was terminated on November&#160;15, 2023, and where upon she was engaged as a consultant. Ms.&#160;Lackey continued to served as a consultant to the Company during 2024. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(7)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This amount reflects the total payments made to Ms.&#160;Lackey pursuant to a consulting agreement during 2024. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(8)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Of such amount, $44,998 represents a <span style="white-space:nowrap">one-time</span> retention bonus, $193,846 represents a <span style="white-space:nowrap">one-time</span> separation payment, $489 represents the dollar value of group term life insurance premiums we paid for the benefit of Ms.&#160;Lackey during 2023, $60,000 pursuant to a consulting agreement post separation and the remaining amount represents the amount we contributed to Ms.&#160;Lackey&#8217;s 401(k) plan account pursuant to our matching program. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(9)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Mr.&#160;Boyle was terminated on December&#160;22, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(10)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Mr.&#160;Boyle served as a consultant to the Company from January 2024 through June 2024. This amount reflects the total payments made to Mr.&#160;Boyle in 2024. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(11)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Of such amount, $331,989 represents a <span style="white-space:nowrap">one-time</span> separation payment that was January of 2024, $56,171 paid for unused vacation time upon separation, $1,585 represents the dollar value of group term life insurance premiums we paid for the benefit of Mr.&#160;Boyle during 2023 and the remaining amount represents the amount we contributed to Mr.&#160;Boyle&#8217;s 401(k) plan account pursuant to our matching program. Of such amount, $518 represents the dollar value of group term life insurance premiums we paid for the benefit of Mr.&#160;Boyle during 2023, and the remaining amount represents the amount we contributed to Mr.&#160;Boyle&#8217;s 401(k) plan account pursuant to our matching program. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(12)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Dr.&#160;Deniger was terminated on November&#160;15, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(13)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Of such amount, $45,623 represent a <span style="white-space:nowrap">one-time</span> retention bonus, $182,500 represents a separation payment, $16,846 paid for unused vacation time upon separation, $331 represents the dollar value of group term life insurance premiums we paid for the benefit of Dr.&#160;Deniger during 2023, and the remaining amount represents the amount we contributed to Dr.&#160;Deniger&#8217;s 401(k) plan account pursuant to our matching program. Of such amount, $340 represents the dollar value of group term life insurance premiums we paid for the benefit of Dr.&#160;Deniger during 2023, and the remaining amount represents the amount we contributed to Dr.&#160;Deniger&#8217;s 401(k) plan. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">48 </p>

</div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="display: none"><ix:header><ix:references><link:schemaRef xlink:type="simple" xlink:href="tcrt-20241231.xsd"/></ix:references></ix:header></div><div> <div> <div style="line-height:normal;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div id="toc921291_13" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Narrative to the Summary Compensation Table </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We use base salaries to recognize the experience, skills, knowledge and responsibilities required of all our employees, including our named executive officers. Base salaries are reviewed annually, typically in connection with our annual performance review process, and adjusted from time to time to realign salaries with market levels after taking into account individual responsibilities, performance and experience. Mr.&#160;Hogue was employed as interim CEO in 2024 and so has not yet undergone his annual performance review or any salary adjustments related to the same. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:23%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:52%"/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Name</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Title</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">2024&#160;Base</div></div><br/><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Salary&#160;($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">2023&#160;Base</div></div><br/><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Salary&#160;($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Percent</div></div><br/><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Increase<br/>(%)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dale Curtis Hogue Jr.</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Interim Chief Executive Officer</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">250,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr> </table> <ix:nonNumeric name="ecd:AwardTmgMnpiDiscTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" id="ixv-3318"> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Equity Compensation </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our compensation committee believes that long-term equity incentive compensation is a critical component of our executive compensation program that links the interests of our executive officers with those of our stockholders. In 2024 and 2023, equity-based awards for our executive officers were granted in the form of stock options. Stock options align executives&#8217; realizable compensation with the creation of stockholder value and serve as an effective long-term incentive vehicle to retain talent and incentivize performance. Executives only realize value from options if our stock price increases following the grant date. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><ix:nonNumeric name="ecd:AwardTmgPredtrmndFlag" contextRef="P01_01_2024To12_31_2024" format="ixt:fixed-true" id="ixv-5961">Stock options granted to our executive officers vest over four years, with 1/16th of the options vesting each quarter.</ix:nonNumeric> </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><ix:nonNumeric name="ecd:AwardTmgHowMnpiCnsdrdTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" id="ixv-5962">We do not grant equity awards in anticipation of the release of material nonpublic information and we do <ix:nonNumeric name="ecd:MnpiDiscTimedForCompValFlag" contextRef="P01_01_2024To12_31_2024" format="ixt:fixed-false" id="ixv-5963">not time</ix:nonNumeric> the release of material nonpublic information for the purpose of affecting the value of executive compensation.</ix:nonNumeric> </div> </ix:nonNumeric> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Other Compensation </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We provide certain additional benefits to executive officers that are generally available to all employees, including medical, dental, vision and life insurance coverage either directly or by reimbursement, as well as 401(k) matching contributions. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Employment and Change in Control Agreements </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We had the following employment agreements in place with our named executive officers in 2024. On January&#160;20, 2024 the Board appointed Dale Curtis Hogue, Jr. as Interim Chief Executive Officer of the Company. On January&#160;21, 2024, the Company entered into an employment agreement with Mr.&#160;Hogue, under which he will receive an annual base salary of $250,000. In addition, Mr.&#160;Hogue was awarded 40,000 shares of common stock of the Company with an exercise price of $18.00. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Consulting Agreement with Kevin S. Boyle, Sr. </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Boyle served as our Chief Executive Officer from August 2021 pursuant to an employment agreement entered into in August 2021 until December&#160;22, 2023. Mr.&#160;Boyle had an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">at-will</div> employment relationship with us. Mr.&#160;Boyle&#8217;s employment agreement required us to take all steps necessary to elect Mr.&#160;Boyle to our Board in connection with his hiring. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Boyle Separation and Consulting Agreement </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&#160;22, 2023, we entered into a Separation and Release Agreement, effective December&#160;22, 2024, with Kevin S. Boyle, Sr. (the &#8220;Boyle Separation Agreement&#8221;), the Company&#8217;s Chief Executive Officer, in connection with Mr.&#160;Boyle&#8217;s termination. Pursuant to the terms of his employment agreement, upon his termination Mr.&#160;Boyle was deemed to automatically resign from our Board of Directors. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><div style="display:inline;">49</div> </div> </div> </div> </div> </div> </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Boyle Separation Agreement superseded in full all of the terms of Mr.&#160;Boyle&#8217;s employment agreement. Pursuant to the terms of the Separation Agreement, and subject to customary conditions, we agreed to pay Mr.&#160;Boyle a <span style="white-space:nowrap">one-time</span> separation payment in an amount equal to six months of Mr.&#160;Boyle&#8217;s base salary and the cost of six months of COBRA premiums for Mr.&#160;Boyle, or approximately $331,990 less all applicable income and payroll taxes, deductions and withholdings which was paid in 2024. Mr.&#160;Boyle has agreed to make himself reasonably available to us to provide information related to his transition. The Boyle Separation Agreement also provides for a customary mutual release of all claims by us and Mr.&#160;Boyle against one another. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also entered into a consulting agreement (the &#8220;Boyle Consulting Agreement&#8221;), effective January&#160;1, 2024, with Mr.&#160;Boyle pursuant to which he will continue providing strategic and advisory services to us. The Boyle Consulting Agreement continued for a period of six months. The Boyle Consulting Agreement provided for compensation at a fixed rate of $15,000 per month and reimbursement for any usual and customary expenses incurred by Mr.&#160;Boyle in connection with performing services pursuant to the Boyle Consulting Agreement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Consulting Agreement with Ms.&#160;Lackey </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We entered into a consulting agreement (the &#8220;Lackey Consulting Agreement&#8221;), effective November&#160;16, 2024, with Ms.&#160;Lackey pursuant to which Ms.&#160;Lackey will continue providing legal services to us, including assisting in its ongoing exploration of strategic alternatives. The Lackey Consulting Agreement will continue indefinitely until terminated by the Company or Ms.&#160;Lackey upon 30 days prior written notice. The Lackey Consulting Agreement provides for compensation at a fixed rate of $400 per hour and reimbursement by the Company for any usual and customary expenses incurred by Ms.&#160;Lackey in connection with performing services pursuant to the Lackey Consulting Agreement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Consulting Agreement with Mr.&#160;Groenewald </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We entered into a consulting agreement (the &#8220;Groenewald Consulting Agreement&#8221;), effective February&#160;22, 2024, with Mr.&#160;Groenewald pursuant to which Mr.&#160;Groenewald will act as our Vice President, Finance, including assisting in our ongoing exploration of strategic alternatives. The Groenewald Consulting Agreement will continue indefinitely until terminated by the Company or Mr.&#160;Groenewald upon 30 days prior written notice. The Groenewald Consulting Agreement provides for compensation at a fixed rate of $15,000 per month and reimbursement by the Company for any usual and customary expenses incurred by Mr.&#160;Groenewald in connection with performing services pursuant to the Groenewald Consulting Agreement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_15">Role of our Compensation Committee, Management and Consultant </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Compensation Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our compensation committee is responsible for reviewing, evaluating, approving, administering and interpreting our executive compensation and benefits policies, programs and plans, including our equity compensation plans. In particular, with respect to the compensation of our named executive officers, our compensation committee is responsible for reviewing and recommending to the outside, independent and <span style="white-space:nowrap">non-employee</span> members of the Board the compensation levels and performance goals relevant to the compensation of these officers, and for evaluating the officers&#8217; performance in light of those goals and objectives. The outside, independent and <span style="white-space:nowrap">non-employee</span> members of the Board approved the compensation committee&#8217;s recommendations for the 2024 compensation of our named executive officers. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Management </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our human resources, finance and legal departments work with our interim Chief Executive Officer (the &#8220;Management Team&#8221;) to design and develop new executive compensation programs, to recommend changes to existing compensation programs, to recommend financial and other performance targets to be achieved under those programs, to prepare analyses of financial data, to prepare peer group data comparisons and to prepare other briefing materials for consideration by the compensation committee and ultimately, to implement the decisions of the compensation committee. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">50 </p>

</div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="display: none"><ix:header><ix:references><link:schemaRef xlink:type="simple" xlink:href="tcrt-20241231.xsd"/></ix:references></ix:header></div><div><div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Management Team recommends to the compensation committee for its discussion and ultimately, approval, proposed corporate performance and strategic goals and their relative weighting for the upcoming fiscal year, and provides input on the level of attainment of the prior year&#8217;s strategic goals, for purposes of determining awards under the annual performance bonus plan for all our executives, including the Interim Chief Executive Officer. For executives other than the Interim Chief Executive Officer, the compensation committee will consider the individual performance of the executives, as assessed by the Interim Chief Executive Officer, and the compensation recommendations submitted to the compensation committee by the Interim Chief Executive Officer. Our Interim Chief Executive Officer and other members of management generally attend our compensation committee meetings for a portion of the meeting. No executive officer was present for or voted in the compensation committee or the Board&#8217;s final determinations regarding the amount of any component of his or her own 2024 compensation package. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Consultant </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2024, our compensation committee engaged Pearl Meyer and Partners, LLC. (&#8220;Pearl Meyer&#8221;) as its independent compensation consultant. Pearl Meyer provided independent market findings to the compensation committee and has provided advice to the compensation committee as to employee director compensation, Interim Chief Executive Officer compensation and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-employee</div> director compensation in 2024. The Company utilized FW Cook in 2023.&#160;Pearl Meyer was determined to be free of conflicts of interest and able to operate as an independent compensation advisor. As part of its duties, Pearl Meyer provided the compensation committee with the following services: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">completed a competitive analysis of our 2024 executive compensation programs; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">prepared a competitive analysis of the Board&#8217;s compensation program, including observations and recommendations; and </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">prepared a competitive analysis of the Board&#8217;s compensation program, including observations and recommendations. </div></td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Trading Policy &#8211; Hedging and Certain Transactions </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have a policy that prohibits our executive officers, directors and other members of management from engaging in short sales, transactions in put or call options, pledging transactions, hedging transactions or other inherently speculative transactions with respect to our stock. Any violation of these policies may result in disciplinary action, including dismissal for cause. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Policy Prohibiting Insider Trading and Related Procedures. </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our <ix:nonNumeric name="ecd:InsiderTrdPoliciesProcAdoptedFlag" contextRef="P01_01_2024To12_31_2024" format="ixt:fixed-true" id="ixv-5967">insider trading policy</ix:nonNumeric> has been reasonably designed to promote compliance with applicable insider trading laws, rules and regulations, and Nasdaq listing standards. Our Insider Trading Policy was filed as Exhibit 19.1 to our Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">10-K</div> for the fiscal year ended December&#160;31, 2024. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">5<div style="display:inline;">1</div> </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size: 10pt; margin-top: 1.67em; margin-bottom: 1.67em;font-weight: bold;"><div style="font-weight:bold;display:inline;"><a href="#toc">Table of Contents</a></div></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="toc921291_16" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Outstanding Equity Awards at 2024 Fiscal <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Year-End</div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding option awards and restricted stock awards held as of December&#160;31, 2024 by our named executive officers. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Option Awards</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Stock Awards</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Name</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;Securities&#160;Underlying<br/>Unexercised Options</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Option<br/>Exercise&#160;Price<br/>($/Sh)(1)</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Option<br/>Expiration<br/>Date</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Shares&#160;or&#160;Units&#160;of&#160;Stock&#160;That<br/>Have Not Vested</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Exercisable&#160;(#)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Unexercisable&#160;(#)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Number<br/>(#)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Market&#160;Value<br/>($)(2)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dale&#160;Curtis&#160;Hogue&#160;Jr.</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">667</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">277</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">334</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">18.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ferdinand&#160;Groenewald</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,406</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2.42</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">8/13/2034</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Melinda Lackey</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,387</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">617</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">183.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/9/2031</td>
<td style="white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">925</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">540</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">315.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">9/14/2032</td>
<td style="white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,167</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">75.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3/15/2033</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,406</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2.42</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">8/13/2034</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Each stock option was granted with an exercise price equal to the fair market value of our common stock on the grant date. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Market values are calculated based on the closing market price of our common stock as reported on the Nasdaq Capital Select Market on December&#160;31, 2024, which was $1.91 per share. <div style="letter-spacing: 0px; top: 0px;display:inline;"></div> </div></td></tr></table><div id="toc921291_17" style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Stockholder Engagement </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2024, our stockholder engagement included individual investor meetings with stockholders and prospective stockholders. Conversations spanned topics including, but not limited to, clinical development plans and corporate strategy. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that ongoing, appropriate, and transparent communication with our stockholders is critical to our success long-term. We will continue to have a strong stockholder engagement program and communicate with our stockholders and prospective stockholders through our press releases, investor conferences, SEC filings, individual meetings and investor presentations. We believe that all of these communications together enable us to have a meaningful <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">two-way</div> dialogue, where the management team and Board can better listen to and understand stockholder perspectives, answer questions, and provide context to ongoing activities. Over the course of 2024, our stockholders have provided us with valuable feedback and external viewpoints that inform how we think about our business and strategy, and we are committed to continuing this dialogue. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&#160;14, 2023, we announced a strategic reprioritization of our business and wind down of its <div style="white-space:nowrap;display:inline;">TCR-T</div> Library Phase 1/2 Trial. In connection with the reprioritization, we reduced our workforce by approximately 95% to date and continue working to reduce costs in order to extend our cash runway. We continue to explore strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. We engaged Cantor Fitzgerald&#160;&amp; Co., or Cantor, to act as strategic advisor for this process. </div><ix:nonNumeric name="ecd:PvpTableTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" continuedAt="TextSelection_140659383" id="ixv-3755"> <div id="toc921291_14" style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Pay Versus Performance </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table and related disclosure provide <div style="display:inline;">information </div>about (i)&#160;the &#8220;total compensation&#8221; of our Chief Executive Officer, and our other named executive officers (the &#8220;Other NEOs&#8221; or the <div style="white-space:nowrap;display:inline;">&#8220;Non-CEO</div> NEOs&#8221;) as presented in the &#8220;<div style="font-style:italic;display:inline;">Summary Compensation Table</div>&#8221; included elsewhere in this proxy statement, (ii)&#160;the &#8220;compensation actually paid&#8221; to our Chief Executive Officer and our Other NEOs, as calculated pursuant to the SEC&#8217;s <div style="white-space:nowrap;display:inline;">pay-versus-performance</div> rules, (iii)&#160;certain financial performance measures and (iv)&#160;the relationship of the &#8220;compensation actually paid&#8221; to those financial performance measures. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>5<div style="display:inline;">2</div></ix:exclude> </div> </ix:nonNumeric></div></div><ix:continuation id="TextSelection_140659383" continuedAt="TextSelectionAppend_140659383_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_140659383_1" continuedAt="TextSelectionAppend_140659383_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%;clear:both"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_140659383_2" continuedAt="TextSelectionAppend_140659383_3"><ix:exclude> <div style="font-size: 10pt; margin-top: 1.67em; margin-bottom: 1.67em;font-weight: bold;"><div style="font-weight:bold;display:inline;"><a href="#toc">Table of Contents</a></div></div> </ix:exclude></ix:continuation> <div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_140659383_3" continuedAt="TextSelectionAppend_140659383_4"><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This disclosure has been prepared in accordance with Item 402(v) of Regulation <div style="white-space:nowrap;display:inline;">S-K</div> under the Exchange Act, and does not necessarily reflect value actually realized by the executives or how our compensation committee evaluates compensation decisions in light of company or individual performance. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:21%"/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 7pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Summary<br/>Compensation<br/>Table Total<br/>for PEO:<br/>Boyle (1)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Compensation<br/>Actually Paid<br/>to PEO:<br/>Boyle(2)(3)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Summary<br/>Compensation<br/>Table Total<br/>for PEO:<br/>Hagen(1)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Compensation<br/>Actually Paid<br/>to PEO:<br/>Hagen (2)(3)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Summary<br/>Compensation<br/>Table Total<br/>for PEO:<br/>Cooper(1)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Compensation<br/>Actually Paid<br/>to PEO:<br/>Cooper (2)(3)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Summary<br/>Compensation<br/>Table Total<br/>for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-PEO</div><br/>NEOs<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(1)</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Compensation<br/>Actually Paid<br/>to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-CEO</div><br/>NEOs<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(1)(2)(3)</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Value of<br/>Initial Fixed<br/>$100<br/>Investment<br/>Based On<br/>Total<br/>Shareholder<br/>Return<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(4)</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/>Income<br/>(Loss) (in<br/>thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2024To12_31_2024_MrhogueMemberecdIndividualAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5968">308,344</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2024To12_31_2024_MrhogueMemberecdIndividualAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5969">354,483</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5970">296,337</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5971">286,513</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-5972">3.66</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="0" scale="3" sign="-" format="ixt:num-dot-decimal" id="ixv-5973">4.679</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2023To12_31_2023_MrboyleMemberecdIndividualAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5974">1,716,946</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2023To12_31_2023_MrboyleMemberecdIndividualAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5975">1,459,330</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5976">665,709</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5977">594,363</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-5978">2.78</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal" id="ixv-5979">35,410</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5980">1,792,818</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5981">1,841,265</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5982">856,928</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5983">486,598</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-5984">5.79</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal" id="ixv-5985">37,730</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><ix:nonNumeric name="ecd:NamedExecutiveOfficersFnTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" id="ixv-4056">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><ix:nonNumeric name="ecd:PeoName" contextRef="P01_01_2024To12_31_2024_MrhogueMemberecdIndividualAxis" id="ixv-5986">Mr. Hogue</ix:nonNumeric> served as our only PEO in 2024. <ix:nonNumeric name="ecd:PeoName" contextRef="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis" id="ixv-5987"><ix:nonNumeric name="ecd:PeoName" contextRef="P01_01_2023To12_31_2023_MrboyleMemberecdIndividualAxis" id="ixv-5988">Mr. Boyle</ix:nonNumeric></ix:nonNumeric> served as our only PEO in 2023 and 2022. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">The&#160;Non-PEO&#160;NEOs</div> for whom the average compensation is presented in this table for 2024 are Ms.&#160;Lackey and Mr.&#160;Groenewald and for 2022 and 2023 are Dr.&#160;Deniger and Ms.&#160;Lackey. </div></td></tr></table> </ix:nonNumeric>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The amounts shown as Compensation Actually Paid have been calculated in accordance with Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">S-K</div> and do not reflect compensation actually realized or received by the Company&#8217;s NEOs. These amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as described in footnote 3 below. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Compensation Actually Paid reflects the exclusions and inclusions for the CEO and the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-CEO</div> NEOs set forth below. Amounts excluded, which are set forth in the &#8220;Minus Stock and Option Awards from Summ. Comp. Table&#8221; columns below, represent the Stock Awards and Option Awards reported in the Stock Awards and Option Awards columns of the Summary Compensation Table for each applicable year. Amounts added back to determine Compensation Actually Paid are made up of the following components which are set forth in the table below, as applicable: (i)&#160;the fair value as of the end of the fiscal year of outstanding and unvested equity awards granted in that year; (ii)&#160;the change in fair value during the year of equity awards granted in prior years that remained outstanding and unvested at the end of the year; (iii)&#160;the fair value as of the vesting date of equity awards that were granted <div style="display:inline;">and </div>vested in that year; and (iv)&#160;the change in fair value during the year through the vesting date of equity awards granted in prior years that vested during that year. The fair value at the end of the prior year of awards granted in any prior year that failed to meet applicable vesting conditions during the covered year are subtracted, although there were no such awards for the CEO or the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-CEO</div> NEOs in 2022 or 2023. Equity values are calculated in accordance with ASC Topic 718. </div></td></tr></table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>5<div style="display:inline;">3</div></ix:exclude> </div></ix:continuation> </div></div> <ix:continuation id="TextSelectionAppend_140659383_4" continuedAt="TextSelectionAppend_140659383_5"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_140659383_5" continuedAt="TextSelectionAppend_140659383_6"><ix:exclude><hr style="color:#999999;height:3px;width:100%;clear:both"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_140659383_6" continuedAt="TextSelectionAppend_140659383_7"><ix:exclude> <div style="font-size: 10pt; margin-top: 1.67em; margin-bottom: 1.67em;font-weight: bold;"><div style="font-weight:bold;display:inline;"><a href="#toc">Table of Contents</a></div></div> </ix:exclude></ix:continuation> <div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <ix:continuation id="TextSelectionAppend_140659383_7"><ix:nonNumeric name="ecd:AdjToPeoCompFnTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" continuedAt="TextSelection_140659444" id="ixv-4095"> <ix:nonNumeric name="ecd:AdjToNonPeoNeoCompFnTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" continuedAt="TextSelection_140659445" id="ixv-4096">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Reflects the cumulative shareholder return over the relevant fiscal year, computed in accordance with SEC rules, assuming an investment of $100 in our common shares at a price per share equal to the closing price of our common stock on the last trading day before the commencement of the applicable fiscal year and the measurement end point of the closing price of our common stock on the last trading day in the applicable fiscal year. For 2024, the closing price of our common stock on December&#160;31, 2024 was $1.91.&#160;For 2023, the closing price of our common stock on December&#160;31, 2023 was $10.61. For 2022, the closing price of our common stock on December&#160;31, 2022 was $97.37 </div></td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div></ix:nonNumeric> </ix:nonNumeric> <ix:continuation id="TextSelection_140659444">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:23%"/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Summary<br/>Comp.<br/>Table<br/>Total for<br/>PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Minus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Stock<br/>and Option<br/>Awards<br/>from<br/>Summ.<br/>Comp.<br/>Table</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">&#160;Year-End</div><br/>Fair Value of<br/>Outstanding<br/>Unvested<br/>Awards<br/>Granted<br/>During Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Change<br/>in Fair<br/>Value of<br/>Unvested<br/>Awards<br/>Granted in<br/>Prior Years</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Fair<br/>Value of<br/>Awards<br/>Granted<br/>and<br/>Vested<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Change<br/>in Fair<br/>Value of<br/>Prior Years&#8217;<br/>Awards<br/>Vested<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Minus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><br/>Fair<br/>Value of<br/>Stock<br/>and<br/>Option<br/>Awards<br/>Forfeited<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Comp.<br/>Actually<br/>Paid to<br/>PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024 &#8211; Curtis Hogue</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2024To12_31_2024_MrhogueMemberecdIndividualAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5989">308,344</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2024To12_31_2024_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_MrhogueMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-5990">11,090</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2024To12_31_2024_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_MrhogueMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5991">56,661</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2024To12_31_2024_MrhogueMemberecdIndividualAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5992">354,483</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023 &#8211; Kevin Boyle</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2023To12_31_2023_MrboyleMemberecdIndividualAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5993">1,716,946</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-5994">689,580</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5995">679,749</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-5996">247,749</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2023To12_31_2023_MrboyleMemberecdIndividualAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5997">1,459,330</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 &#8211; Kevin Boyle</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-5998">1,792,818</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-5999">904,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-6000">795,785</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-6001">685,522</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-6002">354,781</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-6003">487,403</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-6004">1,841,265</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> </ix:continuation><ix:continuation id="TextSelection_140659445">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:16%"/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Avg.&#160;Summary<br/>Comp. Table<br/>Total for<br/>Other NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Minus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Avg.<br/>Stock and<br/>Option&#160;Awards<br/>from Summ.<br/>Comp. Table</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Avg.<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Year-End</div><br/>Fair&#160;Value<br/>of&#160;Outstanding<br/>Unvested<br/>Awards<br/>Granted<br/>During Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Avg.<br/>Change in<br/>Fair Value<br/>of&#160;Unvested<br/>Awards<br/>Granted in<br/>Prior Years</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Avg.<br/>Fair<br/>Value of<br/>Awards<br/>Granted<br/>and<br/>Vested<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Avg.<br/>Change<br/>in Fair<br/>Value of<br/>Prior<br/>Years&#8217;<br/>Awards<br/>Vested<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Minus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Fair<br/>Value of<br/>Stock and<br/>Option<br/>Awards<br/>Forfeited<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Comp.<br/>Actually<br/>Paid to<br/>Other&#160;NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-6005">296,337</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2024To12_31_2024_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-6006">3,087</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2024To12_31_2024_NonPeoNeoMemberecdExecutiveCategoryAxis_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-6007">606</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2024To12_31_2024_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-6008">7,343</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2024To12_31_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-6009">286,513</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-6010">665,709</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-6011">62,254</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-6012">10,904</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2023To12_31_2023_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-6013">19,996</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2023To12_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-6014">594,363</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-6015">856,928</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-6016">386,561</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-6017">87,953</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-6018">66,031</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-6019">5,427</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="ixv-6020">11,117</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-6021">486,598</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table> </ix:continuation></ix:continuation> <div style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">5<div style="display:inline;">4</div> </div> </div></div> </div></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_18">INFORMATION REGARDING THE BOARD AND CORPORATE GOVERNANCE </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This section provides further information regarding the Board and the independence of our directors and describes key Corporate Governance Guidelines (the &#8220;Corporate Governance Guidelines&#8221;) and practices that we have adopted. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_19">Independence of the Board </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board has undertaken a review of the independence of our directors and considered whether any director has a relationship that, in the opinion of the Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a member of our Board. Based upon information requested from and provided by each director concerning such director&#8217;s background, employment and affiliations, including family relationships, the Board has determined that all of our directors, other than Mr.&#160;Hogue are &#8220;independent directors,&#8221; as such term is defined in Nasdaq Rule 5605(a)(2). In making these determinations, our Board considered the current and prior relationships that each <span style="white-space:nowrap">non-employee</span> director has with the Company and all other facts and circumstances that our Board deemed relevant in determining their independence, including the beneficial ownership of our capital stock by each <span style="white-space:nowrap">non-employee</span> director. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_20">Board Leadership Structure </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;22, 2023, the Board appointed Mr.&#160;Weis to serve as its Chair. Prior to that, Mr.&#160;Weis had served as a member and chair of the audit committee for all of 2023 and 2022. The Board has elected to separate the chair function from that of the interim Chief Executive Officer, who serves as our principal executive officer, due to a belief that separating these functions, and empowering a <span style="white-space:nowrap">non-executive</span> director to chair the Board meetings, reinforces the independence of the Board in its oversight of our business and affairs. In addition, we believe that having a chair separate from the Chief Executive Officer creates an environment that is more conducive to objective evaluation and oversight of management&#8217;s performance, increasing management accountability and improving the ability of the Board to monitor whether management&#8217;s actions are in the best interest of the Company and our stockholders. As a result, we believe that having a chair separate from the Chief Executive Officer can enhance the effectiveness of the Board as a whole. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_21">Director Attendance at Board and Stockholder Meetings </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board met 19 times during 2024, either in person, by teleconference or videoconference. Each current director attended at least 90% of the aggregate number of meetings of the Board and of the committees on which he or she served which were held during 2024 or the portion thereof that he or she served as a director or committee member. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As provided in our Corporate Governance Guidelines, we encourage attendance at our annual meetings by members of the Board. All of the then-current directors attended our 2024 annual meeting of stockholders either in person or by teleconference. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_22">Board Committees </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has established three standing committees: an audit committee, a compensation committee and a corporate governance and nominating committee. Each committee operates under a charter that has been approved by the Board. Current copies of each committee&#8217;s charter are posted on the &#8220;Investors&#8212;Corporate Governance&#8221; section of our website, <span style="font-style:italic">www.alaunos.com</span>. Our website and its contents are not incorporated into this proxy statement. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">55 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The members of the committees in 2024 are as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:60%"/>

<td style="vertical-align:bottom;width:12%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:11%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:11%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Audit</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Compensation</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Corporate</span><br/><span style="font-weight:bold">Governance<br/>and&#160;Nominating</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert J. Hofmeister, Ph.D.(1)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">X</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">X</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert W. Postma</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">X</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">X</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">X</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jaime Vieser</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">X</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">X</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holger Weis</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">X</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">X</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) Dr.&#160;Hofmeister resigned from the Board on April&#160;15, 2025.</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">*</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Committee Chairperson </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Audit Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The current members of the audit committee are Mr.&#160;Weis, who serves as the committee&#8217;s Chair, Mr.&#160;Postma and Mr.&#160;Vieser. As set forth in the audit committee charter, the primary responsibility of the audit committee is to oversee our financial reporting processes and internal control system on behalf of the Board. In that regard, the audit committee is responsible for, among other things, the appointment, compensation, retention and oversight of the work performed by the independent registered public accounting firm employed by us. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each member of the audit committee is an &#8220;independent director,&#8221; as such term is defined in Nasdaq Rule 5605(a)(2) and meets the criteria for independence set forth in Rule <span style="white-space:nowrap">10A-3(b)(1)</span> under the Exchange Act. The Board has also determined that each of the audit committee members is able to read and understand fundamental financial statements and that at least one member of the audit committee has past employment experience in finance or accounting. The Board has determined that at least one member of the audit committee, Mr.&#160;Weis, is an &#8220;audit committee financial expert,&#8221; as that term is defined in Item 407(d)(5)(ii) of Regulation <span style="white-space:nowrap">S-K</span> promulgated under the Exchange Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The audit committee held six meetings during 2024. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Compensation Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The current members of the compensation committee are Mr.&#160;Postma and Mr.&#160;Weis. As of April&#160;30, 2025, the new chair of the compensation committee has not been elected yet.&#160;As set forth in the compensation committee charter, the compensation committee reviews our compensation policies and practices and makes recommendations to the Board in connection with all compensation matters affecting our executive officers. Dr.&#160;Robert Hofmeister served as the chair of the Compensation Committee in 2024 and through April&#160;15, 2025 when he resigned from the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each member of the compensation committee is an &#8220;independent director,&#8221; as such term is defined in Nasdaq Rule 5605(a)(2) and meets the criteria for independence set forth in Rule <span style="white-space:nowrap">10A-3(b)(1)</span> under the Exchange Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The compensation committee held six meetings during 2024. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Corporate Governance and Nominating Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The current members of the corporate governance and nominating committee are Mr.&#160;Postma, who serves as the committee&#8217;s Chair, and Mr.&#160;Vieser. As set forth in the corporate governance and nominating committee charter, the primary responsibility of the corporate governance and nominating committee is to consider and make recommendations to the Board concerning the appropriate size, function and needs of the Board and its committees. In that regard, the corporate governance and nominating committee is, among other things, responsible for establishing criteria for membership on the Board, recruiting and recommending candidates to fill newly created or vacant positions on the Board and reviewing any candidates recommended by stockholders. In addition, the corporate governance and nominating committee evaluates and assesses the performance of the Board as a whole and its committees. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">56 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each member of the corporate governance and nominating committee is an &#8220;independent director,&#8221; as such term is defined in Nasdaq Rule 5605(a)(2) and meets the criteria for independence set forth in Rule <span style="white-space:nowrap">10A-3(b)(1)</span> under the Exchange Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The corporate governance and nominating committee held two meetings during 2024. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_23">Director Nomination Process </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The corporate governance and nominating committee (or a subcommittee thereof) recruits and considers director candidates and presents qualified candidates to the full Board for consideration in accordance with the Corporate Governance Guidelines and the corporate governance and nominating committee&#8217;s charter, which is available on our website. Our website and its contents are not incorporated into this proxy statement. The Board and the corporate governance and nominating committee will consider the minimum general criteria set forth in the Corporate Governance Guidelines and may add any specific additional criteria with respect to specific searches in selecting candidates and existing directors for service on the Board. The corporate governance and nominating committee considers a nominee&#8217;s education, general business and industry experience, ability to act on behalf of stockholders, potential concerns regarding independence or conflicts of interest and other factors relevant in evaluating Board nominees. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The corporate governance and nominating committee believes that a Board comprised of directors with diverse skills and experiences relevant to our industry and operations will result in efficient and competent oversight of our various core competencies, which include drug development, strategic partnering, commercialization activities, regulatory compliance, corporate finance and accounting. As such, the corporate governance and nominating committee gives consideration to the interplay of a director candidate&#8217;s experience with that of other members of the Board and the evolving needs of our business. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board continues to ensure that our corporate governance policies reflect the importance our Board places on diversity. More specifically, our policies emphasize our commitment to seeking to attain diversity and balance among directors of race, gender, geography, thought, viewpoints, backgrounds, skills, experience, and expertise. As a result, under our policies any search firm retained to assist the corporate governance and nominating committee in seeking candidates for the Board will be instructed to seek to include diverse candidates in terms of race, gender, geography, thought, viewpoints, backgrounds, skills, experience, and expertise from, among other areas, the traditional corporate environment, government, academia, private enterprise, <span style="white-space:nowrap">non-profit</span> organizations, and professions such as accounting, finance, marketing, human resources, and legal services. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Qualified candidates will be considered without regard to race, color, religion, sex, ancestry, national origin or disability, and the corporate governance and nominating committee will consider director candidates recommended by security holders. If the corporate governance and nominating committee approves a candidate for further review following an initial screening, the corporate governance and nominating committee will establish an interview process for the candidate. Generally, the candidate will meet with at least one member of the corporate governance and nominating committee, along with other members of the Board and management, including our Chief Executive Officer. Contemporaneously with the interview process, the corporate governance and nominating committee will conduct a comprehensive <span style="white-space:nowrap"><span style="white-space:nowrap">conflicts-of-interest</span></span> assessment of the candidate. The corporate governance and nominating committee will consider reports of the interviews and the <span style="white-space:nowrap"><span style="white-space:nowrap">conflicts-of-interest</span></span> assessment to determine whether to recommend the candidate to the full Board. The corporate governance and nominating committee will also take into consideration the candidate&#8217;s personal attributes, including, without limitation, personal integrity, loyalty to us and concern for our success and welfare, willingness to apply sound and independent business judgment, awareness of a director&#8217;s vital part in our good corporate citizenship and image, time available for meetings and consultation on our matters and willingness to assume broad, fiduciary responsibility. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">57 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_24">Risk Management and Oversight </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One of the Board&#8217;s key functions is informed oversight of the Company&#8217;s risk management process. The Board does not have a standing risk management committee, but rather administers this oversight function directly through the Board as a whole, as well as through various Board standing committees that address risks inherent in their respective areas of oversight. In particular, our Board is responsible for monitoring and assessing strategic risk exposure, including a determination of the nature and level of risk appropriate for the Company. Our audit committee has the responsibility to consider and discuss our major financial risk exposures and the steps our management has taken to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. Our corporate governance and nominating committee monitors the effectiveness of our Corporate Governance Guidelines. Our compensation committee assesses and monitors whether any of our compensation policies and programs have the potential to encourage excessive risk-taking. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In carrying out their risk oversight functions, the Board and its committees routinely request and review management updates, reports from the independent auditors and legal and regulatory advice from outside experts, as appropriate, to assist in discerning and managing important risks that may be faced by the Company. The Board is committed to continuing to evolve its risk oversight practices as appropriate given the fast-paced changes in the biotechnology industry. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_25">Stockholder Communications with Directors </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have established means for stockholders and others to communicate with the Board or individual directors. If a stockholder wishes to address a matter regarding our financial statements, accounting practices or internal controls, the matter should be submitted in writing addressed to the chairperson of the audit committee in care of the Secretary at our principal executive offices at 2617 Bissonnet, Suite 233, Houston TX 77005. If the matter relates to our governance practices, business ethics or corporate conduct, it should be submitted in writing addressed to the chairperson of the corporate governance and nominating committee in care of the principal financial officer at our principal executive offices at the address stated above. If a stockholder wishes to address a communication to an individual director, it should be submitted in writing addressed to such individual director in care of the principal financial officer at our principal executive offices at the address stated above. If a stockholder is unsure where to direct a communication, the stockholder may direct it in writing to the chairperson of the audit committee, or to any one of our independent directors, in care of the principal financial officer at our principal executive offices at the address stated above. All of these stockholder communications will be forwarded by the principal financial officer to the addressee. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_26">Code of Ethics and Business Conduct </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board adopted a Code of Ethics and Business Conduct to be applicable to all officers, directors and employees. The Code of Ethics and Business Conduct is intended to be designed to deter wrong-doing and promote honest and ethical behavior, full, fair, timely, accurate and understandable disclosure, and compliance with applicable laws. In addition to provisions that are applicable to officers, directors and employees generally, the Code of Ethics and Business Conduct contains provisions that are specifically applicable to our Chief Executive Officer and senior financial officer(s). The Code of Ethics and Business Conduct is available on our website at <span style="font-style:italic">www.alaunos.com</span>and a copy may be obtained without charge upon written request to our Legal department at our principal executive offices at 2617 Bissonnet, Suite 233, Houston, TX 77005. Our website and its contents are not incorporated into this proxy statement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_27">Corporate Governance Guidelines </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has adopted Corporate Governance Guidelines to ensure that the Board will have the necessary authority and practices in place to review and evaluate our business operations as needed and to make decisions </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">58 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that are independent of our management. The Corporate Governance Guidelines are also intended to align the interests of directors and management with those of our stockholders. The Corporate Governance Guidelines set forth the practices the Board intends to follow with respect to, among other things, Board composition and selection including diversity, Board meetings and involvement of senior management, Interim Chief Executive Officer performance evaluation and succession planning, and Board committees and compensation. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_28">Whistleblower Policy </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have adopted a whistleblower policy applicable to our employees that provides for protection from retaliation or discrimination by the Company due to reporting issues relating to compliance with applicable laws and regulations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Clawback Policy </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has adopted a compensation clawback policy which provides for the recoupment of incentive-based compensation in the event of an accounting restatement. The clawback policy is intended to comply with Section&#160;10D of the Exchange Act, the rules promulgated thereunder by the SEC, and applicable Nasdaq listing standards.&#160;In the event we are required to prepare an accounting restatement (as defined in the clawback policy), any executive officer who received excess compensation (as defined in the clawback policy) during the three completed fiscal years preceding the date of the accounting restatement will be required to repay or forfeit such excess compensation. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_29">Corporate Governance Documents </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please visit our investor relations website at <span style="font-style:italic">www.alaunos.com</span> for additional information on our corporate governance, including: the charters approved by the Board for the audit committee, compensation committee and nominating and governance committee, and our Code of Ethics and Business Conduct. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of any amendment to, or waiver from, a provision of our Code of Ethics and Business Conduct, we will promptly post on our website relevant information regarding the amendment or waiver, including the date and the nature of the event. Our website and its contents are not incorporated into this proxy statement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_30">Report of the Audit Committee </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The audit committee reviewed and discussed the audited financial statements for the fiscal year ended December&#160;31, 2024 with management of the Company. The audit committee discussed with the independent registered public accounting firm the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (the &#8220;PCAOB&#8221;) and the SEC. The audit committee also received the written disclosures and the letter from the independent registered public accounting firm required by applicable requirements of the PCAOB regarding the independent accountants&#8217; communications with the audit committee concerning independence and has discussed with the independent registered public accounting firm the accounting firm&#8217;s independence. Based on the foregoing, the audit committee recommended to the Board that the audited financial statements be included in the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the fiscal year ended December&#160;31, 2024 that was filed with the SEC on April&#160;1, 2025. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AUDIT COMMITTEE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holger Weis (chairperson) </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Robert W. Postma </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jaime Vieser </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">This report is not &#8220;soliciting material,&#8221; is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference in any of our filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether before or after the date hereof and irrespective of any general incorporation language in any such filing. </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">59 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_31">DIRECTOR COMPENSATION </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_32"><span style="white-space:nowrap">Non-Employee</span> Director Compensation </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2024, each of our <span style="white-space:nowrap">non-employee</span> directors was compensated as described below pursuant to our <span style="white-space:nowrap">non-employee</span> director compensation policy: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">an annual cash retainer fee of $50,000 for service on the Board; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">additional annual cash retainer fees for board committee service as follows: </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:74%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Chair</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Member</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Committee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">20,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compensation Committee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">15,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">9,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Governance and Nominating Committee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The chair of our Board also received further annualized cash compensation of $30,000 for 2024. All cash retainers are to be paid on a quarterly basis in arrears to <span style="white-space:nowrap">non-employee</span> directors who continue to serve as members of the Board on the last business day of each calendar quarter. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in connection with a director&#8217;s initial election to the Board, he or she receives options to purchase 2,560 shares of our common stock on the date of each new <span style="white-space:nowrap">non-employee</span> director&#8217;s appointment to our Board. <span style="white-space:nowrap">One-thirty-sixth</span> of these options shall vest each month on the monthly anniversary of the grant date. <span style="white-space:nowrap">Non-employee</span> directors are also entitled to receive options to purchase 1,280 shares of our common stock on an annual basis upon their election at the annual meeting of our stockholders, with the chair of our Board receiving additional options to purchase 640 shares of our common stock. <span style="white-space:nowrap">One-twelfth</span> of the annual option grant will vest each month on the monthly anniversary of the grant. If a new director is appointed to the Board between annual meetings of our stockholders, they will be entitled to a prorated option grant. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As set forth in its written charter, the compensation committee annually reviews director compensation practices in consultation with our compensation consultant and recommends any changes for adoption by the full Board. As such, the director compensation described above is subject to change at the discretion of the Board. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_33">Director Compensation Table </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding the compensation earned for service on our Board by our <span style="white-space:nowrap">non-employee</span> directors during the year ended December&#160;31, 2024. We reimburse members of our Board for reasonable travel and <span style="white-space:nowrap"><span style="white-space:nowrap">out-of-pocket</span></span> expenses incurred in connection with attending Board and committee meetings. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:61%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">Name</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Fees<br/>Earned or<br/>Paid in<br/>Cash&#160;($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Option<br/>Awards&#160;(1)<br/>($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Stock<br/>Awards&#160;(1)<br/>($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Total&#160;($)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dale Curtis Hogue, Jr.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,740</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,740</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holger Weis</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">109,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">23,090</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">132,090</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jaime Vieser</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">68,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,815</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">80,815</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert J. Hofmeister, Ph.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">71,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,815</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">83,815</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert W. Postma</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">81,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,441</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">93,441</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The amounts reported in the &#8220;Option Awards&#8221; and &#8220;Stock Awards&#8221; columns represent compensation expense recognized (or that will be recognized) for financial statement purposes under ASC Topic 718. In the case of each of our directors, the option award and/or stock award was granted on June 06, 2024. For a discussion of the assumptions relating to our valuations of these stock options, please see Note 3 to the financial statements included our Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2024. These costs reflect our accounting expense for these stock options and do not correspond to the actual value that may be recognized by the directors. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">60 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_35">LIMITATION OF LIABILITY AND INDEMNIFICATION </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Charter limits the personal liability of directors for breach of fiduciary duty to the maximum extent permitted by the Delaware General Corporation Law. Our Charter provides that no director will have personal liability to us or to stockholders for monetary damages for breach of fiduciary duty as a director. These provisions do not, however, eliminate or limit the liability of any of the directors for: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any breach of the director&#8217;s duty of loyalty to us or our stockholders; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">voting or assenting to unlawful payments of dividends, stock repurchases or other distributions; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any transaction from which the director derived an improper personal benefit. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any amendment, repeal or modification of these provisions will not adversely affect any right or protection of a director in respect of any act or omission occurring prior to such amendment, repeal or modification. If the Delaware General Corporation Law is amended to provide for further limitations on the personal liability of directors of corporations, then the personal liability of the directors will be further limited to the greatest extent permitted by the Delaware General Corporation Law. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Charter also provides that we must indemnify directors and officers in certain circumstances. We believe this provision is important in attracting and retaining qualified individuals to serve as directors and executive officers. Our bylaws, as amended, also provide for the indemnification of our directors, officers, employees and other agents to the maximum extent permitted by law. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We maintain director and officer insurance providing for indemnification of our directors and officers for certain liabilities, including certain liabilities under the Securities Act of 1933, as amended. We also maintain a general liability insurance policy that covers certain liabilities of directors and officers arising out of claims based on acts or omissions in their capacities as directors or officers. We have also entered into indemnification agreements with each of our directors. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">61 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_36">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following discussion relates to certain transactions that involve both the Company and one of our executive officers, directors, director nominees or five-percent stockholders, each of whom we refer to as a &#8220;related party.&#8221; For purposes of this discussion, a &#8220;related-party transaction&#8221; is a transaction, arrangement or relationship: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">in which we participate; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">that involves an amount in excess of $120,000; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">in which a related party has a direct or indirect material interest. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_37">Related-Party Transaction Policy </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have a related person transaction policy that sets forth our procedures for the identification, review, consideration and approval or ratification of related person transactions. For purposes of our policy only, a related person transaction is a transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships, in which we and any related person, directly or indirectly, are, were or will be participants in which the amount involved will or may reasonably be expected to exceed $120,000 in any calendar year. Transactions involving compensation for services provided to us as an employee or director are not covered by this policy. A related person is any person who is, or at any time since the beginning of the Company&#8217;s last fiscal year was, an executive officer, director, or nominee to become a director of the Company or a beneficial owner of more than 5% of any class of our voting securities, including any of such persons&#8217; immediate family members and any entity that such persons owned, controlled, held a control position in or held a 5% or greater beneficial ownership interest in. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the policy, if a transaction has been identified as a related person transaction, including any transaction that was not a related person transaction when originally consummated or any transaction that was not initially identified as a related person transaction prior to consummation, our management must present information regarding the related person transaction to our audit committee, or, if audit committee approval would be inappropriate, to another independent body of our Board, for review, consideration and approval or ratification. The presentation must include a description of, among other things, the material facts, the interests, direct and indirect, of the related persons, the benefits to us of the transaction and whether the transaction is on terms that are comparable to the terms available to or from, as the case may be, an unrelated third party or to or from employees generally. Under the policy, we will collect information that we deem reasonably necessary from each director, executive officer and, to the extent feasible, significant stockholder to enable us to identify any existing or potential related person transactions and to effectuate the terms of the policy. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In considering related person transactions, our audit committee, or other independent body of our Board, will take into account the relevant available facts and circumstances including, but not limited to: the risks, costs and benefits to us; the impact on a director&#8217;s independence in the event that the related person is a director, immediate family member of a director or an entity with which a director is affiliated; the availability of other sources for comparable services or products; and the terms available to or from, as the case may be, unrelated third parties or to or from employees generally. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The policy requires that, in determining whether to approve, ratify or reject a related person transaction, our audit committee, or other independent body of our Board, must consider, in light of known circumstances, whether the transaction is in, or is not inconsistent with, our best interest and those of our stockholders, as our audit committee, or other independent body of our Board, determines in the good faith exercise of its discretion. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="toc921291_38">Certain Related-Party Transactions </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as described below, there have been no transactions since January&#160;1, 2023 in which we have been a participant in which the amount involved exceeded or will exceed $120,000, and in which any of our directors, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">62 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
executive officers or holders of more than 5% of our common stock, or any members of their immediate family, had or will have a direct or indirect material interest, other than compensation arrangements which are described elsewhere in this filing under the sections titled &#8220;&#8212;<span style="font-style:italic">Executive Compensation</span>&#8221; and &#8220;&#8212;<span style="font-style:italic">Director Compensation</span>.&#8221; </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Underwritten Offering </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&#160;29, 2022, we entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Cantor Fitzgerald&#160;&amp; Co. (the &#8220;Underwriter&#8221;), as the sole underwriter, relating to the issuance and sale in an underwritten offering (the &#8220;Offering&#8221;) of 161,524 shares (the &#8220;Firm Shares&#8221;) of the Company&#8217;s common stock, par value $0.001 per share, to the Underwriter at a price of $92.87 per share. Under the terms of the Underwriting Agreement, the Company granted the Underwriter an option, exercisable for 30 days, to purchase up to an additional 24,228 shares of common stock (the &#8220;Option Shares&#8221; and, together with the Firm Shares, the &#8220;Shares&#8221;) at the same price per share as the Firm Shares. All of the Shares sold in the Offering were sold by the Company. The net proceeds to the Company from the Offering, excluding any exercise by the Underwriter of its option to purchase any of the Option Shares, are expected to be approximately $14.6&#160;million after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. Entities affiliated with our directors, Messrs. Postma and Vieser purchased an aggregate of 13,333 Firm Shares at a price per share of $97.50. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Underwriting Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Underwriter, including for liabilities under the Securities Act, and other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates and were solely for the benefit of the parties to such agreement. The Offering is expected to close on or about December&#160;1, 2023, subject to customary conditions. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing summary of the Underwriting Agreement does not purport to be complete and is subject to, and qualified in its entirety by, reference to the full text of the Underwriting Agreement, which was filed as Exhibit 1.1 on our Current Report on Form <span style="white-space:nowrap">8-K</span> filed on November&#160;30, 2023. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Indemnification Agreements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have entered into an indemnification agreement with each of our directors. These indemnification agreements and our charter and our bylaws indemnify each of our directors and officers to the fullest extent permitted by the Delaware General Corporation Law. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">63 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_39">DELINQUENT SECTION 16(A) REPORTS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;16(a) of the Exchange Act requires our directors and executive officers, and persons who own more than 10% of a registered class of our equity securities, to file with the SEC reports of beneficial ownership and reports of changes in beneficial ownership in our securities. We are not aware of any delinquent Section&#160;16(a) reports in the year ending December&#160;31, 2024. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">64 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_40">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information with respect to the beneficial ownership of common stock as of April&#160;30, 2025 for: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">each person, or group of affiliated persons, who is known by us to be the beneficial owner of greater than five percent of our outstanding common stock; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">each of our directors and director nominees; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">each of our named executive officers named in the &#8220;Executive Compensation&#8212;Executive Compensation Table&#8221; section above; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">all of our directors and executive officers as a group. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined in accordance with the rules of the SEC. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities, or have the right to acquire such powers within 60 days. Common stock subject to options that are currently exercisable or exercisable within 60 days of May&#160;5, 2025 are deemed to be outstanding and beneficially owned by the person holding the options. These shares, however, are not deemed outstanding for the purposes of computing the percentage ownership of any other person. Except as otherwise indicated, all persons listed below have sole voting and investment power with respect to the shares beneficially owned by them, subject to applicable community property laws. Percentage ownership calculations are based on 1,639,521 shares outstanding as of May&#160;5, 2025. Except as otherwise noted below, the addresses for persons listed in the table is c/o Alaunos Therapeutics, Inc., 2617 Bissonnet, Suite 233, Houston, Texas 77005. All share numbers have been adjusted to reflect the <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-15</span></span> and <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-10</span></span> reverse stock splits of the Company&#8217;s common stock effected on January&#160;31, and July&#160;17, 2024, respectively. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:77%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Number of<br/>Shares<br/>Beneficially<br/>Owned</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Percentage&#160;of<br/>Common&#160;Stock<br/>Beneficially<br/>Owned (%)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name of Beneficial Owner</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Shares</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">%</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5% Stockholders:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert W. Postma (1)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">247,336</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">13.11</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Named Executive Officers and Directors:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dale Curtis Hogue, Jr. (2)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4,442</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8195;&#8195;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin S. Boyle, Sr. (3)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8195;&#8195;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ferdinand Groenewald (4)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">282</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8195;&#8195;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Melinda Lackey (5)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,482</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8195;&#8195;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert W. Postma (1)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">247,336</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">13.11</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holger Weis (6)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6,123</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8195;&#8195;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jaime Vieser (7)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">33,792</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2.02</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert J. Hofmeister (8)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,095</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8195;&#8195;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Drew Deniger (9)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8195;&#8195;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current executive officers and directors as a group (11 persons)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">297,552</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">16.14</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">*</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Represents ownership of less than one percent. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of (i) 29,083 shares of common stock held by Mr.&#160;Postma, (ii) 33,333 shares of common stock held by WaterMill Asset Management Corp., where Mr.&#160;Postma serves as the principal, (iii) 24 shares of common stock held by the IRA of Mr.&#160;Postma&#8217;s spouse, (iv) 181,159 shares of common stock issuable upon the conversion of the Series <span style="white-space:nowrap">A-1</span> Convertible Preferred Stock within 60 days of April&#160;30, 2025 and (v) 3,737 shares of common stock issuable upon the exercise of options exercisable within 60 days of April&#160;30, 2025. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 8,277 shares of common stock issuable upon the exercise of options exercisable within 60 days of April&#160;30, 2025. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">65 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 0 shares of common stock held by our Former Chief Executive Officer Mr.&#160;Boyle. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 282 shares of common stock issuable upon the exercise of options exercisable within 60 days of April&#160;30, 2025. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(5)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 2,482 shares of common stock issuable upon the exercise of options exercisable within 60 days of April&#160;30, 2025. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(6)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of (i) 1,068 shares of common stock held by Mr.&#160;Weis, (ii) 127 shares of common stock held by Mr.&#160;Weis&#8217; spouse, (iii) 16 shares of common stock held by Mr.&#160;Weis&#8217; children, and (iv) 4,912 shares of common stock issuable upon the exercise of options exercisable within 60 days of April&#160;30, 2025. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(7)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of (i) 19,434 shares of common stock held by Mr.&#160;Vieser, (ii) 8,333 shares of common stock held in Brushwood LLC, where Mr.&#160;Vieser serves as the manager, (iii) 2,167 shares of common stock held in Uniform Transfer to Minors Act accounts by Mr.&#160;Vieser&#8217;s children and (v) 3,858 shares of common stock issuable upon the exercise of options exercisable within 60 days of April&#160;30, 2025. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(8)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 3,095 shares of common stock issuable upon the exercise of options exercisable within 60 days of April&#160;30, 2025. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(9)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 0 shares of common stock held by our former VP, Research and Development<span style="font-style:italic"> </span>Dr. Deniger. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">66 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_41">HOUSEHOLDING OF PROXY MATERIALS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SEC has adopted rules that permit companies and intermediaries (such as brokers) to satisfy the delivery requirements for Notices of Internet Availability of Proxy Materials or other annual meeting materials with respect to two or more stockholders sharing the same address by delivering a single Notice of Internet Availability of Proxy Materials or other annual meeting materials addressed to those stockholders sharing the same address. This process, which is commonly referred to as &#8220;householding,&#8221; potentially provides extra convenience for stockholders and cost savings for companies. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This year, a number of brokers with account holders who are our stockholders will be &#8220;householding&#8221; our proxy materials. A single Notice of Internet Availability of Proxy Materials or other annual meeting materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that they will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate Notice of Internet Availability of Proxy Materials or other annual meeting materials, please notify your broker. Alternatively, you may direct your written request to Alaunos Therapeutics, Inc., 2617 Bissonnet, Suite 233, Houston, TX 77005, Attention: Legal Department or contact us at (346) <span style="white-space:nowrap">355-4099.</span> Stockholders who currently receive multiple copies of the Notice of Internet Availability of Proxy Materials or other annual meeting materials at their addresses and would like to request &#8220;householding&#8221; of their communications should contact their brokers or contact us in the way described above. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">67 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc921291_42">OTHER MATTERS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the Annual Meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border-spacing:0;margin-left:auto">


<tr>

<td style="width:99%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By Order of the Board of Directors,</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">/s/ Melinda Lackey</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Melinda Lackey</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-style:italic">Legal and Administration; Secretary</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">[&#9679;], 2025</td></tr>
</table></div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">We have filed our Annual Report on Form <span style="white-space:nowrap">10-K</span> for the fiscal year ended December&#160;31, 2024 with the SEC. It is available free of charge at the SEC&#8217;s web site at www.sec.gov. Upon written request by an Alaunos stockholder, we will mail without charge a copy of our Annual Report on Form <span style="white-space:nowrap">10-K,</span> including the consolidated financial statements and financial statement schedules, but excluding exhibits to the Annual Report on Form <span style="white-space:nowrap">10-K.</span> Exhibits to the Annual Report on Form <span style="white-space:nowrap">10-K</span> are available upon payment of a reasonable fee, which is limited to our expenses in furnishing the requested exhibit. All written requests should be directed to Melinda Lackey, Secretary, Alaunos Therapeutics, Inc., 2617 Bissonnet, Suite 233, Houston, TX 77005. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">68 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">Annex A </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">FOURTH AMENDED AND RESTATED </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">CERTIFICATE OF INCORPORATION </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ALAUNOS THERAPEUTICS, INC. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Alaunos Therapeutics, Inc. (the &#8220;Corporation&#8221;), a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the &#8220;General Corporation Law&#8221;), </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">DOES HEREBY CERTIFY: </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. The name under which the Corporation was originally incorporated is EasyWeb, Inc. The date of filing of its original Certificate of Incorporation with the Secretary of State of the State of Delaware was May&#160;16, 2005. The date of filing of its first Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware was April&#160;26, 2006, the date of filing its Second Amended and Restated Certificate of Incorporation was January&#160;31, 2025, the date of filing its Third Amended and Restated Certificate of Incorporation was July&#160;16, 2024 (as amended, the &#8220;Existing Certificate&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. The Board of Directors of the Corporation duly adopted resolutions proposing to amend and restate the Existing Certificate in its entirety in the form set forth on Exhibit 1, declaring said amendment and restatement to be advisable and in the best interests of the Corporation and its stockholders, and authorizing the officers of the Corporation to solicit the approval of the stockholders therefor. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. This Fourth Amended and Restated Certificate of Incorporation, which restates and integrates and further amends the provisions of the Corporation&#8217;s Existing Certificate, was duly adopted in accordance with the provisions of Sections 242 and 245 of the General Corporation Law. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">IN WITNESS WHEREOF</span>, this Corporation has caused this Fourth Amended and Restated Certificate of Incorporation to be signed by its Interim Chief Executive Officer this [&#9679;] day of [&#9679;], 2025. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">EXHIBIT 1 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">FOURTH AMENDED AND RESTATED </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">CERTIFICATE OF INCORPORATION </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ALAUNOS THERAPEUTICS, INC. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <span style="font-style:italic">Name</span>. The name of the corporation is Alaunos Therapeutics, Inc. (the &#8220;Corporation&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <span style="font-style:italic">Address; Registered Office and Agent.</span> The address of the Corporation&#8217;s registered office is 2711 Centerville Road, Suite 400, Wilmington, Delaware 19808. The Corporation&#8217;s registered agent is the Corporation Service Company. The Corporation may from time to time, in the manner provided by law, change the registered agent and the registered office within the State of Delaware. The Corporation may also maintain offices for the conduct of its business, either within or without the State of Delaware. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <span style="font-style:italic">Purposes. </span>The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the Delaware General Corporation Law. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <span style="font-style:italic">Number of Shares. </span>The total number of shares of all classes of stock that the Corporation shall have the authority to issue is [the sum of the shares of common stock and the shares of preferred stock] shares, consisting of: [the then-current amount, divided by any whole number between [&#9679;] and [&#9679;], rounded up to the nearest whole share] shares of common stock, $0.001 par value per share (the &#8220;Common Stock&#8221;), and Thirty Million (30,000,000) shares of preferred stock, $0.001 par value per share (the &#8220;Preferred Stock&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Delaware General Corporation Law, upon the filing and effectiveness (the &#8220;Effective Time&#8221;) of this Fourth Amended and Restated Certificate of Incorporation, each [any whole number between [&#9679;] ([&#9679;]) and [&#9679;] ([&#9679;]] shares of Common Stock issued and outstanding or held by the Corporation in treasury stock immediately prior to the Effective Time shall be combined into one validly issued, fully paid and <span style="white-space:nowrap">non-assessable</span> share of Common Stock, without any further action by the Corporation or the holder thereof, subject to the treatment of fractional share interests as described below (the &#8220;Reverse Stock Split&#8221;). No fractional shares shall be issued and, in lieu thereof, any holder who otherwise would be entitled to receive fractional shares of Common Stock shall be entitled to receive cash (without interest) in lieu of such fractional share interest, upon the submission of a transmission letter by a holder holding the shares in book-entry form and, where shares are held in certificated form, upon the surrender of the holder&#8217;s Old Certificates (as defined below), in an amount equal to such fraction multiplied by the closing sales price of the Corporation&#8217;s Common Stock as reported on the Nasdaq Capital Market on the trading day immediately preceding the date of the Effective Time. Each certificate that immediately prior to the Effective Time represented shares of Common Stock (each, an &#8220;Old Certificate&#8221;) shall thereafter represent that number of shares of Common Stock into which the shares of Common Stock represented by the Old Certificate shall have been combined, subject to the elimination of fractional share interests as described above. As soon as practicable following the Effective Time, the Corporation will notify its stockholders holding shares of Common Stock in certificated form to transmit their Old Certificates to the transfer agent, and the Corporation will cause the transfer agent to issue new certificates representing the appropriate number of whole shares of Common Stock following the Reverse Stock Split for every one share of Common Stock transmitted and held of record as of the Effective Time. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Preferred Stock may be divided into, and may be issued from time to time in one or more series. The Board of Directors of the Corporation (the &#8220;Board&#8221;) is authorized from time to time to establish and designate any such series of Preferred Stock, to fix and determine the variations in the relative rights, preferences, privileges and restrictions as between and among such series and any other class of capital stock of the Corporation and any series thereof, and to fix or alter the number of shares comprising any such series and the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
designation thereof. The authority of the Board from time to time with respect to each such series shall include, but not be limited to, determination of the following: </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">a. The designation of the series; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">b. The number of shares of the series and (except where otherwise provided in the creation of the series) any subsequent increase or decrease therein; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">c. The dividends, if any, for shares of the series and the rates, conditions, times and relative preferences thereof; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">d. The redemption rights, if any, and price or prices for shares of the series; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">e. The terms and amounts of any sinking fund provided for the purchase or redemption of the series; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">f. The relative rights of shares of the series in the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">g. Whether the shares of the series shall be convertible into shares of any other class or series of shares of the Corporation, and, if so, the specification of such other class or series, the conversion prices or rate or rates, any adjustments thereof, the date or dates as of which such shares shall be convertible and all other terms and conditions upon which such conversion may be made; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">h. The voting rights, if any, of the holders of such series; and </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">i. Such other designations, powers, preference and relative, participating, optional or other special rights and qualifications, limitations or restrictions thereof. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <span style="font-style:italic">Election of Directors.</span> Unless and except to the extent that the <span style="white-space:nowrap">by-laws</span> of the Corporation (the <span style="white-space:nowrap">&#8220;By-laws&#8221;)</span> shall so require, the election of directors of the Corporation need not be by written ballot. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <span style="font-style:italic">Limitation of Liability.</span> To the fullest extent permitted under the General Corporation Law, as amended from time to time, no director of the Corporation shall be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director. Any amendment, repeal or modification of the foregoing provision shall not adversely affect any right or protection of a director of the Corporation hereunder in respect of any act or omission occurring prior to the time of such amendment, repeal or modification. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <span style="font-style:italic">Indemnification.</span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.1. <span style="font-style:italic">Right to Indemnification.</span> The Corporation shall indemnify and hold harmless, to the fullest extent permitted by applicable law as it presently exists or may hereafter be amended, any person (a &#8220;Covered Person&#8221;) who was or is made or is threatened to be made a party or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (a &#8220;Proceeding&#8221;), by reason of the fact that he or she, or a person for whom he or she is the legal representative, is or was a director or officer of the Corporation or, while a director or officer of the Corporation, is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, enterprise or nonprofit entity (an &#8220;Other Entity&#8221;), including service with respect to employee benefit plans, against all liability and loss suffered and expenses (including attorneys&#8217; fees) reasonably incurred by such Covered Person. Notwithstanding the preceding sentence, except as otherwise provided in Section&#160;7.3, the Corporation shall be required to indemnify a Covered Person in connection with a Proceeding (or part thereof) commenced by such Covered Person only if the commencement of such Proceeding (or part thereof) by the Covered Person was authorized by the Board. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.2. <span style="font-style:italic">Prepayment of Expenses.</span> The Corporation shall pay the expenses (including attorneys&#8217; fees) incurred by a Covered Person in defending any Proceeding in advance of its final disposition, provided, however, that, to the extent required by applicable law, such payment of expenses in advance of the final disposition of the Proceeding shall be made only upon receipt of an undertaking by the Covered Person to repay all amounts advanced if it should be ultimately determined that the Covered Person is not entitled to be indemnified under this Article 7 or otherwise. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.3. <span style="font-style:italic">Claims.</span> If a claim for indemnification or advancement of expenses under this Article 7 is not paid in full within 30 days after a written claim therefor by the Covered Person has been received by the Corporation, the Covered Person may file suit to recover the unpaid amount of such claim and, if successful in whole or in part, shall be entitled to be paid the expense of prosecuting such claim. In any such action the Corporation shall have the burden of proving that the Covered Person is not entitled to the requested indemnification or advancement of expenses under applicable law. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.4. <span style="font-style:italic">Nonexclusivity of Rights.</span> The rights conferred on any Covered Person by this Article 7 shall not be exclusive of any other rights that such Covered Person may have or hereafter acquire under any statute, provision of this Third Amended and Restated Certificate of Incorporation, the <span style="white-space:nowrap">By-laws,</span> agreement, vote of stockholders or disinterested directors or otherwise. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.5. <span style="font-style:italic">Other Sources.</span> The Corporation&#8217;s obligation, if any, to indemnify or to advance expenses to any Covered Person who was or is serving at its request as a director, officer, employee or agent of an Other Entity shall be reduced by any amount such Covered Person may collect as indemnification or advancement of expenses from such Other Entity. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.6. <span style="font-style:italic">Amendment or Repeal.</span> Any repeal or modification of the foregoing provisions of this Article 7 shall not adversely affect any right or protection hereunder of any Covered Person in respect of any act or omission occurring prior to the time of such repeal or modification. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.7. <span style="font-style:italic">Other Indemnification and Prepayment of Expenses.</span> This Article 7 shall not limit the right of the Corporation, to the extent and in the manner permitted by applicable law, to indemnify and to advance expenses to persons other than Covered Persons when and as authorized by appropriate corporate action. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <span style="font-style:italic">Adoption, Amendment and/or Repeal of <span style="white-space:nowrap">By-Laws.</span></span> In furtherance and not in limitation of the powers conferred by the laws of the State of Delaware, the Board is expressly authorized to make, alter and repeal the <span style="white-space:nowrap">By-laws,</span> subject to the power of the stockholders of the Corporation to alter or repeal any <span style="white-space:nowrap">By-law</span> whether adopted by them or otherwise. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <span style="font-style:italic">Certificate Amendments.</span> The Corporation reserves the right at any time, and from time to time, to amend, alter, change or repeal any provision contained in this Third Amended and Restated Certificate of Incorporation, and other provisions authorized by the laws of the State of Delaware at the time in force may be added or inserted, in the manner now or hereafter prescribed by applicable law; and all rights, preferences and privileges of whatsoever nature conferred upon stockholders, directors or any other persons whomsoever by and pursuant to this Third Amended and Restated Certificate of Incorporation in its present form or as hereafter amended are granted subject to the rights reserved in this article. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">Annex B </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">CERTIFICATE OF AMENDMENT OF THE THIRD AMENDED AND RESTATED </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">CERTIFICATE OF INCORPORATION OF ALAUNOS THERAPEUTICS, INC. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Pursuant to Section&#160;242 of the </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">General Corporation Law of the State of Delaware) </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Alaunos Therapeutics, Inc. (the &#8220;Corporation&#8221;), a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the &#8220;General Corporation Law&#8221;), </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">DOES HEREBY CERTIFY: </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. A resolution was duly adopted by the Board of Directors of the Corporation pursuant to Section&#160;242 of the General Corporation Law proposing this Amendment of the Third Amended and Restated Certificate of Incorporation and declaring the advisability of this Amendment of the Third Amended and Restated Certificate of Incorporation, and authorizing the appropriate officers of the Corporation to solicit the approval of the stockholders therefor, which resolution setting forth the proposed amendment is as follows: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">RESOLVED</span>: that the first paragraph of section four of the Third Amended and Restated Certificate of Incorporation of the Corporation, as amended, be and it hereby is, deleted in its entirety and the following paragraph is inserted in lieu thereof: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;4.<span style="font-style:italic"> Number of Shares.</span> The total number of shares of all classes of stock that the Corporation shall have authority to issue is Eighty Million (80,000,000) shares consisting of: Fifty Million (50,000,000) shares of common stock, $0.001 par value per share (&#8220;Common Stock&#8221;); and Thirty Million (30,000,000) shares of preferred stock, $0.001 par value per share (&#8220;Preferred Stock&#8221;).&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. This Certificate of Amendment of the Third Amended and Restated Certificate of Incorporation has been duly adopted by the stockholders of the Corporation in accordance with the provisions of Section&#160;242 of the General Corporation Law. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">IN WITNESS WHEREOF</span>, this Corporation has caused this Certificate of Amendment of the Third Amended and Restated Certificate of Incorporation to be signed by its Interim Chief Executive Officer this [&#9679;] day of [&#9679;], 2025. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">Annex C </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">AMENDMENT NO. 1 TO THE 2020&#160;ALAUNOS THERAPEUTICS, INC. EQUITY INCENTIVE PLAN </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS AMENDMENT NO. 1 TO THE 2020 ALAUNOS THERAPEUTICS, INC. EQUITY INCENTIVE PLAN (this &#8220;Amendment&#8221;) is made effective (the &#8220;Effective Date&#8221;) upon the approval of the stockholders of Alaunos Therapeutics, Inc. (the &#8220;Company&#8221;) of this Amendment. All capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Plan (as defined below). </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">RECITALS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company maintains the 2024 Amended&#160;&amp; Restated Prairie Operating Co. Long-Term Incentive Plan (the &#8220;Plan&#8221;); </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, pursuant to the Plan, the Board of Directors of the Company (the &#8220;Board&#8221;) has the authority to amend the Plan from time to time; and </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board approved this Amendment pursuant to a resolution of the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, BE IT RESOLVED, that the Plan is hereby amended as follows, effective as of the Effective Date: </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">AMENDMENT </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">1.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The first sentence of Section&#160;4(a) of the Plan is hereby deleted and replaced in its entirety with the following: </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#8220;Subject to adjustment in a manner consistent with&#160;<span style="text-decoration:underline">Section 2</span>, 1,130,745 shares of Stock are reserved and available for delivery with respect to Awards, and such total shall be available for the issuance of shares upon the exercise of ISOs.&#8221; </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">2.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This Amendment shall be and is hereby incorporated into and forms a part of the Plan. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">3.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Except as expressly provided herein, all terms and conditions of the Plan shall remain in full force and effect </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alaunos Therapeutics, Inc. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By: /s/ Dale Curtis Hogue, Jr. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name: Dale Curtis Hogue, Jr. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: Interim Chief Executive Officer </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g921291dsp005.jpg" alt="LOGO"/>
 </p> <p style="font-family:Times New Roman; font-size:0.5pt"><span style="color:#FFFFFF">ALAUNOS THERAPEUTICS, INC. ATTN: SECRETARY 2617 BISSONNET, SUITE 225 HOUSTON, TX 77005 SCAN TO VIEW MATERIALS &amp; VOTE VOTE BY INTERNET Before The Meeting - Go to www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions and for electronic delivery of information. Vote by 11:59 P.M. ET on July 2, 2025. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. During The Meeting - Go to www.virtualshareholdermeeting.com/TCRT2025 You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions. VOTE BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions. Vote by 11:59 P.M. ET on July 2, 2025. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: V75255-P34532 KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY ALAUNOS THERAPEUTICS, INC. The Board of Directors recommends you vote FOR the following: For All Withhold All For All Except 1. To elect each of the four nominees for director named in the accompanying proxy statement (the &#8220;proxy statement&#8221;) to hold office until the 2026 annual meeting of stockholders and until his successor is duly elected and qualified or, if sooner, until his earlier death, resignation or removal (&#8220;Proposal 1&#8221;); Nominees: 01) Dale Curtis Hogue, Jr. 02) Robert W. Postma 03) Jaime Vieser 04) Holger Weis To withhold authority to vote for any individual nominee(s), mark &#8220;For All Except&#8221; and write the number(s) of the nominee(s) on the line below. The Board of Directors recommends you vote FOR proposals 2, 3, 4, 5, 6 and 7. For Against Abstain 2. To ratify the selection of Cherry Bekaert LLC as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025 by the audit committee of the board of directors of the Company (the &#8220;Board&#8221;) (&#8220;Proposal 2&#8221;); 3. To approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers as disclosed in the proxy statement (&#8220;Proposal 3&#8221;); 4. To approve the amendment and restatement of the Company&#8217;s amended and restated certificate of incorporation, as amended (our &#8220;Charter&#8221;), in substantially the form attached to the proxy statement as Annex A, to, at the discretion of the Board, effect a reverse stock split with respect to the Company&#8217;s issued and outstanding common stock, par value $0.001 per share, including stock held by the Company as treasury shares, at a reverse stock split ratio of 1-for-5 to 1-for-20, inclusive (&#8220;Proposal 4&#8221;); 5. To approve the Certificate of Amendment to the Company&#8217;s Charter, in substantially the form attached to the proxy statement as Annex B, to, at the discretion of the Board, increase the number of shares of common stock authorized for issuance thereunder from 5,000,000 shares to 50,000,000 shares (&#8220;Proposal 5&#8221;); 6. To approve an amendment to the Company&#8217;s 2020 Equity Incentive Plan to increase the number of shares that the Company may issue under the Plan from 130,745 shares to 1,130,745 shares (&#8220;Proposal 6&#8221;); 7. To approve a proposal to adjourn the Annual Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Proposals in the proxy statement (&#8220;Proposal 7&#8221;); and8. To transact any other business as may properly come before the Annual Meeting or any adjournments thereof. Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date </span></p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g921291dsp006.jpg" alt="LOGO"/>
 </p> <p style="font-family:Times New Roman; font-size:0.5pt"><span style="color:#FFFFFF">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice and Proxy Statement and Form 10-K are available at www.proxyvote.com. V75256-P34532 ALAUNOS THERAPEUTICS, INC. Annual Meeting of Stockholders July 3, 2025 9:00 AM This proxy is solicited by the Board of Directors The undersigned hereby appoint(s) Dale Curtis Hogue, Jr. and Melinda Lackey or any of them, as proxies, each with the power to act without the other and to appoint his or her substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side, all of the shares of common stock of, ALAUNOS THERAPEUTICS, INC. that the stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders of the Company to be held at 9:00 AM EDT on July 3, 2025, virtually via live webcast at www.virtualshareholdermeeting.com/TCRT2025, and any adjournment or postponement thereof. This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors&#8217; recommendations. Continued and to be signed on reverse side </span></p>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>tcrt-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 09-May-2025 [04:10:34] {AM}-->
<schema targetNamespace="http://www.alaunos.com/20241231" elementFormDefault="qualified" xmlns:tcrt="http://www.alaunos.com/20241231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ecd="http://xbrl.sec.gov/ecd/2024">
<annotation>
<appinfo>
<link:linkbaseRef xlink:type="simple" xlink:href="tcrt-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="tcrt-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="tcrt-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
<import namespace="http://xbrl.sec.gov/dei-sub/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
<import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
<import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
<import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd" />
<import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
<import namespace="http://www.xbrl.org/2006/ref" schemaLocation="http://www.xbrl.org/2006/ref-2006-02-27.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://fasb.org/srt-roles/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd" />
<element name="MrboyleMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="tcrt_MrboyleMember" substitutionGroup="xbrli:item" />
<element name="MrhogueMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="tcrt_MrhogueMember" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>tcrt-20241231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 09-May-2025 [04:10:34] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" />
<definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecd_AllIndividualsMember_117937851" />
<loc xlink:type="locator" xlink:href="tcrt-20241231.xsd#tcrt_MrboyleMember" xlink:label="loc_TCRT_MrboyleMember_117937894" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember_117937851" xlink:to="loc_TCRT_MrboyleMember_117937894" order="100" />
<loc xlink:type="locator" xlink:href="tcrt-20241231.xsd#tcrt_MrhogueMember" xlink:label="loc_TCRT_MrhogueMember_117937902" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember_117937851" xlink:to="loc_TCRT_MrhogueMember_117937902" order="101" />
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>tcrt-20241231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 09-May-2025 [04:10:34] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<loc xlink:type="locator" xlink:href="tcrt-20241231.xsd#tcrt_MrboyleMember" xlink:label="loc_tcrt_MrboyleMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tcrt_MrboyleMember" xml:lang="en-US">Mr.Boyle [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tcrt_MrboyleMember" xlink:to="lab_tcrt_MrboyleMember" />
<loc xlink:type="locator" xlink:href="tcrt-20241231.xsd#tcrt_MrhogueMember" xlink:label="loc_tcrt_MrhogueMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tcrt_MrhogueMember" xml:lang="en-US">Mr.Hogue [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tcrt_MrhogueMember" xlink:to="lab_tcrt_MrhogueMember" />
</labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>tcrt-20241231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 09-May-2025 [04:10:34] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
<presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecd_AllIndividualsMember_117937850" />
<loc xlink:type="locator" xlink:href="tcrt-20241231.xsd#tcrt_MrboyleMember" xlink:label="loc_TCRT_MrboyleMember_117937894" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember_117937850" xlink:to="loc_TCRT_MrboyleMember_117937894" order="100" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="tcrt-20241231.xsd#tcrt_MrhogueMember" xlink:label="loc_TCRT_MrhogueMember_117937902" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember_117937850" xlink:to="loc_TCRT_MrhogueMember_117937902" order="101" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g921291dsp005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g921291dsp005.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0   !D
M  #_X0-V:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 Y+C$M8S P,B W.2YA-F$V,SDV.&$L(#(P,C0O,#,O
M,#8M,3$Z-3(Z,#4@(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T
M<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR
M9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<$U-/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS=%)E9CTB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@
M>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(B!X;7!-
M33I/<FEG:6YA;$1O8W5M96YT240](GAM<"YD:60Z.#E!-4)#-C,S1$(Y13 Q
M,3@V138Y,3,S-C(Q-44T038B('AM<$U-.D1O8W5M96YT240](GAM<"YD:60Z
M-$)!.34Q13 R0S,R,3%&,#E#13)#,T-!134V,$,P-3<B('AM<$U-.DEN<W1A
M;F-E240](GAM<"YI:60Z-$)!.34Q1$8R0S,R,3%&,#E#13)#,T-!134V,$,P
M-3<B('AM<#I#<F5A=&]R5&]O;#TB061O8F4@26Y$97-I9VX@,3DN-" H5VEN
M9&]W<RDB/B \>&UP34TZ1&5R:79E9$9R;VT@<W12968Z:6YS=&%N8V5)1#TB
M=75I9#HT-V(P96(U92TV,F)A+30Y-C4M.&%F92UE83 R8V)C-64Q838B('-T
M4F5F.F1O8W5M96YT240](GAM<"YI9#HR-3)C9F%E-"UA961B+6(W-&(M.6(R
M,"UA.#,Q9F)B-C$R-S8B+SX@/"]R9&8Z1&5S8W)I<'1I;VX^(#PO<F1F.E)$
M1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4
M9,     !_]L A  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0(! 0(" @$"
M @,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P/_P  1" /  N8# 1$  A$! Q$!_\0 P0 !  (# 0$! 0$!
M  8'! 4)" ," 0H+ 0$! 0$!                 0(#!!   00#  $" P,$
M# P$ 0(7!0(#! 8  0<($1(3% DA%1;6%Y<:,2*V-U=WM]=8F#D*02-ST]15
M=9755AA943(DF6%Q)1DS@4(V>+C(>3JA4K)3-+0U)B<X@I*C$0$!  $# @4#
M! (" @(#     1$A A(Q44%A(@,3\*%2<8$R,Y&QP='A0H)#\6(C_]H # ,!
M  (1 Q$ /P#_ '\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8%5=%[OP_D$H9"ZUV3E7+IIIA^4&B=%Z'4:3
M*+1HKB&I4@9'LI@8[/8C.N)2XMK2TH4K6M[UO>L+);T5Q_UL>&?]+?QC_3WR
MO\J\''=VI_UL>&?]+?QC_3WRO\J\''=VJ84;R5\<NH'VZIS3O_$^B6EZ+)G,
MUJC=5HMM/NPH2=+F3&PP \0(KBQ$*UMUS3>T-ZWZJWK!99UB[,(8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M,+=^W?LLG9_T8LKRF P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M34'^HG?* A8$UQ#A3E!GD\\(6$:U C+(3#C(]#VGFG5Z-\-,YTP\Q#_KV![
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M>-T?GT&PM4ZTS(R'69FS"DQH[GO5\3V^FR;MF)G_ (1WZY7_ /:IPC_\(?\
M3\_^Z>H62GM];^E=@;#8J_409:SVLZ'K%: P))4Y8;"3A!0849#;4],(EBQ)
M^- '0(K*=K<>><0VA.M[5O6LK#C!8/J8]K\PC9?EWTB>0"^S#X4Z4!MOGIVU
M@]4_"SG<MA:8Q!7/WH[42X^3EK$N+5[8=;0V&2[I"GB"F=JPZ<)MF=_^/%<_
MC1]*_FO->J#?*KRCZ%:O.+S;C-)W#\A>V0AJ!/,-*=E2=@O'/D(S6Z)Q"L0G
MYKNX^H#+Y76UK4N<K;J];)=]LQ--KJAA@P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MFBJ[/L%KFA8+[WJIN.Z2G+:3]FWE[^W#DWN P& P& P& P& P& P& P& P&
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M(A/5D,0"+3BH-LAL-$!RT1Y*?:6[)-TVM]7?K,\KK%$$2>X4XRCI$8/WR7=
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M '-RW)Z1TZT=.KAE_J<N*7KHZ+<V]1:TW+D7MQ&O3[I7O6EJ-7V[G3HLP_\
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MY'PM2&&7],O-R&?C-(=^%(:WZM/M>]*OAO-;WZI5KT4G_!O ^V P& P& P&
MP& P& P& P& P&!APA\ :RJ..@PQ["WGI"V(49F*RJ1(7MQ]]3;"&T*>?<WM
M2U;U[E*WZ[WO>!F8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MZ^W[=?9Z>OVZ^SU_8]?_ )<#^>].U;1I2=KUK2MH]=>[6M_L;VGU]=:W@?K
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MLH,J,G&;')MG.;&$%U]I#[:*Y-@.;1\!EOW3Q;MQYO(%FJGU,)O?[2*1T[J
MOQQ(=7M-2CF*T%'KO0?A4VQSNR#.@5W3U4D*<Z4*M<G7+HT=;KC"Z2PT55[I
M>U>XUG;CS5O68'UB$1;F?MUJL,JT"*],Z7S.J#1L:/3['V8/;*G6P_$[C(9I
MR9D+AUNY9S99B9.UO<V#8[^00G:D"X^E%_\ YK+YTKZF]2Y!TNLV\AT;HG6@
MZJ^]P^]D8(P8&LC7&2%?O%?@=5&0*O&=@R/* J<-U.U/PVUH A!$26RG;TA/
ML:I>&=.B%#.-^>Q0A8!]JO':@8Z]4>RR.@VZC"1M=L5KZB3\7^7TBO:)$!-1
M9L[%2J?;8UD<@KB/-38XB- UIY32OA8,[6)7XOU2ZO5 =.#UKI\H*$YE'@-/
M6J]M%+,H](\>.'\SDU9T_$K:"Q M7>K4^Y6L>==(,M2WST-M]QI/S&XH]'5&
MJQR?ZC(N? LIH?=RUPO,WC(OOCJ(H\?7^G5>E<<MO-K/,MTN *8LBB8^04BS
M!D84A,,L2]VR3>H^DO,%SM9%2Y_]3SDO&N-<CYM*Z1,C<ULO$9+)D\_ 64$T
MRF\4\>0-ZYVY&:K8P-9>?3>B@[^U$CR$/2V(KXU3.MMN?&A#.RW+6=*XQ]3*
M_<VD\Y.W[L-R WKP\Z+0.B #M;JBX,[OU\J'61!R$9):#"%+I:BUAJ:ZZ2&0
MW71+822B4G:),A4T2[)<^:V"%;^I/#N0\,&M/8#W+!-^.1ZM-L\8#LI%YC,Z
MC&-&?SS"&:+J;UA^U<9E2ZV BP)(N16RK;<Q]Q>MH?:)Z/W>8!'CI]3.NJY?
MJN-W((2XAXVQ>2\K,M[&RP%-A3.3>)U.L5$J-655XI,=<IQ3EM[:7;IA%^*M
M9@9);0SIG_T9K.S_ #7I95+^I*5!J9*]4\D8A-Z9RH4ET8,I(";&J0+@]YC7
MV8Z@953@Y-S-]XDU]N5(;E2&Y(V&[)B[9^*_\0SZ&LK->^J\/LG*/O3J'4WJ
MS7S9B;:)4VD52QE)4PS7>53I$RZQ6Q=6AVN@M6AJXCX8L<SHB-C/17F$[]6'
M88SL5?-XE]26TT[DTGI1GN'0[\!B=5K-V#E)8$90U-6V9X]G EE)5N,.(UKI
M==CGN>V]P>P18;,ATG(*&F8[,;;3)<[)TZ/OV:3]4_GW/S1<'8/)V[OG=+GS
MZ[3Z]'*7QB_39/EA%JPKGY(#R>RQZOSP$@UR:64;(Q/DYS8B<R]-94N5N:)P
MSX/2_3#OU(;=$J3U%"=0HI 3XY6.CL_MJ\AACR"4-$ZC]@O\/5;,-6H1:!FY
M8X8/C*D-58VG[QD0R#+C>V"3C]U5-T?ZFYU\8HMT;R.J%>BSP\077PD^IDK0
M)H1#H7<Y5B#WJW.4!^-=NC!>;F:;%8-0TLM*?CKTA3LF*N;)+Z/)M#_C/U/M
M@+CUS\EN(3.E=N#^0_B_:^C2;#18-A#1.-\;YZ&KO0PP);PK[LD)Z!>UG+!,
M$1V&8DW99MEQ&]1D:2PG*3IT>:.P^#7D3U#E;7+H_"="^G"^P]MZ-;O+ P$B
M74UY$1;?S+R6$<RD7"J6,0NT5DU6['TNNPFD.2)"*=MI4VONIT/BZTPLNW.<
MZ83SK7B!T*53_*M/./!X48M7DL:\> T"89B!$7/EE+%\5!UKNUZK=P/"41S7
M9!=]ASY8*9*D1T3[)*9L<EUQUA3;PFZ9F;T1GJWBKY8F4^3OW+XYDNDI[B@Y
M5-2[Z9^?/EPM^ZC*M@#KDR-9X;P1'9/$7D,AZG4U<N5IN25DM$&I#<*-MIU@
MF[;IET:\+./=(Y[Y5^0MV?YG:*1ROJ=5K9Y97K<:FVSJYSJ,2/6PQ+0KIE=J
M@6TQN<PZX&9;<#60F;D/FTO3H*XT=;B7C.ZRSS=8,,& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P-"-M-8-.0V@]C EG2(^26'M#2X^>Y.%0IC8Z83AHBR'52A\0
M@\AAUY&E-MO*TA6]*WK6!OL!@?E:T-H6XXM+;;:5+6M:M)0A"=;4I:U*WI*4
MI3KUWO?V:U@?-F1'D:4J.^R_I"DI7MEU#ND*6TV^A*MH4K25*8>0O6M_LH7K
M?[&]8&*2*BPT=N67(PA<5Z>+%M22$IF&PZ3.$H@8,/;=?6VA<TJ7GL18[6M^
M]Z0\AM&MJ5K6P^3)P+)*R <<L-?-1(+1.4)9FQG2,<<_.GC&9S\-#BI#41TD
M+DQTN*3I.WH[B-;]R%:T&UP&!@H*#7)VQB"$)9+3+TC<!$IA4W4>,Y'9D/;C
M)7M[33#LMI*U>WT2IQ.M_:K7J&=@8D6?!FJEHAS(TM4"6N!.3&?:>5#G-M,O
M.0Y6FU*VQ)0S(;7MM7HK25IWZ>F]8&+#.A",\@*'EQLXF)9@R"@^).C2)@Y@
MGN6D<]-C,N+>C-3E0'],J7K6G-LK]OK[5>@??1,;LDH-HA!V71!036*U+8V2
M0-=?<BMD%0?B?-)@N2FEMI=VGX>W$[3K?KK>L#*:>9>TI3+K;ND..,KVTM+F
MD/,KVVZTK:-[TEQIQ.TJ3O[4[UZ;P/I@?-IYE_2E,NMO)0XXRM32TN:0\RO;
M;S2MHWO27&G$[2I._M2K7IO[<#!+F!-?&RS)TG #"![7QIQ,I+8@P(;.UI;^
M+*ER5M,,-^]>M>JE:UZ[UK V6!\VGFGDJ6RZVZE+CK*E-+2XE+K#BF7VE;1O
M>M.,O(4A:?V4JUO6_MU@8,<P)EDR(6*3@2"X=@?)*BV);#I ;'+:E;%OSX:%
MJD1&B.H+WP%+2G3OPE^WU]N_0,AB="DR)L2-+C/RAKK3!".R^TZ_!??C,S&&
M9;2%;7&=>B2$.I2O6MJ;6E6OLWK> F3H8Z.Y+GRXT**RE:W9,M]N.PVA"%.+
M4MUU2$)TEM&U;]=_9K6]X'\'D():!"*"YD4B-)1(Q <0A/M2H4Z#,91(B3(D
MEE2V9$63'<2MMQ&]I6A6MZWO6\#+P/FZZTRG2WG6VD;<::TMU:6T[=?=0PPW
MI2MZUMQYYQ*$:_94I6M:^W>L#XPIL,E#BD!TJ-.@3H[,N%-AO-R8DN+(;2ZQ
M)C2&5+:?8>:7I2%IWM*D[UO6_3 _,DB/AR!\29/AQ)1>2["%1I,IAB03F,0I
M9-Z(/9=6ER;)9&P'Y"FV]*6EAEQS>O:A6] '$1Y>!"*B9T,H+)16)PXD.E,3
M8$^%*:2]&F0ID9;L>5%D,KTMMQ"E(6G>MZWO6\#ZR94:&TI^7(8BL)WK2GI#
MJ&6M;5OT3K:W%)3K:M_9K7K]N\#X#"8XT-'F \Z(4$EH,0F+)CY#4R 1'3V&
MY4*="EL+<8E1)<9U+C3B%*0M"M*UO>MX&K(VZJB*Y-MY2QA(%5'1WY<^QRR<
M-D+$C1751Y#SY);VHB$-2$;;WZK_ /IFO;_YOLP>20I5I:4J3OU2K6E)W_XZ
MWKUUO_ZNMX']P,&,4&S9$F)#(0I<J&VP[+CQI3#[\9N2Y):C.2&FEJ6RA]V$
M\E&U:UI2FEZU]J=^@9V P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P.69;QN%6[K_ %0U
MQGL55C$#Q,F8V''VBXL(Y5$L;@L9%N=2>K11(J;::?VOG71RN@*EM"G"MBG.
M3/@N_$T^;SB:IC"XA?B=<M]*O?<PAR-6A'CT]+BU2T7M^S2.=\P.W4W/LMLC
MBRC)N$:[$-UMMYF%IR/+^[G&=NS&T^FAGR06=X@]F@QZ[J-W@H1H=/CQRAP<
M"L]F:Z.3.KY%7*ATB"-M-F-KV[,Z):!DHO'9F$Q; XG+W)D*D*>5J..4[:MQ
M9O&WN'0:?PJH7WM D<;B4^U67O&FTFVW#-LOLEE[J0R)/@O2QSE">8M;X<:'
M7.'(C06D*;5+:;4VR,S7'1#A'A;;F'M */V@%36P5L@R;E7^;= /BIPZ]S>+
M\#!#B<V5+#'Y^S5>B\TE.P1[K<)1$!:7=J=B[3ZOBWR;:%XRG4VFJBA79(=G
M <EZIPC1JN&C?6C#]*LM?D^//1#DL2K10BU8SO3IU7(.OJ+NO0!K1Q#_ +].
M?.-.#+-L?AQ+ 2^G78+V<#R$S<;@1:YQT()8+'$E@2G2.\W.^F]RATHS$ %[
M27C] 77H4/\ ]2AYYE*F_AKD*:0.7DW-5\83%[Y#Q1$7MQ@B*C)-6R).B=)O
M+\4QJ\6;FEL&)!$!43GI38E-" &([$"=#4[!V><UI2M)6O8Y:JY@>)G3[$OI
MR@7E*:*Q -B:JS<-5T/"1(@#6+132,OA]HAE:J>E[ PJX"6TP?1-E/-.E)*%
M0Y+3CVW1RG9/*SX*600<W&F=0E2Z-+LIJW6R!N\WU5IOI4MS.N5E<^ZF14RN
M,$R@BVAT2U2TMMIG,Z;<<98<_P 7H<O\M5ROQ[[U!,]?@V;HY-$J5RJ%6*YV
M$M=S<E^\=@7=I]RJ5XD5*-<2T*"!J26( I&FVA\@L+:TRXCT6MID6Q).9\$Z
MK5.^U!1?R)@66+SF0KH]OK3DFSZ/$A_3*7>JH<'$WBBB$*?7+!T8&LP-B)F1
MF0J0RT?*O[>9?C$MF.BK)OA09I[;-7I?;17,[MT(S-"TA^L%;MO\5402OO\
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M-F/R5H:%L*U*UI2FTDN[-RTQOPV/1N7-\TKEAH)88_Y$TKKK8:T<_>F44'7
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MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MJX0P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MT=BFUS51%P8 R#7G1,22,9@C)T8G"C[CR6G4O(9)Q&Y.]N>Y2Y"-.JWM?[;
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M*D(5Z;4E*MZ]=:VI.M^GNU[5>GKK[/=K[-_^.L#0V.JU^VA2]=L(Q@B'/"I
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MA[;[DEN"J9[/F50VY+JG$M;5[-+5M6M>N][P,S 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MX?;;F+ZC7%V'73?)3F">"[K]:<E48%R>F]1)U>]K>4VNY/GHT>B"[.2>GON
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M1.5$@JFKDCA;T RJ(RC<Z$IM6X,OXC'Q'?A_$48;W 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MM6_LUK6M[W@9$LD.@;1J>0A0MNZ5MO4N4Q&VYI'II6T:><1M>D[5KU]/V/7
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M%_24ZTE.M<@J'IK6M>FM:_\ FW]C6L+SW]Z],<.\:O'_ ,9@ANM^/G'.><:
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MM"@E&'V(\]D<1D,I=3K2M-O+3Z^BMX26SH\Q;^E!]-'>MZWX+>,&];^S?_\
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MY;1?NU%GILYL#IO[RWOYZ:XEQ6HR/C+&=UF,UN?)\?XLW?I]2F>:O@/QZ_\
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M@0Q\*+!B08:=)B0HT1A##$2*G2&M)C1FF](1KVI]$ZU]FOV,.;-P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P&!&+I2JAT:J6"B7^L ;I2K6,E!
M+/4[0*A'*[8 \U'PY@LR'(LR(!(?*;W[7&7D+;6G[-ZWK!TUC_+]R;PEZ?S;
MQY\$/S#\)B\.[C_]%H[9;>@V\OP,\:17>4UH_P"=H3E=PZ[50)CG=A,\Q%42
MRB8(%R29'0F(Q2#\N^EMQM#D=KNEMS<SC_TK<-XE^0ED+]@K'=QOD-4!EJJ'
MUJ@=\[;Q#A72WI:YO5/,WQ>LU'L?/>90I-L/EP/4P5>(31==8)3Y1JL-SV8T
MIU&G'TES-,8\/]/85JH_;^A_0J\M.6#?%*#RR]2!/8J5RKE_&>(73D+/7JO&
MOT758ZM7_&@R\5Z'R9_J<53Q&36)SKT^/_C'/=IMY&M&=)[DUT<_/,3Z5ODC
M0WH]?HW.:9VF,]X\>>7:)U8YQQKH WE/ 25QMGBBQ Y=X.C%W0Z[ROR*CUNI
M&CU">G3I+<JR+)*9'(:>VVV:V[YC]Y_SU>C?)KAMVMIKS>V3\;O)_J?F+U@U
MQ(M],+R2&4;H$N/R>DQ.1\J&\Z3KKZ&H8#Q@,\EZX.L!GHT0Z^!D'M2GG'6B
M:9*6=$VWIK./BM23Q3JLCZG\?L)W@_5C/@N0\CZ_3[]26ZT=77[/YW1^"2Z5
MOSRWRUVN;>>\;F(,UNE226U_=+UF0BRK2MJ-J7E3,X8S.6/MV>G/IL>'-NXO
MY%>3#_1)-_,\[\5#\WQ;\ HMZ"$8(JG^,5\@53OUI=J1DDIQ-ZD,6RVQ*,DX
MC>W& E#B#_=[D2=*)OW9DQX]5*<"3'\:YOE3U'MOAIWWJ/U(JC>O,/I=8[1'
MX1TKJ8OLE,EE+J3X15N.=RKX8Y4*Q13/*Y8"KPJ<F>,DCY[+S;@]+ON?66ZX
MDOHT<Y(7BSYX<U\7?(OP]Z=XVWHN1\C#/@WY1-&4S#7DCS:Q>1:?*CC03S6D
MWB54!(G5?K5YCI@VV35ER&U( PS"FY&VT.+:C6=N99>F9_TL2O\ CB.I<[Q,
MK?EGX8=JZOS?EUR^K]7.G<GYEXW]:Z=S&I7_ *%U+CA7B\3QFK@02:)T;A]L
MJ,-Y_FQ)\@P@.IV4A1*.]'><;&<YNVS.CH-+XSY61/I?_3LYYU:L=&M_>J/Y
M7^!%BZ$$D39W0[W5*)5/+6F69".B6,0Z545E\RY2Q$8LI=Q]]C3@^3(>?6CW
M.J,9G.V=,7_21?2FYS:.-=Q\H^:CN16<SR=QMNXQ?,#K/CQT#QY[_P!,OUGZ
MITTN:Y#V*=T5>G_)$GS\>53*'WT/'ABUC9C,3;6U^U66&^YD[]G/"Y\A\WN9
M3.Q>/W*>#];)"_!USR5I7@3<HH:P)J5YN_U)KX'JW#+:'L[<20+<KOA-Q/H%
MWC6 F_OY0 A+&GU)_:-JFK6=MUOCU_;_ +;*A4#R,\9^9<,\=;UXO^0%=YCX
M6_5-X-V[G#%$#7[R?T/\3^D<J[08)Q!5MYS3I93H;W+NLSRT8LQ%@N21D8J,
M;=;]%M+6--US+,V?IJVW9N;JZ'Y+&>P]=\6.\]2\6[=]4.H]=-U4KXN]@O<L
MYRF=])0?S\/92G&TT8C<70XSL:XHM_3XK6QIUG;;^FGV5>P328EF<?\ +UC6
MN'>82?HQ=YY72ZGVBGW^PV[KQ?@'&#]W?A>0]1\0BOD Y8ZMP=^X2[$]/ =+
MF^.&IP46P\6W+$*FQ(*Y#3T?>VR9V\Y=/_+QGW?Q8:Z_3O+"J>(OBGY#\+\-
M.H\G\%.8W/E#_(NE<4+W?N43S8YV1Z%T+FO);!#'6X27YGX[?.,6NWQH$:(3
M=0R[N5.V/<DI++TY6<M?]-3"IOEO3>OV*_=\XKY 6.5Q'ZG7@%$M?0J7R7I'
M0E]EY7X]>+/8>8D?)*G5^D CYNRUNW1I@::92/C2-#CA!Z(XE*VTIPOILQ+-
M9707Q)\4B.OJ#7^W(@]5@^&?-*T,\O\ Q!YS?N=6JB5NE^0WFTQ;Q_?V68]K
M'AR+!;FT>H3I8^M2X<>147^CD4J:;VY&]IC=<;<?^W2_L\7>:7BMY+E/*GR:
MI?-.5=7)<KY7>)/UA>*VZM@S\FL7'R6JW->1T&'PBOE8+>HAF^G+I0[&92";
M4MYU!E+GPM_$]5&MMV\9;C/18O)?'[S-F]3\(.LT8'+XITCK?'/J?^0W<SW7
MN(77I-=H-M\K>W\.Z;4>0W>MAN@<J=JG18=/:@B1[,HIIR,BNRVTQ'_8O38M
MVXLO31YR\+O'OH=.[SX(D^W\"L Y=<^FUX44,:0ZCX+=G[D4K78*OTGR'F6>
MM5?JP.6+K_B9TBMMG!,DD:L+$U#<>1%VXTC37O47=9B\>]\?K*P/I=^._E;P
MCN7TPN;] Y7V-/&:EXM>0O:HMTME>M#4;B_0._5#D\/J/CET1\K'3NL&AO5Z
M@0L0"+-^&M<&R/16M?\ H-H14WW;9;,9RE'E%Q/IHCO/U.!W'N%]&[^_Y*>*
MOFI)M'6;IXT=-K?6>$6Q[QK!UOG''^$^19+7X1\A.-=>L QF"$IE=AJ(@B.W
MWU/N(TXG8VV8F=-9XHQOGG:^:=@EW*^>%IOO_DK*\EO%>7Q6X]7\=>S=HH%>
M\18M;X57! CA?2Z.8CTGQ5Z'P,O'LIZU-65B HD2B./K3.3*9<1#,QI<3'W1
MCA?C7Y9<E[5XOAU<G[,;XMUSS_\ /#R=M4PA6K,XO@M_!#_.3D;;EE:D1=/5
M[FWD7SJZT8U7'G=(@O%8DM;/VSV?>6W;9=9G$_X55PSQY="_3G\1*?T'Q6LA
MN12?+/P(LGEGS.M?3<[YSGH$^D4\'?6KYOL44U$N<[S E5]Z2YHF>""T0D?,
MZ0Y%]9+?J6WUW%\+C7ZPZZ>)TON'BWX-><'1J-P/MPVL1^P]OO7@%XLVX!83
M76 7.RU8J0?G-,US^1*+6:AU"T=M08+CZ],^$]7*Z13\9F*TWMEJN=Q=TG^7
M)L'X7>7E:\9.N?3N[3PKM(JI=<[5]/3OL>_<^M)CLJ-VBU][Y91O.>UQ>I54
M-!C4XU^*JXYTIH2[Z*%0BDV5[]QV5J3&^6W,W2SI?_"52N6]ZM=GEV/SA\6>
ML=*!5GZM'(-=S@BN W[L-7[#S_C_ --6T<">\@*WSZJU6S3K;RSHO1@PLFVY
M&@R(\$D13'<TAYA7M&G3;9GC_P O<0KBG?XWT2//GF">7=E"R+U7O-=[Q'\?
MK;HU:>Y4C@5Q>LSG".4D S9&Q66-86!SZMC@2Y4J>)@RHH]?M<C[:0\&<SY)
M=/#+RT:H'=P-6\MQ'T]_%;OG(.1>37#O%WQ6JW/[#SBZ</K!+R4N]DMXOR!\
MAZISJX"(1'B%*H?CQ*W!-6^4'%CBUE:A*;1,=;^.LNF9RLS*U-+\(;#9 GB5
MP#O7@E*<D^*'U+0O, L^TU!OMP=?TZ;YR?O78.<4\KVA5=2*Z#RWEMLN$>LE
M]/:3!@E1D%$I"9#K?N'+K9>L^Z*=-\<KQN%]<4&-\>3+_3NEM>6;/"D"?!'L
M;_4+E0RM'XT-K4+F7F'!=7SDG0C#8:;#'4,>-^?DO,N+9?VG6VMEEGIUT_7_
M (=)/!F)#XUY*=TO7&_&_P AN&>%/4@GBOR:G<V(\3Z-319KRAG%+_%Z5VRH
M\,+"(5AXUR,;3I]=&VBQS1803/(0MRU:=TRN2NL;M9K9=VKNWAS,!@,!@,"A
M>D>.7/.JVI=IMDBX;W/J#-!L]?"V\R!K%VIT<M.-M5RX"Q3\99<2J<4DZ?8^
M*VW,C2'(\G3T=:FMES8^43QOH,<?>@+Q&YD:K?[>Y>B51(V>4_7Q%DD7O\Y,
MZ76V&VF9@A@A;O\ U#K"7UL^S?PDI2W^UP9J-RO##QKFO:FRN7 734@IT@L<
MLR6E1K9;'NN1K'&Z%&MMHA[CG;! L.[,Z]MF1(4F/(B07F/A.08BF1RJ= >%
M54/+KY(@=OMR+59BXP@)F\7$I8RL 9>1P 4;%[FR5-NS8GRE;C;:5(^,^AW;
MCNW%..K4H9K5D/&#AIT?S0/:^? [L$Y%1)/.Z&"O$1BW!0]?FCJZ'EO*%GFI
MT.8;D!ZQ&AJGO(7*^56^UI>D27TN#-0K?A/X^KK52JKM;-/#J-=*_>ZS(=MM
MA46@&*SS<%R05"47U/T0EUY-#K(^&\.><7$D*ALON(4^TVXD9J><X\=N><S&
M%8(QVUV&::J ;G\VQ76U%K/86Z-78<Z$!J8V;->TR$!BVR<AQ+,)J/IZ2\M]
M_;KZMN8+;48B^)7+0Y:LG*K.OE,*U38S0Z56KD1C:?:&T>J<X=9(1YZ2,28D
MO4**'BSE[;T[(V.9<VK3FE*4,U*#WCMSLY'FZ:5:*\7D=+(]=A6FL6@J&LX*
M]F*\Y4BY0(4:=7\I$)UB0]!?A+0Y#=8?7[FMJVE21FHA*\-^#202:[JN%XHU
M @8"1\I:; U,T-'4F\<\>;605/7.D/G:MT@RR3>=<6\1>FJ??4M]*'$CE<Y6
M;2N*<]Y]?ND=*J@N6.M/6(=&B7A[98E)&DU<['%Q5=G1P\B2X-&$U0#+J)DB
M.VVY.VAM3^UK1I6"VW1%6?&/D4>M2:DT&*:"2^.$>#OL;L!?;RN<%7Y<F:,U
M)W*^.F>X]-<WJ9K?S*=;UK2O36L&:^C?C=SI%@K9Q3UN>A52Z6'I >HOVLH[
M3$=!LMHMMPFW&0"4Y[)1B,;N\]<;2U[C,Z4UZ->L=A38S6\+\*YR;K=]JTX<
M32.Z-=&.BG9$(\8'%X=X@N5N2(L]<,P9D<E7"P(C41TN$Y$<:^7E1DN)^W:O
M490??B5QV0+)0"T6TV"><AW=@_:3EP.SK8;(WY_GLDO8YQOYII]NQ#'.4UW0
MB3'TQ]S-B8[<)+#;:4Z'*I79O';D]R6>_%-=<-Q[1;S-WL$"83(_(%3M@XRO
M@9?<B,S):0F#,YJXJ+\!OV-HD;^91I+^M+T,UI:]XP<O"%H=B([MUXLL,C"F
M)L?1+@<NAB1 %TJ^<_$UF:^:DOM3*L/K?33J=0G$*;D2R+TN1MZ4M3VQFOD(
M\6.3UWD='XO6V;77ZOS(Z_9^=EAMRL&KI3; ^0L,]101;I<V47<=VU:B$);<
MI<AA\;+=B/-N1UJ;V,W.6A,^%W K!1[)0#%=.3@EM#UH98)CUQLZ[(1F5>^7
M+IL.TNV?9/9Q-Q(7?H!>;/)I?U)F_.N-.J4QOX6#E<Y3.M>.]%K$Z'+C$;B1
MB!^FG>MUD(9LLF<%JEQLV^A*/.@(NFF7F1A)?3RREQ'W7V4[<:]FDZ8;TD97
MQA# 8# 8#>_3[=_9K7V[WO\ P8'';KWU^/I&<0OAWFUX\S*1(MM9FR!I^+2*
MQT7I(H82B.J8E#W;-0*?9*R_,BO(4AUMF8ZIIQ*DK]JM;UHW/;WV9PK+]93^
MC#_3!:_0UWG^;+&B_%O['ZRG]&'^F"U^AKO/\V6-#XM_8_64_HP_TP6OT-=Y
M_FRQH?%O['ZRG]&'^F"U^AKO/\V6-#XM_8_64_HP_P!,%K]#7>?YLL:'Q;^Q
M^LI_1A_I@M?H:[S_ #98T/BW]C]93^C#_3!:_0UWG^;+&A\6_L?K*?T8?Z8+
M7Z&N\_S98T/BW]C]93^C#_3!:_0UWG^;+&A\6_L?K*?T8?Z8+7Z&N\_S98T/
MBW]C]93^C#_3!:_0UWG^;+&A\6_L?K*?T8?Z8+7Z&N\_S98T/BW]C]93^C#_
M $P6OT-=Y_FRQH?%O['ZRG]&'^F"U^AKO/\ -EC0^+?V/UE/Z,/],%K]#7>?
MYLL:'Q;^Q^LI_1A_I@M?H:[S_-EC0^+?V/UE/Z,/],%K]#7>?YLL:'Q;^Q^L
MI_1A_I@M?H:[S_-EC0^+?V/UE/Z,/],%K]#7>?YLL:'Q;^Q^LI_1A_I@M?H:
M[S_-EC0^+?V/UE/Z,/\ 3!:_0UWG^;+&A\6_L?K*?T8?Z8+7Z&N\_P V6-#X
MM_8_64_HP_TP6OT-=Y_FRQH?%O['ZRG]&'^F"U^AKO/\V6-#XM_8_64_HP_T
MP6OT-=Y_FRQH?%O['ZRG]&'^F"U^AKO/\V6-#XM_8_64_HP_TP6OT-=Y_FRQ
MH?%O['ZRG]&'^F"U^AKO/\V6-#XM_8_64_HP_P!,%K]#7>?YLL:'Q;^Q^LI_
M1A_I@M?H:[S_ #98T/BW]C]93^C#_3!:_0UWG^;+&A\6_L?K*?T8?Z8+7Z&N
M\_S98T/BW]C]93^C#_3!:_0UWG^;+&A\6_L?K*?T8?Z8+7Z&N\_S98T/BW]C
M]93^C#_3!:_0UWG^;+&A\6_L?K*?T8?Z8+7Z&N\_S98T/BW]C]93^C#_ $P6
MOT-=Y_FRQH?%O['ZRG]&'^F"U^AKO/\ -EC0^+?V/UE/Z,/],%K]#7>?YLL:
M'Q;^Q^LI_1A_I@M?H:[S_-EC0^+?V/UE/Z,/],%K]#7>?YLL:'Q;^Q^LI_1A
M_I@M?H:[S_-EC0^+?V/UE/Z,/],%K]#7>?YLL:'Q;^Q^LI_1A_I@M?H:[S_-
MEC0^+?V/UE/Z,/\ 3!:_0UWG^;+&A\6_L?K*?T8?Z8+7Z&N\_P V6-#XM_8_
M64_HP_TP6OT-=Y_FRQH?%O['ZRG]&'^F"U^AKO/\V6-#XM_8_64_HP_TP6OT
M-=Y_FRQH?%O['ZRG]&'^F"U^AKO/\V6-#XM_8_64_HP_TP6OT-=Y_FRQH?%O
M['ZRG]&'^F"U^AKO/\V6-#XM_8_64_HP_P!,%K]#7>?YLL:'Q;^Q^LI_1A_I
M@M?H:[S_ #98T/BW]C]93^C#_3!:_0UWG^;+&A\6_L?K*?T8?Z8+7Z&N\_S9
M8T/BW]C]93^C#_3!:_0UWG^;+&A\6_L?K*?T8?Z8+7Z&N\_S98T/BW]C]93^
MC#_3!:_0UWG^;+&A\6_L?K*?T8?Z8+7Z&N\_S98T/BW]C]93^C#_ $P6OT-=
MY_FRQH?%O['ZRG]&'^F"U^AKO/\ -EC0^+?V/UE/Z,/],%K]#7>?YLL:'Q;^
MQ^LI_1A_I@M?H:[S_-EC0^+?V/UE/Z,/],%K]#7>?YLL:'Q;^Q^LI_1A_I@M
M?H:[S_-EC0^+?V/UE/Z,/],%K]#7>?YLL:'Q;^Q^LI_1A_I@M?H:[S_-EC0^
M+?V/UE/Z,/\ 3!:_0UWG^;+&A\6_L?K*?T8?Z8+7Z&N\_P V6-#XM_8_64_H
MP_TP6OT-=Y_FRQH?%O['ZRG]&'^F"U^AKO/\V6-#XM_8_64_HP_TP6OT-=Y_
MFRQH?%O['ZRG]&'^F"U^AKO/\V6-#XM_8_64_HP_TP6OT-=Y_FRQH?%O['ZR
MG]&'^F"U^AKO/\V6-#XM_8_64_HP_P!,%K]#7>?YLL:'Q;^Q^LI_1A_I@M?H
M:[S_ #98T/BW]C]93^C#_3!:_0UWG^;+&A\6_L?K*?T8?Z8+7Z&N\_S98T/B
MW]C]93^C#_3!:_0UWG^;+&A\6_L?K*?T8?Z8+7Z&N\_S98T/BW]C]93^C#_3
M!:_0UWG^;+&A\6_L?K*?T8?Z8+7Z&N\_S98T/BW]C]93^C#_ $P6OT-=Y_FR
MQH?%O[/6/B=]7OZ<?F]=E\T\:_*2D7GH^HTB;%H1,=:Z%;3$2&UM^8_70G0*
M_5YEFU#CH4Z\D>F2XRTA3CB4HUM6$W;-VV9LT=)<,& P& P.._U^.NWOB'TB
M_,V\<V.3:S;7Z/6*1&/#)#L0D,%=)Z+3N?V9T?*84AZ+,?K-DF,MNH4E;6W?
M>G>E:UO1OVYG?,KH\!/ ;Q*\<O$;@W/N?\(Y?IC7+J,9L=B,46LE[3=+49K0
MTF>M-I.D1LHD6*E"4MUS7Q75-QFMI882VPVVVDF[=;=5<\S\O/IW];KHFSTS
MC026--^6 KP_&(F\.I ^;+OUE@2#--N[$21K3KW'[S76$$PQY'NU/@/MN(9]
M?>E!;MW3_&5KS>L^#<#RH.>'KW(:4KK5?Y"[V&?);XY3E4K<!E>Y+M%8LZH2
M6W>G(K?L.?<WPM.?<CB9?O\ 9ZZU$Q>/+P>=[[YW_3DYSR,/VNP<"?>IQOQG
MX=Y8160WCW1R]@1ROR ZG6N0TAI82(^N2];(=GM4=TB/8V]MB$AQQI;[B4M*
MJS;NMQYX34SY6^"#1N74*)XWK[1?U=+LG-JU0>0\+YK9[#>DTWCG+.ZVOH-3
MESR02KN\R!T/LU=VHK.(P=R2)!J'%:?D.LH=''=X]&_XEY'^"/D?T^L\QXAP
M81T%TWR:F=D/W&#Q7GH:I<XJW0F;?^#X-]9M+X*Z0K$3(T8B.D11X<BD439U
M%(.1'E:3A+-TF:A'4_+;PZXST3M_/^A>%%U"L>/M4IU]Z#?=<2X%)HB:/T:Z
M&.?\\M8::ST%5@)#;I:*Z18BM[&M2V$0G79;,9OV*66;;9F7JS>A^6W@K1^I
M3>,@O&AGK'0(G3V>3M#>9\MX,^,(63?#1/D),DP+-=KI2*TX)%\_,-Z?4Y+;
MD[(H7&:9<5K2E";=UF?!M:IY3^ MF[MUC@<OA JGF>0L=ID';U;>+<XB<U+,
M^/$6@SNQNB#XB8:*P&*9!Z8(>4\9'B69J'G/DUR-L/:0..[&55S/J ?3Q:X5
MR3OPSQ@L=@K76Y/:FF:H+\>.:1NC\_B^/-7L%XZV1Z74CQH*[7VJO2ZV^5U&
MCO3B$R&XSN-'=6\VA0X;LX2T3YE>!QV'U.R!_&&60YORB^<_YJ5ZFQQKBJ:I
M8K?TR[<>HU6@5<*];&NDNQ7YO;PTQV7/ #XB(*).].*?:2PX..[OJV'2/*OP
M[Y\<E@8'A?;NDOPO)U[P_D2^>\2X0_ 1W9=9I]M"UGXMPO=.?^0LX:Y-*A$-
MMZAI7$DIDKC[2U\83;>_AEGAO*+PKN!JJT_G'B:>Z?T.RENO19W.Z1P/ETJR
MT>N<1[38/'^\7^_3#)P)4:Y3E=,J\Z&+5LHZ1,(C.KAPWO@OZ:'&^-73XQW'
MQ,\M =PN'+/'($QS^LV^P4P+?[5R/F0FN]$GU.S6.GV:92XL.85M#$()8JO)
MCOMG!P6=Z+9=1'4RZAS9++.O53]\\JOI]<U[\(\<;?Q<$-NYKMJ_'^*7_,A1
MW:6ST)?!Z1Y!C6IYY&OB0 IRK]$$BX<MV.E#EAE(AJTC2D/*+-NZS+(Y/Y(>
M%_=K#S&N\;\4R_17+_S+C/7+.7 \#YHU7>'4WOH)-GYDKLQHP5%Q!!\Q7M[G
M/"@VSA*'"TF0^RAAUEQP7;9UKWK^8/A7\"W)?T<T[_@V&<T_,'PK^!;DOZ.:
M=_P;!FGY@^%?P+<E_1S3O^#8,T_,'PK^!;DOZ.:=_P &P9I^8/A7\"W)?T<T
M[_@V#-/S!\*_@6Y+^CFG?\&P9I^8/A7\"W)?T<T[_@V#-/S!\*_@6Y+^CFG?
M\&P9I^8/A7\"W)?T<T[_ (-@S3\P?"OX%N2_HYIW_!L&:?F#X5_ MR7]'-._
MX-@S3\P?"OX%N2_HYIW_  ;!FGY@^%?P+<E_1S3O^#8,T_,'PK^!;DOZ.:=_
MP;!FGY@^%?P+<E_1S3O^#8,T_,'PK^!;DOZ.:=_P;!FJ$\H9'B]XI<#Z7Y"W
MGQ^HI^J<O",'# :J\WYIL^1:E%AP9B..58_P\!9<5,)M[6Y,G18[3>E+6XE*
M=[PLS;B*.!>4OTR-@D3.D3/$?CEKABHQ:TT*Z'O'$R8I[<XI!&08I>Q<\L%T
MH$Z=(28'R%-#B\U3$8C'6]\/3GV%X[_#*\^KRO%7DU!Y_P!/(\*H%DHW0NB\
M7Y_"L%9YGS]Z&%;[M=*Y0J7=#RBL<5\K36;!;1VILAOXK[#$G3FF5:2KT,S-
M>$*E]0GP"OU:BV*K>,@ME,B[=GJDAJ[4'AE!@!@W%;-R.ND.A'C]AL#0872;
MZCN57DU=Y3NY)=)9AKX+3Z]-X;X;NZ:\Q\[OI>=8ZV$YA7*[Q<7!M=><FTZ\
M7.@4BD!;9<&>Z6[@#G.0HJT"1=C>L[]RJ>G(VU141Y4<C#TA>W7TMX2[=TF4
MKXEY@_3'[#PR#W&='\:N:0FH=8<N5,NPSE+=PY^6N9 ^-J]<L@T;'F[4<.2J
MN01&8C?&4ZN%)2G6U1WM(%V[I<(+U7SM^G#R:I>2%O-<ZXB1@\*_#_X+8%#.
M+ON^2.K'P>@=_@N\0=VY\O8(::UT6!$5(<4W'U,6C7O]K[&W!-FZX\WOKK=2
M\;>-\@Z;VBS<*YU.K7*N;7/I]@'A.94:4;F J-6"5K*PQ$:5 A1)!61 %N(C
MH<>:;6]M.E+3K>U:,S-N'FGC'D'X#=6#<L=L%#\>^0W?M$9\CSCEEVF>-5AN
MUC#^]]L:1BJY5:^AUG2S3L20U&B;(ZG*E1GX^V=2&7&DENW=&^N_:? :N>,5
MP\LJ10.1]UY?6=QA@;7$N?<\NICHUT+&@]6K/.^>(^ /$V"YVJW6& )A1_FV
MFMSY26W'6_:O:!C=GCXJ3F^87A(JT<- USQHK=G%]\I?BM>JC9(//.71H4 7
MY7=EG<7JT,Y#DIU.B%Z<=@+?-1TI<4RA*FF]N/H4C1>.[77IG[.EGY@^%?P+
M<E_1S3O^#89S3\P?"OX%N2_HYIW_  ;!FO)P.^^*:3EQ"]/\?>7\4_"-QD45
M,^^@.*/1; =@ :O:"KPANL3#TM@ & W44],)36XD.*J8E#JT*]/<7%\%X7:M
M>'_-FY3U_IW *<S"!NV66]8J=1!3,>OL&PM;?,.O2Q3;:![!ZQP(BW-[]J'Y
MC*-^FW$^I-:JFWW+PMIEB=J\[F?'BAEXX5J8F#7>?4T[*EV\#3^@70U7BS0\
M(\FJO1!W-R+*'B*F&'I;:FD*VIMWV%Q4:%=A\#2D?DQ#5&XA$"=8"FR$0Y*I
MG/TC:V7"!^='G:S874C=JCD9(?I<&6AY&E0]0];DJ=TPMIQ8QN32RV;PH &$
M@(M"X:>,0[R+H]FA#J=S]I53<F$2(@J<,/3AL6-L)52@IZ*5>96[J!*0IA[V
M.IVC0Q4@Y(UXF]MF]";Y_P EY&9%<^L *O2S\?GU)6.*RCM(K5[8<A(T)U,C
MH9%6F/I29#;2U>NG$:4TMM:B7,ZLR"GPF(PR<Z-7/'[4<+%L$XQJ52*:/D"8
M55>KK%@EDX<\)&F0(PQ5N%*6MUM"=M$HSB=J;?;4H:JMIW4O!>[W8)2Q?..4
M07;/%+ZK)*P<PJ@!DZ< ]2L_("M<A0"H.,31/:N-7<89<=:;8E*DQT,K6Z\A
M&RXW8RERK5X$N1EO0!_C:0?<,)KHV(S5J(APP=?&&C$&(,4L-Z389 97"$AF
M<U\2"N- E/:=VW&>4@8W>;%I=N\&+M'M#D*H</'OTJ9,'V5HISVIP8[$D9"H
MDDK)#D)0!B)90D)_I(6/J?!4]%>?(,I;4KXK?N&-R47/7AISR[PZ!=>?\>K9
MV9SRT]2^.4Y=6XX&)2Z<7KX,V2(6%5?^YX+S9*RQ6VF''DO/[5O2$[W[=*),
MWHD@FK>(QRJ0KP*HO"I=3(&H-;CG-4.FM1$V(C98U-B )>GPK3T VNV3&AJH
MCZ&WVYJ],K0ES]K@U5Q:;AX#5"$?F%@_ '55NM6>UD8 JA5$N26,J$*PD#4>
M#$'@WUSC2(53).L0&][F2F8+SC+:VVUKT7&Y,J@.\-[T7@UZL4CAY&Q$*R-M
MS #\WE3C&$A"HP0:CNOP9()IUB:R*L$"1(B*])45F;'6\VA#[6UDUBLXU\\)
MVK!U019N=<3I@[EO1D<LE&K+1:? 0=M<.DA+W9]C8+E>3(;!54,?8W+(+WN,
MTEMYYQ3<="'7"XJZJK2?%"\*M&J?S_AUC32SQ"KVEX30J;,C!+$)WO10+,E-
M!=QM$1JM>V0TE:E,J_:K]-_9A-9U0!)[P-5(!0U"_'AF=9"$H6('RJ/48A!Z
M?","Z_*CRH$H"S,%[9.'8$3:I2&4;D$(B-;VJ4QIP8W>:>A*7XI6F#.(5;GW
M";$Q KH.UR%C*717F6@-H$O'*T3?D:$_"CPC@EG<B.XO>M*8]'/_ "[UO8U5
MJ)M'@>3@%I+@CQMC2ZS7!]EMD)JMT BD!%GMUW?P53H0AR&4D-2;:+9]D13K
MBW"<+6D>LR-ITN-WFTO/KQX3W]FPSF:!P8&-!ZOTMF25KG-=2"0+FMTO%-M5
MF0/8'KEP0<1VC/RDNOI0K;*EI4E+D=]*!9NC!-]'\(*[.IPDI0N"Z+VD^1$S
MH<&N<UGL506, =#L\NQV$DR/U CP(P3FL^0\QI>Y;+6MN*;^&VXM(Q5OEPOA
MV"(L"BU*X5"G/VB'2OAN4"HJ:C6LC KA,<!(RVP2X8H@1AW 4J.F2XSI]1&,
MA&U+>;2HFK:<TYUX^]-YW1.C#>$<Q&#KY4*Y<((XCSFD;GP(ED$1"\>'-W&%
M/1]RXS4O2'/AK4CWZWZ;WK[<%S+A-OS!\*_@6Y+^CFG?\&P9I^8/A7\"W)?T
M<T[_ (-@S3\P?"OX%N2_HYIW_!L&:?F#X5_ MR7]'-._X-@S3\P?"OX%N2_H
MYIW_  ;!FGY@^%?P+<E_1S3O^#8,T_,'PK^!;DOZ.:=_P;!FGY@^%?P+<E_1
MS3O^#8,T_,'PK^!;DOZ.:=_P;!FGY@^%?P+<E_1S3O\ @V#-/S!\*_@6Y+^C
MFG?\&P9I^8/A7\"W)?T<T[_@V#-/S!\*_@6Y+^CFG?\ !L&:?F#X5_ MR7]'
M-._X-@S3\P?"OX%N2_HYIW_!L&:?F#X5_ MR7]'-._X-@S3\P?"OX%N2_HYI
MW_!L&:?F#X5_ MR7]'-._P"#8,U_GQ_O'7C'Q7G7@G)\VN4<^J?)?)WQ&ZEQ
MOH/(NN\VKPFF6^!(E=,K%=E@292OQ1[Q< Z@OJ2B/)^*EB3'2IOVZ6\EPZ>U
M;RXW^-?Z.Z"=E6BB4JS3FVFIMBJ5<.S&F-;TPW*+AX9"0VSI6]JTTAZ1O2?7
M>]^F'*]4MP& P&!PJ_O*7]C#YA?Y'C7\O7,<E=/:_G'3ZJ4R=T?P\JW/1EM-
MT$A>O&^OT^'>*TW!=L=/?LG-(8=NS5]!-B4.V;";F?,Q-OM.LZD-HVM"DZVG
M=8Z5X(:^C/R"BO5Y[QZ[3VGBB*LYXRF D.:<3VN#"N?BBB["N96F.UVARXR(
M+>Z?>Y064)BNQPVH4>-\O&86SK>S7R7Q6%7?I7<[%]5%^0YWM/:[1Y%J\@V^
M\W7ILFTRQ@&^-.<TE\4(\T)<<&RFN1"JA,XY-77VY<,0T=C1O1;<[U]=;'.X
MQIA'Z5])'GE6KT.M&N[==OD"HUWQ=YERG\4#N<MJYSPWQ.\@Z]Y$T#EC: 5.
M#LV_1NRUJ*.+F2Z9).2+8:0A33J5NNCGY?5?B@?20H7%)+]BX%WSL'(^@"NW
M]LZKSRYP!_/;=^ */W>F\QHMHX!%K=WJ9ZOV#E5="<@KVZ^F<RX2$NB8FD25
MLM+9=%WV]9IA.:1]+WE7/^D^)]S = N;=<\.@4Z)S&MN N>(MAJQ'PUX%W0Y
M?NT1*E%ZO9 5_*=!('#5;22CUZ8>^#*^40AE#.ASN+.ZP?(CP!YYY($O(Z?;
M+E:AC'DMQG@W$[<,'PZ[,'"ZYP;J'0.H"I8Y@L+F)F2;5-Z'*@DFI?QHZH;2
M--H2O:U*)-UF,>%>>>D_1WX99^A2.@\W.A^/I_/3$[:+YZ*X9PVW\B#GV^ A
M. 38D3F-NI4ZJ*^>$A=&=3%,?.L&75/-N:UK2<+\EQB]GVOOT?\ CUSMOD!<
MAW4>B4@OY52.RAO(694QU.@%.F<L[4;Y(8,<L+'?N39AH55X_+Y4 (02]LD.
M@6DNTAW_ ![>VQSND[-L-^CWXOP^G"[67>M'0N7A^O'.YPN!]DEM]MHF^C6?
MAL'A=A*SS76=W*[&8Y .#&$T,3B$E$4E 3MGV,K4U@YW'GA^R/TH^>%#_EN1
M>ZF?@#?*^X,=)FN@N;<@%]"YMT0)=N7=$I)FL=9_!TJYGJU2+;R4;*A5TTY/
M"JVIS3C"M;3[1SNGDL^M?3TJHFKU4?8NN=#NMU'^: ?SGO'0RL"G#2/0NNAQ
M[81D5)  0 VN5FE)KL"! :B#F&WFF(*%;>6\MUQ9.7^L-!5?IP#^7789U#B?
MD)U+EG2OO;M;%RL$,!S6UBNB<\[7Y'W?R;F4"S5:WU(N+C[H=YZ"38KY@?N&
M4C0IC[<AR4EW>M%N_.EFC:\M\%;/Q?OEZ[Y1N\3OQ#W#I53.][@O<NY=60]Q
MYI0PW6':]41H"@UBKA-=$+6_H,!PW>B34^QD P5B"EUK6M+22[LS%1WLOTM^
M1=OZAU3IUMOW0(\GJQB_GR <5JOQ8]=,WCQKY1XX0B]:)+%.E!YBDQN0#+((
ME;<4['/>J][4RAMM)9OQ,?77+9<-^G6GQG)46?POR0ZI2F!W(N#\CZ\$EUKE
MUI"=O9\=J"US:A7DO'L%.F3*->Y53CLPBD@#(APY\:-'2J,EQE#V"[L]9XN@
M]3%F0=6K06Q6:9=; ( B!ARXD1H@,0MAB /CQ25EG"*_#' 1<PY,:7*<CPH[
M$1A;NT,MH;TE.C"08# 8# 8# 8# 8# 8# 8# 8'F;S*YEROL'B[VRA]PL)2J
M<@FTF:>Z19 [PZ/.#5"CR8MZ,SM.EAI<=J*U$K:OF=.QG4JC?$3Z:WO6]%VV
MRZ=7!/I5$^F?TGG'$_)+93RG$<,Z%V?MOG?S;Q]K%5YI5 /+O(?Q-HA+JW;R
M5CIE@K<"]5RQ'ZSQ,H'76)Q>6&00*25L,0ER&I<>.LN^::<NG^7^@+JG-Z+Y
MA>-5DY[89%E#T?N_-(OPBH9^&*NM79LHR&;KEE!2GV"\ 5<:F05%(075-RFH
MY"*VK:7$I]-UREXW/9X>$_1U\9P>KBD;;NOL(N/$_&_AS[/W_5E1@X;QO,<R
M,C[8%C?@[3$>[=/<XU6&K7+<2ZR0;#L?!9C+UM6S7.O/%^\6?"#D7DK3/%ZZ
M]<[R[T+RW9)3^: T1*;+J?-*]0O+<GYVPJI-N$6C1Y 1B\]O<-1 >SCY&>6A
M,2![+WQ8C3J(LNZS,QB?]813Q!\=?#/R:/5PKX[7WRHYMTGPXY?QBI4#HAV)
MR)@O6X<+H'F -$'H(DC6;S3K2<L2;G=1IEHJ+=@;&R(+L=EJ8E;Z*NZ[IUQB
M_P#A><OZ&GBTS6[35Z?TOR!H4&[\_+\FMTH!9Z&1(V'F=GY]R2D7&I3Y%LYQ
M8FVF[:4XJ%/RIL5N,0:+;DHBOQX+_P F@GR;O)[L\Z[9RRB^&_D++[2Y>4<J
M.\P-<QN2^:0()/H7W5UQ#/)F]4^&2V@8NPKFW-K49<G_ -.TYO2W=;0E6MF=
MN>4QU>) ?B3X86TURTQ+M-P\<24L1XO0+9XL62R<5H1KHY?Q_P"CW\MXK&NB
MTX1%L1P=8]]#8,SX.ZL8'1[0N/MJ6B6F,ZPAAKENGGY_[2W? ?I_WWQ[\/O$
MB3Y+UFU\EX)>J=7^<UD#WNB!C?9.A<#KS]: 5BPFZ%.!'B]GI-H-0#TF%771
M<UFPQ(+CNDHU\%PF=V;NQK7F6%X^?2IX.&J_3X7FA 1S7E'8N"@*?&'=LYWT
M"M<_-3?+&R>2_%^5220L58K,W6Y_1[O/CLN%IKLIJL,K<=F(:B/3431<[[IC
M7_P[^H6AU"'6EH<;<0E;;B%:6A:%ZTI"T+3O:5(4G?KK>OLWK*YOU@>$+[Q;
MQ_M\WK5MWWK55T:=NE>[-/$73FJQ\&I=<KG-*3:J >?/""S-/CG6N1#-Q)7N
MC%H\KYC3$C6G/8@UFSP2[MM!\9.NRJ*$Z%T:KCFZ'#)PT5=B_5<>U8JGTBM,
M5F-6;1!(OR9D^N$R<D(6'Z1MEQTP+&NH<6G6VW1+9T5_6O'/AT=%8I\+K=G@
MW03%B17HAZV\^G7^XM\^K7:^67"UGANA\MPC,OD/K%B(%IK332D3GFWD(AK:
M6QH9K)WP;QCDC'9+'8(S@^^<OO?/!$V)>*,^R3K#7*>;\PMY.L.-076B,^M5
M;D4*1(<9^,S%D*D*>;^%M#;8S5?.\!\9^B/4@";O][+@[4[9D<^Y[*(U6 OF
MT'N#!3LQNIF6Q8EJW"U=%'B79([[\?D3&HPY,>,ZVY[_ (Q<V/3]8YI3>&A>
MDS;OVDZ_.[$9%J.7J]6"E4DBP3@<]KW-PT2JRZ\%J H7.CU^J,/M[;:<DJG;
M=?TKTWI"#.<X\GF,-X?>.\4.D4#\C3S<OHY.TT\R8'6WDCA'I'QP?):Y:*7&
M2FJO17SC*>(AGB$B$W]]KEKG.2']JE;^&7-[)O2^6^/-VN=_KX7HYFTS&;+5
MB2_A%ZHZ#>U*[G8O*V#5*H6%P/B'V(-LCD69R=..S&!2?AK<TZW\QH9N,J^L
MW+/'KB=H6U>;IVBP&>.^.\N;77MU>'-'5O@M=KG0.5B*4,*UVDCQ1VQ#FNC3
ME,ZE//G9CJ8[CSBV4JTX66WMU;)' >9R;-QGWW=^HP:E>8??;#1>G6:M5[I$
M*O<_YD(Y_&!.U> ,VX0H-BM% !V<S(G3OEHDP SMG6VW?AQ29JXO**M\<.T-
M7?KQ?K.*I5$H13;9GFS0^U.&(96Y\VO=1*5N!%!V:58;,+Z-SD#)"L0FWFR,
MC>XKS$MF1\+!,YQ.J-5N+PVRBKMXOQ+C=[38.UB[%TT[TMA@1'F%BEW"A;/"
MOU:+#!L:M""06%-%R J8X[4>.N$PI2'5I<6X-9ZNR B.&<#LELN'*XUBZR,I
M5+(@*S;8)-JL ^>V/KM<X<!Y^*)#[?-#LV8A>&.:GX$Q^+">;&2I\'YE;2UM
MRT/#-ZK/YMROQVX_T<_TG?7:88MDP96I-AFVN=R%LO$/VRHTBFP[>T?AAAEF
MK^ND5^E#O9 9ELB9CJE+C1])6A"!;;HT77*+XW(-6^PFO(IOF]FL%Y)5:TS1
MEOY^_/@O=^"\UXQ.YQ)$G0IYH*U;YG,@_P H\]'1/B$HSCB)"6/CM8)E:G&0
M?*G:/US@7-)W0@(NH6;H-5/$'(ANK&J^3OQ(^8F+H=KF#8>R#8!9=Q(TG&5*
M6S\%E2WG7=;6H7.95$U?QH\6J(+MC3G=([SQTW^&K05FW7F G4>X,V#F5@=$
M)C# XX<+L*I?,Q278BT*E.?&><=TMY[3B1G<L'Q[KG/N8RKMP)ZT""O3>HG^
MV=:M8*JV!BSQ>>@73]4$"J']XO011,5!I=-NP$<'8F#HOQ6(SJVVDMI]NQ==
M6F9\5?'\97P(:!U4F.D4MB?9:V=_%5(<(A2.KAQV6.N#C<H.X,F)KUWX8'::
MU)8<@N2%28SZ'/>E#8S5:0.)>*.K)7@9SO!<U:[=U-R_A2Y*Y<UW^=,W2;%U
M;MW1 \-%;#MCGJ7.9[:7@GX/P(:=CH[+3>TJ9^.X7.[MHW-M\:/&@!S4]TFQ
M]Y/B_'S<^T]-N4YFT49^BFCMHH]TY)/MTFWQJS-+(;15KQN&Q'@3FHJIL"(Y
M\-;VG]2!FYQC5H!G#_'?ICEFN5D\E[>>>I'395AZ5NW6/E :%'L7.;ESVL"K
M'-!,UB((I0V04X&/C03$1F%*(BGI#29&T2=>R&;/!T2YK5 E$YY1:36I[Y6N
MU&H5RM@2<J3&F22(<*(B#ALY^7":8ARG9<..AQ3C2$-KVKU3K6MZUE9NMS4V
MPA@,!@,!@,!@,!@,!@,!@,!@,!@<%O[S)_8S^57^T.*_RW\^PZ>U_9':'CG[
MT/*_XMZ/^Y@7AB]5D80P& P.%7]Y2_L8?,+_ "/&OY>N8Y*Z>U_..O7 ?WB>
M*?Q2<X_<<&RL7JMO"/#/F)<>[TVY^),/CW2!])"]5\BQ/'NBP9O-AEZ=D5TQ
M0>A7S9L>0FD82P$^$]SM,!*U)=C[026M2=N-M8:VR:Y[.=E(^KCV:F<AYJOK
M'C61OW2K)OGS[UGK]Y!4FG&Z]T03V X"GF9UDJ@"O4#H!;?)) X=7GI#\.;*
MDL?_ #HVM2VTFN$SI=%C>6?GWW7Q_P#/(!RFOCH]JY'!Y5SZ\&.5@:5 M'5K
MXNPUORN-VEBD1(5GB76>8@S>,UV)'DPATL"'40<48>91*B*T)MEVY\7[_P#H
MQ8Z+KG4:7Q&.9GW+H^Z5,GT+HQ:U4:<#F0.2[A7+F%[F<MKHCI,:NV7KL<+9
MH&D#IP0D())2B4U'^+L<&VY7]2#J_:?)/Q+Y$[RL!QF%TW[KMO0JZ0O+EVN)
MNF7WP\Z)Y!4]\ ,D\WJ^H].KQV.'%D[$Q-2G5H@S@Z8[C2-2GR7;)+6BZ+]1
M[M]\M[?)>(<P&40_'\FN6<RL5L/620>.TZAS?*0GPFUC.AU-_EQ45R_IW0!E
M;6=K,*0LVQ)IY'9;3S;C3;3A9LG6]FM\C?/#O_*O*GMW/*?:Z981= LW-:V
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M@?S>M;UZ;UK>O76_3>O77KK?KK?_ ,NMZP'IKUUOTUZZ]=:W_AUZ^GKZ;_\
MCZ8#VIUZ>B=:]/7T^S7V>O[/I_\ +@/37KZ^FO7T]/7_  ^G_AZ_^& ]-:]=
MZUK6]_;O?I^SOTUKUW_X_9K >FO7U]->OIZ>O^'T_P##U_\ # ;UK?IZZUOT
MWZZ]=>OIO7^'7_AO _GL1O[=H3Z^NU>OMU_YE:]JM_L?L[3OTW_\,#^^W7IK
M7IKTUZ;UKTUZ:]OVZ]-?X/3>OLP&]:5K>E:UO6_LWK>O76__ )=;^S> ]J=[
M]=IUO>_;Z[]->N_;OU3_ /Z[^W7_ (8']P&]:WK>MZ]=;^S>M_;K>M_LZWK
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M4GT G;03;&B*8<K [JT6Y7;H%OGI[<^-M<@A9#%7U?%)"3&5Z^5FLNRMM_\
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M^$V0W)(H;5\LAW>O3#7'=C+W7ADP& P& P& P& P& P& P& P& P& P& P&
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M)J[MN*4PF9@5S=F)"934!J6ZTY,5%>VTE>FG-I&+-ESWG_+K-A@P.=?U1R,
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MF3+>J80UNN#^Q1S5 +QW0I=1,*6W1Q;<$E"?GR5R8[SBW(;"E:4H8VR>:&P
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MZWKUWZ>N$9> P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M[M1*BGU],["Q2ZY9?O7I[7-N"3ATRB^-X\9-KM\J$1KN/CE5E/F*O84R9T:
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M]H/>>O5D9MR*)C.KZ [4AG/"QO>V]OFJM9CH:+O<@5(AD-ZDI$LF9W07R/\
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M<B24Y1&HT@7"(4KE_6> ]+W3;25#W,?'M3<V#R P'8F2(6I#4&W2VW?C,M?
M>+-V)C&K0\2^F%9N2]V\>^P%^^1^A1>%"P,*/'LE'/OW5^-7^ ]*X+$I]9M\
MKI<X96>;.QKXT?<&N"9\O9F.\OYSV/ZTT+OS+,=7M7E_!K=SGI_7>IOWH!93
M_<^O[MEZDD*@08FC^15/GOX&X_R.F2(]LU&#_@F9%;*S"$AB8T1FDBRTQ([D
MU#D<S;F8>H\(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# XMEOHQ<N3Q^IT*FWL'6[R'O7DA<+AT(OQBJW$5T]/DLSTX+8GKM
MS\D;B02=TH51Z4Y!JYQR>XL8Y%VMR/(C2Y4)PZ?)<Y\'MSQ \,:+X?,=D;JA
MF5;9_7^D";N0M5B$P$WA(>M\JYQRNLU:S6UI;I*ZK$PN?KG?.R?@^Z64D[2P
MW[E;69W;N6%!^7'TRA7ESU.W]?L7D'U:@6IKE7/^><0CT);8P!R8U0^F([4U
M=SH?9#X/49A7J]?K)-V'*4/:;:K49A*]^];FB[=W'P>*J7]*;NTSR'[V<FWH
M3RSFA(1T(12^A,@:F<Z3U*5UCS,K/ES=H5]U4B82RF.?S9%>D@TO2C86SP!Q
M!J-#?2J&LA,+=\Q._P#X6-2OH=<ZK<VC.V+L2KZ,I%-D5",#LG)J],&3$ZY'
MY4<G$D5,D;(50PZ#B^3KDR,CVN?#6#:;2I.I"EM3!?<M^OT_Z2P7]'F #$%X
M8CO:8TQ4OPHMH)F3R2&8JDKKGADJDLPNN]%K)N_$I%NM750-'BA338F?68FQ
M"6T*;?EM[F.4^3R[_=TX\DN1%N^\#ZSQ$3?B/,)76*.;Y_-OH04R6,U\':HN
MP]GD!(4F=!::,2Z[*EQXDC;OK"D/(D:2YMK2%&)<7+DU9/HD F#J'>9>2)\=
M2!YLO:P% [ES 'Y'"@MJLWC/,\4;.31*M%HKBI<25RZ(#^2C+:3\C. LK][S
M+SS"C?R=XED#Z-]<K@FY J;W&6$#$GO%&Q5$*4YM&MH9'4/$^V<WL=>Z_P!7
MA6"[2E]$OE\$\RA@CZPKE.@S0[KFG(RY>D2TCGY*\/?0^3;X][7<?*ZQV$]?
M8\9HS9)'*X""!"9"YGY@<SCGBL1V_21*SKPWRVD//:&QQ0Q/W"RU&A1FY3OP
MR_)Y?6G_ $Z8>*_B)5/%(AVAREE8BP/7;-S&S-54551E3!U"3SK@/*N%R&QL
M(3)=B2G+1KEZ3$EWX3"TR)RFM_$TWIU9C=NY.:/]YD_L9_*K_:'%?Y;^?8:]
MK^R.T/'/WH>5_P 6]'_<P+PQ>JR,(8# 8'"K^\I?V,/F%_D>-?R]<QR5T]K^
M<=>N _O$\4_BDYQ^XX-E8O5;>$,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<%O[S)_8S^57^T.*_P M_/L.GM?V
M1VAXY^]#RO\ BWH_[F!>&+U61A# 8# X5?WE+^QA\PO\CQK^7KF.2NGM?SCK
MUP']XGBG\4G./W'!LK%ZK;PB)V2]TJGSJV-M=KKU;(7 NT!JL,V6A#)%A-O+
M:;8%!VI;S2I\]]Z0VVAIOW+6XZA&M;4M.MC"68# K\3U?FIV\G>9!KS62?0J
MO$;(6.EPBT219 <%]:&X\PJ);<W+A19+B_:TXXE*'-Z5I.][2KT+BXSX+ PB
M'&.@TD!MM):S"8BW2PL"RWN2EYUXX:,LUX8'9:C:><=*2S+Z6-,)UMU*O7:D
MZ2E6]#"0DBHP/'^:*D(8Z/O;B4O39#4="U-1GYCC;>W5)^*XB+%<<VE/JKV-
MJ5Z>FMX 25&G10PX&FQB0@R/AE11&&ZEZ(0&D8S<N#-BO(WM+L:5%>2XA6OL
M4E6MX&?O>DZVI6_32=;WO>_V-:UKUWO?_P FL#6!#0FRA1%B $8A<$?&0#04
MM >3(@DQ)2*U.'$(4A&]H?B38;Z'&UZ^Q2%:WK]G _L,R)(R94. 1AS9,)&E
MRVHC[<C<?6YY,4I+JFE*0EQLF%EQUH]?<V]'<0K6E)WK V>!H%VBO(L[%+46
MB?BJ2"DV9H$E>US]5^)/C"WBSS2$JU'A;(RT,H6YM.G7/=I'NVA?M'FBP#L7
M*K45^XZST.GV$MLS/KVH(4\/)O*."H$PF2%)U"?>2J; @#Y#CJ-;WM&F'/7T
MVA6M%Q8LC"-)9+)7Z< ,6JUFA=<K5?'RBQP\:FQQHD2,A-*>ESR$^6XU&B18
M[2=J6M:M)UK6#JTS71J%(IK70XUPKLFBO,H?:ML8K$D@'&G)VA:5)),.N1M[
MT3W\NK7N]4/ZVA6M*UO6ABYQXII@8ZI<1$MJ N5'3.D1Y$MB$IYM,MZ)$<BL
MRY34?:M/.1XKTUE#B]:VE"GD:WO6UI]0C4._4<@EE<"X5B8B2(-'XZXQT8\A
MX%6R#(FPF6UHDJ2L6#*2$1Y<C6_A1WEI0XI*MZU@?VF7NF=%#:L5#M(*X =R
MGX*3-=)12PQ<J-IO;[+<V&X['<4A#J%?M5;UM*TJUO>MZWL66:5)9,F-"C2)
MDR0Q$AQ&'9,J5)=;8C1HS#:G7Y$A]U2&F6&6D;4M:MZ2E.M[WOTP-<%L 2Q,
MS9 (I"+,#2Q0#/=@OHD-Q#(66Y +#7U(WO2)@^:TIIU&_M0M.];P,Q)"$N>\
M+3(;V08AQR#T36]_&;A2WI4>-(5KT]--O/PG4IW_ .+>\##38 BS[U524A*L
M<</&L#X73Z-D6@DR;*'12BXWK\1,)^?!>:2O]C:VU:_9U@;C U)X\&JX4K8[
M$3AA@(.!**F"Q!Y$:"-'065R)<V7(<WI#,>.PC:EJW]FDZ]<#;8&-#FPR,9J
M:/EQIT-_2E,2X;[4J,\E*E(5MI]A:VG-)6G>M^F]^F];U@?@@0A"H4DB1DMQ
M(,-I3\J2]O>FF6D_^9Q>]:WO2=>N!^]S8>IB1VY<;1!<9<U$';[6IBX;3K;#
MDM,7W_'5&;?=0A3FD^S2U:UO?KO6!DX&G$V (>67;#%(1-P 8D5\TB&^AY0L
MW$CQ)<D7-TC>_@36(TYE:D;^W27$[_PX'Z,G@U>CQ)9PG#%1IQ8,!AOSGT,-
MR3-A)Q0P,8RI>]:7,*E9K,=A&OM<=<2G7V[P,4;:ZV8,'  LU GFJS):A6 ;
M%?2[*#RWX \HU%GMI]?EWW!Q6,_I"OVWPGT*]/16L"08# 8&LAFA)"5*@P",
M.;*A(^)+9BOMO[CZU/)"EI=4UM2$.-$P\J.M'K[FWHZT*UI2=ZP,V1(8B,/R
MI3[,:+&9<D29,AQ#+$=AE"G'GWWG%);:9:;3M2E*WI*4ZWO>_3 T54MU;O 2
M'8ZF7C' <]IA^&1B?%TQ(9E18\Z,ZW\9MIS;<B'+:=1OV^BFW$JUZZWK>!(\
M"-:N56^^+" V>&I+5(0..VB*N2A'X?$%]$EC9QB0OVQ1[4MH/)<3IU:5?"9V
MYO6D>BMAG!CP6PQY<H&3AE8T L7 S'H+Z'VXQD 1DB#8QY2-[TB8+*0W6'D;
M^U#K:D[^W6!I++T.B4TG7 EKN%<KIFWSONVK"2YB#!)6&;\:+&4P(@R'D2IZ
MFY,YAM>VTJ2AQ]M*MZVM.MC%J98# 8&@DVBOP[()J$DK%;LYP87-"@GN4N?+
M$ GAL8N3TTVE7PH,&28BM+=<VE'Q7T(UO:E:U@;2?/ABX<D@0D-Q841I3TF0
M[O>FV6D?^9:]ZUO?IK_Y,#]1)D2?'1+@RHTV*[M>FY,1]J3'<VTXMES2'F5+
M;7MMUM25>F_L4G>M_;K C]3NU3O4%\G4#T"P#H\J1"<G#7%/1=OQGWHSOP7_
M &I;D,[>CKTAUO:FG-:]R%*3O6]C&.K9&3X6O,P7SA2$*9)%Q0 >[.?0PB8:
M.S6AH<6PI>]:<FDI[Z&64:^U;BM:U]N\#;X# 8$>5;*VBS:IJC0_5JV+B&ON
M#XZ=D]"9[Q>/"(JC:]5HB2GP,U#:]^FE*BN:U]J=X$AP*^I76.8]'EFH% Z!
M3[E.KDA<4]#K5A%F)0AY$R:.WJ?'@R7GH[>R V2QI:M:0IZ.ZC6]J;7K1<6=
M5@X1JC!P17HC4\X2B"H3Y,(%9E37D,,N%K(9@5X"/0M>]:W*+'"D>*PC]EQ]
MY"=?;O6!M<"!&>I\UKM@DU2P7ZH K)#K<^X2@IBPBQA&/5A3,B24L#T>;)96
MV(&Q8KKTA_?^+99;4XO>D)VK1<5(&[16W:RW=&CP=VH/ T69FSM$8C@!VNNP
M-%&CK19#JH+@AT:K4A,A*]M*9WI>E>W[<(A$/N7&2&@'R/5.?ROQ2"-V>N:8
MMH1Q1NO5K4U5A,C4IF[5*'@]#)7S;B=;3'W%?TOV[9<]I<5^J_V_C]L+U\!5
M^F4FPFK4(D'ZZ+"V(:3G%PL289'22<./#D/.+AL$:Z0CK7O6M)D09#>_V[+B
M4C%B=!K $L*"#H,I"*MB3!*ODEPGT/I@FPTA40J+D[1O?PIH^2G:'4;^U"M>
MF\(^!2U5L+.&"RQT6/)&B$(6*@2IK#4R>0),E) ^+'C*7\9;LUD',4U]GHYJ
M*[Z>OL5Z!O\  8$6%W>H&I\L6*L@><1@E)@25#CSF52&C(Y9)N>*^'[M;60A
M*#RMNLI]7&TQW%;UI*=[P82G 8'-DIYX]8/63K+' _!;M_?^>\<Z'=>56/I@
M/IGCK0()J]<RD[&]%%5"I]+ZI6;@8BULXT\.1*=B169\V.YJ/M3.D/+-<9XV
M2O;'%>N4_OO(.8]NY^Z0=I'6:+5^A551>"L870#M@>(:'L%AJUN*@%(T>9IN
M0S[EZ;>2I.E*UK6]DLQ<59V$,#P%?O-#I3'9>I<;\?O#OK/DG,XC(J(7JMNK
M_1N$\QJU=N-VIP?H8:H#5=9Z+53-F(,4FQC9TR1$B*A1_GVF=.K>TZAHU-LQ
MFW#T/XV=\K_DQR"O];KU=L]-22+7*JV&E71@8Q:J3>N;W2P<ZZ!3SFPA,T#E
M3:U=*M.B?,P9DJ%+0TE]AU;3B%;)9BX7MA# \+=;\Q+Q6>V67@G!_%;J'DW=
MN>TBCWOJ<NJ7KC/-*U0Q_39]NA4 4\6Z]?*>[8SQYJB%)*V1K$EF'&9;V\ZE
M;R&\-3;IFW$6YXQ>18WR5H=@LZ*/;>7VVA=&N?(>H<SN[M>FV&A])H4UF+8
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MHMF"]SL/+'>=LPSEE(R+)I89=,B"=_-,MMROGU;VAA_:DN$MM8FO#KJ+X?\
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M0X%K/0'+3:'S%9#3W$EIDL>-YI )2-!G$,K=8F-LO(2U^VU@FYZX(<CN OI
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M^/GE/<ZSWOI?'NI\QNO"O'SH?=*F7KP7QNY/R:P0"I'F8JP/5BR@[ASJ:EZ
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MJMO"& P&!X8Z?XC'+Y;;U8F+51YD>VVL;;&(]XHI.S2]QX_.W>>JY]8I<&W
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ML()=I91 J#KPX;O58:V[,0ZWK:_;&'I3193Z@L=^5&#Q&2TA$[55*R+>,YI
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MD7"6>FSR88?6:BX_*JNP*9:))U'PIFWHND-NDT59:^.^2L/CWBI1*=:>DP"
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M;-^*:/JT6>RI(?)Q84:):4O3$.,O16/D(>E:T]%;4.LKV)ADP& P& P& P&
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M'#.K%S:]FCT0&X98C #G1^;^/]EBE/1IUN6HF3=V\_I<U$@7=E.U>$QMKG?
M.<"KQ7P8;C=/30GF1-=)PH,>#%M=3-1[Q11L8XS' W^> JSHJ6N7\[%W',S$
MI3MA3T>6.75IG/$3G72*#Q2DU(_0YH_B'(C' #T^'5)B=2![=UY>JT(KKT4E
M%<"+=LO")PV5%T\]I*)[_N7[VM?%'*Y2KF7A63I5_O=A/]5LUBK=JJ=VIH(7
M!*%PDBEU.U_)CAE(%Q_FI\*76Z:'@)>$*>5M4 @\\MII.G%;4.36E/'N_=+H
MU"I*.J<TFQN7U>94*Y.K59M$0"JO'ZT"!5#JP\<,N#8^#UFB)K3[X-V)*?&Q
M=S9"4::5MMQL9F597KZ?MMA<Z/L<^OZR70Y@,,.<GDG[% 7:I;D?J<*[O'"+
M=OAN1F[P[? \PG\!QE<G\,16O=KV1%1"\M=>C%5XE32G05P+!Y#5Q%:YC'%3
M+QS\6!*@ M?IETZD[U-/+)9S5A8WJBICC51Q<2=,?7"'_"1\JU&4CXHY::1(
MJ?XI$+8KI4.-<D6OE.Z44J?-69I<I&"Q>G.7L\(MQP0L18"!\%$H%&I5:J$9
MIQ#7H^/*>C"X<QU#XM[]6%U3A4OKMYYSQU7E%2 U\YOQ=FJ6FH5JNM5>S%W2
ME'M8"T$(@VNG1DP97;./M B?H4U(^&,0(:=;;5\RAZ,)<3.-&\M/T^IY L/?
MJ_4R-9K+=HLQPW2Q+Y\+ .1RUXZD:J;GWK&+SI8@QRFHWV ,KS\9I.H7W*S\
M'X"$QM11-R-VCP?5;8EQYS6NP@9I3[DF+OU9M NUFQN[+TB1VA</JQ4=$N8^
M2]>((2W0HXAQ;_P4M!%(7KV?+:BCDK_H'B%"Y\#;"= \C(4B<<*6:T2)708=
MSL[16 )M7-2<GJ@^M@C R.(ZW#?CQ@;DS2I$<@Y86V-)<<<9B.Q9NR],W;Q!
ML-Z['<NF7GJ4"7SP_/JTN?0_N.4&'3JS3R=<-CQ=I>@F8$4DH2D/-8U)EI?V
M]'(+TYIMI.V55GEICQ1VD^%]N@NW$U,[$*L\J[>.?1>10>B,C[,[>2<[IP+E
MD6#9REB_&LB'+"4E?/5["M0T,ROE9VO65IU"W7QR_P!M>CP(-B;@5L%?Z,RJ
M(J^ +%5H5B^_C(&N5<;+TZFKDN?.3]5*Z)JPG;@H$Z3^*Y"A/J<95&E(T^LO
M)%Q?TZ[)$&P:Y.O]#ETRK<\J]#J%)9Y\]#J[[-%O_);_ %)^U#63&OO5Z*9Y
MK/D+D+6^ZT]99"8VF6X_I*'+]7[9^GC=&PXP9,[+JSR6K9&,F9MT8LY^+.?@
MV[F=I;Z.(#1K"'A@.M$XW/Y ^=+]TJ/):+/..>_6G&'QR3WI_B!8.@7DVI?6
M8$7[[Z+*Z<J*Q*,".@'*K( R:NU6"QJ&2D2F G*"1-J95)<!AA ^7\/W(1+W
M\ZLDW8B'VCP4 1B4,?.Z!5HQ/JU;OG,SA S724RS=#*'(ODC=T#)4]T^ITV.
M;$=,DS)<*6MQO3588TS\-&D(9').)OAG>8;EG;KW0ZG+'GPTH $C6RISS'YM
MP+UO*&B5>Y_&DEYP84.N]4+;!E5KAK6PU#BO,:4EE$9(Y=U*4WPN@K(  PWR
M#'%258O]/W?W0VS-2LMWZ!3>44.@3IA$ZR5GD9EYJ$+C,J<(4VX[)BQ"I)MY
M:4:2\J-7=Y+WO'B X?Z%8[]=+X+(5-_H=3Z"F 2KQ0J6*J!=8Y#T 17[4XX8
M?&S1E!B\XE"ZNJ)$9<@-'7UKTK>G_G*SRT:BP^,$+J]PZB4KO?GHMTE/5\U5
M;!5WBLHYR41:KM8[+*EUV2S9=#OBVVK*D"D/,I;2IAA6E>K?^+T,X:.R>"%R
MMD78YV_T^D0)T$'%FHH(.XC9 42) E:Z;YW4I"KBRX/YOT1TDHT:8=VY.<,.
M/.*?>7N/(BEY-:.\'NCS)MJ-RK/3 D*=T'J$\?S&= M)FDVJKG.A]FG40KT9
M(^XQG2%BHM4OHM5>3!5$9&(&-1U-I4W&7 '*/I*\#BZ'J#6#'=HQ6"O76G+<
M[9 VY=WZL0Z# Z&(L+QB=+/+FG8<BEVH1'F0/B?=\?0'2TL;U)UN,.3Z#O"*
MX$P4!H-VNO-0M@U@1I.KP+%IOG6A$(P&G">3O0KBF&'#6Y4I(NQ,/)<6H>/:
M99VTZC2FR<ERTKFQFO5GL/C_ ,SZ#2V!TZIEC-9)[5(LT_GA6VOE*+H([39S
M\X<_6H]BH9N0^ZY-^(Z5?E,KBI5'<6\/.JJ$\&*>-E2M!.U^0-0K,>Q<AM'(
M0UEM@F4=<8MU@N%HM7/T"(%B+2$MA^?ULJ^-2$&(;8-L1TRWX[.XFM*+G-T:
MJM?3YE+K;:RW5T'RSK)]5;,:BV)40#7B]3[!$IP 6TFSQV5AZ5:.CAS$+V-1
MT;D5N(ZVTPZU%5%)RU;(#X V.%&GJ/=H.V2P)+7<^-M!278I$B1;C;6U5+H<
MX1',P!T&\5B1(<T[*:V\N6EF-M*V=,-(;+R:&/\ 3RN7X^8MTOM#T>"@O77"
M,2K(LU:/6-^O&"A6+U2P6-T^;<>[$WLDXC4B,Q%A*1+EH]J4/[3@Y:)%0_$P
MS60UXI8_J=8(WN/T'C]W*)J<4@&+#H8;F[/+]7"QZ,';,[OH5@C0)MMBR-H:
MC+L,5E2DKVEV4X+N\6O >&73]BTSJGVNMA1-J%5420$A:[=H]9@!:^;Y8?D6
MRICI=VT0AWSH#W/)&S3\IUQI:RNW-I==:DN$!RG9[5HG#ZE4N4\ZYK.@CR\C
MGU+A5F!:-P];.1RJA#$(_:0Q0DX3+B39TBA<UV3J2N2J0OWK<6O7NV9SKEY9
M_P"F6=U&B5/FICHE"+1_'*'<.85 M5*V=%D!1EWCCE%K!JQ0/Q(N*,NU0;.0
M2NM05_+ID:2['U'<TUMDN=<]T L7@J5G5[L1?N/: =HK]E ];,F$D:G*A4\.
M4M7-3M/D]!(UE@ZV$7,&#I:9LAK;+BO?%TO3ZGO1])>73">\F\+9(.Y!>@67
MHWXT%:Z'OIJ [;QS\-&X$FM]3CU<0Y7G)S0?35"D=*B1A$EY$K:A .$TIMK;
M#&F$2[O!Z&*4HJ,[!0RW.A-$'A:/3"-6*UN/.: R(==Z?<P9HV;T#$CG$I:$
MM\Q6D6TI+34Z>1DJVXC49WXA,Z:JOH7C [ ZLKN4;I[5F>*=-,7H5,BZ(S6O
MS>'XO9E;Y\/(?B*:/4#?(=.'2UJ9;U'?<!1U;:WMN-N.6W3#SO=/$.Z#*U/Y
M>0\@*G50/89<NN#P\BN6\N788$KZJ;%! Q-%P@$+@0(-]'?D'29;:R$N,-:;
M=>=VGYI!<SKCHDA/P#LAJ%N$1MG/78$AM^9)K4RJV.P4T>X.Z &Z#5*?3@5A
MLI!VDU> >":ES9D"0B<0>FR&GD.,HAZBDY-W7?!F\M%"UAN/9F3AUZU&KN 6
M+ DP(JMW,M.XR^_:Q <;8(@T>0F-<Q(;6VVS_B=G74Z==WIYV2+N_P -$/\
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M<E##>T*U+DOI6^MA*4.EY>-;T_X7?=-?:('^LA.?79 +G?)J?UNIBCHZV-6
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M:A QKX:4:F33E2J<MA$<5"?F;?@"F&8VGU+;^-L<M<JR)^ @BX1PI2J]?&P
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MY:W2S]=GUXXB =8E-3XTE<V+\#VL-NK]I.6N59=E\3*)$CVVNF.^TNL%[O\
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M*9==D,-I;=4M"=:T:F_=-)7LT&#"U@('K5;$C0%=KPL># @@T&,,#A0HF(S
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M1 P[XA$66)V-"BOI[%/#VWHZ=?X_W-DE>AL(8# 8# 8# 8# 8# 8# 8# 8#
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M5M/LM/>QM1..N*A$/S_HH48RQT2C=$$7.59[:*%U:L5Z):9EAKE;MO6@*K>
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MGX>WEO&I+C1!NX]K\;[0B<+ZUXS=&)62Y4 /66I(RG<]L]XE5SH]2Z^7@U4
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M4>M<NMU0&($PH41B45)S%Z84\])<<=5Z$MS=.CU-A'!;^\R?V,_E5_M#BO\
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M5?[0XK_+?S[#I[7]D=H>.?O0\K_BWH_[F!>&+U61A# 8# X5?WE+^QA\PO\
M(\:_EZYCDKI[7\XZ]<!_>)XI_%)SC]QP;*Q>JV\(K#IG6*_RAFO2[*)M\T?8
M[ %K+)"L5<G9(@TM8CX2K@F3.Q;;S\!!4Y8(S#*O8KW;VK?V)0K>BR96?A#
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M_+3A&O+A3K)1.?Q^5 KC.FJK*C*S'YO8_P!W/Q6Y+8AW2MO_ ">I/H]HO*K
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M=E:=2N9N0MM*M#E4BJ_B-S^NV,M=)5BNMCN=CO-$Z-9[(7E5J/)/VOGDBWN
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MSC;JE-Z:2T3E6YL_B]0[54N<4J:8MD<+S:@2.90=1I81<D[494.GQWX=@7-
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M6;@)M]<YK?Y]YLI^^FJC9:P%-DS'57*['(L=+,03[=H^';ZK2-T'49QLL_\
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M+US')73VOYQUZX#^\3Q3^*3G'[C@V5B]5MX0P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MB""#!+I'0; .GC)54MKST.8*L-G*BY+6WXK3B=K9VI#C:5)WI6M;PJ_<(8#
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M'AKYQNL,$&O!3Q\<@O65Y:6VJ\U+1UG<=PXZXK24Q-*W(5O>M:1ZX,[/QO\
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MLK<7#7*=?%>5D\3*L4L ERO]TK-4H<+J50ZB]S\6('0Q;)6G2N#2XJ1+@.Y
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M\T5W_?8W_2<"I^W!P76.:FZ.*Z-4JR5FDJB9%FR"H5@'PR5.N5?N<!,\-'L
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MR+2PK6FQR?PKX75BYQ;I*Z%WBDE+1::8?J8TS6:O!K+%7=)57QUJD$D,1(Z
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M<!^+ZG_S17?]]C?])P'XOJ?_ #17?]]C?])P'XOJ?_-%=_WV-_TG ?B^I_\
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ML7Y4X/FW_4/U8+Z1?\$W7?ZQ?8ORIP?-O^H?JP7TB_X)NN_UB^Q?E3@^;?\
M4/U8+Z1?\$W7?ZQ?8ORIP?-O^H?JP7TB_P"";KO]8OL7Y4X/FW_4/U8+Z1?\
M$W7?ZQ?8ORIP?-O^H?JP7TB_X)NN_P!8OL7Y4X/FW_4/U8+Z1?\ !-UW^L7V
M+\J<'S;_ *A^K!?2+_@FZ[_6+[%^5.#YM_U#]6"^D7_!-UW^L7V+\J<'S;_J
M'ZL%](O^";KO]8OL7Y4X/FW_ %#]6"^D7_!-UW^L7V+\J<'S;_J'ZL%](O\
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C& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g921291dsp006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g921291dsp006.jpg
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M1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4
M9,     !_]L A  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0(! 0(" @$"
M @,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P/_P  1" /  N8# 1$  A$! Q$!_\0 K  !  (# 0$! 0$!
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MNTJ,)Y=G9< L>03&-BBD97.!RR4(D[W#7A:M,)D444FQ!8(MPUHDH980"U\
MO@'+A>.,^*>;.Z;H&FBJM467:T0BJ>[)\S5C5:A4XZ5IYK-7].O5-K4TGMH%
MI/NXDS8>8:M-$6A3!!_O' V(&A$DMV3 %^8QN1S,!Y:1NZ9"!T4-07%&)R(;
M#1;"4XG(=';5%(3!:\ G"#HO>_\ 3>$1=([M86.;5'"VJ/2B= MIZ>V<N6P4
M,;>HC  -,,<)LD>+#7GR1 X-C-)4:#25M-0I7$Q0K/*T(!9(A'!+AJ'3?4U=
M<P\[WWT=( JIQ'.>(+()W-XO US"XRP:6.HAKU+0E3+W9O;TCPH*+WHHM8H3
M!WO_ %%K7PX)QMLGFFAAF\;?D\<V2Z-Z1UE$=02=MCJQP0 ?Q-:]&4MT=\6
M4C4&EIP&^4PPO0RPBUO[K"85BLSM> 5[UK2/&3?$I?/K>N.*R6Q%^XRM@R"/
MU;6L6<F=D63.=+)=,(VO5!7/3ZG(1MC*F=GA2#1IP4OL2A#PU.-L[>"UP91&
M1DO*@,B8A)XX8:5(3PN[?LEA-(+V<>6\FZ4; UF$E:\PM'[!L(?AW\&&7B?I
MS#8O%I'-I!)V1KB400.CG)Y"I<4VFIC1,B<:IV.<50#!@3[0$%[V8#?W>O\
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MU36:!\[%Y&*ZG].%LEH)M%&1LMSA2[6=4TT]?Z)P<9@><A048^((V\(6)P.
M] $TJ2]DFB-T,PUVX7E<_;=?S?GMOTZNG2A!Y[YYY2)?XISMS_QG!>*[JK:
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MK5QZ4R\MF*7EA]LA3-Y)A>O$D.5B\I?<S?M_TY91OT\;/L2*70SU9Z>*[DR
MA])6U^;+.J2?F4H)'U%V^)&SNU)3!B:HM.Y?')6ZU/+6%8N;[.D!C:\*%CN4
M+0P^S&84:O*9UN;V_9U,O_D&>*/0\L'CJF*=8FJX'GB FNVZHHJ"&11 MMYV
M@3=J5-VUB=:T0T#L]34Y:>M7C5A)5K#35!AXQ&;,$9G*?)VNV55KZ]'@HRGZ
M6;HZDN+HJT;<[%X+E_8\RN"S8TMF'S!40C?H\_Q)"N:"(!'FBO(#&)0Y) -;
M$F]^6E.!^][5F#\^BSW-?*27"M?3_IV7J.P>S*[KWC)9-+<M^V>;W3TYNUH<
M[5G'(!Q#2E61ZL6)L@R5U62YCL:A6FBE44>513'%656EEI3D$ORF;&,((LYS
M$MNFN9YIAC'"/0J3U3G+L&6<QI5_(L\OZV8VOHM3-8GO<'F[[2+%6+MZFSI"
M12[4+.<[N*;76/N+.D"-_;6%>6YF)QN!ZH *=ITZR_RQ]1Y?1:H:9"Z1MQ#.
M#&V2U1Z5"*U?3YY&EJ-Q*?6Z2LUCVB?=<AER-<G,/0IGV*4D=7\/. 2,6R2T
MIY(_*/V@-2)[EF--[K7J[=XE[F5=4=H]H\HU>F=KQADYXIFG(RMPE</:$UFH
M45 7-SOTE%]GN$A1&,2-B8;33N)@73W("Q0U$^[;.WK64X\N/6<>6VN6@M?I
MY]3\G5#VI551<]1JX8#+DWI9P)M*DT=K"V5%DUW2E;LS3U)8T+J.P)<R0^;V
M='9F!6ZMS3+3$3<YN0_:^14$(2S"]IRQ;==4;-_IPW6TTC%W.;<.NMF1ZH/6
M30])Q&D'V*\HJK$6<1S>I(^RSQDB=?1-_9:)BB&161LEU?(,W*FII$K0"-V4
M:(@!XX=IG?\ Z_NDJF?3]Z/9NZ9!.+4@MX)9REZ\Z&O:+W_ JTYC40.=TM8D
M5FR"#UM:'0CA8R/H,N"D0=]21-57X694WMC@WHSD =HR0JP4O+CUQZ>K=N2/
M34NKGJN/195Q_GMHC%K4<\7;8O8S@MD40-<45F2'D:P:L@RR>R5 ^.2Z5HBG
MU6TQU)IH&Y@:6D)99!9:8GX"<N<MY>7@HTG]/?O.>P;H1>EX[6U7.+E],'J^
MAK4B<5AW)E#UK)NI)5/ZQD<$A\$::OFRJ2V-#DA*!XVS3>=N*UR5>U.$,Y)H
M\TLR-=^,LUT[3S=.*NY9O&MO5P9KHKWG^3OT&L!I:_\ R<MOH>O:.=&6L/DI
MS2S0"*+.+;V:9N[7NU(W]^1$LKO#E+26RZ"-Q5>) #"ACK-LO#&?KU3%UOP=
M85M^H6Z]!U76,&CSPL]-#HZJX3T@L:X84\P#KM_DL3:Z-E_ON@&STB61")^_
MZ0/J9.88V-VCDQ9Y>C=$F$X\I.&+Y_LY.IO3QZ7DU-OT0H;@B4<DRF*^DYTU
MR[TL!ZE=0I =L=23Z&Q9IK/3,Y1FPGTBTAL\]:'>1ZGTL$VJP@=M)1#U[0TL
M!OM,YMS.WZ1_15#N,JVBG 3CR='JB@K:@E5(NS3)H._M;2]LDAMB4Q+1\@DL
MY/<"G9+)Y*[3\7Q@X.RK:H]0N#[SLP8]!%ARO*WEFN$_-_I>2RP6?@V.WEP@
MBB<&H+TV.GZ%M^%6(AIHR/O76[TLIEH;I^='8K+WY!-C[*-8GEV:Y(K)VJTI
M( M4[2K I3,CI>>,XN]1+9GIP]DR6M^.6J_ZFNVR&)G]+6JN6GIIK.&<S="6
MI071T;>GI1.79I/O*THPSUW)Y,PJV;3?8T7<U+@A5L!1!YQ2<L@8ZLY<<W'_
M +9=KO4IY[ZCOK@JO^*Z/&[/LHO9TINDK]N2;K6 PZ 4H@1)'*Y+'G*%))V)
M1*W24IHUIH5MK&<:<N,>CM%C**UL\!SXWC.7:N6MU>G9ZA"*O/4SYL402OKJ
MKGLW7)?0<*?Z(0H*1KN.W+!;KJ.(WE7S7 ;!N"62>+N;Y3M=H))MQ"Y&(E*A
M ;[$PE68!.*-SEPTOC,MQO#TIK 6V_T%6U5\T,[3R#.O42]+2ZX_ 8J]0N+P
M!96-80-4S=8R]OB1$D;3F<?Q@626]EZ3D.+Z/>QE%J]B$/=)SF);?Y8O_#(.
M/#O1%!)Q2&M>77MXJRA/75-[!J^BJC75FD<3.4I!S\97KH\TK#ETOCD184Z&
MPY>N6ZCIJIG,T "DPLDL(M;$.TN]UO''YHI5\A=I.=<((O9O#29VA=S]W>HI
M?L^C&H9R5T5;%<"O%W8G/GH+.5=,K=*7B$7F*-T=T\HDQ!+N[L^TA11!)!9P
ME X=N/GX3S79]*3DKK"C[>J&:]$P!ZCNH]Z2_+_-4F?'N8Q65K";CK"\;Q>G
MV$GJF:1/*]Q&P0F0M!A:[01(32#2RRSMF%F%@K/.RS3_ -JJ'UUZ>?>CG;G:
MG0?,=:@27%9'8#U#ZY?5<PAC87).1^F^(*RYQN>=%FG21.<B-JBQXN@D*-"K
M]@N-5, AD$&^<OVD:X\N.)+MC]\OA9?IC=*P>G;]K6JJB=U-+QWU/J$N-HJM
MH25!/W&\>0JIY%J^G G-M:V)*FRN)\ICMBQHAV%$I8H;B'DUE$+8!#]UT:)R
MF<W?"-)QZ;O02>"<N*RZHZ)LKFN/KNTQ2+G^9<_<<32?TS++[ET-=H;(H=RP
M_6QNBX_7(4#0^I&$+8\C?820[ZT2G2DJ#PDU>TS=LZ>:<WOTYK.A%FU^]-_,
M,WO%;./1@GW);?=4Z;* 5W'7_4;;'7MOAKY?K_J9%:1S-=4ZQ-"@R9A6/F]Z
M+VAVH]PV(W"=I9O_ -LM"L?TF;GL^N;M-G',33+K"9O0HY)YLYX.>GROUBR,
M]CU9&;-$_,\-5'2;W:*SN&R YE"DDNAI4Q(3S I%^RC%.A0[R72Z=K^BI?J)
MT5-8$W]B.%_4'![=N*Z+S].(-&].+[CJ)XM"HVXA)SW$W#F9+ #9>JN]+*E,
MF:WE40U,K2H8I,C>E#JM4ZTG"(1KC9<8NF*_KMH*,-K!8?4C@AYG!0Y\HNM.
M].5@ =H@Y;Z>6:KR&(/GF&EC3@M=&<1!*0,?]W>"TSAOXG]IHOV(RA"KA5GL
M(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8&O1^(Q2)?'?R5
MC$>C/RFD+G+I'\GV5M9OE!*WK9.WB3O?Q:F3?&LA=MIR_>5I_M%)_LP^<8O+
MKP#V/HWLIE=S(RF:ELB+;5HV)&^KE;8RJG@*8S;<G=W)O;G=<@;3E>@!/.)2
MJ32R][$$H8M:#L.9"7N.Z62%S6QK3KBE(/"J^ZLA_,4@=&.RYU,E@UBV[H/5
MTKDZ=N75C"P%(--,H.4MA83U"HU:620)./VGP1OK-O'"W2CKKGU+$DLS.G*O
MXN5RY]@13(7!["/L$N9Q9M4O<GC2RJR(H99S>[1M@1F.3@4>T%[1-FM+#O(E
M$$W=9ZW.&M]-=1"I.@XY>E90CY_T\OF=),$1CD1D:5"=-&*X9U%8TG>8@[:0
MNJ)Y7A8)&)>UI=: 6['@*3:/)T?HX!9,W%T8[7:E4ES)>4M>&5'3Q/-5:='M
MMOF.JD2)V:+0G<CA$;8D<>+:A.!Z]S4-"72(HH9JY:M7EHRTNS_*$8ZW\\DB
M[EI!H6U0A9]SN6J+1O =!'(F.L++V^5Y."X0\3L:2RXNJAY,F@Z@;.WIC24K
MFD2*E*->!>4 : I0I*'6ME:NL:E);XJ5(Y@TN,IF+M8:5CC]8,-C62L4M-?6
M*ZUX[OI[2PPDZ3M3&R/"0E$Z.BU F9TKH(9):LTOV1QA.M;U%^AJ;FEA.U6Q
MF;)7.;,QLG3G-VFI_2-SBK@[BWL\Y01F3KVI+%I@Y05X=4Z1\3-*U:>S*C@D
MK $&;\N#%QE[Y#>-912?,%:2-]7L\JE"UN:F(2V*3 N++GMY2N:UFCN[ TP"
M@*63O*9G4B1MASF6O5>R\"B1[V'6QBV9\$<0_L_F.>%.:N-VRT&M35"I?8QT
MA=VB41B*K(/7JDE%8,E8I9)V-GC4E;( M4EDOHFY6JVS&F! LT2(6M;'6L93
M75,8O*[[*KJ"CTMBD"J&E[!VXNL=F4.EX'FU)+<2#:!XBLV9X^\(64Z.U\W+
MVM2)& *XI<886,PKR;T6S$RJQ.^GXE9[K+:VZ?Y\IN5<K.O0MP<\*E$O>B[)
M7#>*%KR5W"X3R<U!)JTW'#(66V5RX&^W1N2]6TJ"DIPBA!&,Q.63&LNN$Z03
MICABF*TAS-6#E#JRJ;<;=I?%V"OJBE<5AL=KM$]C;%]G+F&-01&VPBIE[R88
M(B6.!*&.N/@8>0M.+"89HEG*W7=++_UMSK%]/VGVSFI 9%G&8MLC3;;)"H6L
M8H!&6&:2]S<T*1G/6(XTRQ*5M3B-V&#368C=41I:@85:?9A.M2JGL:).#W/H
MPSN(WR3UDC9U4RC[0C5JW)K,D+0H?6%NUXDEI%3N[-2?VQ24HT1P2S21&! $
MXK8R*-,G>:U'RU)NQ9_ (WNHT\:9I%&H_3DQE5QV>@7.2H"1P@]H1UIK%I:H
M+-8J>J)3/1 %JTAH<@J$B@P.R G&F^O\NLW;]9"'AB0W16L]MNFJ]?;T]PCH
MZRLJP.9WATFC,I5(GF3Q"*-5CO\ 6IZB+SLX"%:<UQLQ>E?MK/.6G1^\F: (
MD[8TV>F ]\T!,*;A]TO:^75^QS=SL!O9&"55Y80)@<EK)>XIYC(]1=%%%#\9
M#(XW( K'-\"FVSM11N@+%1)H1@".MSAN$H[7Y;AD@=(S(K>9$;@QFQ-.]*T[
M7)G6.,ZJ?QY+**]1.LP:&-?$F]?8K.M)W'2#EH#GY08%,@"H4[]CA)QMV9-7
MUYSTAB#?-E$\4::W.32:&IV@J%6 IGI4IA21<XS1C<JO314ZRF=?#FIN.6.P
M5;21\6H0Z4J=E$# 8(=:\[CV3S.UR1+%5%K-"AS4HZX<S%;4TR9\C34SW ,@
MJK'Z1S-E8W"'Q:.V"I4@):'%R7)42Y0+V11HC-;#H=:S-']&P^^'Z[(_%V.;
MLZJCK36U5(#Y="I9%4;PZ(8^P/ICDP*Y$QM29P1[^/-E;++&,\ 2@'C"%.J2
MF'"S'YO(^=:<^Q85AZED_P!Q NK8\[R^9JI?%)M%&]+$8^^DQA_EC(Y2&-MK
M?,8NPOZDE*N<68UP1HS3RM'& ]J7L0ZW]7G#U]SSN-O,G'/5*=,PS&.U^O85
MD)L%#8!DTF")*Z0^.M57K(H19#^XRYI6 6M04#4ITY(M#4)MFD%F& &*T.M>
MLRI_S[T)?J%I:7EFIZ7=&M<=1LZEP;P2ADHY<_)487$QT3&K65^<AL0TZ\H:
M?0D*O0P")",L1>BWCBR/=773#JCJ*,6UT:56%?)+!^00*_8ZKE,[MY]?72>Q
MTM_;HD0PD5I'Y.]S+9(C!E(&=O<3#4B<Y3O0"RA[",:XXMM2=@\XN*ROVUML
MI,Z.MGHY2X0QH:XW,7-X6HH(^AC$]4.K2@CJAQBI<!D8]('[XV*0_$JO?LEO
ML!_<X3K4"3KJ;TZ+M9XBXV6YUS:K)$Q1^](&=.:9E$R1,+420KTS=!1(#_7[
M@!% V (SRCITC#IC:#A"*4.!!F_)AJ3E-EI.A[6D%,T;9-MPV *+7>H/#7J6
M-D-121GBJ9Y+:&T]S./<)0[^W2,[$C1IQJ%2@E.N5Z3@%[LD5'[+(,,R9N*A
M22=0V$YFU%%Z4J>/3ZR;&HI3T0\QZ66(L@K!&H.C+B29,RII"AA$O5.LPEDB
ME@4+24-"E1>1$J4*3R0E%E'%Q/';+:YEU0PM'%[[V5%6!0_1Q'0)]],L7>'
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M.J*)'6R9;2X=*T8U&,1+E8K.B.DMVJ.<60A0G=0'KKL2_&>S8!HG;?[5.YB
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M^N<H<F5O]W7:&\*2XN!^*(5*?#VJT1 U&@@&;[,(MG:6;3#"$\8D5M"^95-
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MI,$XX -F"#H&A##KQ\=ZPCP/%OU-'G-6RO\ :%=L;P@&$M<TO$VC38YHC!E
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MM_!K>\&'MDEEUQ#5Q39+[ A,5<CTP5I#?))6Q,:XY&,TTD"LI(YKTIYB89Q
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M>M;U@Q68C=F5O,EQC7$+ A$J<B4PUIS=&Y6POBXI&68428K,2-B]4H F+./
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MDH(2RBP:"'6M:UK#+)X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M\7/R/M*?HP_S@E?4U?/\,L:'Q<_(^TI^C#_."5]35\_PRQH?%S\C[2GZ,/\
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M.Z0](OLV<5L^+8S+3X/&(0F?FQ0:D<FQJLFQ8=7\F-;U1 @')5A\9DBPDLT
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M@F'3VK>W6_;7]'<!?54H@D*DRXLHI;(HE''U841K>B"U3NSHW!063H6]BT4
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MO[,/87_#37[^JQR5T]K[XZ]4#^HFE/V25Q^9S-E8NZ6\(8# 8# 8# 8# 8#
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M,<<S,\?+#>>MT?4U%\0\;]%._>EP6=%YC"Y!UUV76+WVJR\DWQ;3>]T772Y
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MV#0G:(PRJ7]=L@W7F)"Z@WO7W7CLUQG6V>=OZ2/^A'E>8P& P& P& P& P&
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M4EDKZ]*G)I;DUDFU*KUKWAH3$H37L9 BR1E^;6\)QDO/%VRX\V/V7W!)+#]
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MDXV<;FS*BC5Z+Z"ET/+3]QEUI;',]T<Q\UCY*!:SA"X!=2>UZ4/D)\T$S6'
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M5HDC>O6I6IV0.*A(A=A+@-2U40D4'&)TCF-L4Z3F#UH!VTYN@;W[,7@&<P&
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M6];P/.D?&1>N6-B!X:EKDW;V%P;TC@D4KD.]"\F]+$A)PSTN]#^#[L(?A^#
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MR!.3GHB3#",+CC;CPRL_R6O--[&[0:#[J2WL<P57QJCW,!(H6D?T@%Z;H1Z
MRR4RNVF/0Q6LUMRVN2C2-Z,06]<0 T)@P^W.)R^V:8W41Y-F+Q4U.CYYBK@L
M;7'MR>6B_P!'+4_G-/9IP_=%63#>M5K"8!1X@'7=?(DUA@!]SH:Y<NWX:UK>
M]FN4SK?!KG-ETWS *>I.A>;486UKJGFR#S6MHJ<\4.S12Q%;]T+<D&71BP'F
MW)8SS4,$C$;KQ U:-AI6G1&XO8#U)QG_ +-(?"R;U)[M=<_IUAZ.=ZS<8LS2
M1AC7JR61''QWBK$_*FN;1'LRM&MA4&*UI'QF*.%#DIPW!K+4%)5Y@"1G:V:0
M0,L8EQGT_P + 6'=M\UC;#KSZY7N8>T/-H\I-BJ^9!"JV;I56$6O)CZ!/D;6
MD1HXTCK;8GV:42WL4:5O#0N&C52T):GXQ-)(V.LR2ZX5>B_23]6U7=!M4'N*
M1/\ 8ZKHOO.RFZPH&DY\98M(XW01D%8GIYG[M;Y>X6!.S/LG9TKFBC)('%S4
MZ4&I H48#!$%QKKMB+SVG9 )G&_2UM25J&=@.G70$ F;MO:K3>S(G*7\3]+/
M)Z5,<XG^8M*%8X[+)":8(>]>76][%AF3>3ZU:A?'83Y'^A(?':KF,B6L+!?O
M+M'V.T+!T<35;F?T$]QO9I+/IU&*]Y9*2X/.T;DF6L1A+$D/2Z+,]Z]DY%D%
MG'357:S+MM6><G5[T2;*SKAM1=TY0SLBY)8PUS$VVO)E%^G(^W$U44N''MV,
M3-XB>WZ9WD]Y=%85CD X:9&1LU,0"+B2X\,;M]L/J:^#DU(Q*H[6.G[A8?/=
MU76AMN,L="0-DFMJ1*4QEF;JN6QV_'V,D1*NZV620XB1LQ)AT]2IB"2E:U*K
M(6GG4DFMOFFVN>@[Z?\ I-AYDEJQM:9TTR)??5BDH&YC6D(>8'ZJ6<R*Q=O<
MBT6T2_:?HZ6*XNG=R A6+FV'*CA#]H<,>$LF,^'^VI]%=+6O#I)V$^L=P,E>
MK.5FZK%M648NC42<0]"CE4-8IB'<C/>VY5.W%/:TQ=U<!C88LM:C$3TTG&#V
MN.%M, 233U6:Y:F5ER]HO&R;2L4Y_94-[]!P2'PQ#%HVV-$!A%-7-8D&; ;5
ML;2.42:4+6MA %>>H6*"!Z3$Z3IRS?>#5).6-,>3G,B[<N^:2';#6=EOS>PV
M[&N1[&K.56@Q\_O\FBT6OGL""4VM5ML/JL0B6AAD5:3C8T+?*QJ'Y&X)0B--
MT9I4F+C76>/@F>;=7VWS>"QI184[.LZLJ%Z)FE%RM<Z12*M4OEB>Q.;:PN"@
M%#TIAK$Q,B>4%7'+DT$)VW(&U*Y!D:,PY/L\'M,J8EVWL3]9T_NROH/QI7LS
MLI#!9M<<SCM>WE>J=EAPB8Y(D503&=NC5#T$@;%<!9WRQI[%2F)G/<$*Y*24
MJV "=0L,3>)))FJIU/++ N?KKFI[E-LNTE;ZK>.^:ZC4HC\?K1+%+ICM;2.B
MVA).C ;A3@<F>5&I&?'GM4PK4*$YPCYQC<6@*4J"3#5Q.-]<,=WL3)"ISW@3
M\[,ETUJO329G6.U:]"B)D"(>#IO=C.I?$[81'4$N5A:5*!*I5&%NNCS!+/9'
MF[3Z1DIX<=I^+<[NZ,Z$HJ;2NFM6$]V&%QL/DEM+LP,>I2+3>OV"_"KZ(E3>
MS"DQ40IHK2Z2T<C:8THD92D257* E*!NIQ28LZI)+JUB0WSV*2QO)3O:*&O'
MRM./^H>@#"4,>IF:KK =:EMQ:RTROG#DP!ET*:T4DKY&5\KVV-J2?_U$\T*!
M6VB+T$)<<?W7#YWLJRR[/E\#MBS$L[0G\_<VWFWO#BPQ2(:C,DN60W!%9)#F
M8,?0-9:F%:<Z\1#9 .0ESP2)2:2H7+1;+$ S9,9GFC_U ^G7RDF%T9ZZEDTC
MMEQJC+BO\);*322&&BC-:(FM(G56 ]784,*UBW*79*G,:HQX/RHH\>_;I Z*
M-&.,S^#,5+?D\7],HH;:<N6@:[CAADPH>(PPNNW.O2&1AKVMG^9L<Y++9QW7
M$[4CSV^K56E"]<.+N32N3 (V2N#I,(MDZZ(,;>G;A%:$R7 O9B?3HUZC++RF
M@YS)BL'+VKJ>3ZB)#BN6JT[279!TXAD?D:V7DN9"\ML^)&<PE4D/W[52 8F/
MRRQ%,7GT%.V+EULM#J -=@Z$I*U[^=+/1PFFV4HAVA9]>,\:IFO@RR)N<73H
M$$?E:R4/YSF0ZO"_W WW$UO0 . GBV29Q-F,KGM.]YC-N1VAXF3 W16]H_7R
M^W90AA)1;36+FFF\T9ZM5,QJQ*>4WL?J($QX":-$.JI2I82TAHD9IIZ]#L-+
MQDE^OK#0ZKZKZCE"*J(I6K>@2N,=Y]Y3L9JBC.3SA7E;VB;;,WD[=8HY&EFC
MS'9@SQ-K9(R)F92X(B )$_"&8I$KT,E!@O&>/G5^.=[JE2FYKFJ:Z+!/=YTT
MFJ9S%DC6.LE-.?-._P!GRN(5^K@SW%&I).&22 +3(V=[9IDL4N WI.88VFJD
MHQ# 9LTS-FG=I7I=<)M.JZCJ94\Q<4TJ:\K%3RIF-HI.H>IK7*BO&R*PM2HZ
M!D4>BFXJ2":J7=^(;=F/ZA B#[J:C* I4:+QDQFH@D_9=J(+DI5E+7/+0[?/
M/SQS]?M=FJZ1,J5OL2VJR:)S,(_ SE9N^@)@[QY+,V]8B>D1Q<<$61L'@J %
M882.LPCUWFUBWW17(5J./0B978-K=2\]N[A!VN,UU\GN='U2_P LU*(2Q,7Q
M!J;*)E "2U4<5#E3DZE[?$ SS$8 ^9'J+C%LQIA;B/65?[YSAU@3%I;\K+HY
M_LRX877LJ7QN,_&T^+KHEGG$79Y0PLS2VQ/X^D3.YACZL]O;T)0][][)(3FB
MUH-9Q,SRJO;)VQ9UA3EM%!9HVJ:Z[%F4%:^)%J2-L*I8VPZL)TUQ[I^1G&G$
M&?*8U; "G*4MNEFS0)2$X0AULO?CHO6>.\W0<OE$KF)!\G>++<F)A>N'/553
M_-+'6NNXS6LE6P+H!'&$Q^V1%$"G90^A8UA:Q<J2K2U@E"+9VQ@+5.(%D:_\
MQ>CDF6VE')S Z5G%B[L=F=^,J=N)":JC47C@HC)?C11#G]DB^HTV-JE3!W%)
M[F8D*=S'1T2FIC-C7GA.T NL<L;SS5 9V2P'6?1Z.D= S1QDI?J\VHU(WJ3H
M:X?GRNXXFY-OIR4(HDTD0QM:D#@\QQ8("'XU1N+<F#[,\I&(/M0GQK3'_P#+
M)2GK+JD]:RU1$Y(O5S./Q[L\3782)+SM&"K7GG.O1KQ3$$:YT1;KY$8FVQA-
M'42-QF:>)E)W8PQR+.1C:TX?9CI)QWOHN;T;:]F1Z2<20S=F-7/QM^6+((A:
M3LE2PR2*TBANY_L.PRHE"7N<-#U%DKZ;,HP02C7*$:HE026,&DYHS2P89DFM
MWPJU >H;?LT2:+2SIN+4DRQ"G+VG;->R>)5P%LZ!-K#HJTZ=9[!VFFB![BB>
MO6&!5^S261(V(*!0NW+4QJ-8@0Z)T:7$GAEJ;7W!TT[QEC2KCFN,V8S,=:=N
MV-%38LV:$FXH<:HK^5SZ"(TCDE]^0NHK.>)%'F]Q-UMT(*9-Z-,&HT8+"]>/
MY;?F^,B[&ZGFC\ FI78X26;5)9/2'/QA.N?8U%["C:FXI#":9C<Q=;CD4<<%
ME8"KR+LSV^J8T(<B .=IS/?$Y1"4E5"<>,W= N9);;%C3WIU]G5AF+(O"KPD
MM1P&N&R/1-&UQ-JCT8@CV>Z.4B)9?E-(Y/MYD"U.$PU46@T@"3XI1'Z$>*LW
M&)A2&HK#L^*BA=1'=+RY$VVIVUW9&)A<DN25&Z2B'"K&SK+<8;444$M@!,(C
M\DLU.E&Z$?&[8X@(;&Q8F;$Q!9B324U<;X\(Z$<?6E*[>I8J3R]W;)8O:;$M
M^ -EBL:!*U,EK1BMK1EL$B]H-3<WGJ6Q*1-F)@(6&>Y&";S5(S#4?E2#)#HQ
MRF*M#A'!;_)D_LS]5?\ 84K^^^OL.GM?V1VAIS]4-5_LW@_YL->&+NDC"& P
M&!PJ_P E+^S#V%_PTU^_JL<E=/:^^.O5 _J)I3]DE<?F<S96+NEO",>Z-+4]
MHC&UZ;&]W;C34IQJ!T1IG!$8<A5$KD1IB566:0,U(M3%G%"V'>RS2PC#X"#K
M>@\:V,1IR^.OC&/,:_Y1H$S7(??6E J^/FQ&%6%(W/7MTYGQH@2A7GZ+)/\
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M:XZ4^$1-E965WC35$RG0EH;FQI?EJDB+Q!NCI:H)*5 [*E;F4W-Q2;0#AF*
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M:/=(GR&5;$)/+GH;9%8E'4K]+Y&M(1EIDY7M#53T^N9B9"3[1:YN:TXTX?D
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MQXEJ<5B9<F?UD27+58%Y0!F*PFM/W_TL^]NULRGT_H<XQ^N++JUZ&\5TDL&
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MX&PVPBJ1U;!,"8\Q(L$YJDQR$(CMJ!Y2;3.V5A.3$I9%Q7*.I4EM(.7QP&I
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M-1PIA/D-MUDPD2I.T+(P<\SV*M94C22$PTI@5,)BYU( \)WPT@848T^S J1
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MUV_6E+,;[&YC,9U-I+"9"UQV7L"YYK59'JOFEFA4S"/)5*IV0:<DL.$D**.
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MCF;8;+VQ [RLV458\QLY>_M5:26(-3R]JVB4*Q+2GY220UIDI'M2Q#,QZ_\
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MP@\AF77*N*_DN\))#^CWZ9Q"N5-XVV?P\Z ?XDM0(&E4_P!%,=2+9Z9&%3F
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M$QIX+_$ZIC[;6S'?D4FT,*B+U7D+91-,'?GV$N[HWV&SS=:R-J),ZMZ9O<$
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MDAG$-F\SL7HR=2Z+KU<%:FV.MT=:3[*9BM!94I#7I"G D3:V6E#A.VN?5OK
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M#W;'FE>W-9"S<A(?F.6SM"UN*56D(%OS;/3F*$X1#"+9C\E5E'#W24DI4NM
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MY,DRC,>FNY"SPJ9ND?A40E<A5Q"/22TG9(Q&)*O;'&6MJQL\7T2$PA6WK='
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M]RXL?PU+X;%&N04UU*!PD-AR9V=%+>_U;7YL<BGQ;)"D28E0A4*(]-)XV$2
MA4,K2!O*6F^.C"-AV6<<Y\XD]UZC>P=PPKEACBK0X0M?4]@RJ<SXYQ6ENS)9
M$=%7KO'H$TM@$VT"H H/,@NCH:8;HQ.!>VZ+#O1QFPC'\<^+!6IT?8#!U>U<
M]QF3\_05D#4<!L]8[7$O>RY'+UDQLZ9P91%(*A;Y-&T@EZ%%$0F &/2P0U2X
MH&RM!UKSEDG7-RCLCKF^F*.SB]9A"ZF7\ZPCH^TZ5DJ*.N,O;+8A\*@'03_0
MA=I'F.8'2*3 *)6T =W9K* TF$-@CQ)CU)Y $Z@=9M,]L),@MG]3O'5<_I23
M"Y_U J[A%868XNS$Q6*3+W>-6S);KCK,QHM.$I4LR%\815($U4J,+.3JM+=A
M 25[/6Q#''KG7*9[;Z6JREWE%')8HEKK(U,8=9TLC\!@,SL=Z8( Q*243Q.Y
M*V0AD?%;%%4:T_1(%"@(!*S@F%I0'C)." S):TC7;O.ITP^2#=*WM["4]U?'
MG*9L$(F+Y63&YW<Q1204^6]V2V,BF&MR:QT,W:PMB@:SV!AZTHLP9>S >8O6
MI#Z%M9SIF -$P:&A"^+'*WN?ZV&B<5*A*G+07'>U=5*ZN8#4P!F;6,K9-3EB
M<&]>0P\@ ![T 0MZ))FL+)^DJ^1P;4ECSSM4ND$NN>K80!8R/04KG:-*,]MK
MY:QK2]IDYJ5O;CJ6?=:5&B)3*@I ^Q-%[<G8QC5IM+];P.=U54\DE#P!-.YD
MZ5+6DA86F.R$H!-S6/445M[XB:&]0G5+-Q_<0DH7<M?[0Y$6TA$<)0()8Q:+
M>-E]&3ZQN*7T;!B)XPSCG&!,C:6\F/3CT7*7R*M3XY)D(5L?B477LQA7LWA^
MVF5 $;Y%Z@KR V0@5BV(&AQDMQJG&L9<Y3^M:]G;S$GB O$U@\3EKK!9%_\
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MHPX*=B,*"9LPT'@7IKA/4GZN:&&$=!60W0YRDL(Y\F4=C3X^-+NB&7(&<3)
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M-IT+6-KC6"NXBK,':0XX0:F@22%-JHE3OXB&[ >R/<BD)P!EJ1DZ^.=&I_\
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MVRU.@GZ)GTF'ZBG'M<5Q(8D^U+);$JA-'('7M9OL:A[VR*HU9,+JT:K4,;[
M1S&-2M:L=T"1R5I3GIM4-CZL3*QEJ%IF@$>R':^+5:]X9@E5A:!P2U+N8W"'
M50.CZR<PR&$K3*MJW<NBLQ*B\3:W&O5<<<AEK8>C2C<GY$].ZM#H12I4?O18
MRRWE:V^K^0JWIZ0US)H*_P \;W* 1>RHFN"I=F->DL1OM>?JK6EBF<IE,;$
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M%NALO#8$(JE[>8R75L2FQ#(>PM\C0MC-$&F5/*EF3+5)Z%.\/#DA1+5&U))
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M6!\CE!"?0!*#BB FFE)R]G& *T8>>/19)(-C$'0S3C!:"$.OA%O?AK7C@?7
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ML;B4RH1RRAN:'"8;;4R-0@<NI98&%N!030K]L#'_ /Q->(A"BXX]>WIC\_\
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M3R;DVVTM,3E=(V=K2(CY2[5S#+("JA2U*Z.2M8QF1R<(RC#CBT1NU(#2_9;
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M+TQ9A*=:-.2-6G)-_P#XI1*D0-G%%F__ )!"+6A?^N!]"DJ4@U0>0F().5C
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M"\I,XWT53J;A#U!R8]=;<TBOJK>[@T'W+$I?:#?2;9$Z]Z-F]IZ>C84]3GM
MWH!\#:*US<#6]? U)461N$04^9.<6UIR1"V6\N/IUT^L+(6QQW45@\6\;.%7
M^E;<47)YG[;H":="T7/Z=C:ZXYM 1P]$P]%O$90/4M==W.VR5<G92WE8%=X2
M(33M1OVP2=#RI.5[7/+>-?3\G].[OX DW,-[).XC?4Z8;OC_ 'D8N3)Z78>
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MGM??'7J@?U$TI^R2N/S.9LK%W2WA# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MNEO"& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MLK%W2WA# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M_DI?V8>PO^&FOW]5CDKI[7WQUZH']1-*?LDKC\SF;*Q=TMX0P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!P6_P F
M3^S/U5_V%*_OOK[#I[7]D=H:<_5#5?[-X/\ FPUX8NZ2,(8# 8'"K_)2_LP]
MA?\ #37[^JQR5T]K[XZ]4#^HFE/V25Q^9S-E8NZ6\(8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M!PJ_R4O[,/87_#37[^JQR5T]K[XZ]4#^HFE/V25Q^9S-E8NZ6\(8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M7WQUZH']1-*?LDKC\SF;*Q=TMX0P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P&!P6_R9/[,_57_84K^^^OL.GM?V1V
MAIS]4-5_LW@_YL->&+NDC"& P&!PJ_R4O[,/87_#37[^JQR5T]K[XZ]4#^HF
ME/V25Q^9S-E8NZ6\(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8&.>',A
MD:'1Y5 .,3-+<N<U!:<OVJ@PA F-5' (*\=>T.$65O00^.O$7AK X;<-75T[
M?/-D;]5CH?L)X@=&O<=M2^#N3ZWJ:J%%61#GJ)D3739&9-,GF)O%SR6QFQE8
M2G1Q<TCX@!\8%C1EHPD^.A'3E)+TDU>TWUH7&)P =B7)QQ8-1,]C<=7?VIRN
M!XM.!R,V\:\HR"-UF2*&RS482.!U,V4O@C\WNI*%06\I-)%!FMJMJ2#$V#X]
M<9\<5BYCZN-UJJ8Z\/C_ "&KJF_::X6CG==11ZS+4BTGBLNI6;(Y405+9,IA
M:$T;'*Z^5196K6Q,9GM'4L@"8IR3&';,)'29FNF<(]WZHMFU*A>KSOFO)T?+
M8%Z/47[6EM(0RUH4LI.2F*+A<V%,_L'GJU-+V*SI@U%%GF#,<532VMQH&_20
M]02)>:7IG3_ZPFAW]8YTA#/>9-K<A36M["IPSBB1(X"OM:%R#<MJSN"WT=/0
M28#DD<:G!NCDFAKUM68\L)A:G8=I=%D+#=&>U 3IY737]FT]!^L/ .?IOT-7
M#]5Y.Y14'2U#<NP9=*;:B%<P.P)G=]$EW^.43&>RIN)9J?@4"B)"T+DN5:=#
M33$Q82"1FJ"R<F2>W;)?1JD$]9U#=J2@8OSIS%);JO2XWCI%+)*P9+@KALBT
M C_*;]'HW:$N;;C/TLAMBLDB<Y>TZAYK> HE_+<"QG&MX0F;!2^WC>XG_E)W
MI8=#S^6^DM4?25QR9[L"=$0:^9M)7NS9>Q1]Y=?DA;%L!;&>5S:3KT48CGQ:
MSLB9M,7+U1;>WE$:&:;HDL0\)SDG/$V5U2^NPP&0.VGHGG,J<3^J[1Y @ (=
M2?0E?6U$)\U=F3AT@%?/<'ME QLD:6O;"_L2LES;%1"0@)FBA%+AISO> &OC
M]=-?#R2*1ZP,D5K4M/(^.I<H[)6]@2?C\CG0%PPC49T_P^EFGH9^L<^\-L_Q
M"7 D-2O:96+86H:_W\SW32??_P#&R)T\<_QQENOI57U?=T<O]461.&Z6RRU6
M'M7MJ.PNK[0F3>D=(LFAMD.R6$4:NF3<FDC.QLL4-* S%K$I2](E)#[8H)Q>
MM!%4YR2R3;$5UY2]6OI&P.8^3'FP^8&*R>K^R+'OF.497=:VBRPR%RN$4:Z2
M=PL*Q9I(I4RJR*FCU>-K<6T>[>,B<GA462I) '2L12<MX26ZZ1=Q@[0*Z:X"
MZFNR#,4QI2SJDB'5%83J&O;@UJ)=3M]4;'Y4T21H(D<>4+F-Y^(WY 0M;71$
M8(E4E-(.T$L0A% )UQRDOHYU<Z^M$XTERS1ZWMBC[8BZU;Z<<>ZJKZVW.=PJ
M>2'IXJNF2L8M/0N;.WJ$AU>V%,)/8+4Y(2G56:G4('3VZH](:6<G :OMYMZ^
M>'1[@;U&HCW ^W1 R8I&8A8E'%5R[21+7USP?H2MGB-6HTO#C&%\:M: $HF9
M>]M2R.+V]\:S4Q"AJ7)]:T(\DXHX9GEPO'%\*Y_V#ZOQ%U\T=<S:*PR:TLAY
M]MFL:]&7!;^JENZX;G-1UO!J54!L&D9374Q4TBQ2XA68K(-=$[H%WCZ@TI.<
MD6&%FE3+73%D\_TV3W8/J^NL6GTR*BG(TWF] PCN.O/3Z>+^%:D&CI7S\RJ=
MP^ R]436AZ)RE0X!!7N6:2:=/:>T<G$GV $Y) ]JRZDX::W7&7VK#U>G&=W/
M H._\ES>%U!8_:=^\'1B]16="W]*LNZDE5B[2JOF\3H$$G+@\N;:V6>+B,P
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M&];_ /7 YF5OZ5U&4^_/Z.L[2Z0B7/TL>+">9-QFFLYN=>4G85IMS\@G;*7
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MQ8[6Z1N2U%5*,W/ 9=T#:^K#5(JBC,B2R6+1-L1)8]'6MN*CRU+H)1Y1 3U
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M\:>'72%,%*%6$K8M"-3G9C&-'ELOT=.7[0MN=6>Z3KI".L=D7I7W3TRH^&W
M>PT6\]#ULNC"]EMU3"PL2E>*2N!D11_&!&W#;6K,![?:32D)1Y8G.R>&R=ZL
MX(@-*7"^V;6%P="1*%22T)]=+MS:WSM@%ST=9]GZ=%4XDI$;40PZ;HD;Y(7E
M0\B9R9"6PE/(_>BT0!ZUK"7E;,7"]&&3 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8'!;_)D_LS]5?\ 84K^^^OL.GM?V1VAIS]4-5_LW@_YL->&+NDC
M"& P&!QI_P @JL9I;?I =HQ6 LBV1R)!"8G-]L[:G-5+U+%7-EPN=RLY*F(
M8:<8VQ>/+%0@AUO>P$"\/'?AK%;]NXYQ;'@7J^@.E>1*"LRI;0ALC85=50-M
M=$I$A:M/$5DC5&&QO?HI*6L2D*UDD+&Y)C"#R#P %ORZ,!YRAEC$3E+QN*N'
M\KXG^5$=_#;;]\X9/E?$_P J([^&VW[YP'ROB?Y41W\-MOWS@/E?$_RHCOX;
M;?OG ?*^)_E1'?PVV_?. ^5\3_*B._AMM^^<!\KXG^5$=_#;;]\X#Y7Q/\J(
M[^&VW[YP'ROB?Y41W\-MOWS@/E?$_P J([^&VW[YP'ROB?Y41W\-MOWS@/E?
M$_RHCOX;;?OG ?*^)_E1'?PVV_?. ^5\3_*B._AMM^^<!\KXG^5$=_#;;]\X
M#Y7Q/\J([^&VW[YP'ROB?Y41W\-MOWS@/E?$_P J([^&VW[YP'ROB?Y41W\-
MMOWS@/E?$_RHCOX;;?OG ?*^)_E1'?PVV_?. ^5\3_*B._AMM^^<!\KXG^5$
M=_#;;]\X#Y7Q/\J([^&VW[YP'ROB?Y41W\-MOWS@/E?$_P J([^&VW[YP'RO
MB?Y41W\-MOWS@/E?$_RHCOX;;?OG ?*^)_E1'?PVV_?. ^5\3_*B._AMM^^<
M!\KXG^5$=_#;;]\X#Y7Q/\J([^&VW[YP'ROB?Y41W\-MOWS@/E?$_P J([^&
MVW[YP'ROB?Y41W\-MOWS@/E?$_RHCOX;;?OG ?*^)_E1'?PVV_?. ^5\3_*B
M._AMM^^<!\KXG^5$=_#;;]\X#Y7Q/\J([^&VW[YP'ROB?Y41W\-MOWS@/E?$
M_P J([^&VW[YP'ROB?Y41W\-MOWS@/E?$_RHCOX;;?OG ?*^)_E1'?PVV_?.
M ^5\3_*B._AMM^^<!\KXG^5$=_#;;]\X#Y7Q/\J([^&VW[YP'ROB?Y41W\-M
MOWS@/E?$_P J([^&VW[YP'ROB?Y41W\-MOWS@/E?$_RHCOX;;?OG ?*^)_E1
M'?PVV_?. ^5\3_*B._AMM^^<!\KXG^5$=_#;;]\X#Y7Q/\J([^&VW[YP'ROB
M?Y41W\-MOWS@/E?$_P J([^&VW[YP'ROB?Y41W\-MOWS@/E?$_RHCOX;;?OG
M ?*^)_E1'?PVV_?. ^5\3_*B._AMM^^<!\KXG^5$=_#;;]\X#Y7Q/\J([^&V
MW[YP'ROB?Y41W\-MOWS@/E?$_P J([^&VW[YP'ROB?Y41W\-MOWS@/E?$_RH
MCOX;;?OG ?*^)_E1'?PVV_?. ^5\3_*B._AMM^^<!\KXG^5$=_#;;]\X#Y7Q
M/\J([^&VW[YP'ROB?Y41W\-MOWS@/E?$_P J([^&VW[YP'ROB?Y41W\-MOWS
M@/E?$_RHCOX;;?OG ?*^)_E1'?PVV_?. ^5\3_*B._AMM^^<!\KXG^5$=_#;
M;]\X#Y7Q/\J([^&VW[YP'ROB?Y41W\-MOWS@/E?$_P J([^&VW[YP'ROB?Y4
M1W\-MOWS@/E?$_RHCOX;;?OG ?*^)_E1'?PVV_?.!_.S_DN7I6+IZ>SUR/&9
M6S2_HWJVS:8KZF*BBKDB?9O)7(BTHL^J7/3 W'*'!.Q$%M/NWO0P!*&L4DDA
M%L8_#4=?:G\NWA']#->L:R,P&#QMQV5MPCT0C3&OV0/VA.UC2RHD"K9(_@\Y
M7MTXO+O_ -=97)M^ P& P/P:46<682<6 TDT RC2C0!,+,+,#L(RS "UL(P#
M#O>MZWK>MZW@</+9_P <STDK=G;]8;AS>O@SW)UJAS?&^IK-L6M(HL<U1PSU
M*Y/#XQ(T<;:!G&&;WLI"F3)];WO>B];WO>SI/=YS3*-OLP7I%_1-;O\ 47<7
MZ4X7YN?U#[,%Z1?T36[_ %%W%^E.#YN?U#[,%Z1?T36[_47<7Z4X/FY_4/LP
M7I%_1-;O]1=Q?I3@^;G]0^S!>D7]$UN_U%W%^E.#YN?U#[,%Z1?T36[_ %%W
M%^E.#YN?U#[,%Z1?T36[_47<7Z4X/FY_4/LP7I%_1-;O]1=Q?I3@^;G]0^S!
M>D7]$UN_U%W%^E.#YN?U#[,%Z1?T36[_ %%W%^E.#YN?U#[,%Z1?T36[_47<
M7Z4X/FY_4/LP7I%_1-;O]1=Q?I3@^;G]0^S!>D7]$UN_U%W%^E.#YN?U#[,%
MZ1?T36[_ %%W%^E.#YN?U#[,%Z1?T36[_47<7Z4X/FY_4/LP7I%_1-;O]1=Q
M?I3@^;G]0^S!>D7]$UN_U%W%^E.#YN?U#[,%Z1?T36[_ %%W%^E.#YN?U#[,
M%Z1?T36[_47<7Z4X/FY_4/LP7I%_1-;O]1=Q?I3@^;G]0^S!>D7]$UN_U%W%
M^E.#YN?U#[,%Z1?T36[_ %%W%^E.#YN?U#[,%Z1?T36[_47<7Z4X/FY_4/LP
M7I%_1-;O]1=Q?I3@^;G]0^S!>D7]$UN_U%W%^E.#YN?U#[,%Z1?T36[_ %%W
M%^E.#YN?U#[,%Z1?T36[_47<7Z4X/FY_4/LP7I%_1-;O]1=Q?I3@^;G]0^S!
M>D7]$UN_U%W%^E.#YN?U#[,%Z1?T36[_ %%W%^E.#YN?U#[,%Z1?T36[_47<
M7Z4X/FY_4/LP7I%_1-;O]1=Q?I3@^;G]0^S!>D7]$UN_U%W%^E.#YN?U#[,%
MZ1?T36[_ %%W%^E.#YN?U#[,%Z1?T36[_47<7Z4X/FY_4/LP7I%_1-;O]1=Q
M?I3@^;G]0^S!>D7]$UN_U%W%^E.#YN?U#[,%Z1?T36[_ %%W%^E.#YN?U#[,
M%Z1?T36[_47<7Z4X/FY_4/LP7I%_1-;O]1=Q?I3@^;G]0^S!>D7]$UN_U%W%
M^E.#YN?U#[,%Z1?T36[_ %%W%^E.#YN?U#[,%Z1?T36[_47<7Z4X/FY_4/LP
M7I%_1-;O]1=Q?I3@^;G]0^S!>D7]$UN_U%W%^E.#YN?U#[,%Z1?T36[_ %%W
M%^E.#YN?U#[,%Z1?T36[_47<7Z4X/FY_4/LP7I%_1-;O]1=Q?I3@^;G]0^S!
M>D7]$UN_U%W%^E.#YN?U#[,%Z1?T36[_ %%W%^E.#YN?U#[,%Z1?T36[_47<
M7Z4X/FY_4/LP7I%_1-;O]1=Q?I3@^;G]0^S!>D7]$UN_U%W%^E.#YN?U#[,%
MZ1?T36[_ %%W%^E.#YN?U#[,%Z1?T36[_47<7Z4X/FY_4/LP7I%_1-;O]1=Q
M?I3@^;G]0^S!>D7]$UN_U%W%^E.#YN?U#[,%Z1?T36[_ %%W%^E.#YN?U#[,
M%Z1?T36[_47<7Z4X/FY_4/LP7I%_1-;O]1=Q?I3@^;G]0^S!>D7]$UN_U%W%
M^E.#YN?U#[,%Z1?T36[_ %%W%^E.#YN?U#[,%Z1?T36[_47<7Z4X/FY_4/LP
M7I%_1-;O]1=Q?I3@^;G]0^S!>D7]$UN_U%W%^E.#YN?U#[,%Z1?T36[_ %%W
M%^E.#YN?U#[,%Z1?T36[_47<7Z4X/FY_4/LP7I%_1-;O]1=Q?I3@^;G]0^S!
M>D7]$UN_U%W%^E.#YN?U#[,%Z1?T36[_ %%W%^E.#YN?U#[,%Z1?T36[_47<
M7Z4X/FY_4/LP7I%_1-;O]1=Q?I3@^;G]0^S!>D7]$UN_U%W%^E.#YN?U#[,%
MZ1?T36[_ %%W%^E.#YN?U#[,%Z1?T36[_47<7Z4X/FY_4/LP7I%_1-;O]1=Q
M?I3@^;G]0^S!>D7]$UN_U%W%^E.#YN?U#[,%Z1?T36[_ %%W%^E.#YN?U#[,
M%Z1?T36[_47<7Z4X/FY_4/LP7I%_1-;O]1=Q?I3@^;G]0^S!>D7]$UN_U%W%
M^E.#YN?U#[,%Z1?T36[_ %%W%^E.#YN?U#[,%Z1?T36[_47<7Z4X/FY_4/LP
M7I%_1-;O]1=Q?I3@^;G]0^S!>D7]$UN_U%W%^E.#YN?U%M>0O1.]-SB"Q2K?
MHOGY,&UT)9Q+'8EARV7V?)HL4H)&F/W$SYL\O".-*SDYHRQ*T9!2S91@R_:^
MS&(.S/+W.?*8MT=6L,& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">PRE 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Alaunos Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001107421<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text"> <div id="toc921291_14" style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Pay Versus Performance </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table and related disclosure provide <div style="display:inline;">information </div>about (i)&#160;the &#8220;total compensation&#8221; of our Chief Executive Officer, and our other named executive officers (the &#8220;Other NEOs&#8221; or the <div style="white-space:nowrap;display:inline;">&#8220;Non-CEO</div> NEOs&#8221;) as presented in the &#8220;<div style="font-style:italic;display:inline;">Summary Compensation Table</div>&#8221; included elsewhere in this proxy statement, (ii)&#160;the &#8220;compensation actually paid&#8221; to our Chief Executive Officer and our Other NEOs, as calculated pursuant to the SEC&#8217;s <div style="white-space:nowrap;display:inline;">pay-versus-performance</div> rules, (iii)&#160;certain financial performance measures and (iv)&#160;the relationship of the &#8220;compensation actually paid&#8221; to those financial performance measures. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This disclosure has been prepared in accordance with Item 402(v) of Regulation <div style="white-space:nowrap;display:inline;">S-K</div> under the Exchange Act, and does not necessarily reflect value actually realized by the executives or how our compensation committee evaluates compensation decisions in light of company or individual performance. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:21%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 7pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Summary<br/>Compensation<br/>Table Total<br/>for PEO:<br/>Boyle (1)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Compensation<br/>Actually Paid<br/>to PEO:<br/>Boyle(2)(3)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Summary<br/>Compensation<br/>Table Total<br/>for PEO:<br/>Hagen(1)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Compensation<br/>Actually Paid<br/>to PEO:<br/>Hagen (2)(3)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Summary<br/>Compensation<br/>Table Total<br/>for PEO:<br/>Cooper(1)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Compensation<br/>Actually Paid<br/>to PEO:<br/>Cooper (2)(3)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Summary<br/>Compensation<br/>Table Total<br/>for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-PEO</div><br/>NEOs<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(1)</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Compensation<br/>Actually Paid<br/>to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-CEO</div><br/>NEOs<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(1)(2)(3)</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Value of<br/>Initial Fixed<br/>$100<br/>Investment<br/>Based On<br/>Total<br/>Shareholder<br/>Return<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(4)</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/>Income<br/>(Loss) (in<br/>thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">308,344</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">354,483</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">296,337</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">286,513</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3.66</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(4.679</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,716,946</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,459,330</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">665,709</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">594,363</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2.78</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(35,410</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,792,818</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,841,265</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">N/A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">856,928</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">486,598</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5.79</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(37,730</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Mr. Hogue served as our only PEO in 2024. Mr. Boyle served as our only PEO in 2023 and 2022. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">The&#160;Non-PEO&#160;NEOs</div> for whom the average compensation is presented in this table for 2024 are Ms.&#160;Lackey and Mr.&#160;Groenewald and for 2022 and 2023 are Dr.&#160;Deniger and Ms.&#160;Lackey. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The amounts shown as Compensation Actually Paid have been calculated in accordance with Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">S-K</div> and do not reflect compensation actually realized or received by the Company&#8217;s NEOs. These amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as described in footnote 3 below. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Compensation Actually Paid reflects the exclusions and inclusions for the CEO and the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-CEO</div> NEOs set forth below. Amounts excluded, which are set forth in the &#8220;Minus Stock and Option Awards from Summ. Comp. Table&#8221; columns below, represent the Stock Awards and Option Awards reported in the Stock Awards and Option Awards columns of the Summary Compensation Table for each applicable year. Amounts added back to determine Compensation Actually Paid are made up of the following components which are set forth in the table below, as applicable: (i)&#160;the fair value as of the end of the fiscal year of outstanding and unvested equity awards granted in that year; (ii)&#160;the change in fair value during the year of equity awards granted in prior years that remained outstanding and unvested at the end of the year; (iii)&#160;the fair value as of the vesting date of equity awards that were granted <div style="display:inline;">and </div>vested in that year; and (iv)&#160;the change in fair value during the year through the vesting date of equity awards granted in prior years that vested during that year. The fair value at the end of the prior year of awards granted in any prior year that failed to meet applicable vesting conditions during the covered year are subtracted, although there were no such awards for the CEO or the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-CEO</div> NEOs in 2022 or 2023. Equity values are calculated in accordance with ASC Topic 718. </div></td></tr></table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Reflects the cumulative shareholder return over the relevant fiscal year, computed in accordance with SEC rules, assuming an investment of $100 in our common shares at a price per share equal to the closing price of our common stock on the last trading day before the commencement of the applicable fiscal year and the measurement end point of the closing price of our common stock on the last trading day in the applicable fiscal year. For 2024, the closing price of our common stock on December&#160;31, 2024 was $1.91.&#160;For 2023, the closing price of our common stock on December&#160;31, 2023 was $10.61. For 2022, the closing price of our common stock on December&#160;31, 2022 was $97.37 </div></td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:23%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Summary<br/>Comp.<br/>Table<br/>Total for<br/>PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Minus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Stock<br/>and Option<br/>Awards<br/>from<br/>Summ.<br/>Comp.<br/>Table</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">&#160;Year-End</div><br/>Fair Value of<br/>Outstanding<br/>Unvested<br/>Awards<br/>Granted<br/>During Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Change<br/>in Fair<br/>Value of<br/>Unvested<br/>Awards<br/>Granted in<br/>Prior Years</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Fair<br/>Value of<br/>Awards<br/>Granted<br/>and<br/>Vested<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Change<br/>in Fair<br/>Value of<br/>Prior Years&#8217;<br/>Awards<br/>Vested<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Minus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><br/>Fair<br/>Value of<br/>Stock<br/>and<br/>Option<br/>Awards<br/>Forfeited<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Comp.<br/>Actually<br/>Paid to<br/>PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024 &#8211; Curtis Hogue</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">308,344</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(11,090</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">56,661</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">354,483</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023 &#8211; Kevin Boyle</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,716,946</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(689,580</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">679,749</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(247,749</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,459,330</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 &#8211; Kevin Boyle</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,792,818</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(904,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">795,785</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(685,522</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">354,781</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">487,403</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,841,265</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:16%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Avg.&#160;Summary<br/>Comp. Table<br/>Total for<br/>Other NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Minus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Avg.<br/>Stock and<br/>Option&#160;Awards<br/>from Summ.<br/>Comp. Table</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Avg.<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Year-End</div><br/>Fair&#160;Value<br/>of&#160;Outstanding<br/>Unvested<br/>Awards<br/>Granted<br/>During Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Avg.<br/>Change in<br/>Fair Value<br/>of&#160;Unvested<br/>Awards<br/>Granted in<br/>Prior Years</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Avg.<br/>Fair<br/>Value of<br/>Awards<br/>Granted<br/>and<br/>Vested<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Avg.<br/>Change<br/>in Fair<br/>Value of<br/>Prior<br/>Years&#8217;<br/>Awards<br/>Vested<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Minus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Fair<br/>Value of<br/>Stock and<br/>Option<br/>Awards<br/>Forfeited<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Comp.<br/>Actually<br/>Paid to<br/>Other&#160;NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">296,337</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(3,087</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">606</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(7,343</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">286,513</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">665,709</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(62,254</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10,904</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(19,996</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">594,363</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">856,928</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(386,561</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">87,953</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(66,031</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,427</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(11,117</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">486,598</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Mr. Hogue served as our only PEO in 2024. Mr. Boyle served as our only PEO in 2023 and 2022. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">The&#160;Non-PEO&#160;NEOs</div> for whom the average compensation is presented in this table for 2024 are Ms.&#160;Lackey and Mr.&#160;Groenewald and for 2022 and 2023 are Dr.&#160;Deniger and Ms.&#160;Lackey. </div></td></tr></table> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Reflects the cumulative shareholder return over the relevant fiscal year, computed in accordance with SEC rules, assuming an investment of $100 in our common shares at a price per share equal to the closing price of our common stock on the last trading day before the commencement of the applicable fiscal year and the measurement end point of the closing price of our common stock on the last trading day in the applicable fiscal year. For 2024, the closing price of our common stock on December&#160;31, 2024 was $1.91.&#160;For 2023, the closing price of our common stock on December&#160;31, 2023 was $10.61. For 2022, the closing price of our common stock on December&#160;31, 2022 was $97.37 </div></td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:23%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Summary<br/>Comp.<br/>Table<br/>Total for<br/>PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Minus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Stock<br/>and Option<br/>Awards<br/>from<br/>Summ.<br/>Comp.<br/>Table</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">&#160;Year-End</div><br/>Fair Value of<br/>Outstanding<br/>Unvested<br/>Awards<br/>Granted<br/>During Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Change<br/>in Fair<br/>Value of<br/>Unvested<br/>Awards<br/>Granted in<br/>Prior Years</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Fair<br/>Value of<br/>Awards<br/>Granted<br/>and<br/>Vested<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Change<br/>in Fair<br/>Value of<br/>Prior Years&#8217;<br/>Awards<br/>Vested<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Minus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><br/>Fair<br/>Value of<br/>Stock<br/>and<br/>Option<br/>Awards<br/>Forfeited<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Comp.<br/>Actually<br/>Paid to<br/>PEO</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024 &#8211; Curtis Hogue</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">308,344</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(11,090</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">56,661</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">354,483</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023 &#8211; Kevin Boyle</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,716,946</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(689,580</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">679,749</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(247,749</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,459,330</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 &#8211; Kevin Boyle</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,792,818</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(904,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">795,785</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(685,522</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">354,781</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">487,403</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,841,265</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 296,337<span></span>
</td>
<td class="nump">$ 665,709<span></span>
</td>
<td class="nump">$ 856,928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 286,513<span></span>
</td>
<td class="nump">594,363<span></span>
</td>
<td class="nump">486,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Reflects the cumulative shareholder return over the relevant fiscal year, computed in accordance with SEC rules, assuming an investment of $100 in our common shares at a price per share equal to the closing price of our common stock on the last trading day before the commencement of the applicable fiscal year and the measurement end point of the closing price of our common stock on the last trading day in the applicable fiscal year. For 2024, the closing price of our common stock on December&#160;31, 2024 was $1.91.&#160;For 2023, the closing price of our common stock on December&#160;31, 2023 was $10.61. For 2022, the closing price of our common stock on December&#160;31, 2022 was $97.37 </div></td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:16%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Avg.&#160;Summary<br/>Comp. Table<br/>Total for<br/>Other NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Minus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Avg.<br/>Stock and<br/>Option&#160;Awards<br/>from Summ.<br/>Comp. Table</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Avg.<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Year-End</div><br/>Fair&#160;Value<br/>of&#160;Outstanding<br/>Unvested<br/>Awards<br/>Granted<br/>During Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Avg.<br/>Change in<br/>Fair Value<br/>of&#160;Unvested<br/>Awards<br/>Granted in<br/>Prior Years</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Avg.<br/>Fair<br/>Value of<br/>Awards<br/>Granted<br/>and<br/>Vested<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Plus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Avg.<br/>Change<br/>in Fair<br/>Value of<br/>Prior<br/>Years&#8217;<br/>Awards<br/>Vested<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Minus</div></div></div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">&#160;Fair<br/>Value of<br/>Stock and<br/>Option<br/>Awards<br/>Forfeited<br/>During<br/>Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Comp.<br/>Actually<br/>Paid to<br/>Other&#160;NEOs</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">296,337</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(3,087</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">606</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(7,343</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">286,513</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">665,709</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(62,254</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10,904</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(19,996</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">594,363</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">856,928</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(386,561</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">87,953</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(66,031</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,427</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">(11,117</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">486,598</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 3.66<span></span>
</td>
<td class="nump">2.78<span></span>
</td>
<td class="nump">5.79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(4,679)<span></span>
</td>
<td class="num">(35,410,000)<span></span>
</td>
<td class="num">(37,730,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=tcrt_MrboyleMember', window );">Mr.Boyle [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,716,946<span></span>
</td>
<td class="nump">1,792,818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,459,330<span></span>
</td>
<td class="nump">$ 1,841,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mr. Boyle<span></span>
</td>
<td class="text">Mr. Boyle<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=tcrt_MrhogueMember', window );">Mr.Hogue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">308,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 354,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Mr. Hogue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Mr.Boyle [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (689,580)<span></span>
</td>
<td class="num">$ (904,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Mr.Boyle [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">795,785<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Mr.Boyle [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(685,522)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Mr.Boyle [Member] | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">354,781<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Mr.Boyle [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">679,749<span></span>
</td>
<td class="nump">487,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Mr.Boyle [Member] | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(247,749)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Mr.Hogue [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">$ (11,090)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Mr.Hogue [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">56,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(3,087)<span></span>
</td>
<td class="num">(62,254)<span></span>
</td>
<td class="num">(386,561)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,953<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(66,031)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">606<span></span>
</td>
<td class="nump">10,904<span></span>
</td>
<td class="nump">5,427<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">$ (7,343)<span></span>
</td>
<td class="num">$ (19,996)<span></span>
</td>
<td class="num">$ (11,117)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=tcrt_MrboyleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=tcrt_MrboyleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=tcrt_MrhogueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=tcrt_MrhogueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure</a></td>
<td class="text"> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Equity Compensation </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our compensation committee believes that long-term equity incentive compensation is a critical component of our executive compensation program that links the interests of our executive officers with those of our stockholders. In 2024 and 2023, equity-based awards for our executive officers were granted in the form of stock options. Stock options align executives&#8217; realizable compensation with the creation of stockholder value and serve as an effective long-term incentive vehicle to retain talent and incentivize performance. Executives only realize value from options if our stock price increases following the grant date. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock options granted to our executive officers vest over four years, with 1/16th of the options vesting each quarter. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not grant equity awards in anticipation of the release of material nonpublic information and we do not time the release of material nonpublic information for the purpose of affecting the value of executive compensation. </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgPredtrmndFlag', window );">Award Timing Predetermined</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock', window );">Award Timing, How MNPI Considered</a></td>
<td class="text">We do not grant equity awards in anticipation of the release of material nonpublic information and we do not time the release of material nonpublic information for the purpose of affecting the value of executive compensation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MnpiDiscTimedForCompValFlag', window );">MNPI Disclosure Timed for Compensation Value</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgHowMnpiCnsdrdTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgPredtrmndFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgPredtrmndFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MnpiDiscTimedForCompValFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MnpiDiscTimedForCompValFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( #1)J5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( #1)J5IQE/LY\P   "L"   1
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M3Z?>%I7@M:CJ]\GUA]]5V/7&[NS_,K[EWXPO@K*!7_]"?@)02P,$%     @
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M3@H\W/[O#;#"Q([A[8N_ 5!+ P04    "  T2:E:G(W0-'L"  #\!@  &
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M'I_T+^QC<25]W%Y)'W?_V,>[]\U?7_UN%59I=^3+_GU=?0)02P$"% ,4
M"  T2:E:1L=-2)4   #-    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( #1)J5IQE/LY\P   "L"   1
M  "  <,   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( #1)J5J97)PC
M$ 8  )PG   3              "  >4!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ -$FI6IR-T#1[ @  _ 8  !@              ("!)@@
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( #1)J5H0?JG4
MS@P   =A   8              " @=<*  !X;"]W;W)K<VAE971S+W-H965T
M,BYX;6Q02P$"% ,4    "  T2:E:@00%WO\#  !3"P  &
M@(';%P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ -$FI
M6CRE,S@1 @  W00  !@              ("!$!P  'AL+W=O<FMS:&5E=',O
M<VAE970T+GAM;%!+ 0(4 Q0    ( #1)J5KR[WNK!@,  "T0   -
M      "  5<>  !X;"]S='EL97,N>&UL4$L! A0#%     @ -$FI6I>*NQS
M    $P(   L              ( !B"$  %]R96QS+RYR96QS4$L! A0#%
M  @ -$FI6OV<!5>' 0  !P0   \              ( !<2(  'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( #1)J5H!9<7NP    *L#   :
M  "  24D  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M #1)J5J.L*?6)P$  &<%   3              "  1TE  !;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@     ,  P $ ,  '4F      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>27</ContextCount>
  <ElementCount>21</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>10</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="d921291dpre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d921291dpre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="d921291dpre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="d921291dpre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="PRE 14A" isUsgaap="true" original="d921291dpre14a.htm">d921291dpre14a.htm</File>
    <File>tcrt-20241231.xsd</File>
    <File>tcrt-20241231_def.xml</File>
    <File>tcrt-20241231_lab.xml</File>
    <File>tcrt-20241231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g921291dsp005.jpg</File>
    <File>g921291dsp006.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="60">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d921291dpre14a.htm": {
   "nsprefix": "tcrt",
   "nsuri": "http://www.alaunos.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "d921291dpre14a.htm"
     ]
    },
    "schema": {
     "local": [
      "tcrt-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_def.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_pre.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "tcrt-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "tcrt-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tcrt-20241231_pre.xml"
     ]
    }
   },
   "keyStandard": 21,
   "keyCustom": 0,
   "axisStandard": 3,
   "axisCustom": 0,
   "memberStandard": 8,
   "memberCustom": 2,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 27,
   "entityCount": 1,
   "segmentCount": 10,
   "elementCount": 268,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 60,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d921291dpre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d921291dpre14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d921291dpre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d921291dpre14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d921291dpre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d921291dpre14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "4",
     "firstAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d921291dpre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d921291dpre14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r96",
      "r112",
      "r147"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r89"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r100"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "tcrt_MrboyleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alaunos.com/20241231",
     "localname": "MrboyleMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mr.Boyle [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "tcrt_MrhogueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alaunos.com/20241231",
     "localname": "MrhogueMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mr.Hogue [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r183"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r95",
      "r111",
      "r146"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r91",
      "r107",
      "r142"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r92",
      "r108",
      "r143"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r99",
      "r115",
      "r150"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r94",
      "r110",
      "r145"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001193125-25-116509-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-116509-xbrl.zip
M4$L#!!0    ( #1)J5J[748^#&$! ,E9"@ 2    9#DR,3(Y,61P<F4Q-&$N
M:'1M[+UY<]O(M3?\_WP*E)+<*S]%R:16RY[XOK1,9Y38DB+)XTP]]50*))HB
M8A#@8-%R/_U[MFXT%FZRJ&UPZR:Q2+#1RSFGS_H[/__/S3APKE2<^%'XU__N
M;+;_VU'A(/+\\/*O_]T]/SPZ^N__>?_3SZ,4'H-'P^1MX(??_[HV2M/)V]>O
MKZ^O-V_Z<; 9Q9>OM]KM[=?X==]-U)H\CM]ZOOF!_?#>:_[2/%H9^GJ;GNT<
M'!R\IF_-HXE?]R ,VGG]KR^?SP<C-78W_#!)W7!0F(L_8^[EYSU5FGBB!IN7
MT=5K^ )^L;6C'_23:&>KLS]K:'Y"_R =Q&GA:3=PLS!*-@?1F$;N;&UW\FE,
M8C5P4^5-?<'!:S<>Q%&@7N</ZY\/HBQ,X]OZE<B7A=5DR<:EZT[,#X9NTJ<7
MR1>%AV^"&:O^UV?KS+(TGC%_^%8_J 9>_63AB\*[$VL3S23AP^+9W$Q[:P=/
M'*A*_>O#V>?\\;3^^?S1UVGLALDPBL=N"FR#;]O::&]M=/9L0INU+V4F@9=N
MP"(+O]"+GO7>SNY&^\V&H93IO(/\NX9\K%P/_B?UTT"]/SWK.9V=[L^O^<^?
M?AZKU'4&49BJ$#8A53?I:_SA.V<P<N-$I7_]>O%IX\V:@V_94+]G_M5?UP[Y
M\8V+VXE:>PV#O)9W]"/OUDG2VT#]=0U7L#%2_N4H?1OB_(-W?7?P_3(&ZO,V
M!E$0Q6^O1WZJWJV]_]GSK_3O/#^9!.[M6R>,0@5?^3=O<705\S]]SU,A_1.^
M/\[&*O8'3NB.\9?*?_LQ&L!G84I3<WPD*OI%9Z>]MWNPO0LKH<7>I&=J^->U
MTW;GW_#_2#L746?KW]O\[[5\GPHOFO[>+KS4PQ=_"MS+Q=Y!L_-OKC9V]]L'
M:^^';I"HA=_7"^$ ;P_AA;$;'(6>NOF'NEWZO9WVVOLVR,].>Q\D5>7EKXL;
M'JNABN&F4,G[GY&:WR8D<N%E#@GJMREL^E_7$G\\"9#,Z;-1C'-!V;>A9=SF
M3>(!V=#P]ICT9Q)E,?U%@ONM+(CF//6P''E8T::8/WT//QCZ*G9HIJJ6UPZ/
M_E'<A/*/8;S7M>-/8)<BS_P)]TB<?@0I_!YGM='NP/_K7^;?Y7/U\F<[6\#0
M^5L\>?)UZ3VO"WLR>XNVK2W:?I);M+W$%FVO8HNVK"W:>I);M+7$%FVM8HL*
MC/;O+_$HNLS4%S7N ],./) [_I7O96[0O?&3!]A!V09UB9)6_O;@?3>3P!_X
M*4_,\7SXFI3;-9CDV_(L41:]+2SEY]>U ^5[E;_Q&4J"XAGV?D]ON]>QEQR%
MY]EX'-\>1N-)DH87_>!3%'<G03_X+38GW/7^<Q'A$[AU<\[_WZ<J,E_U;M0@
M2_TK=0@+N(SBVZ=,(855KKW'CY;8ING4L]#+I^P4?F4V] =?T7" S0&'H_#R
M*/P4_PK;D9P,?X53O?R8G@Q/X_BWV)P[? ST?7@5>PT[>&_ONF<-;SPOWCB.
M0MC8XWF4^V\A "*(DZ$A@+_%8>IU0V\^\SPCVE]ZK:LC^M+Q_)$H\]ZD]H(D
M_HP(].D)YS\PG?Z(?OWR2/-)J-%_*&HL^'U 1>U'M\$+L=BMI:ST#!_=,54\
MPQ^SV&>=_XLR49Z$J%FQ5?('Y8![M-C_,.SP])3"AC=6P1OFA/E@0Z]LHAZ%
M]$WR*?"(" ZCT$L^QO"/AE.(+N]G!QN^>5Y\T]AI3TYY>D@[[8E18^-W;?RN
M3Y,R&[_K,U*Q_U!T6DC?:3Q=SS*_J'B&B]Z"I*77W@N:T4ZR-/'"2[@FOH97
MP(#/_C*\ZY)?AJQY8G1J"?Z387G?ZVW'/^*EN-S>-)3ZB!*UL2M>O%WQQ"BS
ML2L:N^(YT&GC)_Q#^PE?$#7^@4(Z3X),7TC<YHEQP(]2<>,\> K.@X8WGK9?
MX@]T5SQ!AT7#'4_RYFB<)(_B)&FXX4G[7_Z85\43<<PTO+$L;V2ASXSQ%?[Q
M[Z_G'W/Z&RLWR6+U7G";WL*7>A#]E1D5A]$()@:RY+6%5?,:-I1P;?+_FH&,
M8T!O&/FG!(F#\]]P _\R?#N 755Q\>MKWTM';]]L[OKA.^O10 W3=V,WOO3#
M#?SW6\?-TDA_$M/KZ:/B:/)]&DW>.NU)^LZ1#_I1FD9C^6P(F[J1^/^KWCJ=
M-^:#H3OV UC$?_V>1>F["R"QQ#E6U\Y9-'9#_O"=8\W0X=645DM#7?/V]*/
M,YMC]N;K\=%%[Z-S?M&]Z)T[LM6OR]O\#!9RWCO\>G9T<02KZ!Y_='K_.ORE
M>_RWGG-X\N7+T?GYT<GQ_:UNZ\%7]\U-1GYXF49AR_EXZ&RU=W<.IJXGGRK-
MU%I>._]3%@>?K+W_KS]U]MKOJ@/-81:;^?8VV_->A7/I1S&PM/ZDL]F&QYPD
M"GS/^5.;_N\=L^!6YR_O*J]?D 4+RYEYVGR23X^8[:<1V6S#O]E@]*BW)0RN
M&D8X_*7W\>MGP=S"U3]GPE\_RP+E%$0T IUM)!-WH!#8[#IV)^^<0*4P.GT*
M;((SOX'7\[INJJ-V=MR-3KOS:HG]68Q4'GZ#CHX_G9Q]Z5Z@@#OK_?/KT1F(
M\Z-CY_3LY%^_L5S_TCN^>,XT8%.T8Z_W.9_;:1S=W#KG*2A<J.LYIUF<9"[\
M(XV<<S5 A$*68YV==?>5$PV==*2>]2F"YAW[J0_#]VX&(S>\5$YWD.+*.@?;
M.\UM]J.W61VEE\Z]TRX?>^F\U]Y_\@/E.?U;(K<S=>DG")N9_M>?WG0.=M[]
MUY\.]G?VWCD/.1'7.04;YM:)8$8Q3,L-9\QM9\[<MG;N8VZ'(S7X3K-P)Y,X
MFL0^L+'3CV[>UKS]APCXIY]3MP\WX$ %P<3U"%AXK;U&?\MM1W]7:9PLOW?.
MAY.SC[VSC<.3SY^[I^>]M_H?,U=8V0ZA='V_:KKNM-M_05S4--83F+B7:J,?
M*_<[P@?[GGKK7D6^1P]Y12MKYR_OKE2<^@,WD"G#GI2M+MP-(KF?7Z=>89!%
M?OM#(K)"!HN+2+(7'5NB.&*=HN!7@3_V0S>^=<J7@.9R6"K\%YJ^=/H-.=TS
M.>V\''(J7&'+:<'+W=^'43AD5Z ;M& AL?,U45HO.8S&8S]!)YAS$@:WSKJ;
M.!,5CWV8$ GQF6J\:/&U:OK>NGJUOO7J5>$"K,C8E:Z\>@,WC-HPZK*,^E$-
M_=!'WW,C]AMJND=JZL)YHKGH!LX7H"C018.D(:F&I)8EJ?.(@E&PC8:."EX)
M//W]=_?NB]O::6^2/VYKB;OU63AQ9S<<R.W78_AFV7X#![O[:^^[W/7$N0##
MV)VH#,@N:3E'X6"SW'_@_AQ'/T!\=W4!X_Z@HIGOF /JY?E$#3 J[3E^Z!RE
MB7,X KFBXE?WZ!9\Q,6>JCB)PO7DE?/)#Y G2TI#R_&'S@FY1"ZJ+I&%-N%^
M_#2G[BTI,3!GF>DGI9SUJ2Z25XV/I/&1S+F*CB-G"$048Y.<6'F;C3K3J#/+
MTA!*H8GK>\XD5E=^E"7!K7/MIR/\VSC@QEIA;DBL(;$[D=@@&D\R=')%< ?3
M^8(ZHFY&?M]/C0!##]@1W-O.UNYZ_Q5ZQHHQ,/2.)2N)<N^M^Z_63:#;#;U[
M?TM[H]/9G*>Z5YUWUG__Y/STT\^3.@5%C2OZ"7YD469?#:,8*#.X=F\I__'U
M!/NT&2+FYFA_.J#_>R<GN WKR*G^W2!0;@SZ6#I:>_T>Y_*0^6(_.;5+KR'K
M956S=Q5MLV8Q6WN=?>>#GX"N&2I0*L\SH AG:WN;=O)QY_8+"&W*>+KXE[._
MWV[OEN=T9W$\>9F!X?KCN@\U?Z'S.CZY.#KL.2>?G.[Q\=?N9^=+KW=Q=/PW
M_.3\XN3P'[^<?(8+[/P)D-9%Y/25\XL*2&[_/0/=8+OE@(U=H;%[MY?^+]R"
M>_L'[_[? [T/EHI6&'#2X/L(M@/L2K35IOL.WJY\2M_PVHP]T+M@W_WP"D7.
M;92ADPFG2MOBAF'F!LY8*?)(P8P+*UC'!__K3V^VMMKONOSH%WZ4/NR\>S5[
MD<ZZ_/A:M>079CC^D?XTBAWK79C%[H:W^B4M!Z[0P0@4RR! BAHA15WY<9K1
MVO"^53>#($O\*P5_1W1IP@,N:!178!IGGA]M1!@QNU;]@9N !!9Z9.X6HFPY
M;NH<O&VW'7=SO.GTX$$5APYN+(?B<(;#* BB:]RL219/HD0EE9/,3VEO27GI
M:.U51EJ]+CI/3Z8IS5=6G3MKJZC5@"+C+*NI6OOM%+?8^6'95GD9<+<*%*B0
MR@4RE&CL,,IB4.? QE'P:Z0/#[3000K_0"\D><S(,S,8,#D3T9!_*3%!*9O#
M2M\9%@.&18:$]P[]@7*R,/4#S<)[\U@8F8-_,?(39#/T92798*! &XD=^,Q#
MN4S+@SGCX[_#>.SSBV)R@"51%"KX9V4<T.@"+'?QE)N.6J"()[!GU/<7GXC5
M.+J"J6DA<!I'P##P04<O[1VQ3E63;9CI;LRT]4R8*08:&7+R6T*41Q0S= Z!
MJ.);YX/Z[L*LG<^?3]$'C8_YH:<F*L3,"* K=, JM/@F63_P!\1B2)Q _T,_
M'EOY$LAWQ)M^"CSJ)[ 1SBV0K0-CX>,?U8#*@N0BZ(BZ()EY>'.D:'Q2BH4J
M<&OI._M"Q*?ZD1LCRQJAD)1G90_V 9\V0U089JMAF-4PS/8S81CR[E\ITEM<
M^'_OR@?I?>OTW<0'70LI"2\9%2:NYB6+U)!Z.OOO$KF7E"[/DQL%;PFX!H Y
M M!GS+U5N:K*5+G=4.5JJ'+G>5$E4<NY&D2@.[BZK3QI$J 0&/*90I+T U$\
MY'$/-CS&6M@!!K/@=WX(ALPDBHFV6TBL^E?KJ(-IHX$CD[G1 '2<9'T8DK+I
M@EO1VN!^<-,4%#GXO=A"95*'-X"YHVZ<+O!61'8!/H8L$BN;P4ANMQPU'*)V
MZ,(*X)P2L0.=9!+ %4'N<%C:!!^1%Y9WP4^23#8ARE*<,MU.>+O RVBTEC.!
M:POTJ4PY?VYOMML=\G FL&J%:P7[AW[#KR8326XQ?>'@51I37>@M_RRAE=7/
MFC8;E_DS4'XX/9]P[?W<!SH;L.D;NS^_Q@??R__@3MS7T%OM5FEPV@XT!ZM2
M:Z>16JN16KO/4&H=%@5-UTBO*7PJ,N9>9,N'Q60+D#(R+<\WS*@8'HT\8F#\
MERTDT&DYBF+8'(^UW@03BP;TXUAE(#-C9QA'8V>WU6ZW\3]Z()CM;KO\885Y
M=AOF60WS[#TSYD$E=!ZS@"75=GJ_9WYZB]Y 3&K'M-P \VBB.72=CH0O].4U
M=F_YEG28BO$[&HK(N;/=;NWO[%K$W&F5/JO0\EY#RZNAY?WG1LLHHYDF@'!<
M[S^@5+()5/1YT[=.@,D,C@?_3;ZQ4*$G#;,<0-Q:25@HW*4XPQEF,:60)9S[
MR28:ZGI7$=\[>$=@R:987J".(5<)"\0PPQ@]($F&YIJ/W^$/R>?8PM=2S=ZU
MGU!4?( Q1O:HH.;9RK/#T!<G=XMF@F1A8V\_YQ:*;S<<<X\<\^:9< QF/28N
M6CJAKA3M@YH= @>@7H,R&AE Q: 0@5JB'$X<J.,EY!:T29C;D.82)O9HN#F?
MNNX_?C=2R#Y _:13Y:N"V8]Q"<,,M3Q/@9;F]Z<[20K._A1=Y6$$QZ@V,3JV
M\-/HEN\K_% ,PRI?L_/4%BAB[7W0CD=77A>)4 G%O4-:J@@=."9\&E7%#-8O
M=V[QJ#97'JG\+<I,;(\X'P5MFJJ0+6*P>V%3_ DJZ7ZM8.:(7PM5<I2WM^@5
M^#U3">X+!CABWM_*[XP,IE^(HD .Z3@*D?GPR/-?ZQ@+[/25GW 2/T)[22B2
M?L]Q%WER$X[W]<7AV04ZE3>+]FXY@+[V_H,:N%E2RRV&'LBN+\ZP15%=VC^@
MGIH]K!LOQ+LIB<)-8SAC1D\Q7:A)&%I%Y@3)&B=6&)LG-<*$EJMG_L65"/4N
MQR4VN>ZSG&4@@PGW$IL7A!A) /B6WH9"FFB^EMEKY#)^!#I .HE"EEI&3,.-
M4.)-PU"U@[>*,V>258HI- M]8-GY/J'.WH;G7_JI=O5@14<<!=J$6 ?U*TQS
M =V/;O# ON=P"VX<1]>OY'L_=HY9Y,*&'2$EA2IUNE>N'[A]/T#3!<L$2%3F
M=5^X([GT7 <U$%D0\Q!!YJ ?S]&S&$236ZUT\4],,NRKBF#]P4RK7',J)[N6
M]9M[U:Q$TP&.K>A8-J\)7_U$NM3[GVJ4)=+%7O.=+\_-T;F<I6:Z-D_! A%\
MZYS@&@H^&/SCHX[BM7*]I#!#ZU65-XE\PT/5ZWN4U;U.7@,KPE7IN<YG=_!=
MW3[CQ2RTD(>:S IOBZK20/]^"VH?*']K[S^K2Y"P*'B[WM@/J30)]9YW&)*)
M50JFJ77'KW"B>2*ING&3I5[6^='\OJ+!\%,Q(WJ5JNN\T_D-%4NZ$>$Z!\JY
M=?SQ)(K1;[SI?!LILJ$P8R@BM76&RF;RW5H. H(F^4!\N=LJ;!\5C G\"W4C
M;]-!!=O<^_0@WT7I*(ZR2[8E].77HGL25,S)""Y\G0+$]]M ^>PO<3'T9%V!
M?;S7_(!^BR9-D.O70(*@2&@5VOH-_H#=Y##XIO-K))HI$' V8,T=K2]T7/A>
M?J$O?UVWEET$)YQ4YL$W.BA3U@[2#W&9'(";:AAN.D?\?EMARE,8:\T:5NR+
M^AK^%^4CHH](K\FJO6$+".=YJREOT^G9SXK[=:Y1U7*N02F++TW2*$\BH6PP
M_%_0"1,?M8WH2ORQ_C02TEM+>09S3&C4BAJ3Y,G5,%!1-&CO8+Z0BHG96EA+
MC7Z;^U-C'U.#I1.>HL*^;3OS]=>#?51??YJE+/"J]0O_0E0$3Y?_YY%48)[=
M\FY%FWZQ# ,YCRC(IX2]MQOZP^6N5M<9Q5BG_R<@NX.MSM9!Y]^=M??__-H[
M1UQ*1B#N'I]_PV*'[H>3KQ?.Q2^]\YZ <G[I7O3.CKJ?^;E?3[!&XN?7[GNC
M*BRR$TR9FC[+/ZI!5YHYSMU'L!F2A +8P?<TGSMI_WND_$_[!E0 9-[PKVL[
MCV4B/'U2WEI[#X1Z>G(.)/J2Z/*@H<LEK,6EB7)[I42Y39"YDJ7O]*S4;.,
M:6AU$5IM2&G'(J4MY\R5/"LAIW,[[?_(2NX_RY/[3SFYOYLG]W_RX_%+HK_.
MZB[QA@!W+0+<=KHZ9?Y7RKD('=.DAE*,=.;\BZ*N[8:Z5D9=>Q9U[3C=4GZ-
M9,-WK>3V,YW<7LHY/;*3V]'/TM/)Y&>2EGU.F9WGE)9-9C?E>]*G+XI<=QIR
M71FY[EODNELAUUEIT.A&E+1G_/-(IVWBY]T\V_C%D>-60XXK)$?7HL<]B^"
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M_L!:C0LO,3JEOHU:K(<G6:RLZP.48C!PT=GW^#3\(5=:3U!IG46^I+TCK:%
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M?;NIQ)4UUM83LQ4XY=TUQ8>UB46%]*H\5VD61],6BL19)\S<H885 U'I8=1
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M4\/?S2^4;&BRH<GE:-)V%2UB"S9$V!#AO1,A_"?<P):*+N$ W$DZ&C^2K56
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MM#Y$4V:*!_XRQ)[/R)9IF\XWR62DO-T9["5,U2KSX<#%CFM2K&'81O0T221
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MU!];;USZ_1JX"V0IWN1VX]5I2']]DEV1@*-B)H)KP-4B[+@I#=LDQ\&,]P-
M7G;">CZ1*OP9XE>FN*-Y;4@=^!:Y].L;[]5 :>9M_*P>H@,U,YQ+66W2GY'*
M<$WYCIS0PL=C(9CE@+[U^7*.U5%9D-/()578<'U+5HZA@JRXT$+-M;0(K6.L
M@OWX*F1RNQ/YWS]$FPWAA9$;1HR<ZDRE4F'UO4!<<*])T>T\N^U3?O\8>&+N
M1((_&D77\X)LMM)#B>_D-2/7I2'96%UB=BAA>D71=P0QA@TQ7U,X$A4]3-C%
M<0ROK3I==YZ@_Y O1J!?-9"7\U5+V05-9$I29-\BD0FJ'@;<!#LC]V]+%"_%
M!ZYDD+5 UH7?<VL-E)W0."T)6U)Z.!+NJ]GPPIC7U$9#]T.F.D'S((_DQTX(
M8\'>?^"\-7ZMG4U(+TYL4<KX,FI^_UTQ^/PZ,J'_U>5+Q;HY_$>,<5F<6C$"
MFR?839VHB<EC=9.BW,M)?H&31C5MOX;$V1&&%68$Y\Y+6\SMM6>HPB+!9ITK
MW0HX%"43@. FQ U=1<1=>]6E 1"LQ]/&P"2##M"6%_>I^$)>*R7#^2%%7CGV
M_M@<>):?C!3/?D )TD,)HFMGRZQY*#$?V7KK</4AE>O)B$3HT%"5$NA1%L^^
MB5/G18"4:(9 .#"5#19FN&5\KKU_ZOJL BEY48X*(S'_7.2AZ@+V>:@SY;%:
MR91NF(NC5 %VZY#W;*2YP8";"'GE0.VQ&@:Z'JW.(5@G!3!A( .Z6 (HMRQJ
M"GRP\.Y9$#J8%T_"$G,W12<B&#YUPSCJ.:QR!N2'.2:O.$6/D+FEX77.B!/,
MZS0K$?OJ(2O=YE'[H7T+ELGZ;N>@I>JLNN2P>/WR:9A2&LX"#E2:,M%0SO#8
M3U.&]X<3*S?VK9&1:"/D0SSCHK@W3;CL88OB;')CHJ1K30H?#+ =4#-KJ[8>
MG(RX0HY*+@1Z!O/U<VI?3U[ER>YS^,1& #V!82UN333V)XH?X B8G9%10\H"
M,'>JW-NYI+=48GXY);9C[P.XTU5AMK9Y:@ P](^ZA:6/LX3QHJX47V?E&:,E
M>:E( ]!@:S'6KU,MN@3(N2O-#8([H8>P3@2T>,6;SG&AL#"7'Q84!1 ]7%K\
MZR&.9"(/2MERN[(OMDJ".!BI'^2'JFQP.>J680>SRLN>HFQ3/=< LP>"0-;-
M_0<BJQ:B>'DN>;NP/P(SR-*J=H!*'!)@JE]NO CVOE#KB#G=)A+N>%& G>:[
M(RSOA:3KH<T=^^P["M2E"L6?P@Y-ZQ18>[<LB-P$X.9[QGXF<Z0ZKDXN8JL9
M'RS-Z$%@+!:[1*\Y959#=AF]!/5I0>XW',XJ.QD+G)S*24&V'[/P/'Q9(4NR
MG>LIGEA+Q5=4WC["6GYKZX&E* ;5O[6UVRFX"52W $:B.,/T<=D3*[S88.[U
MR9O!2C'YTW!OPD2MW$:O\1Z?7YP<_N.7D\\?>V?GSODO)U\_?RR&'>D2\]1
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MCJD44N#(%]0JK!^6]8J!I?DGN>;/P6'MZ["+2K77C7!?Z;=D[[:,9X&"R^Z
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MO3\K)N3#8I:J6FE*\J>> </?%"DQ2IAWNZ&0RKPJ02HG&N5;[)[3;PB^M^K
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ML&?D1Q!)#$+;<<6)W(6YJQ%B' P90B TK<8B4(PQ+K9OV[M(=$U)%=NKK(1
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MSA3XU=9!+0-JNY-H@'%&/O_)L$H0,SNC(<E.HJZYC)3H_ZBMJR1-,L3AT%_
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M4GTEYY];T^JHF6G'J!M;MD-]?Z\8"<$)%W4L']_UF&^?9\H?6"PC>=3"2'Y
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MC^_.OWK*7[[TX!YY5[^=8PSGT#O]_/EW<*(_G9]???C\JW?QWK.^=+D2@H7
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MUD+:5VLEB5%J;*>I$ZK%B0BE*67Y8SE61"SON[N/+5$,#D*Y@%9,*2\G6-:
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M?:5:+**1%G8S2RGMKI52]; <O(3#<H7-_K0V(&.8#T5!_2J<IG.3X(XM^'&
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MPUS@<?6RVJ?Y]P>["SW&?-K]SV+?76S S_]-CU!F=3RKRLJ3<7ARC(W:V3Z
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MQ1/^1K;(Y:'@JXAZ&EFD''+3S;1]EQ,-K##Q@9>(\4TQQ[W'A57<=-R>=Y\
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MY(<PYV? &5G/$LIHAWAB29<D];C. 4M/13(B;V2^:W:):O1D$I ;#TDVWI6
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MYB#@PJ<V7-F@32IIX'A7$/TT$M;G9DM5K*]X1[K#=H) N8;&D,ZJ1QG5#F(
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M#QCG)'#//C7SRZO)XOZ)_OY2E<6O_P!02P,$%     @ -$FI6J?@8"UYN (
ML_0" !$   !G.3(Q,CDQ9'-P,# U+FIP9^R[95B<0;,H. %"@B80++B[RP"#
M!7=W=V>0P3TAN#L$#6X9?' )[NX>W-U]\YT]W[EG[Y[G[MG=L_?9'[=^O$]U
M=4E7=5>]W3WSOLZ_K@/PQ#VL+0  :6EZP'O ?X/7(P"&F*NIK2?@#0#A;]OL
M+VD=WLW*Q<41Q,)B[\QL;.9@8LYLZ@!F\3!V9&%C9F4!\ MY.!J;VIJ[D)J8
M6UK;"Y"?-K>3DUJ;"9!K<LFSRCN*FEM92WE!S%6]%-1,O6Q-><W(A01)^3U
M'F!'L+F+,:D'V,[>&>0A0/XORD%_\7^06<A)_X7%Q5: 7/@?':1:\DJDH@X0
M<U)>9C8F4U96=E)N7F9CH#&0@Q?(8\Q(RL[*SLG"RL'""F1B8P-QL8-8N4C_
M%<C_&H2868!4Q"3^U=S?E@#YO_KE[N[.[,[![ "Q9&'CY>5E865G86=G^LO!
MY.QI[V+LP63O3/%/#6+FSJ80:T<7:P=[TG^TC4T<7%T$R,G_Z07845[^WQ3_
MAP$#@UG^R>WLHF)N\3_F=E;S=#1G43%W=G"%F)K_9:?X=Z;^QZ+_8/P[&I B
MQ/KOO!C;B3F8NH+-[5VDQ03(__8PFUF;@7AXA;E$1($<'&(BO.*L;&P\0'$@
M+QL'!Y"=C4N<4QCX3QW_D2RGB# O%YLX*[LH!SL;FP0KKZCX7U146)P+R"K*
MRL7]3UEI>V<78WM3\W_*6O^;K)C$_U 6) HQ-W9Q@*@Y.-C]<Q%(V_^= 6M+
M>U(V7F9.4EI-:WLS!W=GNG],S[^.U!QB[69N)@%Q )/^2WQ!UO_.OJOK/XQS
MF[":FW"9,P'938R9.'F!7$P\QA;F3.;&K.RF)J9<YFS&?QW_WX7-_CO'_XJS
M<[&;6AB;<S(9FYN9,)EP<YHP\9JPLS(9\W"P69B8 -G8N8'D+'\'Q/+?+9A_
MDOZNPG^@_Y8!?QO_ED/F]G\3!_(W0UY/ .C_XC+ [/??3'SSN@0(!+SYSP/<
M?P/X?X-_]OU+]YM_W_.?A-?? (SW\+_A=N#?8 #@,-[ 8[QY[09T_"T7</^J
M_%\K">([A+=([^'AWB"C_!_H_P)OX. 1/@+>(,#_ X-'0$5%> .'^_8O$1'P
MYMU[#,Q/6$ADV#BSN"GX;.1UW)KN]7-:J;S(PA3.4]/JKDDS&GC:RNR4/XR=
MJ#YS?!,!>C3T>X)R5*I5.6NYJ&EX N+S,/Z:>P,/]Q8>X5_<_X=%##(X3#9E
M86-R^$]G.2I.W]@YXJHZ)M9% D3/32A>%P&H\']=P(#'  @!7@'^>*B(\&^^
M_C9B_5_(_T+^_XVHZ^,VG[T(TYHQPQ9X-9G3K$.V$<,FO(@D$FAKK<K)2E00
M):M3\8YN*$ ;*AN+DY-!##JKUZV'*%2MV'W/=AZ6STQ/IL\"%^V#+83N;D7_
M)TI)$,& (6'3MYN#C*GV<\$P:R_&'\.SQ2L:$6#!(UKIR1TY.U;X[O?EC&(,
MNJXCW+7<T(<RKP[S3).CSO\)01#J9)GK^GUR>_WY86CZ3C*&=5^<Q?45 &^]
M@N;T@)VI_M6I[,W#Z1=,U:U0.^ULNUTD;?)3N8+$_1&PS"+L^-%TXO@D7:!E
M]93\TO]D]%ENS_G0&?UNZ(^FCAG2TINPKB9%L[VR(+M0^W8L2M!*PIE<N%[0
MF[*1Z-SOUTB.VWL1H_:B%Q2/%+GK#LUU=_/]1VLK^0^IKJ;&0S,MNF<H7\5P
MJ$PIYSS:S?;E P6HG/53\H)=I\ROXKT9EQ1L0'X:<E:O@+=(U[:VUP;S-,UU
M'HN#9T+[O-L54R0'2U?]W%O%HR9DT7VSH'F0<\OB69E>RDJ)DZQ>,\K;JUC2
M&42*.$:,JRCO3-G5TMGK"H<EUGJ_E4?&S.PKD\&+U/\)H1^K:W^RF/&_H_1_
MW)A*Z)EZ!92] A*>$;:=67EXK_E?IH5^UK\"[$B2LY_'NBXTY;/[W/=.B34Y
MWGSK82F/F9XJ>&;CURIT\>.5@"Z!''0/*GD%C&:. U0\G]%4&#0(>%$$HC_^
MR+/ 20S]@C6,Y\_UN9Y()]/)1A39?*JHOMJAZ4J]72'K\MJ]5L\VI8(11#-5
MWY^-=.1BZUO:M443/F=9@+W3\UTST9%U'TDL[AL:DNL6/?]Q#;KJA(# H1/^
M[+-QD]T^!S<_>.RE\!6@Q5(Z<UN<\:#H_(&H(3LTHW,;%$_3?B],."$JP-J-
MJ)UTB&"TE6B/4B/1;V(3THW!<M(_A2=7C1^[DRI=5F,QMINEL/0L !52'I@V
M2,4],!1?5S?X+E/7%2+:=N:,2:D"<D4[DU-(L4CC_^$Y==C=\V/J/ M\MUE;
M.)FT'T7C=ZTIL"QT-?1T"G$X);C'L'GXIC'AD'OIM"8;_6-[9;=[U7-^J22=
MR&KBV_>WW:79%.YQ#HD8:]HWI#O]L%M5JR\J-I.XI]&P+=>VZ<U7P&ED$]GU
M]4/Q/==5MVU7@ &O^CVL[W+,;;^+1;WYV;[32[LJ4:OEP'$<9JV^!/ 41L*=
M2=9%]O^CJ)%8-QVL7@MF^/7H3?VT#;V8._R&&C/1/S8=TZ&=V.CNY'9B*%\Y
M_A#:B&/)&]76!T9 /Q1O#GCOUDPG\5:4KIYTT%[4::?7*2QRWZXITVCI^.'N
MQ"WEZY7"M_D6\8U,<_\0O -?Q3YTIPEL:/</S-RQ+RW.I+/Z#QUR/_+)YPBJ
M/KT"]G4\=^-P#=:\9BK<1MU,7;,^^Z<8<OC]? 6L(IY)7&Y4@(XIV]*I[0ST
MK_(O_.Q> ?P%-P$;P3HN)O%( \#;4>)R:7P"YXK8F2)R&-=:8(C[V;-*8KG-
M<;UE?3//:(SF/>XU]T/,,ZL'';N@QXR/RFF6\OV;B4/^L8Y1Q8UF 7XMT0(,
M9!F6X(>\NCLHKH=60.&;&D3:=KN2BR)NW.6^GN5@:2!XS9>W+_SGH:#&*\"3
MK_-$DV.X@H+7,-#7/7B&7!QV0_QVI-X(=]*S@*@O=<':NE(\A5QPI:+/_Q6@
M24^Y).H8GR2X^:$//(<YG>X+G8L<-=Q;ZGH%T/&VI[5Q05AH>=EWJ6/F;$:T
M2-$9@],Y#&GP]7[>R%35+>A&DO88] /UD/C ,M;V?8M+*NDJZDW;3?KUN&63
M'J+P24):]H];W-$&#"KE+\S+#+71/:87>;WH*H#6;GB@C>EY4Y\FDB@I\Q\B
MN6:@N(4W]=6/\(!"J=K1NH;1N@NE7]S5LJ[[@32IS^K9V[=_!/E]%1N)GPA.
M)*4HL4F*A]B/TSM/GF1EP'4D6P9?^+N58=^I!![<U<O<@G C"@HJ?$*X;R)J
M0$>SOBNAYCMF[-.A)W6/'^I"?G@F%<P:F$_O@YNF0A=C-^W)=!;5H:>ZL\^N
MP21R_Z55Z14@N/@*.$]7?P7\B?N;!Q$*BKB*+Q4OBE>?DH9__]F=OGQ4>@E8
M>Z[TT_&_%?HPH _T)UK+:_'4&T9\1^M7.1?^S-<SH=PD]'7N0[$#.NQ*V(C/
MDG:WTT# +5<5$[';@$87&AJ"=A$35S;?*QJ=8MP&DG/(O"M.[:OW5FY-X)8-
M?P4P&LJ<XA=<L91LAXT5]:%=IO2Q%)Z*KOLJA&RSCM$:85:$NC[6@YKG\"O@
MW>0:JQB[W^D,!L6_P:1.Y$/JKR'RW5DOD5IV6_,E;M%?\*+8O]TV3/!?N8>?
M?/IXR=&Q1M$T1O)]^A@WFF%+,O**NPG 8";[B2)WP,';=?T;U6^N'#D%ZZ+W
MXJQT]Q_$DM"D116LTO-O!73MAE:)-7S5^2M/_&5? 1P/#J '_WO#SK'5L+DG
MYW-'^9CLQ2.BA)](!^H7\E>"G;="4(VMA**  @W\C%2(:J-3V_D4_G1KPX92
M I^;=)M<']6QH9AA6>]+DM&3K>\8TLK&\@U_.Z.(,RF@J<9/IZ@ !"CX%>44
MH7!04B&[[Q#%>.RKK%K;ZRQ7@X$I0 !>2;\'.H\V/C*24%?X*7MV]+X"FGNF
MH"\"]ZAKAEN":LTR%Q)L!C33I$GEZ3_U?=SPVN+LHD#58<*V*8-GA:-6D;4U
M*/8"=+6-K;WN4C4CE.GV^S\BN;(-/^3MNOQ!N\DZOGKXM:KH,;9=53KTHGE7
M,\00^&MDSLL(!0AU.4E0V;T^WZ(N+P%-%N'LA$A,_::6]:WU0LVH,^E:6F-.
M;QI->NE](L%2P@W*(@WD80U5-6[1_P,7B<B&J-39*8.^=4T;B(A%P%M('4,!
MI\M@?4,L0F0]38>BD 0]9(@^W?;71/1O81I\2!&_<-ZK4\UR%@SSQY6Z_"Q1
MGE]\Y2W>X,O)O?NN+XS$>XEZ+@@C2A?[8C.?]_*36I=@_TG9RM[B;?'^L3;U
MT8WNWX*'<&8[0$)J^T+IZ;Y!I2_ T.R!.Z<^0PHAHF+YN.<:,CS)Q+Y8(:([
MO-?XQ_)^_%;PQ,$Z01#E0IEDC0J5_5C1UN7'4G.!1_J@ S3%XS*EESENW3]2
M2':,6^)><PO[XQQ^(]K>\L3XTVYB5W,TI-Z5<;M.URE1N#C 4L:>,?Z<88*B
MQ#J!KG=R=@'"56^VU)Q4$]&Z)D."ANZ!](<[YH5U2;:#UZL@ .CP<PSSLAJN
M\-*W%K]%.QC!=RMG@.QWO& QQMJB\B53[]1J-WC,OBSY>;E>9Z_P,RO/R/7@
M*^!1;9WDY>,KH&CW%>!RC4+EL'3H+W,PIKQ-.%2OS*C77CE.3R24J4O: !R0
M:=7LU2Z3,&[*/ 2/8NIP%MM#6T^7E[)6>*;2)L?S*W16R]@7?AULUJQ^],R^
MNO9<HIE"*<BKN;M%VQZFN]JX2#[2 'OPG$9N3K[SR-E2#L*%7=#1@GML\% P
MPV=;'U=OMGR]7?-\ZDY>?+U;K3<,IZ>^>DI:9/:A=C;>S6W[FB>^\)PS]%<N
M[K8F<O0[R,2*E."8#L+/E)PPR*B9<I68F0B02#N-?3^=9!T]3K:=!3$$_Q>6
M-?BG1]M70"]8\Q40(/D*:&/BY=<7>FB_%QI7T.2 _YZM.G8L^H#B?]-Q;_T*
M6'X2HG)9>'+WBS[?=H8@0Z_-,:P.8!\(TM<EC#UE%(>S,C>.3\/Y_'"VHIW'
M[N6%7W+=!^%P$.8^KBLH62:,O=>2@,&Q]\OQ]%\)%*6Y>G%WR>W*\7<+'<X3
M_V['RXM<]VE+? 7$&_#R;HGQ9GWQ_*:P/O-'&6,)2JC.^;$OTOG3L %SS##4
M=VL)E?O3&O8,C<ZUK8UR14QY*XO97/VS!Z]D]"23*W%>EWT5WSO@Q4W'YJ[*
M-O80I2U&DR+*K[E.%[@LR_[8$0C#9$.-7MTTXVA\0]7,N5GC)PAG'<X.IK?;
M59/I@4#FD&#.E^9W1)?._?2&W/&RD7?I5D>N.D3[$:D+%"VQ[M\GW(WWW)!-
M-D*]6/$#O2,]U?<HU<YQ=H7>WB--ZBK$YNHW5!O -M9(7MH-0/=,4RV4F_QC
MB2ZW(,O$BUV40^PA5,O?W!N>O9XSZ3\#RZ_@:N!\5^P$O$G4XYC;?F_7Y+H^
MY]<WUJDM*> \NEFL)IQ4W;7/=(_%WXZ1WZ? G?OIAZ\,K5)8_H&P/(>Z\Q9Y
M6G;MKT 6NAYB+'<U,I682)Q"<ZYDOD\(2M]5+V>$*>O)CI ].X@<=2?/2%=
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M?"#%8M+;IV?ST]L8_E7^>A9C-C=<7W#1T!@7B5$\&#CG.(D(1%NOE<<T^[!
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M%55UH7'2=[)>C'X\)H3DU2EBDT>8*ZU:K[J2+EC:L3$R SQ\?]8]\>VKJ!X
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MD88[(_&()<P0!3L(_\C$,CG6#@7!>I;_%Z:W'_A\==HCW$Y:[\ 9S)@\P*-
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M?Z%-FGA44FF9T8 HQLU&HGOL&GH!^59C!,.JJNVDRCC6&ZP5PJ["\X%-9V_
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M>RYLVH_S>^:AK2,6##2ZX5>BU6LEP]&%G< SN,>,U!$6\?L=<1E>I-^"46*
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M*=<A^D 3$T=O_VGTA_H=:C.A<"7=0*R7(77$K!RA<DT85J$FBMMIAT=XBIG
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MCS7\=VWQMQN#Q89 %;T!^Z^IU8%Z3'FJ!8/]'2Y^9^Q1/8S>).WF_L3==BL
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M/^E\U:01K1T\\PP.B&6&R+T<":>36W0U\:U3A^"6?)9>K9TZ;AJ9L<H!"SD
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MB25D?]6T_/<S3 U"6PG"$&8LB1\2"@F%1]8:6MEMX"+YOUZ 'YJ77TE)Y.^
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MU-<]9*>CS<N]ZOJN4^1'?M3.4FVR\VC3:$\2I8>RSI$Q@07X$P?INXD"3,D
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M:HO1_P!YPP*=$F$NYG ?M5O?9Q0#M_S,MY[7BV-ZM>X 4;HD:8LR93 /Z=(
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M,>5W4O.SQO\O]SKW'=A;TQA.2)CO1D@=:Y++G3\U9(#:).(%>@LG4!4+AZ.
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M5HMZID8] NTRET_-NYCQ!_;-4CS:-FG(59E>F$R*(S]UV';L%4*K7TP88TF
M(!*\U^\.Q'G%JKSG/RK42S .P8]J+A4WY685ZDAC-3Y)PQ-Y8U"W;X$!D$(Y
M]SKA %U<"NJ.NXJ+D^'$F+_V<IW25@7V*Q%YD%<RE[=JZLW9H:6BAP$Y_@K<
MV+P1<,(I,?%%O,IB"[6.9#L",0C3(AM+K;T(DX.;3 :.)0 UJI9S3-0@J-3[
MH7AK_X8'[RD@_NS:FTL_IN\32\&5L(A']]#OA.:7C+3JN:[!5;YO: *F]W,B
M;PJ-6HN[CJ-T/VG$X@LU\6YCH=+6XHEZ+8-FS,C'0Z>C/KHIDH.)4/!]2DC>
MV%J3;L2<75KF'J@.>:N@2*FL_8":>K&RT>2*>O&T(,</,^6)TWST:,D[H70\
M+2SK:Q]+6=[W<U_,7TXK!PAH)$L0S\/U$&"'"C\L/TC])''05;J?X18('M*T
M"<EDHLT3461@SM"IK[BCBPA_1C8#46\QK\JJ"O[D$6PWSD6:A+1ALP0H/O$
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M';NJI%HSD?:&SG3PSO9?/OMKAX*E#<1< ]NRZ[*!<>$,]O6R8*ZVS;=^HCE
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MOKT. 69"/5U4)? $#E<A]@BCD]VY5F-<NTRC"V@\1YYQ-:MI4#*OM4>F[P9
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M_P$V2']=]7WP,WOW\%7UWDGJ;E7VXDUTI\/G=?KPG[B9.P^D)$P$Y=!_7<"
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M,S7%9.$U\@,UV6.NS5RT=D72>MQDM=TB:U!!?/#W+-6UC^&'<ZB60% AIN/
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MY/XYCM!#/BZWR!V7R1GR--A5OUH2]H2F;DFKK:X3W_=5[LS8N9?EQ*.XK_5
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MLIJ6P>KQ2:)'5CY+EDI%H!EPY;/.-1:T^U L<V*R9/S2;-KBD/PJ:IO 1"4
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M,E$ZHY]"4-:@0C'BL.Y;*)N\KL#=:B<9772R-(NG5+ +$MB,NU*J*:FNY7#
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MC9MU<GJP==NBP83^7**W-O(OA$";$DEY OV&F$:$G#P%Z6=3=(H2 ,B0([0
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MJ3R(VI* A.J8@2VTOL$ E.T7&D64#.YC,48'$S'CDLPUVQCSXKC"^D0;R2<
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M@KI45I$!/B\I<G1O#E=.SE#V0HS56^3R;RA<\-WK/>(2?OE!:IEOXI*DU%Z
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M<'TKY\[022C77OJ*'T=2.*VWS&HG(I^6:'>&>_^C+D'%O/@9KIUV'W>F8QT
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MUY25C!I_*3?X<I =3$+F)^90';JW[G60)!5"C(@S;1"I<_>;N9Q1X:OCCV_
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MR:8F$KN_=%ZE4G2'31\-ZG6=2?IS?9L]BG4M->T[?+"O<C-^XT+2DDYZG7.
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M1@<^*-ASI0JE6BY63XITU$MBF/3BLZ\]E +(ZCA(8BB'C_%XKLK_</7AARE
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MZQVV5+FM"AZI+/TX:>'(C<]CQKD)[YM$.\9C_6VC<,N*JVI\G+?;(,X!RUC
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M@!0FU#2S,T9/D<:YF)"RU%Q;D(MT\'&K2S[&*O(,HNT>.!X&FEV6E\X9+[=
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M@,C_(;R'?B_\OONV,!T8W.OCY04*JJ9<J<!O* 6SFK06@*B-C',S.# NDN6
MD,8$D>,=6K'6#7_KU<6JZ<:9G^MD'@<3@EQIRI6!38=O0ENB0;F0T1NDJ_5'
MJ7TAXP2-_T7;6P7% 31MHP2"NP?7Q=T]N"P.BR[N[FX)[N[NSN*N">[N[NX0
MG.2\;_VWI^I\5>?_[OIFJKIG>JK[Z>EGFOS=W69#'2O5)2]3RRZ& CM)VMO4
MS+HMLDY@NJ3\AAL][.)='7-S(73#KKV_K?:NCN#M=;K"96 +B?*GR2H4<[PF
M=/=/@5K]UHZYCU"C2G[J0HFTX56IVA<5OR\)1,'0GEMUK/8*YDO=KZZ62M4_
MG[_=88U@Z6RD^T51B]XS:TM%,,YZI_IONS'6&6Y>I)W;-:I2T;CMZ;NKER,G
M!:D=CZX2W)O^]BX5Z$"B\?227$F^ZR/\>1]7.=+A:+AZ*M@'?^(!5G'5V-/<
M76;0!EZ%X OFN4H4\5J &.P\=/Q9RR2:)'O?@:X^SY74K2<,3Q-30I:29,3>
MS=^IJQ-.<Q9QPT=:8J,"8GS6/%(75\O6OH B<6-(_71;IT..U#=!%;$HJ5?2
MO1I/K;%[YIVG.GYJ=P^E\[2J'9Z>6.4(#\NEL 1H S,SB&ZY2J5FARIO*<?A
MB%XE8>(K\8GAE)P.)=@/"W=F4N#.Q'(9QIQ%8.'8A]AI\QAOCS?L_=+?4K:9
M5'C81U-BL*'_JAFG!81]<Q(N@V(P!%+ SJL7"UM.B1AU8#?J(HB=S+B#<CVC
M#+C2O"N.<)Z8XJP!"WY.?H9TV'0+6$\WS%8U48/-![%=PU DX&B1@\0G+],Z
MO[9(VY>WEG!$G-KJ K7:;"RVV%['#@($;-QJ^T\2G#.*# 6<&A?RM@:R A";
M\JO_)/D']"CAV[NIE4O/BM0V)N,%#A+F4I1VX$E$.W :?K5X[*]/EK]3K_5&
M].%@'1-$ZNS:X'@)-VQ0I8FI =:L,3]&]]B4"&S#^<I\1P2>2*\EPTE@[2-'
M4[FLKU2M)T1TCBU(!T4?:$6C:FQ5K/HE5B80JS"'_!;X]"Q1$='>^5XNO*(J
MUH)!SX"$)IXJ5:.-VJUF]!F'S:+'+^@?*AWSAJ^P-*=S2"H U?6=Y_>ZNVU/
MEUN!P;%V3:L(&'>A-0+/('$)*B84X5NB_8BC;N-81OODB.6L+SNIO:^:OK?X
MUNJ]0TWWR(A<3E]@#VT-6QYX4HI3#-;)86EFIXJX;BFG6M]LN)6,ELRX>=!$
MCP.IA!_>KG/GMW=/*3/S$(_"EF]?]TJXU]AX7?8]-;H<#'=OH7F3H!Z'SY@2
M)9S]_IN2NJ1N09X\D\AB)INQG4/80$(S<[O-^ER;V_TB<ZOQEVJG?U H06OT
MEE^]H7\'W2BP:X'4>P8!X[Q2O7+QLP6CE(6:'#24_6VB](<Z:W(Q7QKF%AA&
M8QE$-O0L'F>GKS/\JS]XARQA'GB\1Q)-=],K\UN6*WC.KW92<ZBE=[P8"?NM
M//N3B!-L24+W+-H(PGA)1C!Q@HCG>:[7/"4$$WNY)[NECO6S:G3+#W648GVK
M-;]PT7DS7A%?LKNI%':V?+,+*MF+(]X,I'"S&G1KG<SWPRL<%M>6]$@I1W:U
ME)ZZ(11B/PO;QB9K&VZ8/L]J(2+1@%FL=!1P?Q?N*LEIU[Z "6,K8J0S8(</
MDLLEVCS9<K>:/--U82HG(=@2(@S*HWB)(B2X3^I4Z:!>$*6DG&FGX8^&M9BD
M9ZT%B1KN#B02"F'@9QS9\8A!IAP5ZJ7UX#,20FN%0BXMZF$??N ("B[;6 I?
M3.D)D$#0W74_QEJ1ZC7MGWB17[\;O@1A$S:11WY)S2Z,%CPTX1!0QVQ!XAVT
M/[WP;CL.^P_.D6,*:C?'SEW\\+M';X^W>6(MT!%@_NL4J7$^Z$%\7Y^>F&C)
M\NMCKC\,IIPDV*$)T<(753QI,LU4=MZT_4!.@WO:9#KWE]?G0O9C+=>)#Y>T
M,]6!#[P.&]K$S @I2'AV0!UNJ%E+%"92FT ]4:)6]-'>-,O\>;_(--O9UV!9
M8?,(_K*[>+"W2:]B*=Z;&ZZ6FA<S6]'^9X]A;K]4=M+GIJ3D@P<<XD@Z<0I?
MGY.<?V65N/$P.;NR+T]%-5">^6H_&OSA?ULUZK/BV.P-HYY,> F]0@E2:^O5
MIX$:?U;B73)#X33P<),AQFOGZ8VU6=TGVHA*O''AK/+&Y$F)N3X+?5AY?88_
M3WO3.<OM9^:J:E/X\M4?N#:S[K,:):-AL2>'Q[P@@8J))>HH7]9'4A[,0MRV
M8WQ:I9MC3FB5M/H@1(;G!_+->Q _]H5D4.G3H#C4:6J)UZL,KS+/1XM5DX2I
M.4&;$#IUW<+SMAY+*^4MW*2X*]N[<!/8X_,*XWVY3CX(["-X7;3]!P6TXQ5I
MUSQTO^; Z^7HT.6:P3Z9T=*!P4,X!N0A/0KXFPS3FY&J3W9<NMN^J#[.KYEE
M="Q4[3:[Y)/X2KB]N;P9#:CE[M?-,[(Q\@J4),-[CU\+O8VP#-*KK*?R #5M
MDR0L78U]M94;;AR:SS%:I>V\%G+O9Q 5YYF6$C\35OAQ-$M-#CUE5TKG7K>2
MBUTK?E]<:HV>'>P5 ZFC7AI@<J(<X/M]U!&M@^B<FT?,B]ZZF(Z[ ^[T63#?
MP\?&/W4ER54<R_4+U_BV',RTCJ8CW*>7:&3G&-)XKMBS&8@"K=876.@>6&3L
MEX9R;U,X?;DXNBWN>E'):AUR#^OGTP-B54A)KI,=S]S.U&W [1-'5A W*XO
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M=]P.Y@A/X,8_*-I*D7BK[JI?W2\W^-50%8-GO*X/-8%5K54:9;\U?\)U$5Z
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M%19!,X&;*D?[&P&9 H_!^#1OKE^+V-P\0F1B%PMCQ;XED'>BWH03-CLW#DL
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MLE:[N+?L3^(80G8A3B*84QY;F.8Y3]G.DI<\ F=_CUX4U)#/42O+:)5!GJK
MXD\AD4[#=%%:-)<H'PD@"705G3!?DT^5(* ]&')@Z*5B5/Y/B'6WO[1H6;S!
M[- G:U"^"GS4E:I/1*:H9/[FT*U&!7\YY-!42H#.(DK6QWAO&M>'\2U$+&.
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MV]\BLN=W2ZV2=#HE7_K^@QT(."T\6+WSM4->;1LHJ"G<&,\ N+Q<^ ZVV;J
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MJU4TU0"*.5ZQ-RZDQT\M3-72IQ0*-J-$2[Q$VMBOTI<2MY=8[XH4>+/?[;X
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M:?_C_8J"_KOX/CY_@PL(6?/860/M. 7YK*TX!40$@9S"5O9VG'96/'PVUC9
M.UZKOQ/_OXUM_X>)_S7G _+9V%O9"7!:V=E:<UH+"5ASBECS\7!:"?/SVEM;
M"_+R"0G2<_]-B/M_V##_[OJ["_^%_U4!?QO_54-VKG\+Q_-OA?RY!N#\QY0!
MMGU_*Q'ASP8@ H#P?RZ(_TV0_DO^/?8?PPC__<C_H?SI ^"C(_4A'B,AX ,0
M\1&0\!'^# )J_AX7B/_I_#]/$C1T%%0,9"1$3 2L_T?_?P@"(A(R'@" B@0
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MO]+!95%+L!,/;VV([?8)C*<_%_[4;7WL:<KO?.,;I[;Z2\1\LKU\3J$\S?X
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M/]P&KPV$QVCH&U3G'MPO^]7!,W[$>=,O(Q[.HZ*B*Z)CHE-MJQ@ONXX2@2=
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MKU0F04;!,SVYRM&ERXO8!+QH\C9'8*^TF\OKS.BM,SC32J%(IAM>\?+;X*Q
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MFJ7Z:A4<R"214-A*_\5TNTO>I85M*6^;H:=^@J,E".Y82TNNO&1^6B4:?:P
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MQSSM" .^.*1XGFS:87&N0"S9QAPY:'D6NV3IWMVB&V/A7K:X=N+(7\=8>I?
M+B[MVWTG&3TFR(X88==A!Y;7S['O7>Y+4-3C,<7KH*C#XE1677]I?&')]E#2
M$PBA<S0%,&C^%<R L="X969?$1H__#ZV=V1_56WR@NB*_7A!L<].3/D>&^OV
M!6>GK-&MHH&J,\ZO5/\4[(& 4.E4X>SQIZC^Z<[1 *<E\V>XH2M^INIK+HC
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MQ"/W'8R^U+KX;O=S#* 0F<.J=+V>UN&_?2?P2M:AE361H_8%S,".KML#D0D
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M8)3D@L9N:]:FR3=,0"$*^&O8=\6743);/U^@?!57L!3YR/)9!\QOU!=H[2$
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M!XRWW[2D."X;/!-!9D215:UT9;[^Z6Z\V3$45@(.S1,2*'\M=3GT:]3],WO
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M)M>\^R0H#U5+7URL%B_K0[A:[>Q$1Q8D.O7N/2RB7\VBOR"@Q0IV"6*+##8
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M4;GE.Y-*3Y#":69I#!AB?6/;^2G7)0B2V12I;RBPZ=P,[,N.2(20IBF]X?'
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M6_6.-1J_2QT>^*WSD(3;6@PBQ" RRT$>#G=-%L-A%V5&NH=/J-%,9&A?2M\
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ME#)$F-]75&T:<@-E@/0GYEF,NK9HMO,T$?$L[K)'&7/T_,7>@.7Y%85MK52
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M*&2&PS&;>:-33'75!;]%]$AZ;:U7C*O[:#BJ72CAZ''4 &>Z5M?0NCR_(:$
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MA@-?L=^_S!!Q='>S8Q']C=!X+K72V-[E5XY.NV^QCV?Q@00DFU-FR<9E2X1
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MR$"3*X2Z%P_CHR"A#W/;7T\),8YZ0<&5SV&[YQVS%0'+7Z6[;SL2'@]"9@=
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M8TCT'8>G %] 6]W+_Q@@<)\Q-0@K<T]5<:#20*NS;J\GO9%!5@[YRF!1Q:U
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M*!.W3WRWZ<W26C6]_]VTE_]/!B)_5_\/4$L#!!0    ( #1)J5K%>J O00,
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M>0X\(F,I,@JA8HWIO,@()UK(Q16LZT!JHV16E/!C@PW6;>I6IJ8\+;<<&NK
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MV%CIF(2-!EY T=JT++^EX5Z H!U29F<NY!^W;C:S 6,C7E2KJEAF3$V@SN%
MR+(<F).9'8/.PO BB2\NSX/]%$[RJ*G4SD88[<(]LR>SB<S%EL%1$[?OIK==
M4"N?])X)82"[5C))6U*S["3P]"GN$:3)I.'#=%&Q0WBE%/7I8]E;$*?T(&0!
MTOQ"@:DSK90@)13CW02.6G4^W9C^208+,5^^F,$#T-Y_$D3_609'>CAD$/Y-
M!N3Q=^ .V[_M^A=02P$"% ,4    "  T2:E:NUU&/@QA 0#)60H $@
M        @ $     9#DR,3(Y,61P<F4Q-&$N:'1M4$L! A0#%     @ -$FI
M6J?@8"UYN ( L_0" !$              ( !/&$! &<Y,C$R.3%D<W P,#4N
M:G!G4$L! A0#%     @ -$FI6L-0,V>BNP$  O\! !$              ( !
MY!D$ &<Y,C$R.3%D<W P,#8N:G!G4$L! A0#%     @ -$FI6L5ZH"]! P
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E,#(T,3(S,5]P<F4N>&UL4$L%!@     '  < Q@$  ([@!0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>d921291dpre14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:tcrt="http://www.alaunos.com/20241231"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tcrt-20241231.xsd" xlink:type="simple"/>
    <context id="P01_01_2024To12_31_2024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_MrhogueMemberecdIndividualAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrhogueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_MrhogueMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrhogueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_MrhogueMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrhogueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_NonPeoNeoMemberecdExecutiveCategoryAxis_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_MrboyleMemberecdIndividualAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To12_31_2023_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">tcrt:MrboyleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="Unit_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:DocumentType contextRef="P01_01_2024To12_31_2024" id="hidden140659358">PRE 14A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="P01_01_2024To12_31_2024" id="ixv-5709">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="P01_01_2024To12_31_2024" id="ixv-5710">0001107421</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="P01_01_2024To12_31_2024" id="ixv-5957">Alaunos Therapeutics, Inc.</dei:EntityRegistrantName>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-3318"> &lt;div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Equity Compensation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Our compensation committee believes that long-term equity incentive compensation is a critical component of our executive compensation program that links the interests of our executive officers with those of our stockholders. In 2024 and 2023, equity-based awards for our executive officers were granted in the form of stock options. Stock options align executives&#x2019; realizable compensation with the creation of stockholder value and serve as an effective long-term incentive vehicle to retain talent and incentivize performance. Executives only realize value from options if our stock price increases following the grant date. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Stock options granted to our executive officers vest over four years, with 1/16th of the options vesting each quarter. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;We do not grant equity awards in anticipation of the release of material nonpublic information and we do not time the release of material nonpublic information for the purpose of affecting the value of executive compensation. &lt;/div&gt; </ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgPredtrmndFlag contextRef="P01_01_2024To12_31_2024" id="ixv-5961">true</ecd:AwardTmgPredtrmndFlag>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-5962">We do not grant equity awards in anticipation of the release of material nonpublic information and we do not time the release of material nonpublic information for the purpose of affecting the value of executive compensation.</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:MnpiDiscTimedForCompValFlag contextRef="P01_01_2024To12_31_2024" id="ixv-5963">false</ecd:MnpiDiscTimedForCompValFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="P01_01_2024To12_31_2024" id="ixv-5967">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:PvpTableTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-3755"> &lt;div id="toc921291_14" style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Pay Versus Performance &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The following table and related disclosure provide &lt;div style="display:inline;"&gt;information &lt;/div&gt;about (i)&#160;the &#x201c;total compensation&#x201d; of our Chief Executive Officer, and our other named executive officers (the &#x201c;Other NEOs&#x201d; or the &lt;div style="white-space:nowrap;display:inline;"&gt;&#x201c;Non-CEO&lt;/div&gt; NEOs&#x201d;) as presented in the &#x201c;&lt;div style="font-style:italic;display:inline;"&gt;Summary Compensation Table&lt;/div&gt;&#x201d; included elsewhere in this proxy statement, (ii)&#160;the &#x201c;compensation actually paid&#x201d; to our Chief Executive Officer and our Other NEOs, as calculated pursuant to the SEC&#x2019;s &lt;div style="white-space:nowrap;display:inline;"&gt;pay-versus-performance&lt;/div&gt; rules, (iii)&#160;certain financial performance measures and (iv)&#160;the relationship of the &#x201c;compensation actually paid&#x201d; to those financial performance measures. &lt;/div&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;This disclosure has been prepared in accordance with Item 402(v) of Regulation &lt;div style="white-space:nowrap;display:inline;"&gt;S-K&lt;/div&gt; under the Exchange Act, and does not necessarily reflect value actually realized by the executives or how our compensation committee evaluates compensation decisions in light of company or individual performance. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:21%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 7pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Summary&lt;br/&gt;Compensation&lt;br/&gt;Table Total&lt;br/&gt;for PEO:&lt;br/&gt;Boyle (1)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Compensation&lt;br/&gt;Actually Paid&lt;br/&gt;to PEO:&lt;br/&gt;Boyle(2)(3)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Summary&lt;br/&gt;Compensation&lt;br/&gt;Table Total&lt;br/&gt;for PEO:&lt;br/&gt;Hagen(1)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Compensation&lt;br/&gt;Actually Paid&lt;br/&gt;to PEO:&lt;br/&gt;Hagen (2)(3)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Summary&lt;br/&gt;Compensation&lt;br/&gt;Table Total&lt;br/&gt;for PEO:&lt;br/&gt;Cooper(1)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Compensation&lt;br/&gt;Actually Paid&lt;br/&gt;to PEO:&lt;br/&gt;Cooper (2)(3)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt;Summary&lt;br/&gt;Compensation&lt;br/&gt;Table Total&lt;br/&gt;for &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;Non-PEO&lt;/div&gt;&lt;br/&gt;NEOs&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(1)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt;Compensation&lt;br/&gt;Actually Paid&lt;br/&gt;to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;Non-CEO&lt;/div&gt;&lt;br/&gt;NEOs&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(1)(2)(3)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value of&lt;br/&gt;Initial Fixed&lt;br/&gt;$100&lt;br/&gt;Investment&lt;br/&gt;Based On&lt;br/&gt;Total&lt;br/&gt;Shareholder&lt;br/&gt;Return&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(4)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&lt;br/&gt;Income&lt;br/&gt;(Loss) (in&lt;br/&gt;thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;308,344&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;354,483&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;N/A&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;N/A&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;N/A&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;N/A&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;296,337&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;286,513&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;3.66&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(4.679&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,716,946&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,459,330&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;N/A&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;N/A&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;N/A&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;N/A&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;665,709&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;594,363&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;2.78&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(35,410&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,792,818&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,841,265&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;N/A&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;N/A&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;N/A&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;N/A&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;856,928&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;486,598&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;5.79&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(37,730&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Mr. Hogue served as our only PEO in 2024. Mr. Boyle served as our only PEO in 2023 and 2022. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;The&#160;Non-PEO&#160;NEOs&lt;/div&gt; for whom the average compensation is presented in this table for 2024 are Ms.&#160;Lackey and Mr.&#160;Groenewald and for 2022 and 2023 are Dr.&#160;Deniger and Ms.&#160;Lackey. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The amounts shown as Compensation Actually Paid have been calculated in accordance with Item 402(v) of Regulation &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;S-K&lt;/div&gt; and do not reflect compensation actually realized or received by the Company&#x2019;s NEOs. These amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as described in footnote 3 below. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(3)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Compensation Actually Paid reflects the exclusions and inclusions for the CEO and the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;Non-CEO&lt;/div&gt; NEOs set forth below. Amounts excluded, which are set forth in the &#x201c;Minus Stock and Option Awards from Summ. Comp. Table&#x201d; columns below, represent the Stock Awards and Option Awards reported in the Stock Awards and Option Awards columns of the Summary Compensation Table for each applicable year. Amounts added back to determine Compensation Actually Paid are made up of the following components which are set forth in the table below, as applicable: (i)&#160;the fair value as of the end of the fiscal year of outstanding and unvested equity awards granted in that year; (ii)&#160;the change in fair value during the year of equity awards granted in prior years that remained outstanding and unvested at the end of the year; (iii)&#160;the fair value as of the vesting date of equity awards that were granted &lt;div style="display:inline;"&gt;and &lt;/div&gt;vested in that year; and (iv)&#160;the change in fair value during the year through the vesting date of equity awards granted in prior years that vested during that year. The fair value at the end of the prior year of awards granted in any prior year that failed to meet applicable vesting conditions during the covered year are subtracted, although there were no such awards for the CEO or the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;Non-CEO&lt;/div&gt; NEOs in 2022 or 2023. Equity values are calculated in accordance with ASC Topic 718. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(4)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Reflects the cumulative shareholder return over the relevant fiscal year, computed in accordance with SEC rules, assuming an investment of $100 in our common shares at a price per share equal to the closing price of our common stock on the last trading day before the commencement of the applicable fiscal year and the measurement end point of the closing price of our common stock on the last trading day in the applicable fiscal year. For 2024, the closing price of our common stock on December&#160;31, 2024 was $1.91.&#160;For 2023, the closing price of our common stock on December&#160;31, 2023 was $10.61. For 2022, the closing price of our common stock on December&#160;31, 2022 was $97.37 &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:23%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Summary&lt;br/&gt;Comp.&lt;br/&gt;Table&lt;br/&gt;Total for&lt;br/&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Minus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Stock&lt;br/&gt;and Option&lt;br/&gt;Awards&lt;br/&gt;from&lt;br/&gt;Summ.&lt;br/&gt;Comp.&lt;br/&gt;Table&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;Year-End&lt;/div&gt;&lt;br/&gt;Fair Value of&lt;br/&gt;Outstanding&lt;br/&gt;Unvested&lt;br/&gt;Awards&lt;br/&gt;Granted&lt;br/&gt;During Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Change&lt;br/&gt;in Fair&lt;br/&gt;Value of&lt;br/&gt;Unvested&lt;br/&gt;Awards&lt;br/&gt;Granted in&lt;br/&gt;Prior Years&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Fair&lt;br/&gt;Value of&lt;br/&gt;Awards&lt;br/&gt;Granted&lt;br/&gt;and&lt;br/&gt;Vested&lt;br/&gt;During&lt;br/&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Change&lt;br/&gt;in Fair&lt;br/&gt;Value of&lt;br/&gt;Prior Years&#x2019;&lt;br/&gt;Awards&lt;br/&gt;Vested&lt;br/&gt;During&lt;br/&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Minus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;br/&gt;Fair&lt;br/&gt;Value of&lt;br/&gt;Stock&lt;br/&gt;and&lt;br/&gt;Option&lt;br/&gt;Awards&lt;br/&gt;Forfeited&lt;br/&gt;During&lt;br/&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Comp.&lt;br/&gt;Actually&lt;br/&gt;Paid to&lt;br/&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024 &#x2013; Curtis Hogue&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;308,344&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(11,090&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;56,661&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;354,483&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023 &#x2013; Kevin Boyle&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,716,946&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(689,580&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;679,749&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(247,749&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,459,330&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022 &#x2013; Kevin Boyle&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,792,818&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(904,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;795,785&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(685,522&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;354,781&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;487,403&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,841,265&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:16%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Avg.&#160;Summary&lt;br/&gt;Comp. Table&lt;br/&gt;Total for&lt;br/&gt;Other NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Minus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Avg.&lt;br/&gt;Stock and&lt;br/&gt;Option&#160;Awards&lt;br/&gt;from Summ.&lt;br/&gt;Comp. Table&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Avg.&lt;br/&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;Year-End&lt;/div&gt;&lt;br/&gt;Fair&#160;Value&lt;br/&gt;of&#160;Outstanding&lt;br/&gt;Unvested&lt;br/&gt;Awards&lt;br/&gt;Granted&lt;br/&gt;During Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Avg.&lt;br/&gt;Change in&lt;br/&gt;Fair Value&lt;br/&gt;of&#160;Unvested&lt;br/&gt;Awards&lt;br/&gt;Granted in&lt;br/&gt;Prior Years&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Avg.&lt;br/&gt;Fair&lt;br/&gt;Value of&lt;br/&gt;Awards&lt;br/&gt;Granted&lt;br/&gt;and&lt;br/&gt;Vested&lt;br/&gt;During&lt;br/&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Avg.&lt;br/&gt;Change&lt;br/&gt;in Fair&lt;br/&gt;Value of&lt;br/&gt;Prior&lt;br/&gt;Years&#x2019;&lt;br/&gt;Awards&lt;br/&gt;Vested&lt;br/&gt;During&lt;br/&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Minus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Fair&lt;br/&gt;Value of&lt;br/&gt;Stock and&lt;br/&gt;Option&lt;br/&gt;Awards&lt;br/&gt;Forfeited&lt;br/&gt;During&lt;br/&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt;Comp.&lt;br/&gt;Actually&lt;br/&gt;Paid to&lt;br/&gt;Other&#160;NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;296,337&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(3,087&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;606&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(7,343&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;286,513&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;665,709&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(62,254&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;10,904&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(19,996&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;594,363&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;856,928&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(386,561&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;87,953&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(66,031&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;5,427&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(11,117&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;486,598&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2024To12_31_2024_MrhogueMemberecdIndividualAxis"
      decimals="0"
      id="ixv-5968"
      unitRef="Unit_USD">308344</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2024To12_31_2024_MrhogueMemberecdIndividualAxis"
      decimals="0"
      id="ixv-5969"
      unitRef="Unit_USD">354483</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2024To12_31_2024"
      decimals="0"
      id="ixv-5970"
      unitRef="Unit_USD">296337</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2024To12_31_2024"
      decimals="0"
      id="ixv-5971"
      unitRef="Unit_USD">286513</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="P01_01_2024To12_31_2024"
      decimals="2"
      id="ixv-5972"
      unitRef="Unit_USD">3.66</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2024To12_31_2024"
      decimals="0"
      id="ixv-5973"
      unitRef="Unit_USD">-4679</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2023To12_31_2023_MrboyleMemberecdIndividualAxis"
      decimals="0"
      id="ixv-5974"
      unitRef="Unit_USD">1716946</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2023To12_31_2023_MrboyleMemberecdIndividualAxis"
      decimals="0"
      id="ixv-5975"
      unitRef="Unit_USD">1459330</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-5976"
      unitRef="Unit_USD">665709</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-5977"
      unitRef="Unit_USD">594363</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="2"
      id="ixv-5978"
      unitRef="Unit_USD">2.78</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2023To12_31_2023"
      decimals="-3"
      id="ixv-5979"
      unitRef="Unit_USD">-35410000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis"
      decimals="0"
      id="ixv-5980"
      unitRef="Unit_USD">1792818</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis"
      decimals="0"
      id="ixv-5981"
      unitRef="Unit_USD">1841265</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-5982"
      unitRef="Unit_USD">856928</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-5983"
      unitRef="Unit_USD">486598</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      id="ixv-5984"
      unitRef="Unit_USD">5.79</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      id="ixv-5985"
      unitRef="Unit_USD">-37730000</us-gaap:NetIncomeLoss>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-4056">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Mr. Hogue served as our only PEO in 2024. Mr. Boyle served as our only PEO in 2023 and 2022. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;The&#160;Non-PEO&#160;NEOs&lt;/div&gt; for whom the average compensation is presented in this table for 2024 are Ms.&#160;Lackey and Mr.&#160;Groenewald and for 2022 and 2023 are Dr.&#160;Deniger and Ms.&#160;Lackey. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName
      contextRef="P01_01_2024To12_31_2024_MrhogueMemberecdIndividualAxis"
      id="ixv-5986">Mr. Hogue</ecd:PeoName>
    <ecd:PeoName
      contextRef="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis"
      id="ixv-5987">Mr. Boyle</ecd:PeoName>
    <ecd:PeoName
      contextRef="P01_01_2023To12_31_2023_MrboyleMemberecdIndividualAxis"
      id="ixv-5988">Mr. Boyle</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-4095">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(4)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Reflects the cumulative shareholder return over the relevant fiscal year, computed in accordance with SEC rules, assuming an investment of $100 in our common shares at a price per share equal to the closing price of our common stock on the last trading day before the commencement of the applicable fiscal year and the measurement end point of the closing price of our common stock on the last trading day in the applicable fiscal year. For 2024, the closing price of our common stock on December&#160;31, 2024 was $1.91.&#160;For 2023, the closing price of our common stock on December&#160;31, 2023 was $10.61. For 2022, the closing price of our common stock on December&#160;31, 2022 was $97.37 &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:23%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Summary&lt;br/&gt;Comp.&lt;br/&gt;Table&lt;br/&gt;Total for&lt;br/&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Minus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Stock&lt;br/&gt;and Option&lt;br/&gt;Awards&lt;br/&gt;from&lt;br/&gt;Summ.&lt;br/&gt;Comp.&lt;br/&gt;Table&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;Year-End&lt;/div&gt;&lt;br/&gt;Fair Value of&lt;br/&gt;Outstanding&lt;br/&gt;Unvested&lt;br/&gt;Awards&lt;br/&gt;Granted&lt;br/&gt;During Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Change&lt;br/&gt;in Fair&lt;br/&gt;Value of&lt;br/&gt;Unvested&lt;br/&gt;Awards&lt;br/&gt;Granted in&lt;br/&gt;Prior Years&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Fair&lt;br/&gt;Value of&lt;br/&gt;Awards&lt;br/&gt;Granted&lt;br/&gt;and&lt;br/&gt;Vested&lt;br/&gt;During&lt;br/&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Change&lt;br/&gt;in Fair&lt;br/&gt;Value of&lt;br/&gt;Prior Years&#x2019;&lt;br/&gt;Awards&lt;br/&gt;Vested&lt;br/&gt;During&lt;br/&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Minus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;br/&gt;Fair&lt;br/&gt;Value of&lt;br/&gt;Stock&lt;br/&gt;and&lt;br/&gt;Option&lt;br/&gt;Awards&lt;br/&gt;Forfeited&lt;br/&gt;During&lt;br/&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Comp.&lt;br/&gt;Actually&lt;br/&gt;Paid to&lt;br/&gt;PEO&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024 &#x2013; Curtis Hogue&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;308,344&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(11,090&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;56,661&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;354,483&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023 &#x2013; Kevin Boyle&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,716,946&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(689,580&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;679,749&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(247,749&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,459,330&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022 &#x2013; Kevin Boyle&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,792,818&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(904,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;795,785&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(685,522&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;354,781&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;487,403&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;1,841,265&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt; </ecd:AdjToPeoCompFnTextBlock>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-4096">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(4)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Reflects the cumulative shareholder return over the relevant fiscal year, computed in accordance with SEC rules, assuming an investment of $100 in our common shares at a price per share equal to the closing price of our common stock on the last trading day before the commencement of the applicable fiscal year and the measurement end point of the closing price of our common stock on the last trading day in the applicable fiscal year. For 2024, the closing price of our common stock on December&#160;31, 2024 was $1.91.&#160;For 2023, the closing price of our common stock on December&#160;31, 2023 was $10.61. For 2022, the closing price of our common stock on December&#160;31, 2022 was $97.37 &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:16%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Avg.&#160;Summary&lt;br/&gt;Comp. Table&lt;br/&gt;Total for&lt;br/&gt;Other NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Minus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Avg.&lt;br/&gt;Stock and&lt;br/&gt;Option&#160;Awards&lt;br/&gt;from Summ.&lt;br/&gt;Comp. Table&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Avg.&lt;br/&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;Year-End&lt;/div&gt;&lt;br/&gt;Fair&#160;Value&lt;br/&gt;of&#160;Outstanding&lt;br/&gt;Unvested&lt;br/&gt;Awards&lt;br/&gt;Granted&lt;br/&gt;During Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Avg.&lt;br/&gt;Change in&lt;br/&gt;Fair Value&lt;br/&gt;of&#160;Unvested&lt;br/&gt;Awards&lt;br/&gt;Granted in&lt;br/&gt;Prior Years&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Avg.&lt;br/&gt;Fair&lt;br/&gt;Value of&lt;br/&gt;Awards&lt;br/&gt;Granted&lt;br/&gt;and&lt;br/&gt;Vested&lt;br/&gt;During&lt;br/&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Avg.&lt;br/&gt;Change&lt;br/&gt;in Fair&lt;br/&gt;Value of&lt;br/&gt;Prior&lt;br/&gt;Years&#x2019;&lt;br/&gt;Awards&lt;br/&gt;Vested&lt;br/&gt;During&lt;br/&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Minus&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;Fair&lt;br/&gt;Value of&lt;br/&gt;Stock and&lt;br/&gt;Option&lt;br/&gt;Awards&lt;br/&gt;Forfeited&lt;br/&gt;During&lt;br/&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt;Comp.&lt;br/&gt;Actually&lt;br/&gt;Paid to&lt;br/&gt;Other&#160;NEOs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;296,337&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(3,087&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;606&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(7,343&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;286,513&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;665,709&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(62,254&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;10,904&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(19,996&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;594,363&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;856,928&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(386,561&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;87,953&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(66,031&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;5,427&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;(11,117&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right"&gt;486,598&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2024To12_31_2024_MrhogueMemberecdIndividualAxis"
      decimals="0"
      id="ixv-5989"
      unitRef="Unit_USD">308344</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2024To12_31_2024_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_MrhogueMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-5990"
      unitRef="Unit_USD">-11090</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2024To12_31_2024_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_MrhogueMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-5991"
      unitRef="Unit_USD">56661</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2024To12_31_2024_MrhogueMemberecdIndividualAxis"
      decimals="0"
      id="ixv-5992"
      unitRef="Unit_USD">354483</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2023To12_31_2023_MrboyleMemberecdIndividualAxis"
      decimals="0"
      id="ixv-5993"
      unitRef="Unit_USD">1716946</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-5994"
      unitRef="Unit_USD">-689580</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-5995"
      unitRef="Unit_USD">679749</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-5996"
      unitRef="Unit_USD">-247749</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2023To12_31_2023_MrboyleMemberecdIndividualAxis"
      decimals="0"
      id="ixv-5997"
      unitRef="Unit_USD">1459330</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis"
      decimals="0"
      id="ixv-5998"
      unitRef="Unit_USD">1792818</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-5999"
      unitRef="Unit_USD">-904000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-6000"
      unitRef="Unit_USD">795785</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-6001"
      unitRef="Unit_USD">-685522</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-6002"
      unitRef="Unit_USD">354781</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_MrboyleMemberecdIndividualAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-6003"
      unitRef="Unit_USD">487403</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2022To12_31_2022_MrboyleMemberecdIndividualAxis"
      decimals="0"
      id="ixv-6004"
      unitRef="Unit_USD">1841265</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2024To12_31_2024"
      decimals="0"
      id="ixv-6005"
      unitRef="Unit_USD">296337</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2024To12_31_2024_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-6006"
      unitRef="Unit_USD">-3087</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2024To12_31_2024_NonPeoNeoMemberecdExecutiveCategoryAxis_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-6007"
      unitRef="Unit_USD">606</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2024To12_31_2024_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-6008"
      unitRef="Unit_USD">-7343</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2024To12_31_2024"
      decimals="0"
      id="ixv-6009"
      unitRef="Unit_USD">286513</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-6010"
      unitRef="Unit_USD">665709</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-6011"
      unitRef="Unit_USD">-62254</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_NonPeoNeoMemberecdExecutiveCategoryAxis_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-6012"
      unitRef="Unit_USD">10904</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2023To12_31_2023_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-6013"
      unitRef="Unit_USD">-19996</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2023To12_31_2023"
      decimals="0"
      id="ixv-6014"
      unitRef="Unit_USD">594363</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-6015"
      unitRef="Unit_USD">856928</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_EqtyAwrdsInSummryCompstnTblForAplblYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-6016"
      unitRef="Unit_USD">-386561</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-6017"
      unitRef="Unit_USD">87953</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-6018"
      unitRef="Unit_USD">-66031</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecdAdjToCompAxis"
      decimals="0"
      id="ixv-6019"
      unitRef="Unit_USD">5427</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      id="ixv-6020"
      unitRef="Unit_USD">-11117</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="ixv-6021"
      unitRef="Unit_USD">486598</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
